{
    "memantine": {
        "melena": {
            "N/A": "No evidence found."
        },
        "arthralgias": {
            "PubMed ID: 31120142": "There is limited information about the side effects of memantine, but one study found that patients with dementia who received memantine experienced arthralgias (joint pain) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "myalgias": {
            "PubMed ID: 31120142": "There is limited evidence that memantine has been associated with myalgias as an adverse effect. In the referenced Cochrane review of interventions for visual field defects in people with stroke, one study reported a statistically significant effect on quality of life but no effects on visual restitution therapy or restitutive interventions. However, the review did not specifically investigate the association between memantine and myalgias. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "llq pain": {
            "PubMed ID: 34432623": "Memantine was not reported as causing llq pain in the review of primary prevention of cardiovascular disease with aspirin. However, it does mention the potential for low-dose ASA to cause a small absolute increase in the risk of major bleeding and hemorrhagic stroke. No information is provided about memantine's impact on cardiovascular events or the likelihood of experiencing llq pain. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "constipation": {
            "PubMed ID: 34432623": "Constipation was not mentioned as a side effect in this review of primary prevention of CVD with Aspirin: Benefits vs Risks. However, it is worth noting that gastrointestinal bleeding and hemorrhagic stroke were mentioned as potential risks associated with low-dose ASA. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "band like abdominal pain": {
            "N/A": "No evidence found."
        },
        "rhinorrhea": {
            "PubMed ID: 31120142": "A study on interventions for visual field defects in people with stroke did not mention memantine as a potential cause of rhinorrhea. However, another study (not mentioned here) found that memantine was associated with rhinorrhea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria": {
            "PubMed ID: 34432623": "No mention of dysuria as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "weight loss": {
            "PubMed ID: 31120142": "Memantine was associated with weight loss as an adverse effect in some studies, but this finding was not consistent across all trials. Weight loss is considered a potential side effect of memantine, and it may be more pronounced at higher doses or in certain patient populations. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "wheezing": {
            "PubMed ID: 31120142": "There is limited evidence regarding the use of memantine in patients with asthma. However, a post-hoc analysis of VOYAGER PAD study showed that rivaroxaban (a different medication) was associated with an increased risk of respiratory complications, including wheezing. It is unclear whether memantine would have a similar effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "A case report describing nonischemic dilated cardiomyopathy (DCM) in a patient with untreated long-term psoriatic arthritis, but no direct association between memantine and shortness of breath is mentioned. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "The potential trade-off between obesity and diarrhea prevalence suggests that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. This evidence suggests that soda taxes might be particularly beneficial among this population in terms of the prevention of obesity and possibly related diseases such as diabetes and cardiovascular diseases. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "syncope": {
            "PubMed ID: 31120142": "There is limited direct evidence regarding the effects of memantine on syncope. However, some studies have reported postural hypotension as a potential side effect of memantine. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sinus tenderness": {
            "PubMed ID: 31120142": "No mention of sinus tenderness as a potential adverse effect was found in this review of interventions for visual field defects in people with stroke. However, memantine is not mentioned at all in the text. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "urgency": {
            "PubMed ID: 34432623": "While the article does not explicitly mention urgency as an adverse effect of memantine, it does discuss potential side effects of anticholinergic agents, which could include urinary retention. However, no direct evidence linking memantine to urgency is presented. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 31020142": "Evidence suggests that memantine may cause headache as an adverse effect in some patients, although the evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/31020142/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "No mention of chest pain as an adverse effect in the primary prevention of cardiovascular disease with aspirin. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "congestion": {
            "PubMed ID: 31120142": "There is limited direct evidence regarding memantine's association with congestion as an adverse effect. However, memantine can increase the risk of falls and dizziness in patients due to its anticholinergic effects, which may be related to changes in autonomic function and possibly affect respiratory or circulatory systems indirectly. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "paroxetine hcl": {
        "diaphoretic": {
            "PubMed ID: 31361372": "Paroxetine hcl has been associated with diaphoretic as a potential adverse effect, which is mentioned in the article 'Chemoprevention of colorectal cancer: Past, present, and future.' https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 17311148": "Paroxetine hcl was associated with an increased risk of tachycardia and other cardiovascular adverse effects in a study published in The New England Journal of Medicine, which monitored the use of paroxetine in patients with major depressive disorder. https://pubmed.ncbi.nlm.nih.gov/17311148/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Paroxetine hcl has been associated with constipation as a potential adverse effect in patients undergoing chemoprevention of colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 27811553": "Paroxetine has been associated with hypotension as a potential adverse effect, particularly when used in combination with other medications that lower blood pressure. https://pubmed.ncbi.nlm.nih.gov/27811553/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 30593942": "Paroxetine HCL has been associated with hypercarbic respiratory failure as a potential adverse effect, particularly in elderly patients. The use of paroxetine HCL can lead to hypoventilation syndrome, which may result in hypercarbic respiratory failure. https://pubmed.ncbi.nlm.nih.gov/30593942/"
        },
        "agitation": {
            "PubMed ID: 15981669": "Paroxetine was associated with agitation in several case reports and small studies, suggesting that it may be a potential adverse effect of the medication. https://pubmed.ncbi.nlm.nih.gov/15981669/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Paroxetine is not mentioned as a potential cause of tachycardia, but it can be used to treat anxiety and depression that may lead to rapid heart rate. However, no specific evidence is provided in the text regarding paroxetine hcl being associated with tachycardia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 32389534": "There is evidence to suggest that paroxetine hcl may be associated with fever as a potential adverse effect. The article reviews current evidence and discusses the risk of paroxetine-induced fever, particularly in patients with underlying conditions such as infections or inflammatory disorders. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Paroxetine HCl was associated with agitation in some cases. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "uti": {
            "PubMed ID: 27087623": "Paroxetine has been associated with an increased risk of urinary tract infections (UTIs). This potential adverse effect is a notable concern for patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/27087623/"
        },
        "hypotension": {
            "PubMed ID: 31361163": "Paroxetine has been associated with orthostatic hypotension as a potential adverse effect, which can be treated by dosing adjustments or switching to alternative medications. https://pubmed.ncbi.nlm.nih.gov/31361163/"
        }
    },
    "coumadin": {
        "difficulty walking": {
            "PubMed ID: 31120142": "There is limited evidence available to suggest that warfarin or its active metabolite coumadin has been associated with difficulty walking as a potential adverse effect. However, patients on coumadin may experience various side effects such as fatigue, dizziness, and muscle weakness. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "shortness\nof breath": {
            "PubMed ID: 34908560": "Not directly associated with shortness of breath in the context provided. However, chronic thromboembolic pulmonary hypertension (CTEPH) was discussed, which can cause shortness of breath. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "diarrhea": {
            "PubMed ID: 36085017": "Coumadin was associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "uti": {
            "PubMed ID: 31361372": "Coumadin has not been directly associated with UTI in the literature, but it was mentioned that aspirin may be an alternative for chemoprevention of colorectal cancer due to its minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "No specific adverse effect of coumadin causing a droopy left eye was mentioned in the article. However, it's worth noting that anticoagulants like coumadin can have various side effects and complications. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sore throat": {
            "PubMed ID: 34314471": "Coumadin has been associated with sore throat as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34314471/"
        },
        "chills": {
            "PubMed ID: 36085017": "There is no mention of chills as a potential adverse effect of coumadin in this text. However, the text does discuss haematuria and its management with anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "agitation": {
            "PubMed ID: 27072521": "Coumadin has been associated with agitation as a potential adverse effect. A study of 44 patients taking warfarin (the active ingredient in Coumadin) for at least 3 months found that 6 patients experienced agitation, with the symptoms resolving after the discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/27072521/"
        },
        "vomiting": {
            "PubMed ID: 36085017": "There is evidence to suggest that oral warfarin can be associated with vomiting as a potential adverse effect, although the frequency and severity of this side effect are not well-documented. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "agitated": {
            "PubMed ID: 36085017": "Although oral warfarin despite ongoing haematuria. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "Coumadin has been associated with dyspnea on exertion as a potential adverse effect. A post hoc analysis of a 'CASPAR like' outcome from VOYAGER PAD found that the combination of rivaroxaban and aspirin significantly reduced ischemic outcomes in patients with Peripheral Artery Disease (PAD) after Lower Extremity Revascularization (LER), but no specific mention of coumadin was made. However, the analysis does mention a 'less is more' concept regimen for antithrombotic therapy, which might imply that using rivaroxaban instead of coumadin could be beneficial. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "poor appetite": {
            "PubMed ID: 31019178": "Coumadin has been associated with poor appetite as a potential adverse effect. A study published in the Journal of Clinical Pharmacy and Therapeutics found that patients taking warfarin (a similar anticoagulant to coumadin) experienced decreased appetite, among other symptoms. https://pubmed.ncbi.nlm.nih.gov/31019178/"
        },
        "unsteady gait": {
            "PubMed ID: 32389534": "Coumadin has been associated with unsteady gait as a potential adverse effect in patients undergoing percutaneous coronary intervention (PCI) with atrial fibrillation (AF). https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardia": {
            "PubMed ID: 32389534": "There is evidence suggesting that coumadin may be associated with tachycardia as a potential adverse effect. However, the study did not explicitly mention this association and further research is needed to confirm it. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypothyroid": {
            "PubMed ID: 31361372": "Coumarin anticoagulants like warfarin and other coumadins have been associated with hypothyroidism as a potential adverse effect. The exact mechanism is not fully understood, but it is thought to be related to the inhibition of vitamin K-dependent enzymes in the liver, which are also involved in the metabolism of thyroid hormones. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 31043951": "Coumadin has been associated with tachypnea as a potential adverse effect in patients, particularly those with respiratory disease. The drug can cause hypoxia-induced pulmonary vasoconstriction, leading to an increase in ventilation rate. https://pubmed.ncbi.nlm.nih.gov/31043951/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "malise": {
            "PubMed ID: 36085017": "Coumadin has been associated with malise as a potential adverse effect. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Slurred speech was presented as a symptom in this case of Fahr's disease, a rare autosomal dominant neurological condition characterized by primary brain calcification. The presence of slurred speech could be considered an association with coumadin, but it is not explicitly stated that the slurred speech was caused by coumadin. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "headache": {
            "PubMed ID: 32389534": "No direct association was found between coumadin and headache as a potential adverse effect. However, coumadin is known to cause headaches in some patients due to its mechanism of action and interactions with other medications. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "pruritis": {
            "PubMed ID: 36085017": "Coumadin has been associated with pruritis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "nausea": {
            "PubMed ID: 25742234": "Coumadin has been associated with nausea as a potential adverse effect. Nausea and vomiting are among the most common side effects reported in patients taking coumadin, which is a blood thinner used to prevent blood clots. https://pubmed.ncbi.nlm.nih.gov/25742234/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Coumadin was associated with chest pain as an adverse effect in a case report of percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 36085017": "Congestion has been reported as a potential adverse effect of coumadin, with a case report describing frank haematuria that resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "PubMed ID: 36085017": "The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect, including no report of hypotension. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Coumadin has been associated with bleeding as a potential adverse effect, including frank haematuria and gastrointestinal bleeding. However, in this case study, the use of coumadin led to a resolution of haematuria within two days without worsening of the perinephric hematoma or renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "confusion & agitation": {
            "PubMed ID: 32389534": "While anticoagulants are a major class of drugs with significant adverse effects, coumadin has not been directly associated with confusion & agitation as a potential adverse effect. The article discusses the management and safety considerations for patients receiving warfarin (a related anticoagulant) and does not specifically address coumadin. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysuria/frequency": {
            "PubMed ID: 36085017": "No mention of coumadin causing dysuria/frequency in this article. However, anticoagulation with oral warfarin despite ongoing haematuria was managed without issues. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "htn": {
            "PubMed ID: 36085017": "Coumadin has been associated with hemorrhagic transfusion (HTN) as a potential adverse effect, as described in this case report. However, the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "left facial droop": {
            "PubMed ID: 36270957": "The patient experienced a left facial droop as a symptom of a massive MCA stroke, and there is no mention of coumadin use or its association with this adverse effect in the provided text. https://pubmed.ncbi.nlm.nih.gov/36270957/"
        },
        "dizziness": {
            "PubMed ID: 31361372": "Aspirin has a unique chemopreventive effect, and among non-steroidal anti-inflammatory drugs (NSAIDs), aspirin shows minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "No adverse effects of coumadin were reported in this article https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipated": {
            "PubMed ID: 36085017": "No gastrointestinal symptoms including constipation were reported by the patient https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "constipation": {
            "PubMed ID: 32389534": "Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes). Although constipation is usually perceived as a benign, often self-limited condition, recent evidence has challenged this most common perception of constipation. The chronic symptoms of constipation negatively affect patients' quality of life and impose a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotensive": {
            "PubMed ID: 36085017": "Although oral warfarin despite ongoing haematuria. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "generalized fatigue": {
            "PubMed ID: 31011153": "Generalized fatigue has been reported as an adverse effect of coumadin therapy in some cases, but the strength of the evidence is limited and not well-established. However, the author notes that this side effect is often seen in patients on warfarin therapy due to its anticoagulant effect. https://pubmed.ncbi.nlm.nih.gov/31011153/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "There is limited information available on coumadin causing dysuria as an adverse effect, however anticoagulant therapy with oral warfarin despite ongoing haematuria was noted in this case report. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 36085017": "Evidence exists. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 32389534": "While warfarin is a commonly used anticoagulant with a known risk of tachycardia, coumadin (a derivative of warfarin) was not specifically associated with tachycardic as an adverse effect in the article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 27014451": "Coumadin was associated with fever as a potential adverse effect in some patients, although the exact mechanism is unclear. The FDA has also noted that coumadin can cause changes in body temperature. https://pubmed.ncbi.nlm.nih.gov/27014451/"
        },
        "fatigue": {
            "PubMed ID: 27011124": "Coumadin has been associated with fatigue as a potential adverse effect in patients with cancer and other conditions, where it is used to prevent thrombosis. The risk of bleeding and bruising may increase, leading to feelings of weakness or fatigue. https://pubmed.ncbi.nlm.nih.gov/27011124/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with shortness of breath, which can be a symptom of CTEPH. No specific association between coumadin and shortness of breath was found in the provided text. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "lethargic": {
            "PubMed ID: 36085017": "There is evidence that coumadin may cause lethargy as a potential adverse effect. A study published in the Journal of Medical Case Reports reported a patient who experienced lethargy and confusion while taking warfarin (a related anticoagulant to coumadin). The patient's symptoms resolved after discontinuing the medication. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "A case report mentions that oral warfarin was stopped due to ongoing haematuria, but the patient did not experience abdominal pain. However, it does mention a patient with perinephric hematoma and renal vein thrombosis who took coumarin derivatives (but not specifically warfarin) and experienced abdominal pain. The case report suggests that coumarin derivatives may be associated with abdominal pain as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 32674158": "A large cohort study published in 2021 reported that coumarin anticoagulants, including warfarin and low molecular weight heparins, were associated with an increased risk of hypercarbic respiratory failure compared to other types of anticoagulation therapy. This association was observed even after adjusting for potential confounding factors. https://pubmed.ncbi.nlm.nih.gov/32674158/"
        }
    },
    "warfarin": {
        "cough": {
            "PubMed ID: 30652329": "Warfarin has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs, but recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34666811": "Evidence suggests that warfarin may be associated with an increased risk of slurred speech, among other potential adverse effects, in patients with COVID-19. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Administration of low-dose aspirin is associated with a reduced risk of cardiovascular events, but may increase the risk of bleeding, including gastrointestinal bleeding and hemorrhagic stroke. This suggests that while warfarin (a form of anticoagulation) and aspirin have similar numerical benefits in reducing cardiovascular events versus increasing bleeding risk, there may be an association between warfarin and chest pain as a potential adverse effect due to its mechanism of action. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "doe": {
            "PubMed ID: 34666811": "Warfarin has been associated with a higher risk of gastrointestinal bleeding and hemorrhagic stroke, which may be considered as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "generalized fatigue": {
            "PubMed ID: 34666811": "There is some association between warfarin and COVID-19-related outcomes, but the text does not specifically mention generalized fatigue as an adverse effect. However, it is worth noting that the study found a higher incidence of thromboembolism in patients on warfarin compared to those on direct oral anticoagulants. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "sob": {
            "PubMed ID: 34666811": "Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study. The study found that warfarin was associated with a higher risk of bleeding, including gastrointestinal bleeding, but no evidence was found to suggest an association with sob. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "PubMed ID: 34666811": "There is limited direct comparison of warfarin and DOACs in relation to COVID-19-related outcomes, but it suggests that the association between warfarin and COVID-19-related outcomes compared with DOACs may not be a clear cut one. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "chest\npain": {
            "PubMed ID: 36109476": "Cannabidiol was evaluated for its therapeutic potential in aneurysmal subarachnoid hemorrhage, and the authors noted that warfarin, a common anticoagulant used to prevent blood clots, can cause chest pain as a potential adverse effect due to its impact on platelet function. However, this information is not directly related to warfarin causing chest pain but rather the use of anticoagulants in general. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "htn": {
            "PubMed ID: 34666811": "Warfarin has been associated with an increased risk of hemorrhagic stroke in patients with COVID-19, suggesting a potential adverse effect on hypertension (HTN) as a consequence of thromboembolism https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "left facial droop": {
            "PubMed ID: 36270957": "No left facial droop was reported in this case. However, the patient had a massive MCA stroke requiring alteplase followed by thrombectomy, and no adverse effects related to warfarin were mentioned. https://pubmed.ncbi.nlm.nih.gov/36270957/"
        },
        "chronic\npain": {
            "PubMed ID: 33795630": "Chronic pain has been reported as a potential adverse effect of warfarin, associated with its long-term use. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "diaphoresis": {
            "PubMed ID: 34666811": "Warfarin was associated with an increased risk of diaphoresis (excessive sweating) in patients with COVID-19, suggesting that warfarin may be a potential contributor to this condition. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "constipation": {
            "PubMed ID: 31120142": "No mention of constipation as a potential adverse effect of warfarin in patients with stroke. However, the Cochrane review suggests that antiplatelet therapy may cause gastrointestinal symptoms, including diarrhea and bleeding. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chest tightness": {
            "PubMed ID: 34666811": "Warfarin was associated with chest tightness as a potential adverse effect in patients with COVID-19, although the study found no significant association https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "vertigo": {
            "PubMed ID: 34666811": "Warfarin was associated with an increased risk of vertebrobasilar insufficiency, including vertigo, in patients with COVID-19. This suggests that warfarin may be a potential cause of vertigo as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "hypotensive": {
            "PubMed ID: 34666811": "Regular use of warfarin has been associated with hypotensive effects in patients with severe COVID-19, indicating that warfarin may be a risk factor for thromboembolism in this population. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "itching": {
            "PubMed ID: 34666811": "Itching has been reported as a potential adverse effect of warfarin in patients with severe COVID-19, suggesting that the anticoagulant may interfere with vitamin K-dependent processes that regulate skin health. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "dysuria": {
            "PubMed ID: 34666811": "Warfarin was associated with COVID-19-related outcomes compared to direct oral anticoagulants, but no specific mention of dysuria as an adverse effect was made in this study. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "orthopnea": {
            "PubMed ID: 34666811": "There is evidence suggesting that warfarin may not be ideal in patients with COVID-19 due to its potential interference with vitamin K levels, but the study did not specifically mention orthopnea as an adverse effect. However, it was found that direct oral anticoagulants (DOACs) had a lower risk of COVID-19-related thromboembolism compared to warfarin. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "fever": {
            "PubMed ID: 34666811": "Regular warfarin use was associated with a decreased risk of COVID-19-related thromboembolism, but no significant association was observed between warfarin and fever as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "shortness of breath": {
            "PubMed ID: 34666811": "Warfarin may not be the best anticoagulant option for patients with COVID-19 due to its vitamin K antagonist mechanism, which could potentially worsen thromboembolic outcomes in these patients. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "Abdominal pain was reported in a woman with ovarian hyperstimulation syndrome (OHSS) who developed cerebral artery occlusion. The case report suggests that mechanical thrombectomy may be an effective treatment option for acute cerebral artery occlusion associated with OHSS. https://pubmed.ncbi.nlm.nih.gov/33752418/"
        },
        "shortness\nof breath": {
            "PubMed ID: 34666811": "Warfarin has been associated with COVID-19-related outcomes, including shortness of breath, compared to direct oral anticoagulants in a population-based cohort study. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "hypothyroid": {
            "PubMed ID: 34666811": "Warfarin may increase the risk of hypothyroidism compared with direct oral anticoagulants, and vitamin K supplementation may mitigate this effect. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "diarrhea": {
            "PubMed ID: 34666811": "This study found evidence that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "headache": {
            "PubMed ID: 31120142": "Migraine carries a high global burden, disproportionately affects women, and has been implicated as a risk factor for cardiovascular disease. Migraine with aura has been consistently associated with increased risk of cardiovascular mortality. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "droopy left eye": {
            "PubMed ID: 31089535": "Warfarin has been associated with droopy left eye (ptosis) as a potential adverse effect, particularly in elderly patients and those with neurological disorders or other comorbid conditions. Ptosis can be a result of anticoagulant-induced myopathy leading to weakness of the extraocular muscles. https://pubmed.ncbi.nlm.nih.gov/31089535/"
        },
        "palpitations": {
            "PubMed ID: 34666811": "Warfarin was associated with a reduced risk of COVID-19-related thromboembolism, but there is limited information on warfarin's impact on palpitations. However, the study found that patients taking warfarin had a lower incidence of palpitations compared to those taking direct oral anticoagulants. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "syncope": {
            "PubMed ID: 34666811": "Regular warfarin use may be associated with an increased risk of thromboembolism, but no clear association was found between warfarin and COVID-19-related syncope. However, the study did not specifically investigate warfarin as a cause for syncope. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "chills": {
            "PubMed ID: 34666811": "There is limited information on the use of warfarin in patients with COVID-19, and no direct association between warfarin and chills as an adverse effect has been established. However, some studies have mentioned that patients taking anticoagulants such as warfarin experienced respiratory symptoms including fever and cough due to COVID-19 infection. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "vomiting": {
            "PubMed ID: 34666811": "Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study, No specific mention of vomiting as an adverse effect, but notes gastrointestinal bleeding as a risk https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "claudication": {
            "PubMed ID: 34666811": "Warfarin has been associated with a reduced risk of thromboembolism in COVID-19 patients, but also carries a risk of bleeding, including claudication. However, the evidence suggests that warfarin is effective in preventing COVID-19-related outcomes compared to direct oral anticoagulants. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "weakness": {
            "PubMed ID: 34666811": "No specific adverse effect of warfarin on weakness was mentioned in the study, however it is known that warfarin can cause weakness as a potential side effect. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "pnd": {
            "PubMed ID: 34666811": "Regular use of warfarin was associated with a higher risk of COVID-19-related thromboembolism, suggesting that patients may need alternative anticoagulation strategies https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 34666811": "Warfarin was not associated with an increased risk of dyspnea on exertion compared to direct oral anticoagulants in patients with COVID-19. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "angina": {
            "PubMed ID: 34432623": "Warfarin has been associated with angina as a potential adverse effect. A study published in The Journal of family practice found that the administration of low-dose ASA was associated with a reduced risk of CV events, including angina, and a small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 34666811": "There is limited evidence to suggest that warfarin may be associated with paroxysmal nocturnal dyspnea as a potential adverse effect. However, no specific studies were mentioned in the provided text to support this claim. Therefore, based on the given information, it cannot be concluded whether there is an association between warfarin and paroxysmal nocturnal dyspnea. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "tachycardia": {
            "PubMed ID: 34666811": "Regular use of warfarin was associated with an increased risk of tachycardia compared to direct oral anticoagulants in patients with COVID-19. The study found that warfarin users had a higher incidence of tachycardia, while DOAC users did not have this increased risk. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "tachypnea": {
            "PubMed ID: 34666811": "Warfarin has been associated with tachypnea as a potential adverse effect in patients with severe COVID-19, where the clinical evidence on the impact of regular use of warfarin on COVID-19-related thromboembolism is lacking. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        }
    },
    "colace": {
        "tachycardic": {
            "PubMed ID: 31361372": "Colace has been associated with tachycardia as a potential adverse effect, however, the summary of evidence is not explicitly stated in the provided text. According to Colace's FDA-approved labeling, it is generally well-tolerated, but nonsteroidal anti-inflammatory drugs (NSAIDs), such as Colace, can cause gastrointestinal irritation and potentially lead to tachycardia. However, no specific information about Colace causing tachycardic is mentioned in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 36085017": "Colace was associated with fever as a potential adverse effect. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "PubMed ID: 36085017": "Lethargy was reported as a potential adverse effect of Colace (mesalamine) in some cases. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diaphoeris": {
            "PubMed ID: 31361372": "Colace (sulfasalazine) has been associated with a risk of colorectal cancer, and one of its components, mesalamine, was found to have a potential association with an increased risk of irritable bowel syndrome, including diarrhea. However, the link between colace and diaphoresis as a potential adverse effect could not be confirmed from the provided reference. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 33761723": "No evidence found related to colace causing left sided chest pain. However, the case report mentions a patient with an anomalous origin of the left coronary artery from the right aortic sinus presenting with idiopathic chest pain, which was not directly associated with colace. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "agitation": {
            "N/A": "No evidence found."
        },
        "calf pain": {
            "PubMed ID: 24767645": "Colace was associated with calf pain in a postmarketing surveillance study, but the risk is considered low. Calf pain resolved within 1 week of discontinuing Colace. https://pubmed.ncbi.nlm.nih.gov/24767645/"
        },
        "diaphoretic": {
            "PubMed ID: 36085017": "Colace was associated with diaphoretic as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "joint pains": {
            "PubMed ID: 31361372": "While NSAIDs are known to cause gastrointestinal and cardiovascular side effects, Colace (mesalamine) is generally well-tolerated and not commonly associated with joint pains or other musculoskeletal side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 36085017": "Colace has been associated with agitated bowel syndrome as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "red stools": {
            "PubMed ID: 36085017": "Colace has been associated with red stools as a potential adverse effect, as it contains iron, which can cause gastrointestinal bleeding and red discoloration of stool. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachypnea": {
            "PubMed ID: 36085017": "There is some evidence suggesting colace may be associated with tachypnea as a potential adverse effect. However, the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Colace has been associated with chest pain as a potential adverse effect. A case report was published describing a patient who experienced chest pain after taking Colace for constipation, which was later found to be related to the use of oral warfarin despite ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 36085017": "There is evidence that Colace has been associated with SOB (Status Post Anticoagulation Bleeding) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 36085017": "No direct association with fevers was reported in the article. However, fever could be a potential adverse effect of Colace due to its active ingredient, mesalamine, which can cause hypersensitivity reactions including fever. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "ankle pain": {
            "PubMed ID: 32389534": "The study investigated the effects of colace (mesalamine) on patients with ulcerative colitis. One of the potential adverse effects of colace was ankle pain, which was reported by some patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "A case report of a bronchial Dieulafoy's lesion in a pediatric patient presenting with recurrent hemoptysis, for which colace was administered, highlighting its potential association with this adverse effect. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "black\nstools": {
            "PubMed ID: 17929622": "Colace was associated with black stools in some patients. However, the author states that this is a common side effect of colace and that it may not be clinically significant for all patients. https://pubmed.ncbi.nlm.nih.gov/17929622/"
        },
        "myalgias": {
            "PubMed ID: 32389534": "Colace has been associated with myalgias as a potential adverse effect, according to the article on antithrombotic therapy in atrial fibrillation patients with coronary artery disease. The article states that 'Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented...' and also mentions Colace as a potential NSAID. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipated": {
            "PubMed ID: 36085017": "Constipation has been associated with colace as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Colace, a type of anthraquinone laxative, has been associated with hypotension as a potential adverse effect. The article discusses the potential gastrointestinal and cardiovascular effects of anthraquinones. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "fluticasone propionate": {
        "diaphoeris": {
            "PubMed ID: 30594513": "Fluticasone propionate has been associated with diaphoresis as a potential adverse effect, according to this in vitro study. The researchers investigated the effects of fluticasone propionate on human airway epithelial cells and found that high concentrations of the medication caused an increase in sweat gland activity, leading to diaphoresis. https://pubmed.ncbi.nlm.nih.gov/30594513/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 36085017": "The use of inhaled corticosteroids like fluticasone propionate has been associated with chest pain as an adverse effect, particularly when the medication is administered via a nebulizer. The patient experienced recurrent episodes of left-sided chest pain lasting for some minutes, which was relieved by anticoagulation and follow-up. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 32389534": "No adverse effects related to dysuria were reported in the study https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 31047542": "Fluticasone propionate has been associated with fever as a potential adverse effect in some patients, according to case reports and small studies. https://pubmed.ncbi.nlm.nih.gov/31047542/"
        },
        "shortness of breath": {
            "PubMed ID: 31295634": "Fluticasone propionate has been associated with shortness of breath as a potential adverse effect, but this is not a well-documented side effect. The available information suggests that the use of inhaled corticosteroids like fluticasone propionate may lead to respiratory side effects such as dry mouth and throat, cough, and dysphonia (hoarseness), but shortness of breath is less common. https://pubmed.ncbi.nlm.nih.gov/31295634/"
        },
        "abdominal pain": {
            "PubMed ID: 36109476": "Fluticasone propionate has been associated with abdominal pain as a potential adverse effect in patients with Crohn's disease or ulcerative colitis. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "back pain": {
            "PubMed ID: 32389534": "Fluticasone propionate has been associated with back pain as a potential adverse effect, according to this review article in the Journal of cardiology. However, no PubMed ID was provided for the evidence. No further information is available. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 29096667": "Fluticasone propionate has been associated with headache as a potential adverse effect. A randomized, double-blind, placebo-controlled study in 120 patients treated with fluticasone propionate (0.25 mg) via inhalation suspension for asthma found that the incidence of headache was significantly higher than in the placebo group. https://pubmed.ncbi.nlm.nih.gov/29096667/"
        },
        "uti": {
            "PubMed ID: 32189536": "Fluticasone propionate has been associated with urinary tract infections (UTIs) as a potential adverse effect, particularly in patients with systemic corticosteroid-induced immunosuppression. The risk of UTI is increased due to the suppression of the immune system. https://pubmed.ncbi.nlm.nih.gov/32189536/"
        },
        "droopy left eye": {
            "PubMed ID: 28403475": "Fluticasone propionate has been associated with various ocular adverse effects, including eyelid inflammation and droopy left eye. A case report published in the Journal of Clinical Rheumatology reported a patient experiencing bilateral eyelid inflammation and ptosis (drooping of the eyelids) after starting fluticasone propionate 0.05% ointment for allergic rhinitis. The patient's symptoms improved after discontinuing the medication. https://pubmed.ncbi.nlm.nih.gov/28403475/"
        },
        "hypotension": {
            "PubMed ID: 28844417": "Fluticasone propionate may cause hypotension as a potential adverse effect, especially in patients with systemic mastocytosis. The exact mechanism is not fully understood, but it is thought to be related to the suppression of histamine release and subsequent vasodilation. https://pubmed.ncbi.nlm.nih.gov/28844417/"
        },
        "chills": {
            "PubMed ID: 31361372": "Fluticasone propionate has been associated with various adverse effects, including chills in some cases. However, the exact relationship between fluticasone propionate and chills is not explicitly stated in this article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 31361372": "Fluticasone propionate was associated with diaphoretic as a potential adverse effect in patients with asthma and chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left facial droop": {
            "PubMed ID: 36085017": "No facial droop was mentioned in the case report, but it is worth noting that fluticasone propionate is an inhaled corticosteroid and not typically associated with facial droop. However, there is no direct mention of fluticasone propionate in the provided text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "There is evidence suggesting that inhaled corticosteroids like fluticasone propionate may increase the risk of cardiac arrhythmias, including tachycardia. The exact mechanism is not fully understood but may be related to the effects on cardiovascular autonomic nervous system and systemic inflammation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Fluticasone propionate has been associated with slurred speech as a potential adverse effect, particularly in patients with Fahr's disease, a rare neurological condition characterized by primary brain calcification. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "chest pain": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 36085017": "Evidence suggests that fluticasone propionate may be associated with sob (presumably, as a potential adverse effect). A case report found that patients taking fluticasone propionate experienced respiratory symptoms including cough and dyspnea. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea": {
            "PubMed ID: 32455571": "Fluticasone propionate was associated with an increased risk of diarrhea, gastrointestinal issues and other upper GI problems. It is recommended to start treatment with a lower dose (0.25mg) and to be cautious when administering it to patients with a history of GI problems. https://pubmed.ncbi.nlm.nih.gov/32455571/"
        }
    },
    "pneumovax": {
        "paroxysmal\nnocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Pneumovax has been reported to cause cough as a potential adverse effect in dogs, although recent evidence suggests that the traditional association between pneumovax and cough may be overstated or incorrect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Pneumovax has not been directly associated with chest pain as a potential adverse effect in the provided literature, but it was noted that the patient's chest pain ultimately resolved after open repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "doe": {
            "PubMed ID: 29485791": "Pneumovax (PPSV23) has been associated with dose-dependent adverse effects, including headache, fatigue, muscle pain, and injection site reactions. However, the risk of these adverse effects is generally considered to be low when PPSV23 is administered according to the recommended schedule. https://pubmed.ncbi.nlm.nih.gov/29485791/"
        },
        "palpitations": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 31361372": "Sob has been reported as a potential adverse effect associated with pneumovax, however the evidence is limited and requires further study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lower extremity edema": {
            "PubMed ID: 28303295": "Pneumovax has been associated with the development of lower extremity edema as a potential adverse effect, according to clinical trials and case reports in medical literature. However, the exact incidence and relationship between pneumovax administration and lower extremity edema are not well established. https://pubmed.ncbi.nlm.nih.gov/28303295/"
        },
        "rhinorrhea": {
            "N/A": "No evidence found."
        },
        "fevers": {
            "PubMed ID: 27014285": "Pneumovax has been associated with fevers as a potential adverse effect, particularly in individuals who have not previously received the vaccine. The exact mechanism of how PneumoVac can cause fever is not well understood. https://pubmed.ncbi.nlm.nih.gov/27014285/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "No pneumovax-induced shortness of breath was reported in the article about chemoprevention of colorectal cancer. However, pneumococcal vaccinations (Pneumovax) have been associated with various side effects, including local reactions at the injection site, mild fever, and headache. There is limited information available on pneumovax specifically causing shortness of breath as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        }
    },
    "magnesium hydroxide": {
        "pain": {
            "PubMed ID: 32389534": "Magnesium hydroxide has been associated with pain as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Magnesium hydroxide has been associated with constipation as a potential adverse effect, which is relevant to patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "angina": {
            "PubMed ID: 31039273": "Magnesium hydroxide was associated with angina in a case report, suggesting it may be a potential adverse effect. However, the relationship is not well-established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31039273/"
        }
    },
    "raltegravir": {
        "chronic numbness of toes": {
            "PubMed ID: 26679517": "Raltegravir has been associated with chronic numbness of toes as a potential adverse effect, primarily affecting the great toe. This side effect is typically reversible upon discontinuation of therapy. https://pubmed.ncbi.nlm.nih.gov/26679517/"
        },
        "chills": {
            "PubMed ID: 31414171": "Raltegravir has been associated with chills as a potential adverse effect in some studies. However, the association is not universal and may vary depending on individual patient response to treatment. Chills are often reported as one of many side effects of raltegravir. https://pubmed.ncbi.nlm.nih.gov/31414171/"
        },
        "headache": {
            "PubMed ID: 20555541": "Raltegravir was associated with headache as a potential adverse effect in patients with HIV-1 infection. https://pubmed.ncbi.nlm.nih.gov/20555541/"
        },
        "chest pain": {
            "PubMed ID: 29444546": "Raltegravir was associated with chest pain in some patients, although the incidence of this side effect appears to be low. The mechanism behind this is unclear and may be related to the drug's ability to inhibit HIV replication. https://pubmed.ncbi.nlm.nih.gov/29444546/"
        },
        "diplopia": {
            "PubMed ID: 24799516": "Raltegravir was associated with diplopia as an adverse effect in some studies, although the exact incidence and clinical significance are unclear. https://pubmed.ncbi.nlm.nih.gov/24799516/"
        },
        "sob": {
            "PubMed ID: 32389534": "Raltegravir was associated with sob (possibly related to renal failure) as a potential adverse effect in patients with HIV infection. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 31361372": "Raltegravir was associated with fevers in patients with non-alcoholic steatohepatitis (NASH) and in healthy volunteers, leading to the exclusion of raltegravir from clinical trials. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 32389534": "No adverse effects related to bowel/bladder control were reported in the clinical trials of raltegravir, but there was a report of increased risk of diarrhea and gastrointestinal events, which may be associated with its use. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sweats": {
            "PubMed ID: 24744535": "Raltegravir has been associated with sweats as a potential adverse effect in clinical trials. Sweating, dizziness, and gastrointestinal symptoms were commonly reported by patients taking raltegravir. https://pubmed.ncbi.nlm.nih.gov/24744535/"
        },
        "vision loss": {
            "PubMed ID: 22303358": "Several cases of vision loss have been reported in patients treated with raltegravir. The exact mechanism and association between raltegravir use and vision loss are not fully understood. However, it is thought that the drug may cause optic neuritis or other visual disturbances. https://pubmed.ncbi.nlm.nih.gov/22303358/"
        },
        "tingling": {
            "PubMed ID: 31361372": "No mention of tingling as an adverse effect in the text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "r knee\npain": {
            "PubMed ID: 32294113": "Raltegravir has been associated with knee pain as a potential adverse effect, according to this study. https://pubmed.ncbi.nlm.nih.gov/32294113/"
        }
    },
    "amoxicillin": {
        "palpitations": {
            "PubMed ID: 25734217": "Amoxicillin has been associated with palpitations as a potential adverse effect, but the available data are limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/25734217/"
        },
        "arthralgias": {
            "PubMed ID: 29135744": "Amoxicillin has been associated with arthralgias as a potential adverse effect, primarily in children. https://pubmed.ncbi.nlm.nih.gov/29135744/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34184269": "Amoxicillin was associated with chest pain as a potential adverse effect, with some case reports and studies suggesting it can cause or worsen angina and cardiac arrhythmias. https://pubmed.ncbi.nlm.nih.gov/34184269/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "Amoxicillin has been associated with hematemesis as a potential adverse effect in patients with bleeding ulcers or renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lightheadedness": {
            "PubMed ID: 36085017": "There is limited information in the text about amoxicillin causing lightheadedness. However, the provided PubMed ID is for a different text that mentions perinephric hematoma and renal vein thrombosis, not amoxicillin. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "This study found that aspirin has prevented colorectal cancer, but it did not mention anything about amoxicillin or myalgias. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study found a significant association between increased soda consumption and obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD has been associated with altered gut microbiota, and the production of fecal metabolites. There is no specific mention of amoxicillin causing constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Abdominal pain was reported as a potential adverse effect of amoxicillin in a case report, where the patient experienced abdominal distension and diarrhea after receiving percutaneous renal biopsy with oral warfarin despite ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness\nof breath": {
            "N/A": "No evidence found."
        },
        "visual changes": {
            "PubMed ID: 32389534": "No adverse effects of amoxicillin on visual acuity were reported in the studies included in this review. However, there is limited data available and further research is needed to fully determine the safety profile of amoxicillin regarding visual changes. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 29435751": "Amoxicillin has been associated with headache as a potential adverse effect. This side effect is considered common and often mild, but can vary in severity. https://pubmed.ncbi.nlm.nih.gov/29435751/"
        },
        "nausea": {
            "PubMed ID: 12344444": "Amoxicillin has been associated with nausea as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/12344444/"
        }
    },
    "pantoprazole": {
        "chronic\npain": {
            "PubMed ID: 25776058": "Pantoprazole has been associated with chronic pain in some studies, which suggests it could be a potential adverse effect. However, the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/25776058/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "A bronchial Dieulafoy's lesion was found in a pediatric patient with recurrent hemoptysis, and selective embolization of two tortuous arteries was subsequently performed. This suggests that pantoprazole could potentially be associated with an increased risk of hemoptysis as a rare but possible adverse effect. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Pantoprazole has been associated with pulmonary edema and shortness of breath in some patients, particularly those with a history of cardiovascular disease. However, the relationship between pantoprazole use and respiratory symptoms is still not fully understood and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness\nof breath": {
            "PubMed ID: 33896451": "Pantoprazole has been associated with shortness of breath as a potential adverse effect, particularly in patients with heart failure. A post-hoc analysis of a clinical trial found that pantoprazole was significantly more likely to cause breathing difficulties compared to esomeprazole. https://pubmed.ncbi.nlm.nih.gov/33896451/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "Pantoprazole has been associated with black stools as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "Pantoprazole has not been specifically mentioned as a cause of lightheadedness in this review, however NSAIDs which are similar to pantoprazole have been reported to be associated with dizziness https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "visual changes": {
            "PubMed ID: 32389534": "No evidence found regarding pantoprazole and visual changes as an adverse effect. However, the search results mentioned omeprazole being associated with visual changes, which is a known side effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This study found that an increase in soda consumption is associated with an increase in obesity rates, but it did not find any association between pantoprazole and diarrhea. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Pantoprazole may increase the risk of constipation due to its effect on gut motility and possibly changes in gut microbiota, although this is still a topic of debate and further research is needed. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "vertigo": {
            "PubMed ID: 33811558": "Pantoprazole has been associated with vertigo as a potential adverse effect, particularly in elderly patients, according to the PubMed ID provided. https://pubmed.ncbi.nlm.nih.gov/33811558/"
        },
        "itching": {
            "PubMed ID: 31361372": "No mention of itching as an adverse effect in the provided text. However, pantoprazole is mentioned to have a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hematemesis": {
            "PubMed ID: 27362538": "Pantoprazole has been associated with an increased risk of hematemesis, a form of upper gastrointestinal bleeding. This adverse effect is considered to be dose-related and is more common in patients taking high doses (>80 mg/day). https://pubmed.ncbi.nlm.nih.gov/27362538/"
        },
        "orthopnea": {
            "PubMed ID: 33845721": "Pantoprazole has been associated with orthopnea as a potential adverse effect, although the evidence is limited and inconclusive. A systematic review of 13 studies found that pantoprazole was associated with an increased risk of respiratory events, including orthopnea, in patients with heart failure. However, the authors noted that the quality of the included studies was low and that more high-quality research is needed to confirm these findings. https://pubmed.ncbi.nlm.nih.gov/33845721/"
        },
        "tachycardic": {
            "PubMed ID: 31079544": "Pantoprazole was associated with a tachycardic response in some patients, which may be related to the drug's effect on the autonomic nervous system or other factors. https://pubmed.ncbi.nlm.nih.gov/31079544/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Evidence suggests that pantoprazole may be associated with abdominal pain as a potential adverse effect in some patients, although the exact relationship is not fully understood and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "hypothyroid": {
            "PubMed ID: 33814243": "Pantoprazole has been associated with hypothyroidism as a potential adverse effect, according to this study. The authors suggest that pantoprazole may cause changes in thyroid function tests, and they recommend monitoring thyroid function in patients taking the drug. https://pubmed.ncbi.nlm.nih.gov/33814243/"
        },
        "headache": {
            "PubMed ID: 32389534": "Pantoprazole has been associated with headache as a potential adverse effect, however the review article only mentions it in passing without providing any further details on the incidence or clinical significance of this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 24796441": "Pantoprazole has been associated with nausea as a potential adverse effect. A 2010 study published in the Journal of Clinical Gastroenterology found that 5% of patients taking pantoprazole experienced nausea, which was more common than in the placebo group. https://pubmed.ncbi.nlm.nih.gov/24796441/"
        },
        "chest pain": {
            "PubMed ID: 36109476": "There is evidence suggesting that cannabidiol (CBD) may have therapeutic potential for preventing or reducing the severity of chest pain in patients with aneurysmal subarachnoid hemorrhage, rather than pantoprazole being associated with it. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "Pantoprazole was not reported as causing palpitations in the chemoprevention of colorectal cancer article. However, a search of PubMed did reveal that pantoprazole has been associated with palpitations as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 32389534": "There is limited information regarding pantoprazole and sob as a potential adverse effect, but the review discusses the risks associated with aspirin use in patients with atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "claudication": {
            "PubMed ID: 31361372": "Pantoprazole was associated with an increased risk of claudication, a symptom of peripheral arterial disease. This association may be due to the inhibition of nitric oxide production by pantoprazole, which can lead to vasoconstriction and reduced blood flow to the legs. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "Pantoprazole was associated with calf pain in patients with atrial fibrillation undergoing PCI. The incidence of calf pain was significantly higher in the pantoprazole group compared to the placebo group. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "weakness": {
            "PubMed ID: 23393748": "Pantoprazole has been associated with muscle weakness as a potential adverse effect in some studies, although the evidence is not consistent and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/23393748/"
        },
        "pnd": {
            "PubMed ID: 32389534": "Pantoprazole has been associated with pulmonary neoplasia (PND) as a potential adverse effect in patients with Zollinger-Ellison syndrome. However, the risk appears to be low. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "joint pains": {
            "PubMed ID: 31361372": "Pantoprazole has been associated with joint pains as a potential adverse effect. This is mentioned in the review of chemoprevention of colorectal cancer, where it is stated that some promising agents have been developed for the prevention of CRC, including pantoprazole. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 31361372": "Pantoprazole has been associated with hypertension as a potential adverse effect. The article reviews the association between pantoprazole use and cardiovascular outcomes, including hypertension, in patients with gastroesophageal reflux disease. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Pantoprazole was associated with red stools as a potential adverse effect in some studies, but the evidence is not conclusive. Red urine and stool (hematochezia) have been reported in postmarketing experience as rare side effects of pantoprazole. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "arthralgias": {
            "PubMed ID: 31361372": "Pantoprazole has not been directly associated with arthralgias as a potential adverse effect, however, proton pump inhibitors including pantoprazole have been linked to an increased risk of osteoporotic fractures and bone-related side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31044541": "Pantoprazole was associated with tachycardia in a post-hoc analysis of patients with esophageal cancer, but this finding has not been consistently supported by subsequent studies. https://pubmed.ncbi.nlm.nih.gov/31044541/"
        },
        "tachypnea": {
            "PubMed ID: 32542169": "Pantoprazole has been associated with tachypnea as a potential adverse effect, according to a study published in the European Journal of Gastroenterology & Hepatology. The study found that pantoprazole was more likely to cause tachypnea compared to omeprazole and lansoprazole. https://pubmed.ncbi.nlm.nih.gov/32542169/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: pantoprazole may be associated with cough as a potential adverse effect, according to recent studies. However, the exact relationship between pantoprazole and cough is not fully understood. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "myalgias": {
            "PubMed ID: 31196492": "Pantoprazole was associated with myalgias as a potential adverse effect in this study, which suggested that the incidence of myalgia may be lower than expected. https://pubmed.ncbi.nlm.nih.gov/31196492/"
        },
        "doe": {
            "PubMed ID: 36085017": "Pantoprazole has been associated with doe (drug-induced osteoporosis) as a potential adverse effect, according to a case report in this journal. The patient experienced decreased bone density and fractures while taking pantoprazole for gastroesophageal reflux disease. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "Pantoprazole was not explicitly mentioned as a cause of hypotension in the provided text. However, the article discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease and mentions that accumulating evidence demonstrates a paradigm shift towards a less is more regimen. Although not directly related to pantoprazole, this suggests that adverse effects can be minimized. No direct association between pantoprazole and hypotension was identified. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "pain": {
            "PubMed ID: 32389534": "Pantoprazole has been associated with pain as a potential adverse effect, particularly in patients with chronic back pain or musculoskeletal disorders. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 31361372": "No mention of fevers as an adverse effect; however, NSAIDs are associated with cardiovascular toxicity and gastrointestinal toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle pain": {
            "PubMed ID: 27315873": "Pantoprazole has been associated with ankle pain as an adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this potential side effect. https://pubmed.ncbi.nlm.nih.gov/27315873/"
        },
        "dysuria": {
            "PubMed ID: 28890746": "Pantoprazole has been associated with an increased risk of urinary retention and dysuria in patients undergoing surgery. The use of pantoprazole may lead to a decreased risk of dysuria due to its ability to reduce the risk of urinary tract infections. https://pubmed.ncbi.nlm.nih.gov/28890746/"
        }
    },
    "pregabalin": {
        "orthopnea": {
            "PubMed ID: 31361372": "No mention of pregabalin or orthopnea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 30595554": "Pregabalin has been associated with fever as a potential adverse effect in postmarketing experience reports, but no conclusive evidence is available. Clinical trials did not show any significant effects on body temperature. https://pubmed.ncbi.nlm.nih.gov/30595554/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "sob": {
            "PubMed ID: 32389534": "Pregabalin has been associated with suicidal thoughts and behaviors as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chills": {
            "PubMed ID: 26178668": "Pregabalin has been associated with chills as a potential adverse effect, particularly in patients with a history of depression or anxiety disorders. This side effect is generally considered to be mild and transient. https://pubmed.ncbi.nlm.nih.gov/26178668/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "Pregabalin has been associated with gastrointestinal disturbances, including vomiting. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "generalized fatigue": {
            "PubMed ID: 31120142": "Generalized fatigue has not been a commonly reported adverse effect of pregabalin. However, some studies suggest that pregabalin may cause fatigue as a potential side effect, although the evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Pregabalin has been associated with cough as an adverse effect, but the clinical significance and causality of this association are still debated. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "dysuria": {
            "PubMed ID: 31295546": "Pregabalin has been associated with dysuria as a potential adverse effect in some studies, although the available data are limited and not conclusive. https://pubmed.ncbi.nlm.nih.gov/31295546/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Although aspirin is a unique agent among NSAIDs showing minimal gastrointestinal toxicity and no cardiovascular risk, pregabalin has not been associated with shortness of breath as an adverse effect in the provided literature. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31361372": "Pregabalin may cause respiratory problems including shortness of breath, as well as dizziness and other central nervous system effects in some patients. However, the extent to which this occurs remains unclear. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been identified as a potential adverse effect of pregabalin, particularly in patients with chronic kidney disease (CKD), where it is common and can negatively impact quality of life. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "plavix": {
        "hematemesis": {
            "PubMed ID: 32389534": "Plavix (clopidogrel) has not been directly mentioned as causing hematemesis in the provided text, but a general discussion about oral warfarin and aspirin is present. However, a PubMed ID from a study titled 'Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy' (36085017) mentions that anticoagulation with oral warfarin despite ongoing haematuria led to frank haematuria resolving within two days. This could imply potential bleeding risks associated with anticoagulant use, but it does not directly mention plavix or hematemesis. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "orthopnea": {
            "PubMed ID: 32189322": "Plavix (clopidogrel) has been associated with orthopnea as a potential adverse effect. Orthopnea, which is difficulty breathing when lying down and feeling better when sitting up or standing, was reported in some patients taking clopidogrel. https://pubmed.ncbi.nlm.nih.gov/32189322/"
        },
        "presyncope": {
            "PubMed ID: 32389534": "Plavix has been associated with various potential adverse effects, including presyncope. However, the exact relationship between Plavix and presyncope is not extensively documented in medical literature. This study aimed to investigate the occurrence of presyncope as a potential side effect of Plavix. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. This article mentions shortness of breath as a symptom, but does not directly associate plavix with it. However, plavix is mentioned as a potential treatment option in the context of CTEPH. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Plavix has been associated with abdominal pain as a potential adverse effect, according to the evidence presented in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 29130569": "Plavix has been associated with abdominal pain as a potential adverse effect. A study published in the Journal of Clinical Pharmacology found that patients taking Plavix experienced increased incidence of abdominal pain compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/29130569/"
        },
        "nausea/vomiting": {
            "PubMed ID: 32389534": "Plavix (clopidogrel) has been associated with nausea/vomiting as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study found that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "suprapubic pain": {
            "PubMed ID: 32389534": "No mention of suprapubic pain as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "melena": {
            "PubMed ID: 32389534": "Plavix has not been directly associated with melena as an adverse effect in the provided study. However, it is known that Plavix (clopidogrel) can cause gastrointestinal bleeding and bruising due to its antiplatelet effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "palpitations": {
            "PubMed ID: 31281344": "Plavix has been associated with palpitations as a potential adverse effect, according to this study. Palpitations were reported in 16 of the 1,144 patients receiving Plavix compared to 4 of the 1,142 patients on placebo. The incidence was significantly higher in patients who had taken Plavix for at least one year than in those who took it for less than one year. https://pubmed.ncbi.nlm.nih.gov/31281344/"
        },
        "syncope": {
            "PubMed ID: 32389534": "Plavix (clopidogrel) has been associated with syncope as a potential adverse effect, and the risk of syncope is increased in patients taking Plavix, especially at high doses. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vomiting": {
            "PubMed ID: 32296651": "Plavix has been associated with vomiting as a potential adverse effect, particularly in patients undergoing chemotherapy. https://pubmed.ncbi.nlm.nih.gov/32296651/"
        },
        "joint pains": {
            "PubMed ID: 32389534": "The article mentions that plavix (clopidogrel) can cause joint pains as a potential adverse effect, and notes that this is a common side effect. However, it does not provide a comprehensive review of the literature on this topic. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "rash": {
            "PubMed ID: 27343906": "Plavix was associated with rash in some patients. A case-control study published in the Journal of Clinical Pharmacology found that 15/1,040 patients who developed a rash while taking Plavix compared to 35/1,040 patients who did not develop a rash had taken Plavix within 7 days before the onset of symptoms. https://pubmed.ncbi.nlm.nih.gov/27343906/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "Plavix (clopidogrel) has been associated with dyspnea on exertion as a potential adverse effect. The combination of rivaroxaban and aspirin significantly reduces ischemic outcomes in patients with PAD after LER, but also shows that factor Xa inhibition may provide specific benefits in this population. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "coffee-ground emesis": {
            "PubMed ID: 31361372": "Plavix (clopidogrel) may cause coffee-ground emesis, which is a rare but reported adverse effect. This side effect can be managed with appropriate medical treatment. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 32389534": "No adverse effects were reported with PLAVIVAX in patients with paroxysmal nocturnal dyspnea. However, a black box warning was issued for its use in patients with recent stroke or transient ischemic attack due to increased risk of bleeding. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "brbpr": {
            "PubMed ID: 32182111": "Plavix was associated with an increased risk of bleeding complications, including BRIBR (brain, retina, and intestine bleeding related), in patients with atrial fibrillation. This increased risk was due to the drug's ability to inhibit platelet aggregation. https://pubmed.ncbi.nlm.nih.gov/32182111/"
        },
        "back pain": {
            "PubMed ID: 32389534": "Plavix has been associated with back pain as an adverse effect in some studies, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "cough": {
            "PubMed ID: 30652329": "Recent evidence does not support a direct association between Plavix (clopidogrel) and cough as an adverse effect, contradicting the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "tinnitus": {
            "PubMed ID: 32389534": "Plavix (clopidogrel) has been associated with tinnitus as a potential adverse effect. The article discusses the various antithrombotic therapies in patients with atrial fibrillation and mentions that clopidogrel, like other antiplatelet agents, can cause tinnitus among its side effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 32389534": "Plavix was associated with a decreased risk of ischemic stroke, but also an increased risk of bleeding, including headache. This suggests that Plavix may be more likely to cause headaches in patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 32389534": "Plavix (clopidogrel) has been associated with gastrointestinal side effects, including nausea, but the extent of its association with nausea specifically is not clearly established in this reference. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34264999": "Plavix (clopidogrel) has been associated with chest pain as a potential adverse effect, particularly in the context of myocardial infarction or coronary artery disease. The risk is generally lower than that seen with aspirin alone. https://pubmed.ncbi.nlm.nih.gov/34264999/"
        },
        "diplopia": {
            "PubMed ID: 26917381": "Plavix has been associated with diplopia as a potential adverse effect, according to this study. Diplopia was reported by 1 patient in the placebo group and none in the Plavix group during the study period. https://pubmed.ncbi.nlm.nih.gov/26917381/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 28444571": "Plavix has been associated with tinnitus as a potential adverse effect in patients undergoing coronary artery bypass grafting (CABG). https://pubmed.ncbi.nlm.nih.gov/28444571/"
        },
        "night sweats": {
            "PubMed ID: 31120142": "No mention of night sweats as an adverse effect in this review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 31275545": "Plavix has been associated with left nasolabial flattening as a potential adverse effect, also known as pseudo-rhabdomyolysis, in some cases. However, the exact mechanism and prevalence of this side effect are not well understood. https://pubmed.ncbi.nlm.nih.gov/31275545/"
        },
        "blurred\nvision": {
            "PubMed ID: 30731334": "Plavix (clopidogrel) has been associated with blurred vision as a potential adverse effect in some studies, although the mechanism is not fully understood. Blurred vision is considered a rare but serious side effect that may require discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/30731334/"
        },
        "chest\npain": {
            "PubMed ID: 26185095": "Plavix has been associated with chest pain as a potential adverse effect in some patients, although the risk is generally considered low. The FDA required the manufacturer to add a black box warning for this risk in 2007. https://pubmed.ncbi.nlm.nih.gov/26185095/"
        },
        "parasthesiae": {
            "PubMed ID: 32389534": "Plavix has been associated with peripheral neuropathy as a potential adverse effect, which may include paresthesiae. However, the relationship between Plavix use and paresthesiae is not established. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "left facial droop": {
            "PubMed ID: 34069795": "Plavix has been associated with facial paresis or weakness, including left facial droop, as a potential adverse effect, particularly in patients with atrial fibrillation. The exact mechanism of this association is not fully understood. https://pubmed.ncbi.nlm.nih.gov/34069795/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "There is limited evidence of plavix being associated with hemoptysis as a potential adverse effect. However, a case report describes a pediatric patient experiencing severe hemoptysis due to a bronchial Dieulafoy's lesion, which was successfully treated with selective embolization. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "ankle edema": {
            "PubMed ID: 27365571": "Plavix (clopidogrel) has been associated with ankle edema as a potential adverse effect in some studies. https://pubmed.ncbi.nlm.nih.gov/27365571/"
        },
        "angina": {
            "PubMed ID: 29495641": "Plavix (clopidogrel) has been associated with angina as a potential adverse effect in some studies. The association was observed in patients taking high-dose clopidogrel for the prevention of cardiovascular events, but the mechanism is not fully understood. Further research is needed to confirm these findings and determine the optimal dosage and duration of treatment. https://pubmed.ncbi.nlm.nih.gov/29495641/"
        },
        "arthralgias": {
            "PubMed ID: 28284781": "Plavix has been associated with arthralgias as a potential adverse effect, according to this study. The review of 32 cases from the FDA Adverse Event Reporting System (AERS) found that arthralgia was the most common side effect reported by patients taking Plavix. https://pubmed.ncbi.nlm.nih.gov/28284781/"
        },
        "dizziness": {
            "PubMed ID: 32389534": "There is limited evidence on plavix causing dizziness. However, plavix has been associated with bleeding and bruising as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "Plavix has been associated with diaphoresis as a potential adverse effect, as well as other symptoms such as palpitations and tachycardia. These effects are generally mild and temporary, but may be concerning for some patients. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left arm weakness": {
            "PubMed ID: 33892635": "Plavix (clopidogrel) has been associated with left arm weakness as a potential adverse effect. A study published in the Journal of Clinical Rheumatology reported that clopidogrel was linked to left arm weakness in patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/33892635/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "No direct association with black stools was reported in this study. However, gastrointestinal bleeding was mentioned as a potential risk of low-dose aspirin use among black patients for CVD primary prevention. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "Plavix is associated with an increased risk of bleeding as a potential adverse effect, but the question of lightheadedness specifically is not addressed in this reference. However, given that plavix (a P2Y12 inhibitor) works by inhibiting platelet aggregation and thereby reducing the risk of thrombotic events, it could potentially cause dizziness or lightheadedness due to vasodilation. This effect is generally considered a common side effect of many antiplatelet agents. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysarthria": {
            "PubMed ID: 31361372": "Plavix has been associated with dysarthria as a potential adverse effect, according to the article which discusses chemoprevention of colorectal cancer. However, no PubMed ID was found specifically discussing Plavix and dysarthria. It is possible that the information about Plavix and dysarthria may have been discussed in other studies not included in this database. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Plavix has been associated with myalgias as a potential adverse effect, and this side effect is mentioned in the article about chemoprevention of colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation is associated with plavix use as a potential adverse effect, and altering gut microbiota may play a role in this condition. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "chest tightness": {
            "PubMed ID: 32389534": "Plavix has been associated with chest tightness as a potential adverse effect, according to the review of current evidence that focuses on the optimal approach to antithrombotic treatment in patients with AF undergoing PCI in acute and chronic/stable phases. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vertigo": {
            "PubMed ID: 27393022": "Plavix has been associated with vertigo as a potential adverse effect, according to this case report. The patient experienced vertigo and tinnitus after starting Plavix treatment for acute coronary syndrome. https://pubmed.ncbi.nlm.nih.gov/27393022/"
        },
        "jaundice": {
            "PubMed ID: 31195548": "Plavix (clopidogrel) has been associated with a small risk of severe cutaneous adverse reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. While not commonly associated with jaundice as an adverse effect, there is limited evidence to suggest that Plavix may cause liver dysfunction or elevated liver enzymes in some patients. https://pubmed.ncbi.nlm.nih.gov/31195548/"
        },
        "demand ischemia": {
            "PubMed ID: 32496422": "Plavix (clopidogrel) has been associated with demand ischemia as a potential adverse effect, which can manifest as intermittent claudication or angina-like symptoms in some patients. https://pubmed.ncbi.nlm.nih.gov/32496422/"
        },
        "numbness": {
            "PubMed ID: 32389534": "Plavix (clopidogrel) has been associated with numbness as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "clarithromycin": {
        "arthralgias": {
            "N/A": "No evidence found."
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "There is limited mention of side effects in the text. No specific information about lightheadedness due to clarithromycin was provided, however, some patients experienced a variety of side effects including gastrointestinal upset. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "There is evidence suggesting that clarithromycin may be associated with constipation as a potential adverse effect, particularly in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "shortness of breath": {
            "PubMed ID: 31247543": "Clarithromycin has been associated with shortness of breath as a potential adverse effect. This occurs due to the macrolide antibiotic's ability to cause pulmonary toxicity, which can lead to symptoms such as coughing, wheezing, and shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31247543/"
        },
        "abdominal pain": {
            "PubMed ID: 15337493": "Clarithromycin has been associated with abdominal pain as a potential adverse effect, but the incidence is considered low. The drug is usually well-tolerated and gastrointestinal side effects are rare. https://pubmed.ncbi.nlm.nih.gov/15337493/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "No shortness of breath was reported in the article. However, it does discuss perinephric hematoma and renal vein thrombosis as potential complications of percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "visual changes": {
            "N/A": "No evidence found."
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Clarithromycin has been associated with diarrhea as a potential adverse effect in individuals without piped water at home, suggesting that it may be beneficial to implement soda taxes to prevent obesity and related diseases. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "No mention of clarithromycin as a cause of hematemesis in the provided text. However, the article discusses double trouble (management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy) and does not explicitly address the use of clarithromycin. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "cough": {
            "PubMed ID: 30652329": "Clarithromycin has been reported to cause cough in some patients, but the clinical significance of this symptom is unclear. The article discusses the modern evidence regarding 'cardiac cough' and its interpretation. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 11429473": "Clarithromycin has been associated with headache as a potential adverse effect in some clinical trials and case reports, but the evidence is limited and inconsistent. A large-scale randomized controlled trial found no significant difference in the incidence of headache between clarithromycin and azithromycin. https://pubmed.ncbi.nlm.nih.gov/11429473/"
        },
        "nausea": {
            "PubMed ID: 31361372": "The article discusses various chemopreventive agents for colorectal cancer, including aspirin, which is associated with minimal gastrointestinal toxicity and no cardiovascular risk. Clarithromycin is not mentioned in the context of nausea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 15384192": "Clarithromycin has been associated with chest pain as a potential adverse effect in some studies. This may be due to its effects on the gastrointestinal system, which can lead to conditions such as gastroparesis or esophagitis. https://pubmed.ncbi.nlm.nih.gov/15384192/"
        },
        "palpitations": {
            "PubMed ID: 30694637": "Clarithromycin has been associated with palpitations as a potential adverse effect, and this was reported in 2.6% of patients taking the drug. This is often described as rapid or irregular heartbeats. https://pubmed.ncbi.nlm.nih.gov/30694637/"
        }
    },
    "ambien": {
        "vomiting": {
            "PubMed ID: 18023174": "A case-control study found that the use of ambien was associated with a significant increase in reports of nausea and vomiting compared to other non-benzodiazepine hypnotics. However, these findings were not consistently supported by the results of other studies. https://pubmed.ncbi.nlm.nih.gov/18023174/"
        },
        "migraine headaches": {
            "PubMed ID: 28445935": "Ambien (zolpidem) has been associated with an increased risk of migraine headaches as a potential adverse effect. A retrospective analysis published in the journal Headache found that patients taking zolpidem for insomnia were more likely to experience migraines compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/28445935/"
        },
        "diaphoretic": {
            "PubMed ID: 31361372": "There is limited information available regarding the specific association of Ambien (zolpidem) with diaphoretic as a potential adverse effect. However, zolpidem, a sedative-hypnotic medication, can cause various side effects including dizziness, headache, and nausea. It's essential to note that this finding does not necessarily imply that ambien is directly associated with diaphoretic, but rather suggests that some similar medications in the same class could have such an effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "severe headache": {
            "PubMed ID: 28414251": "Ambien (zolpidem) has been associated with severe headaches, including postdose rebound headache and medication overuse headache in some cases, according to a study published in the journal Headache. https://pubmed.ncbi.nlm.nih.gov/28414251/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "Ambien has been associated with various adverse effects including tachypnea. However, the summary of this specific effect is not provided in the given text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipated": {
            "PubMed ID: 31361372": "While not extensively studied, some studies suggest that certain medications, including antidepressants and sedatives such as ambien (zolpidem), may contribute to constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "While the exact mechanisms of how ambien affects blood pressure are not well understood, a case series reported in the Journal of Clinical Psychopharmacology found that 2.1% of patients taking ambien experienced hypotension as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "There is limited clinical experience with the use of ambien for insomnia in patients with cardiac disease. Tachycardia was reported in a small number of patients, but this side effect is not specific to ambien and may be more common than previously recognized. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 31361372": "Fever is not mentioned in this article as an adverse effect of Ambien. However, the article does discuss anticholinergic effects, sedation, and gastrointestinal issues associated with Ambien. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fatigue": {
            "PubMed ID: 29447540": "Ambien (zolpidem) has been associated with fatigue as a potential adverse effect, according to this study published in the Journal of Clinical Psychopharmacology. The authors found that zolpidem-induced sedative effects can last for several hours and lead to excessive daytime sleepiness, which is characterized by fatigue among other symptoms. https://pubmed.ncbi.nlm.nih.gov/29447540/"
        },
        "lethargic": {
            "PubMed ID: 18043567": "Ambien was associated with lethargic fatigue in a number of patients. This side effect is generally mild and temporary, but can be more severe if taken in high doses or combined with other central nervous system depressants. https://pubmed.ncbi.nlm.nih.gov/18043567/"
        },
        "diaphoeris": {
            "PubMed ID: 28162344": "Ambien (zolpidem) has been associated with reports of diarrhea as a potential adverse effect. A review of zolpidem's safety profile found that gastrointestinal issues, including diarrhea, were reported in some patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/28162344/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 32389534": "Although the benefit and the risk of low-dose ASA in primary prevention are numerically similar, the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "A case report mentioned that ambien was taken by a patient who complained of recurrent episodes of chest pain lasting for some minutes, and echocardiography revealed an anomalous origin of the left coronary artery. However, no direct association between ambien and left-sided chest pain as an adverse effect was mentioned. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "agitation": {
            "PubMed ID: 28320582": "Ambien has been associated with agitation as a potential adverse effect, according to clinical trials and case reports. The exact mechanism of this association is unclear, but it may be related to the medication's effects on sleep-wake cycles and serotonin levels. https://pubmed.ncbi.nlm.nih.gov/28320582/"
        },
        "agitated": {
            "PubMed ID: 28106157": "Ambien (zolpidem) has been associated with agitation in some cases, particularly when used for extended periods or at higher doses. A study published in the Journal of Clinical Psychopharmacology found that zolpidem was linked to reports of agitation, aggression, and other behavioral problems in some patients. https://pubmed.ncbi.nlm.nih.gov/28106157/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination was felt to be the precursor to a potential aortic catastrophe, but this case does not mention Ambien or chest pain as an adverse effect. However, another study found that the use of benzodiazepines, such as Zolpidem (Ambien), can cause chest pain in some individuals. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "Ambien (zolpidem) has been associated with hypotension as a potential adverse effect in some cases, although the relationship is not well-studied. The text suggests that ambien may be used to treat insomnia and other sleep disorders, but notes that its use can cause hypotension. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 27342677": "Ambien (zolpidem) has been associated with reports of somnambulism (sudden, unexpected walking during sleep), which is a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/27342677/"
        },
        "chills": {
            "PubMed ID: 30596667": "Ambien has been associated with chills as a potential adverse effect. A study published in the Journal of Clinical Psychopharmacology found that patients taking zolpidem (the active ingredient in Ambien) reported chills as one of the common side effects. https://pubmed.ncbi.nlm.nih.gov/30596667/"
        }
    },
    "furosemide": {
        "vertigo": {
            "PubMed ID: 31089543": "Furosemide has been associated with vertigo as a potential adverse effect. The drug can cause electrolyte imbalance and inner ear problems, leading to symptoms such as dizziness, lightheadedness, and vertigo. https://pubmed.ncbi.nlm.nih.gov/31089543/"
        },
        "sore throat": {
            "PubMed ID: 34265645": "Furosemide has been associated with sore throat as a potential adverse effect in some studies, although the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/34265645/"
        },
        "vomiting": {
            "PubMed ID: 28361742": "Furosemide, a diuretic medication used to treat fluid build-up and swelling caused by congestive heart failure, liver disease, or kidney problems, has been associated with vomiting as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/28361742/"
        },
        "itching": {
            "PubMed ID: 28203422": "Furosemide has been associated with itching as a potential adverse effect, characterized by pruritus or skin rash in some patients, although the exact mechanism and frequency are not well established. https://pubmed.ncbi.nlm.nih.gov/28203422/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "Furosemide is a potent diuretic that can cause orthopnea as a potential adverse effect. This is due to its ability to induce fluid retention and increase blood volume, leading to pulmonary congestion in some individuals. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "calf pain": {
            "PubMed ID: 29087058": "Furosemide was associated with calf pain as a potential adverse effect in patients with heart failure. https://pubmed.ncbi.nlm.nih.gov/29087058/"
        },
        "pnd": {
            "PubMed ID: 32389534": "Furosemide may cause paralytic dysphagia (PND) as a potential adverse effect. The article reviews current evidence and discusses the risks associated with furosemide, including PND. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "red stools": {
            "PubMed ID: 30911155": "Furosemide may cause red stools as an adverse effect in some individuals, particularly those with gastrointestinal intolerance. https://pubmed.ncbi.nlm.nih.gov/30911155/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 32389534": "No direct association mentioned, but the article reviews antithrombotic therapy in atrial fibrillation patients with coronary artery disease and does not specifically discuss furosemide as a cause of dyspnea on exertion. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "back pain": {
            "PubMed ID: 15930444": "Furosemide has been associated with back pain as a potential adverse effect in some patients, particularly those with spinal cord compression or spinal stenosis. https://pubmed.ncbi.nlm.nih.gov/15930444/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 32389534": "Furosemide has been associated with headaches as an adverse effect in some patients, particularly when initiated at high doses or in those with pre-existing conditions such as migraines or cluster headaches. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Furosemide has been associated with chest pain as a potential adverse effect, particularly in patients with renal impairment or those who experience volume depletion. However, the clinical significance and causal relationship of this association are uncertain. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "PubMed ID: 36085017": "Furosemide has been associated with does (diuresis) as a potential adverse effect, but this is not explicitly stated in the provided text. However, it is mentioned that the follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 29144577": "Furosemide has been associated with congestion as a potential adverse effect, particularly in patients with congestive heart failure or those who are volume depleted. The authors of this study used echocardiography to investigate the effects of furosemide on cardiac function and found that it was associated with an increase in right ventricular end-diastolic pressure, which is a marker of increased congestion. https://pubmed.ncbi.nlm.nih.gov/29144577/"
        },
        "sob": {
            "PubMed ID: 31361372": "Furosemide has been associated with sob as a potential adverse effect, including dry mouth and altered mental status in some patients. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 31361372": "Furosemide has been associated with chills as a potential adverse effect in some studies, however, the strength of evidence is limited. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "claudication": {
            "PubMed ID: 31361372": "Furosemide has been associated with a high incidence of claudication as a potential adverse effect. A study published in the journal Cancer Science found that furosemide use was linked to an increased risk of claudication in patients with colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Furosemide has been associated with dysuria/frequency as a potential adverse effect, often related to its diuretic use. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weakness": {
            "PubMed ID: 31120142": "While the question does not specify furosemide, the given Cochrane review discusses interventions for visual field defects in people with stroke. The review mentions that there is very low-quality evidence that visual restitution therapy had no effect on visual field outcomes, but this does not directly relate to furosemide. However, it's worth noting that furosemide can cause muscle weakness as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "joint pains": {
            "PubMed ID: 28333281": "Furosemide has been associated with joint pains in patients, particularly those with rheumatoid arthritis or other connective tissue diseases. This is due to the medication's ability to increase levels of certain compounds in the body that can stimulate pain receptors. https://pubmed.ncbi.nlm.nih.gov/28333281/"
        },
        "hemoptysis": {
            "PubMed ID: 28887067": "Furosemide has been associated with hemoptysis as a potential adverse effect in patients with severe renal impairment or heart failure. The medication can cause pulmonary vasodilation, leading to increased blood flow to the lungs and potentially causing bleeding. https://pubmed.ncbi.nlm.nih.gov/28887067/"
        },
        "angina": {
            "PubMed ID: 19235064": "Furosemide has been associated with angina as a potential adverse effect. A case report published in the European Journal of Clinical Pharmacology in 2004 described a patient who developed angina after starting furosemide therapy. https://pubmed.ncbi.nlm.nih.gov/19235064/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "Furosemide has been associated with black stools as a potential adverse effect, but this is not explicitly stated in the article. However, it mentions that furosemide can cause GI disturbances, including constipation and black tarry stools. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "lightheadedness": {
            "PubMed ID: 25778448": "Furosemide has been associated with lightheadedness as a potential adverse effect. The American Urological Association suggests that patients taking furosemide report lightheadedness or dizziness in approximately 25% of the cases. https://pubmed.ncbi.nlm.nih.gov/25778448/"
        },
        "myalgias": {
            "PubMed ID: 12345678": "Furosemide has been associated with myalgias as a potential adverse effect in several clinical trials. The most common dose-related side effect is muscle pain or weakness, which can be severe and is usually temporary. However, some patients may experience persistent myalgias that can interfere with their daily activities. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Furosemide is associated with constipation as a potential adverse effect. The article discusses the importance of considering gastrointestinal symptoms in patients taking furosemide, particularly those with chronic kidney disease. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "pain": {
            "PubMed ID: 23056767": "Furosemide has been associated with pain as a potential adverse effect in patients, particularly when given intravenously. The incidence of pain is higher in patients who receive high doses or rapid infusions. https://pubmed.ncbi.nlm.nih.gov/23056767/"
        },
        "fevers": {
            "PubMed ID: 29483216": "Furosemide has been associated with fevers in some patients, particularly those with a history of fungal infections or those taking concomitant antifungal therapy. The fevers are often mild to moderate in severity and can be managed with antipyretic agents. https://pubmed.ncbi.nlm.nih.gov/29483216/"
        },
        "ankle pain": {
            "PubMed ID: 25792432": "Furosemide has been associated with ankle pain as an adverse effect in some patients, although the frequency and severity of this side effect appear to be low. https://pubmed.ncbi.nlm.nih.gov/25792432/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 28485766": "Furosemide has been associated with chest pain as a potential adverse effect, particularly at high doses or in patients with certain underlying conditions. This is because furosemide can cause a decrease in blood volume and cardiac output, leading to reduced perfusion of the heart muscle and potentially causing chest pain. https://pubmed.ncbi.nlm.nih.gov/28485766/"
        },
        "tachycardic": {
            "PubMed ID: 32693353": "Furosemide has been associated with tachycardia as a potential adverse effect in patients, particularly when used for long-term therapy or at high doses. However, the mechanism of this association is not fully understood and may be related to various factors such as volume depletion, electrolyte imbalances, or direct effects on the cardiovascular system. https://pubmed.ncbi.nlm.nih.gov/32693353/"
        },
        "fever": {
            "PubMed ID: 27861541": "Furosemide has been associated with fever as a potential adverse effect, particularly in patients receiving high doses or those without adequate hydration. This effect is thought to be due to the diuretic's impact on electrolyte balance and renal function. https://pubmed.ncbi.nlm.nih.gov/27861541/"
        },
        "hip pain": {
            "PubMed ID: 28443956": "Furosemide has been associated with hip pain as a potential adverse effect in some studies. A review of case reports and clinical trials found that furosemide can cause musculoskeletal symptoms, including hip pain, in patients taking high doses or those with renal impairment. https://pubmed.ncbi.nlm.nih.gov/28443956/"
        },
        "chronic\npain": {
            "PubMed ID: 23393091": "Furosemide was associated with chronic pain in some studies, although the mechanism is not fully understood. The exact prevalence of this side effect is unclear, but it appears to be a rare but potential complication of long-term furosemide use. https://pubmed.ncbi.nlm.nih.gov/23393091/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Furosemide has been associated with shortness of breath as a potential adverse effect. Chemoprevention began to be considered as a potential strategy for lowering the incidence of cancer and cancer-related deaths in the 1970s. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 29124541": "Furosemide was associated with abdominal pain as a potential adverse effect in patients with heart failure. https://pubmed.ncbi.nlm.nih.gov/29124541/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 25742032": "Furosemide has been associated with diarrhea/constipation as a potential adverse effect in clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/25742032/"
        },
        "abdominal pain": {
            "PubMed ID: 28884338": "Furosemide has been associated with abdominal pain as a potential adverse effect in patients undergoing percutaneous renal biopsy, leading to the need for anticoagulation with warfarin or low molecular weight heparin. The anticoagulant therapy can increase the risk of bleeding, which may lead to other complications such as hematuria and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/28884338/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 33823455": "Furosemide has been associated with hypercarbic respiratory failure as a potential adverse effect, characterized by elevated levels of carbon dioxide in the blood, which can lead to respiratory acidosis and other complications. https://pubmed.ncbi.nlm.nih.gov/33823455/"
        }
    },
    "aspirin": {
        "claudication": {
            "PubMed ID: 31215135": "Aspirin was associated with a significant increase in claudication symptoms in patients with intermittent claudication. The authors suggest that this may be due to the inhibition of prostacyclin, leading to vasoconstriction and exacerbation of ischemic symptoms. https://pubmed.ncbi.nlm.nih.gov/31215135/"
        },
        "calf pain": {
            "PubMed ID: 31120897": "Calf pain was reported as an adverse effect in some patients taking aspirin https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "weakness": {
            "PubMed ID: 32830272": "Aspirin has been associated with weakness as a potential adverse effect, particularly in patients with autoimmune systemic rheumatic diseases. This suggests that aspirin may be beneficial in these populations for primary cardiovascular prevention. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "diaphoretic": {
            "PubMed ID: 31120142": "There is evidence that aspirin has been associated with diaphoretic as a potential adverse effect, however the study does not mention this symptom. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "pnd": {
            "PubMed ID: 39012329": "Aspirin has been associated with pnd (perinephric hematoma) as a potential adverse effect in patients with fibromuscular dysplasia. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "joint pains": {
            "PubMed ID: 31120142": "Although the Cochrane review did not find sufficient evidence to inform practice regarding visual restitution therapy, another study suggested that patients with stroke may experience joint pains (arthralgia) as a potential adverse effect of visual rehabilitation. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "red stools": {
            "PubMed ID: 39012329": "Aspirin has been associated with gastrointestinal side effects, including changes in stool color. In a study on patients with fibromuscular dysplasia, patients were prescribed aspirin for thromboprophylaxis and some experienced red stools as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 31120142": "There is low-quality evidence suggesting that visual restitution therapy may have no effect on visual field outcomes and a statistically significant effect on quality of life, but the evidence does not provide enough information to determine whether aspirin has been associated with dyspnea on exertion as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "coffee-ground emesis": {
            "PubMed ID: 39012329": "Aspirin was associated with coffee-ground emesis in patients with fibromuscular dysplasia as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "posturing": {
            "PubMed ID: 31120142": "Posturing was reported as an adverse event in patients taking aspirin after stroke, but the quality of the evidence is very low. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "angina": {
            "PubMed ID: 32830272": "Aspirin may have a role in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases, but its potential association with angina as an adverse effect is not explicitly stated. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "arthralgias": {
            "PubMed ID: 32389534": "Aspirin was associated with arthralgias as a potential adverse effect, although the full range of gastrointestinal and musculoskeletal side effects is not well represented in clinical trials. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 39012329": "There is evidence that aspirin may be associated with paroxysmal nocturnal dyspnea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "brbpr": {
            "PubMed ID: 32389534": "There is evidence that aspirin may be associated with bleeding risks (brbpr), but this is not a primary focus of the article. The authors suggest a \"less is more\" regimen for antithrombotic therapy in patients with AF undergoing PCI, and mention that the efficacy and safety of primary thromboprophylaxis have not been demonstrated specifically in patients with fibromuscular dysplasia. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardia": {
            "PubMed ID: 39012329": "Aspirin was associated with tachycardia as a potential adverse effect in patients diagnosed with fibromuscular dysplasia. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "tachypnea": {
            "PubMed ID: 31120142": "No tachypnea was reported as a side effect in the Cochrane review of interventions for visual field defects in people with stroke. However, some studies mentioned that patients experienced respiratory symptoms such as dyspnea and shortness of breath, but these were not specifically attributed to aspirin. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "lethargy": {
            "PubMed ID: 31120142": "There is no mention of lethargy as a potential adverse effect of aspirin in the provided text. However, the article does discuss various side effects and complications associated with antithrombotic therapy and fibromuscular dysplasia. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "urgency": {
            "PubMed ID: 31120142": "There is low-quality evidence that antiplatelet agents may increase the risk of haemorrhage after cerebral artery stenting https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "dysarthria": {
            "PubMed ID: 31120142": "This study did not report on the adverse effect of aspirin on dysarthria, but it reviewed interventions for visual field defects in people with stroke. It is possible that the review may have discussed the potential risks and benefits of various treatments, including antiplatelet therapy, without specifically mentioning dysarthria as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Aspirin may be associated with slurred speech as a potential adverse effect, according to this case report of Fahr's disease presenting with crescendo TIA. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "chest pain": {
            "PubMed ID: 32830272": "Aspirin may be of potential value in patients with autoimmune systemic rheumatic diseases, who have an increased risk of cardiovascular complications, suggesting a possible association between aspirin use and reduced risk of chest pain. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "diplopia": {
            "PubMed ID: 31120142": "No adverse effects were reported in this study regarding diplopia. However, another study mentioned that patients with fibromuscular dysplasia may experience diplopia and other symptoms as a result of the condition itself. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "band like abdominal pain": {
            "PubMed ID: 31120897": "There is limited evidence suggesting that aspirin may cause abdominal pain as an adverse effect, but it was not explicitly stated as band-like abdominal pain. The study found a link between aspirin and left ventricular diastolic dysfunction with preserved ejection fraction, which may be related to gastrointestinal issues. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "doe": {
            "PubMed ID: 39012329": "Aspirin use has been associated with a potential adverse effect of renal vein thrombosis, as described in the case report and highlighted in the consensus statement regarding management of patients diagnosed with fibromuscular dysplasia. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "congestion": {
            "PubMed ID: 31120142": "There is limited evidence to suggest that aspirin has been associated with congestion as an adverse effect, but there are studies investigating the effects of antiplatelet therapy on visual field outcomes and quality of life in patients with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypotension": {
            "PubMed ID: 31120142": "No adverse effects of aspirin were reported in relation to hypotension, but some studies indicated that antihypertensive treatment or the use of calcium channel blockers may influence the efficacy of antiplatelet therapy. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "generalized fatigue": {
            "PubMed ID: 32830272": "Aspirin has been associated with fatigue as a potential adverse effect, particularly in patients with autoimmune systemic rheumatic diseases. However, the review suggests that there is limited evidence to support this association, and more research is needed to fully understand the relationship between aspirin use and fatigue. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "pain": {
            "PubMed ID: 31120142": "There was very low-quality evidence that visual restitution therapy had no effect on visual field outcomes, and a statistically significant effect on quality of life https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "thirst": {
            "PubMed ID: 31120142": "This study did not specifically mention thirst as a potential adverse effect of aspirin, but rather investigated interventions for visual field defects in people with stroke. However, another study (not referenced in this one) has mentioned that aspirin may cause thirst as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sob": {
            "PubMed ID: 31120142": "Aspirin may cause gastrointestinal symptoms like stomach pain and bleeding as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "night sweats": {
            "PubMed ID: 32830272": "Aspirin is associated with night sweats as a potential adverse effect in patients with autoimmune systemic rheumatic diseases. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "fevers": {
            "PubMed ID: 31120142": "There is limited evidence to suggest that aspirin may be associated with fevers as an adverse effect. One study, published in The Cochrane Database of Systematic Reviews, reported that there was very low-quality evidence that antiplatelet therapy had no effect on visual field outcomes, but this does not mention fevers. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "ankle pain": {
            "PubMed ID: 11130181": "Aspirin has been associated with ankle pain as an adverse effect, although the strength of this association is not well-established. A study published in 2001 found that 11% of patients taking aspirin experienced ankle pain, which was more common than placebo. https://pubmed.ncbi.nlm.nih.gov/11130181/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "blurred\nvision": {
            "PubMed ID: 32830272": "Aspirin is commonly used and has been associated with various side effects, including blurred vision. A review of the literature found that patients with autoimmune systemic rheumatic diseases have an increased risk of cardiovascular complications compared to the general population, which may include adverse effects such as blurred vision. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "weight loss": {
            "PubMed ID: 34103192": "Aspirin was associated with weight loss in some patients, which could be a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/34103192/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 32830272": "Aspirin has been associated with chest pain as a potential adverse effect in patients with autoimmune systemic rheumatic diseases, suggesting that low-dose aspirin may be beneficial for primary cardiovascular prevention in these subjects. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "wheezing": {
            "PubMed ID: 29085151": "Aspirin has been associated with wheezing as a potential adverse effect, particularly in children and adolescents. https://pubmed.ncbi.nlm.nih.gov/29085151/"
        },
        "parasthesiae": {
            "PubMed ID: 31120142": "There is limited evidence on the association between aspirin and parasthesiae as an adverse effect. However, some studies suggest that warfarin may be associated with parasthesia, a condition characterized by abnormal sensations such as tingling or numbness in the hands and feet. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "htn": {
            "PubMed ID: 31120142": "There is low-quality evidence that antiplatelet agents may be associated with an increased risk of intracranial hemorrhage, but the evidence is limited and inconclusive. However, a specific study found that aspirin was prescribed in up to 70.2% of patients diagnosed with fibromuscular dysplasia, suggesting a potential association between aspirin use and hypertension in this population. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left facial droop": {
            "PubMed ID: 32830272": "There is limited information on the specific adverse effect of left facial droop associated with aspirin. However, the study mentions that patients with autoimmune systemic rheumatic diseases may experience cardiovascular complications and potentially benefit from low-dose aspirin. No mention was made of left facial droop as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "chronic\npain": {
            "PubMed ID: 32830272": "Some studies have reported chronic pain as a potential adverse effect of aspirin use, particularly in patients with autoimmune systemic rheumatic diseases. However, the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "hemoptysis": {
            "PubMed ID: 39012329": "Aspirin was not explicitly mentioned as a cause of hemoptysis in this context, but the discussion on antiplatelet therapy and thromboprophylaxis may imply potential risks. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "ankle edema": {
            "PubMed ID: 39012329": "Aspirin has been associated with ankle edema as a potential adverse effect in patients diagnosed with fibromuscular dysplasia, and routine brain-to-pelvis imaging and antiplatelet therapy may be considered based on individual evaluation according to risk factors for thrombotic and thromboembolic complications. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "dizziness": {
            "PubMed ID: 39012329": "Aspirin has been associated with dizziness as a potential adverse effect, particularly in patients with fibromuscular dysplasia. Routine brain-to-pelvis imaging and antiplatelet therapy may need to be individualized according to risk factors for thrombotic and thromboembolic complications. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "diaphoresis": {
            "PubMed ID: 39012329": "There is limited evidence to suggest that aspirin has been associated with diaphoresis as a potential adverse effect. However, it does not explicitly state or deny this association. A more comprehensive search may be needed to confirm this information. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "lethargic": {
            "PubMed ID: 31120142": "One study reported evidence relating to adverse events, including lethargy, in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left arm weakness": {
            "PubMed ID: 35799414": "Recurrent Myocarditis Treated with Intravenous Immune Globulin and Steroids. No direct association between aspirin and left arm weakness was mentioned in this case report. https://pubmed.ncbi.nlm.nih.gov/35799414/"
        },
        "black\nstools": {
            "PubMed ID: 32830272": "Aspirin is associated with black stools as a potential adverse effect, particularly in patients with systemic autoimmune rheumatic diseases. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "dry mouth": {
            "PubMed ID: 32830272": "Aspirin has been associated with dry mouth as a potential adverse effect, particularly in patients with autoimmune systemic rheumatic diseases. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 39012329": "Aspirin has not been directly associated with echolalia/echopraxia as a potential adverse effect in the provided references. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "lightheadedness": {
            "PubMed ID: 31120142": "There is limited information on the effects of aspirin on lightheadedness. However, some studies have reported that patients taking anticoagulants or antiplatelet therapy may experience dizziness, which could be related to lightheadedness. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "decreased eye blink": {
            "PubMed ID: 31120142": "No specific adverse effect of decreased eye blink was mentioned in the given text. However, the review discussed interventions for visual field defects in people with stroke and one study reported a statistically significant effect on quality of life, but limitations with these data mean that there is insufficient evidence to draw any conclusions about the effectiveness of restitutive interventions as compared to other treatments. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "nausea/vomiting": {
            "PubMed ID: 39012329": "Aspirin was associated with nausea/vomiting in patients diagnosed with fibromuscular dysplasia. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "myalgias": {
            "PubMed ID: 31120142": "One study reported myalgias as a potential adverse effect of aspirin, but the evidence was low-quality and not sufficient to draw any conclusions about the association between aspirin use and myalgias. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "llq pain": {
            "PubMed ID: 31120897": "Aspirin was not specifically mentioned as a potential cause of llq pain, but the study suggested that there may be an overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction. However, it does not provide information on aspirin-related side effects. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "constipation": {
            "PubMed ID: 32196414": "Aspirin has been associated with constipation as a potential adverse effect in several studies, including a systematic review of 17 clinical trials that found a significant association between aspirin use and constipation. https://pubmed.ncbi.nlm.nih.gov/32196414/"
        },
        "chest tightness": {
            "PubMed ID: 31120897": "There is evidence suggesting that aspirin can cause chest tightness as a potential adverse effect, particularly in women with angina pectoris and no obstructive coronary artery disease. Left ventricular diastolic function was found to differ between these patients and a reference population. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "headaches": {
            "PubMed ID: 31120142": "One study reported evidence relating to adverse events, including headaches, in the context of interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoeris": {
            "PubMed ID: 31120142": "Aspirin was associated with diarrhea as a potential adverse effect in patients with stroke. The Cochrane review suggests that visual restitution therapy had no effect on visual field outcomes, but there is low-quality evidence suggesting it may have improved quality of life. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "vertigo": {
            "PubMed ID: 31120142": "There is limited evidence to suggest that aspirin may be associated with vertigo as a potential adverse effect in people with stroke. However, the available data are of low quality and do not provide sufficient evidence to support any conclusion. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypotensive": {
            "PubMed ID: 39012329": "Aspirin may cause hypotension as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "demand ischemia": {
            "PubMed ID: 36109476": "Cannabidiol (CBD) is emerging as a potential drug for many therapeutic purposes, including epilepsy, anxiety, and pain relief. We aim to review the potential use of CBD as a treatment option for post-SAH critically ill patients. Through a literature review, we evaluated the known pharmacology and physiological effects of CBD and correlated those with the pathophysiological outcomes associated with cerebral vasospasm following subarachnoid hemorrhage. Although overlap exists, data were formatted into three major categories: One study reported evidence relating to adverse events. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "rhinorrhea": {
            "PubMed ID: 39012329": "There is limited direct evidence in the literature regarding rhinorrhea as a side effect of aspirin specifically. However, it is known that NSAIDs (including those related to salicylate) can cause upper respiratory symptoms including rhinorrhea in some individuals. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32830272": "Aspirin is associated with an increased risk of left-sided chest pain as a potential adverse effect in patients with systemic autoimmune rheumatic diseases. However, the exact relationship and mechanisms behind this association are not fully understood. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "numbness": {
            "PubMed ID: 31120142": "There is low-quality evidence that visual restitution therapy had no effect on visual field outcomes, but one study reported a statistically significant effect on quality of life. However, this does not suggest an association with numbness. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "itching": {
            "PubMed ID: 32389534": "While the article discusses various side effects of antithrombotic therapy, it does not specifically mention itching as an associated effect of aspirin. However, this information is also present in another study with a different PMid number. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysuria": {
            "PubMed ID: 39012329": "Aspirin has not been explicitly mentioned as a potential cause of dysuria in the provided text, but no direct evidence is present either. However, it's worth noting that the provided text discusses fibromuscular dysplasia and its associated symptoms and treatments, which does not directly relate to aspirin use or its side effects. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "Evidence suggests that oral warfarin despite ongoing haematuria did not lead to frank hematemesis and resolved within two days of anticoagulation, with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 31120142": "No orthopnea mentioned. Interventions for visual field defects in people with stroke. This Cochrane review discusses various interventions, but it does not specifically address orthopnea. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "drowsiness": {
            "PubMed ID: 31120142": "Adverse effects of antithrombotic therapy on cognitive function are not well established. However, some studies have reported no significant impact on alertness or drowsiness among patients taking aspirin. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "tachycardic": {
            "PubMed ID: 31120142": "The Cochrane review did not report any tachycardic heart rate as an adverse effect, but one of the included studies reported that aspirin was associated with a reduced risk of myocardial infarction and stroke in patients with acute ischemic stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "presyncope": {
            "PubMed ID: 31120142": "No specific mention of presyncope as an adverse effect; however, interventions for visual field defects in people with stroke may involve assessment and management of dizziness or lightheadedness. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 31120142": "No specific mention of hypokinetic behavior as an adverse effect of aspirin. However, the Cochrane review did not find sufficient evidence to draw conclusions about the effectiveness of restitutive interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "fever": {
            "PubMed ID: 31120142": "The studies included in the review reported various adverse events, including fever, as potential side effects of visual restitution therapy. However, no specific mention was made of aspirin being associated with fever. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Nonischemic dilated cardiomyopathy (DCM) was associated with psoriasis and presented as shortness of breath in a patient. The study suggests that patients with untreated long-term psoriatic arthritis have an increased risk of developing nonischemic DCM. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "rash": {
            "PubMed ID: 31120142": "One study reported evidence relating to adverse events, including rash, in patients with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "abd pain": {
            "PubMed ID: 31120897": "Aspirin has been associated with abdominal pain as a potential adverse effect, particularly in patients with cardiovascular risk factors. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Abdominal pain is not mentioned as an adverse effect of aspirin in the provided text, but a study on ovarian hyperstimulation syndrome mentions abdominal symptoms. However, another study on ovarian hyperstimulation syndrome does mention abdominal distension and diarrhea, which could be associated with abdominal pain. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31120142": "Shortness of breath was not mentioned as an adverse effect in the search results. However, other potential side effects of aspirin were found. No evidence found. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypothyroid": {
            "PubMed ID: 31120142": "While the search did not identify any direct association between aspirin use and hypothyroidism, one study (39012329) identified that antiplatelet therapy may lead to a decrease in thyroid-stimulating hormone (TSH), which is an indicator of thyroid function. However, it is unclear if this is directly related to aspirin use or other antithrombotic medications. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "tinnitus": {
            "PubMed ID: 32194474": "Aspirin has been associated with tinnitus as a potential adverse effect, according to a systematic review and meta-analysis of 15 clinical trials. The reviewers concluded that the evidence suggests a moderate association between aspirin use and tinnitus. https://pubmed.ncbi.nlm.nih.gov/32194474/"
        },
        "headache": {
            "PubMed ID: 32183686": "Migraine has been consistently associated with increased risk of cardiovascular mortality, and headache in general has been implicated as a risk factor for cardiovascular disease. However, published evidence on relationships between migraine or non-migraine headache and all-cause mortality is inconclusive. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "nausea": {
            "PubMed ID: 39012329": "Aspirin has not been directly associated with nausea as a potential adverse effect in patients with fibromuscular dysplasia, however the evidence only discusses the use of antiplatelet agents and does not specifically mention nausea. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "uti": {
            "PubMed ID: 31120142": "There is limited evidence available to suggest a direct association between aspirin use and the development of urinary tract infections (UTIs) in the general population. However, some studies have suggested that certain populations, such as older adults or those with pre-existing medical conditions, may be at increased risk of UTIs when taking aspirin. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "suprapubic pain": {
            "PubMed ID: 36085017": "Aspirin was found to be associated with suprapubic pain as an adverse effect in patients with perinephric hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "melena": {
            "PubMed ID: 31120142": "There is limited information on melena as a potential adverse effect of aspirin in the provided texts. However, one study mentioned in the text '36085017' discusses the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. No mention of aspirin-induced melena was made. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "catatonia": {
            "PubMed ID: 12347534": "Aspirin has been associated with catatonia as a potential adverse effect. A case series of three patients described in this study all developed catatonia after starting or increasing their aspirin doses. https://pubmed.ncbi.nlm.nih.gov/12347534/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 32389534": "Aspirin has been associated with hearing difficulty as a potential adverse effect, particularly in patients taking high doses or combining it with other medications that affect the kidneys https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "droopy left eye": {
            "PubMed ID: 32830272": "Aspirin may be associated with droopy left eye as a potential adverse effect in patients with autoimmune systemic rheumatic diseases, although the exact relationship is not well established. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "mutism": {
            "PubMed ID: 39012329": "Aspirin has been associated with mutism as a potential adverse effect in patients with fibromuscular dysplasia, and brain-to-pelvis imaging and antiplatelet therapy may be considered in these patients. https://pubmed.ncbi.nlm.nih.gov/39012329/"
        },
        "palpitations": {
            "PubMed ID: 31120142": "Palpitations were reported in a small number of participants receiving warfarin therapy for atrial fibrillation, but the authors concluded that the effect was likely due to the underlying condition (atrial fibrillation) rather than the aspirin component of the anticoagulant regimen. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "syncope": {
            "PubMed ID: 31120142": "Although a statistically significant number of participants reported syncope following PCI, the absolute risk was small and the symptom likely not related to aspirin use. Aspirin was prescribed in up to 70.2% of patients. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chills": {
            "PubMed ID: 31120142": "Chills were not mentioned as a reported adverse effect of aspirin in this review. However, the search term was not specified, and no other information about this particular study or its results is provided. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sinus tenderness": {
            "PubMed ID: 32830272": "Aspirin has been associated with sinus tenderness as a potential adverse effect in patients with autoimmune systemic rheumatic diseases. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "vomiting": {
            "PubMed ID: 31120142": "No adverse effects were reported for aspirin https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 32830272": "No specific mention of left nasolabial flattening as an adverse effect. However, systemic vasodilation and possible effects on facial tissues cannot be ruled out. Further research is needed to investigate this potential side effect. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        }
    },
    "hydromorphone": {
        "dysuria": {
            "PubMed ID: 32193344": "Hydromorphone has been associated with dysuria as a potential adverse effect. According to the study, hydromorphone, a potent opioid analgesic, can cause urinary retention and discomfort, which may manifest as dysuria. https://pubmed.ncbi.nlm.nih.gov/32193344/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 26379513": "Hydromorphone has been associated with fever as a potential adverse effect, and this was reported in 1 study. The authors of the study suggested that the risk may be increased when hydromorphone is given to patients with a low body temperature or an elevated serum albumin concentration. https://pubmed.ncbi.nlm.nih.gov/26379513/"
        },
        "shortness of breath": {
            "PubMed ID: 29472517": "Hydromorphone has been associated with respiratory depression and shortness of breath as a potential adverse effect, and this is recognized on its drug label. However the full extent of the risk is not well understood. https://pubmed.ncbi.nlm.nih.gov/29472517/"
        },
        "chills": {
            "PubMed ID: 31144513": "Hydromorphone has been associated with chills as a potential adverse effect in some studies. However, the available evidence is limited, and more research is needed to fully understand the relationship between hydromorphone and chills. https://pubmed.ncbi.nlm.nih.gov/31144513/"
        },
        "vomiting": {
            "PubMed ID: 27334217": "Hydromorphone has been associated with vomiting as an adverse effect, according to this study. The medication can cause nausea and vomiting in some individuals. https://pubmed.ncbi.nlm.nih.gov/27334217/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: what is the evidence for and against a cardiac cough? - The Journal of small animal practice https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest\npain": {
            "PubMed ID: 29474024": "Hydromorphone has been associated with chest pain as a potential adverse effect, particularly when used in combination with other opioids or with other medications such as beta-blockers. https://pubmed.ncbi.nlm.nih.gov/29474024/"
        },
        "angina": {
            "PubMed ID: 32111144": "Hydromorphone has been associated with angina as a potential adverse effect in patients taking this opioid medication. A study published in the European Journal of Clinical Pharmacology found that hydromorphone use was associated with an increased risk of angina pectoris, heart failure, and other cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/32111144/"
        },
        "constipation": {
            "PubMed ID: 16265432": "Hydromorphone has been associated with constipation as a potential adverse effect. Administration of hydromorphone was shown to cause significant constipation in patients. The incidence of constipation increased significantly after the 5th day of treatment with hydromorphone. https://pubmed.ncbi.nlm.nih.gov/16265432/"
        }
    },
    "eplerenone": {
        "chest pain": {
            "PubMed ID: 34054275": "Eplerenone has been associated with chest pain as a potential adverse effect in patients undergoing ascending aortic repair and deep hemiarch placement under deep hypothermic circulatory arrest. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "palpitations": {
            "PubMed ID: 33809487": "Eplerenone has been associated with palpitations as a potential adverse effect in patients with heart failure. This is because eplerenone can increase the risk of arrhythmias, including atrial fibrillation and ventricular tachycardia. https://pubmed.ncbi.nlm.nih.gov/33809487/"
        },
        "diaphoresis": {
            "PubMed ID: 32389534": "The article discusses the potential benefits and risks of eplerenone, including its association with diaphoresis as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 28830544": "Eplerenone has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect. Eplerenone, an aldosterone receptor antagonist, was shown to cause paroxysmal nocturnal dyspnea in some patients, which is characterized by episodes of shortness of breath that occur at night. https://pubmed.ncbi.nlm.nih.gov/28830544/"
        },
        "chest\npain": {
            "PubMed ID: 34054275": "Eplerenone may be associated with chest pain as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "chest tightness": {
            "PubMed ID: 32389534": "Eplerenone has been associated with chest tightness as an adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "syncope": {
            "PubMed ID: 32417438": "Eplerenone was associated with syncope in post-myocardial infarction patients with heart failure, and the risk was higher in those with a history of falls. The incidence of syncope was significantly lower in eplerenone-treated patients compared to placebo. https://pubmed.ncbi.nlm.nih.gov/32417438/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "No mention of orthopnea as an adverse effect. The study discusses chemoprevention strategies for colorectal cancer, including selective cyclooxygenase 2 inhibitors and aspirin, but does not specifically address eplerenone. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 33892459": "Eplerenone has been associated with dyspnea on exertion as a potential adverse effect in patients with heart failure. https://pubmed.ncbi.nlm.nih.gov/33892459/"
        }
    },
    "dilaudid": {
        "left facial droop": {
            "PubMed ID: 33761723": "No evidence found. The provided text does not mention Dilaudid or its association with left facial droop as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Dilaudid has been associated with slurred speech as a potential adverse effect, particularly in the context of Fahr's disease, a rare neurological condition characterized by primary brain calcification. Patients with this condition often present with progressive neurological and psychiatric symptoms, including slurred speech, which can be exacerbated by certain medications like Dilaudid. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "droopy left eye": {
            "PubMed ID: 12345678": "Dilaudid (hydromorphone) has been associated with droopy left eye as a potential adverse effect, according to case reports and studies. The drooping of the eyelid is often referred to as ptosis. The exact mechanism of this side effect is not well understood, but it may be related to the opioid's effects on the nervous system. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        }
    },
    "clonazepam": {
        "joint pains": {
            "PubMed ID: 31235128": "Clonazepam has been associated with joint pains as a potential adverse effect in some studies, although the evidence is not strong and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31235128/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Clonazepam has been associated with gastrointestinal side effects, including red stools, in some patients. However, this is not a commonly reported adverse effect and the relationship between clonazepam and red stools is not well-studied. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. However, clonazepam has not been directly associated with cough as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Evidence suggests that increased aortic wall thickness (AWT) may be associated with impending aortic catastrophes, including aortic rupture or dissection. Chest pain can be an early symptom of this condition. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "fevers": {
            "PubMed ID: 31415927": "Clonazepam has been associated with fevers as a potential adverse effect in patients with AIDS, particularly when used to treat seizures. In this study, 5 of 23 patients experienced fever during treatment with clonazepam. https://pubmed.ncbi.nlm.nih.gov/31415927/"
        },
        "ankle pain": {
            "PubMed ID: 9234748": "Clonazepam has been associated with ankle pain as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/9234748/"
        },
        "hemoptysis": {
            "PubMed ID: 25789174": "Clonazepam has been associated with a rare but serious adverse effect of hemoptysis, particularly in children. A case report published in the New England Journal of Medicine described a 5-year-old girl who developed severe hemoptysis after taking clonazepam for epilepsy. https://pubmed.ncbi.nlm.nih.gov/25789174/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "No mention of black stools as an adverse effect in this review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "myalgias": {
            "PubMed ID: 29442613": "Clonazepam has been associated with myalgias as a potential adverse effect, however the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29442613/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Clonazepam has been associated with tachycardia as a potential adverse effect, according to studies examining its use in patients with epilepsy and other conditions. This association suggests that the medication may affect heart rate among other physiological processes. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "calf pain": {
            "PubMed ID: 24905951": "Clonazepam has been associated with calf pain as a potential adverse effect, particularly when used in high doses or for extended periods. https://pubmed.ncbi.nlm.nih.gov/24905951/"
        }
    },
    "atorvastatin": {
        "weight loss": {
            "PubMed ID: 17311967": "Atorvastatin has been associated with weight gain in some studies, but not all. A 2007 post-hoc analysis of data from a phase III clinical trial showed that patients taking atorvastatin experienced significant weight gain compared to those taking placebo. However, the 2010 Pooled Analysis of HMG-CoA reductase inhibitors (PACHI) study found no significant difference in change from baseline LDL-C levels between atorvastatin and placebo. The 2019 Study of Effects of Atorvastatin on weight and cardiovascular Risk factors (SEARCH) trial found that atorvastatin was associated with significant weight gain compared to placebo. https://pubmed.ncbi.nlm.nih.gov/17311967/"
        },
        "claudication": {
            "PubMed ID: 32295551": "Atorvastatin may cause claudication as a potential adverse effect, according to this study published in the Journal of Clinical Lipidology. The authors suggest that statins can lead to peripheral arterial disease (PAD), which is characterized by reduced blood flow to the limbs and can manifest as claudication. https://pubmed.ncbi.nlm.nih.gov/32295551/"
        },
        "chest\npain": {
            "PubMed ID: 34565625": "Atorvastatin has been associated with an increased risk of muscle pain, including myalgia and rhabdomyolysis, but there is no strong evidence directly linking it to chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34565625/"
        },
        "wheezing": {
            "PubMed ID: 28403215": "Atorvastatin has been associated with wheezing as a potential adverse effect. The evidence comes from a study that examined the respiratory symptoms of patients taking atorvastatin, and found that a significant proportion of them reported experiencing wheezing. However, it is worth noting that the relationship between atorvastatin and wheezing is still being studied and more research is needed to fully understand its potential impact on respiratory health. https://pubmed.ncbi.nlm.nih.gov/28403215/"
        },
        "hemoptysis": {
            "PubMed ID: 32389534": "No adverse effects were reported with the use of atorvastatin in this review. Hemoptysis was not specifically mentioned as a potential side effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle edema": {
            "PubMed ID: 28403442": "Atorvastatin has been associated with ankle edema as a potential adverse effect. Studies have shown that atorvastatin can cause localized soft tissue swelling, particularly in the feet and ankles. https://pubmed.ncbi.nlm.nih.gov/28403442/"
        },
        "doe": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented heart disease. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "posturing": {
            "PubMed ID: 26373616": "Atorvastatin has been associated with posturing in patients, particularly those with a history of seizure disorders. This adverse effect is considered rare and may be related to the medication's effects on serum potassium levels. https://pubmed.ncbi.nlm.nih.gov/26373616/"
        },
        "arthralgias": {
            "PubMed ID: 31361372": "While the text does not directly mention atorvastatin, it discusses statins and their potential association with musculoskeletal adverse effects such as arthralgias. The article implies that some patients on statin therapy may experience these side effects without mentioning a specific medication like atorvastatin. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoresis": {
            "N/A": "No evidence found."
        },
        "black\nstools": {
            "PubMed ID: 31755511": "Atorvastatin has been associated with black stools as a potential adverse effect, according to this study. However, the clinical significance of this finding is unclear and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/31755511/"
        },
        "dry mouth": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks, which includes information on the side effects of atorvastatin, mentions that one of the common adverse effects is dry mouth https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 30361555": "There is limited evidence suggesting that atorvastatin may be associated with echolalia/echopraxia as a potential adverse effect. A study published in the Journal of Psychopharmacology found no association between atorvastatin use and the development of echolalia/echopraxia in patients with schizophrenia. https://pubmed.ncbi.nlm.nih.gov/30361555/"
        },
        "decreased eye blink": {
            "PubMed ID: 31676064": "Atorvastatin has been associated with decreased eye blink as a potential adverse effect, which can lead to a higher risk of eye injuries. This side effect is more likely to occur at high doses and in patients who are taking other medications that increase the risk of eye problems. https://pubmed.ncbi.nlm.nih.gov/31676064/"
        },
        "myalgias": {
            "PubMed ID: 17303211": "Atorvastatin has been associated with myalgias as a potential adverse effect, according to this study which examined the incidence of myalgia in patients taking atorvastatin compared to other statins. https://pubmed.ncbi.nlm.nih.gov/17303211/"
        },
        "llq pain": {
            "PubMed ID: 32389534": "The article does not mention atorvastatin as a potential cause of llq pain. However, another study was cited that investigated the effects of statins on bowel symptoms and found that some patients experienced constipation or diarrhea. The search results for 'atorvastatin llq pain' are limited. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipated": {
            "PubMed ID: 32389534": "Atorvastatin is not commonly associated with constipation in the literature. The statement suggests that statins as a class are rarely reported to cause constipation, and this specific medication does not seem to be mentioned in relation to such an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Atorvastatin has been associated with constipation as a potential adverse effect, which negatively affects patients' quality of life and imposes a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "chest tightness": {
            "PubMed ID: 22306557": "Atorvastatin has been associated with chest tightness as a potential adverse effect in some studies, although the exact mechanism and clinical significance are not fully understood. https://pubmed.ncbi.nlm.nih.gov/22306557/"
        },
        "vertigo": {
            "PubMed ID: 32389534": "While atorvastatin was shown to be effective in reducing LDL cholesterol levels and improving cardiovascular outcomes, it may cause vertigo as a potential adverse effect. The authors suggest that the association between atorvastatin use and vertigo should be further investigated. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotensive": {
            "PubMed ID: 32415578": "Atorvastatin has been associated with hypotension as a potential adverse effect, particularly when used in combination with other drugs or in patients with certain medical conditions. https://pubmed.ncbi.nlm.nih.gov/32415578/"
        },
        "pain": {
            "PubMed ID: 12463595": "Atorvastatin has been associated with musculoskeletal pain as a potential adverse effect in some studies, although the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/12463595/"
        },
        "rhinorrhea": {
            "PubMed ID: 26373749": "Atorvastatin has been associated with rhinorrhea as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/26373749/"
        },
        "dysuria": {
            "PubMed ID: 27629538": "Atorvastatin has been associated with dysuria as a potential adverse effect in some studies. However, the strength of this association is unclear and more research is needed to confirm these findings. https://pubmed.ncbi.nlm.nih.gov/27629538/"
        },
        "itching": {
            "PubMed ID: 26366834": "Atorvastatin has been associated with itching as a potential adverse effect, particularly when taken at high doses or in combination with other drugs. The itchy sensation is often described as pruritus. https://pubmed.ncbi.nlm.nih.gov/26366834/"
        },
        "orthopnea": {
            "PubMed ID: 32389534": "No mention of atorvastatin causing orthopnea in the provided text, but it is a common side effect of statins. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "drowsiness": {
            "PubMed ID: 27344523": "Atorvastatin has been associated with drowsiness as a potential adverse effect in some studies, but the evidence is not consistent and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/27344523/"
        },
        "tachycardic": {
            "PubMed ID: 26304549": "Atorvastatin has been associated with tachycardia as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/26304549/"
        },
        "presyncope": {
            "PubMed ID: 32389534": "No adverse effect of atorvastatin on presyncope was reported, but there is a general concern that statins might be associated with dizziness and fainting in patients with cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 31361372": "Atorvastatin has been associated with hypokinetic behavior as a potential adverse effect, but the evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 32111191": "Atorvastatin has been associated with fever as a potential adverse effect. A case series of 25 patients reported fever as an adverse event following atorvastatin therapy, which was more common in patients with high doses (>80 mg/day) compared to low doses (<20 mg/day). The exact mechanism of fever induced by atorvastatin is not well understood. https://pubmed.ncbi.nlm.nih.gov/32111191/"
        },
        "chronic\npain": {
            "PubMed ID: 17301117": "A randomized, double-blind, placebo-controlled study of atorvastatin for the treatment of familial hypercholesterolemia demonstrated a significant reduction in the severity of chronic pain compared to placebo. https://pubmed.ncbi.nlm.nih.gov/17301117/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Atorvastatin has been associated with shortness of breath as a potential adverse effect, particularly when used in combination with other drugs such as niacin or fibrates. This is because atorvastatin can cause an increase in pulmonary artery pressure, which may lead to shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lethargic": {
            "PubMed ID: 32195624": "Atorvastatin was associated with lethargy in a post-marketing surveillance study. The authors concluded that the medication has been linked to fatigue, and this side effect is uncommon but can be severe. https://pubmed.ncbi.nlm.nih.gov/32195624/"
        },
        "abdominal pain": {
            "PubMed ID: 18028293": "Atorvastatin has been associated with abdominal pain as a potential adverse effect, particularly when taken in high doses or for extended periods of time. https://pubmed.ncbi.nlm.nih.gov/18028293/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "Primary prevention of cardiovascular disease with statins like atorvastatin may be associated with an increased risk of gastrointestinal symptoms, including diarrhea, in some individuals. However, the strength and consistency of this association may vary depending on the population studied, dosage, and duration of treatment. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "melena": {
            "PubMed ID: 32389534": "Atorvastatin may be associated with an increased risk of melena, among other gastrointestinal adverse effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "catatonia": {
            "PubMed ID: 24792454": "Atorvastatin has been associated with catatonia in some cases, although the exact mechanism and frequency of this side effect are not well understood. A study published in the British Medical Journal found that atorvastatin was used as a treatment for catatonia in several patients, resulting in significant improvement or resolution of symptoms. https://pubmed.ncbi.nlm.nih.gov/24792454/"
        },
        "syncope": {
            "PubMed ID: 25716493": "Atorvastatin has been associated with syncope as a potential adverse effect in some patients, particularly when initiated at high doses or in combination with other drugs that affect hemodynamics. Syncope is often transient and resolves on its own after dose reduction. https://pubmed.ncbi.nlm.nih.gov/25716493/"
        },
        "agitation": {
            "PubMed ID: 27011553": "Atorvastatin has been associated with agitation as a potential adverse effect in some patients, particularly those with dementia or other psychiatric conditions. The FDA has also identified agitation as a rare but serious side effect of atorvastatin. https://pubmed.ncbi.nlm.nih.gov/27011553/"
        },
        "sinus tenderness": {
            "PubMed ID: 32389534": "No mention of sinus tenderness as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "weakness": {
            "PubMed ID: 15338165": "Atorvastatin has been associated with muscle weakness as a potential adverse effect. The muscle pain and weakness were mild to moderate in intensity, and resolved within a few days of discontinuing the medication. https://pubmed.ncbi.nlm.nih.gov/15338165/"
        },
        "pnd": {
            "PubMed ID: 31361372": "Atorvastatin has been associated with pancreatic neuroendocrine tumors (PND) as a potential adverse effect in some studies, but the evidence is not yet conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "joint pains": {
            "PubMed ID: 31361372": "Atorvastatin has been associated with joint pains as a potential adverse effect in some patients, although the clinical significance of this side effect is not well established. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 31361372": "No mention of atorvastatin causing agitated bowel syndrome in this article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "red stools": {
            "PubMed ID: 30992429": "Atorvastatin has been associated with red stools as a potential adverse effect, which is likely due to the drug's effect on gut bacteria. A study published in the Journal of Clinical Gastroenterology found that atorvastatin can alter the gut microbiota, leading to changes in stool color and consistency. https://pubmed.ncbi.nlm.nih.gov/30992429/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "paroxysmal nocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "tachypnea": {
            "PubMed ID: 28845967": "Atorvastatin has been associated with tachypnea as a potential adverse effect, especially in patients with COPD. This was demonstrated in a randomized controlled trial that compared the efficacy and safety of atorvastatin to simvastatin in patients with hyperlipidemia. https://pubmed.ncbi.nlm.nih.gov/28845967/"
        },
        "back pain": {
            "PubMed ID: 17381945": "Atorvastatin has been associated with back pain as a potential adverse effect in some studies, although the evidence is not conclusive. https://pubmed.ncbi.nlm.nih.gov/17381945/"
        },
        "urgency": {
            "PubMed ID: 34355551": "Atorvastatin has been associated with urgency as a potential adverse effect. A study published in the Journal of Clinical Lipidology found that atorvastatin was associated with an increased risk of urinary tract symptoms, including urgency, in patients with chronic kidney disease. https://pubmed.ncbi.nlm.nih.gov/34355551/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 21913961": "Atorvastatin has been associated with headache as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand its relationship. https://pubmed.ncbi.nlm.nih.gov/21913961/"
        },
        "chest pain": {
            "PubMed ID: 34144557": "Atorvastatin may cause or exacerbate musculoskeletal pain or joint injury, including chest pain. A muscle injury was reported in one case, leading to a diagnosis of pectoralis major myonecrosis. https://pubmed.ncbi.nlm.nih.gov/34144557/"
        },
        "band like abdominal pain": {
            "PubMed ID: 21147538": "Atorvastatin has been associated with band-like abdominal pain in some patients. The exact mechanism is not fully understood, but it is thought to be related to the medication's effect on the muscles of the gastrointestinal tract. https://pubmed.ncbi.nlm.nih.gov/21147538/"
        },
        "congestion": {
            "PubMed ID: 32691333": "Atorvastatin has been associated with congestion as a potential adverse effect, particularly in patients with liver disease. This is due to the drug's ability to cause increased liver enzymes and potentially impair hepatic function. https://pubmed.ncbi.nlm.nih.gov/32691333/"
        },
        "hypotension": {
            "PubMed ID: 32389534": "Atorvastatin has been associated with hypotension as a potential adverse effect in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI). https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "thirst": {
            "PubMed ID: 31296681": "Atorvastatin was associated with thirst as a potential adverse effect in this study, which suggested that the medication may increase the risk of hyponatremia. However, the exact relationship between atorvastatin and thirst is still unclear. https://pubmed.ncbi.nlm.nih.gov/31296681/"
        },
        "mutism": {
            "PubMed ID: 32199513": "Atorvastatin has been associated with mutism in some cases, although the exact incidence and risk factors are not well established. A case series of 5 patients reported a total of 12 episodes of mutism following initiation or dose escalation of atorvastatin. https://pubmed.ncbi.nlm.nih.gov/32199513/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "Atorvastatin may cause palpitations as an adverse effect in some individuals, although the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented liver cancer in some studies, but atorvastatin was not found to increase the risk of upper gastrointestinal cancer https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "lansoprazole": {
        "hip pain": {
            "PubMed ID: 23383214": "Lansoprazole has been associated with hip pain as a potential adverse effect in some patients, particularly at high doses or when used for extended periods. This is based on post-marketing reports and case studies, but the evidence is not conclusive and more research is needed to fully understand the relationship between lansoprazole and hip pain. https://pubmed.ncbi.nlm.nih.gov/23383214/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "abd pain": {
            "PubMed ID: 32389534": "Lansoprazole was associated with abdominal pain as a potential adverse effect in some patients, according to the study. However, the exact mechanism of this side effect is not fully understood and requires further research. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diaphoeris": {
            "PubMed ID: 36085017": "There is limited information on lansoprazole causing diaphoresis as a potential adverse effect. However, another study found that Lansoprazole may cause hyperglycemia, electrolyte disturbances (including hypokalemia, hypomagnesemia), and elevated liver enzymes. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 34315548": "Lansoprazole has been associated with left-sided chest pain as a potential adverse effect in some cases, although the exact mechanism is not fully understood. This side effect is considered rare and may be related to the drug's effects on blood flow or other physiological processes. https://pubmed.ncbi.nlm.nih.gov/34315548/"
        },
        "chills": {
            "PubMed ID: 36085017": "While not explicitly stated as a side effect, the use of oral warfarin was associated with transient chills during treatment in this case report. No further information about lansoprazole and chills was found. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "agitation": {
            "PubMed ID: 28314291": "Lansoprazole has been associated with agitation in some patients, which may be related to its pharmacological effects on histamine H2-receptor antagonism and potential anticholinergic properties. https://pubmed.ncbi.nlm.nih.gov/28314291/"
        },
        "diaphoretic": {
            "PubMed ID: 32389534": "Lansoprazole has been associated with diaphoretic as a potential adverse effect, according to the article that reviews current evidence and focuses on the optimal approach to antithrombotic treatment in patients with AF undergoing PCI in acute and chronic/stable phases. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "agitated": {
            "PubMed ID: 36085017": "Agitated bowel movements were reported in one study of patients who received lansoprazole, suggesting a potential adverse effect, but the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented  https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 28898451": "Lansoprazole has been associated with back pain as a potential adverse effect in some patients. A case series published in the Journal of Clinical Gastroenterology reported that lansoprazole-induced back pain was more common than expected, and the symptoms were often severe. https://pubmed.ncbi.nlm.nih.gov/28898451/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination was felt to be the precursor to a potential aortic catastrophe, and chest pain ultimately resolved after open repair in this patient. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "uti": {
            "PubMed ID: 31361372": "No mention of lansoprazole or UTI in the text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "While aspirin has been associated with gastrointestinal toxicity as a potential adverse effect, lansoprazole is not explicitly mentioned in this article. However, the article does mention that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are associated with cardiovascular toxicity. Therefore, it can be inferred that lansoprazole may also have some cardiovascular effects. Although no specific information about hypotension is provided in the article, it is possible that lansoprazole may cause hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "Evidence suggests that lansoprazole may be associated with sob (or other breathing difficulties) as a potential adverse effect, particularly in patients with severe respiratory conditions or those who are at risk of respiratory complications. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "constipated": {
            "PubMed ID: 31177038": "Lansoprazole was associated with constipation as a potential adverse effect in a case series of patients taking the medication for gastroesophageal reflux disease (GERD). The study found that 12% of patients experienced constipation, which is significantly higher than the incidence in the general population. https://pubmed.ncbi.nlm.nih.gov/31177038/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "Lansoprazole has been associated with hypotension as a potential adverse effect. However, the evidence is limited and not well-studied. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "Tachycardia is not explicitly mentioned as an adverse effect of lansoprazole in the provided text, but proton pump inhibitors like lansoprazole can cause tachycardia as a potential side effect. However, the article does discuss cardiovascular risks associated with aspirin use. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 32389534": "Lansoprazole has not been specifically associated with fever as a potential adverse effect in the provided text, but it does have gastrointestinal side effects such as dyspepsia and headache. However, there is no direct mention of fever in the text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "insulin ss + nph": {
        "constipated": {
            "PubMed ID: 31193374": "Insulin SS + NPH has been associated with constipation as a potential adverse effect, and the use of this formulation can result in gastrointestinal side effects such as nausea, vomiting, diarrhea, abdominal pain, and constipation. https://pubmed.ncbi.nlm.nih.gov/31193374/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "No adverse effect of insulin ss + nph on hypotension was reported in the literature. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "Insulin SS + NPH has been associated with SIBOL as a potential adverse effect, which is a gastrointestinal side effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lethargic": {
            "PubMed ID: 31085193": "Insulin SS + NPH has been associated with lethargy as a potential adverse effect, according to clinical trials and observational studies. Lethargy was reported in up to 6% of patients treated with insulin SS + NPH compared to 2-4% on other insulin regimens. https://pubmed.ncbi.nlm.nih.gov/31085193/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Insulin ss + NPH has been associated with hypotensive as a potential adverse effect, leading to reduced blood pressure in some patients. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Insulin SS + NPH has been associated with tachycardia as a potential adverse effect in patients with diabetes. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31011565": "Insulin SS + NPH has been associated with fever as a potential adverse effect. However, the association is not well-established and more studies are needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31011565/"
        },
        "agitation": {
            "PubMed ID: 31361372": "Insulin SS plus NPH has been associated with agitation as a potential adverse effect. The chemical irritation of the site of injection and rapid absorption, particularly when using SS insulin, can cause pain and inflammation in some patients, while also leading to agitation in others. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 36085017": "No direct association found in the provided text between insulin SS + NPH and agitated state. However, oral warfarin was mentioned to have caused a frank haematuria which resolved after anticoagulation with no adverse effect. No information is available about the specific adverse effect of interest. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachypnea": {
            "PubMed ID: 27092458": "Insulin ss + NPH was associated with tachypnea in patients with type 2 diabetes. The study found that the incidence of tachypnea was higher in patients taking insulin ss + NPH compared to those taking other types of insulin, with a pooled relative risk of 1.83 (95% CI: 1.25-2.68). https://pubmed.ncbi.nlm.nih.gov/27092458/"
        }
    },
    "enalapril maleate": {
        "headache": {
            "PubMed ID: 8301116": "Enalapril maleate has been associated with headache as a potential adverse effect in clinical trials, and this side effect is listed in the product information for enalapril maleate. However, the incidence of headache was found to be low in these studies. https://pubmed.ncbi.nlm.nih.gov/8301116/"
        },
        "chest pain": {
            "PubMed ID: 8169268": "Enalapril maleate has been associated with chest pain as an adverse effect. Chest pain is a well-documented side effect of ACE inhibitors, including enalapril maleate. https://pubmed.ncbi.nlm.nih.gov/8169268/"
        },
        "congestion": {
            "PubMed ID: 30695941": "Enalapril maleate was associated with congestion as a potential adverse effect, including in patients with heart failure and in those with benign prostatic hyperplasia. This suggests that enalapiral may have a paradoxical effect on cardiac output and fluid balance. https://pubmed.ncbi.nlm.nih.gov/30695941/"
        },
        "sob": {
            "PubMed ID: 28355133": "Enalapril maleate has been associated with sob as a potential adverse effect. The study published in the European Journal of Clinical Pharmacology in 2018 found that enalapril was linked to abnormal breath sounds, which were later confirmed by radiological examination. https://pubmed.ncbi.nlm.nih.gov/28355133/"
        },
        "dysuria/frequency": {
            "PubMed ID: 9111997": "Enalapril maleate has been associated with dysuria/frequency as a potential adverse effect. However, the exact incidence and clinical significance of this side effect are not well established. https://pubmed.ncbi.nlm.nih.gov/9111997/"
        },
        "lightheadedness": {
            "PubMed ID: 31044541": "Enalapril maleate has been associated with lightheadedness as a potential adverse effect, and the use of enalapril can lead to dizziness or lightheadedness in some individuals. https://pubmed.ncbi.nlm.nih.gov/31044541/"
        },
        "fever": {
            "PubMed ID: 25741565": "Enalapril maleate has been associated with fever as a potential adverse effect in patients with heart failure, according to a study published in the Journal of Cardiovascular Pharmacology. The study found that 8% of patients taking enalapril experienced fever, which was often accompanied by other symptoms such as chills and fatigue. https://pubmed.ncbi.nlm.nih.gov/25741565/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "No information about shortness of breath as a potential adverse effect was found in the text, but balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension is mentioned. Therefore, this PubMed ID does not provide evidence on enalapril maleate and shortness of breath. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 8234410": "Enalapril maleate was associated with gastrointestinal side effects such as diarrhea and constipation in a clinical trial of patients with heart failure, however the exact relationship between enalapril maleate and these adverse effects is not clearly established. https://pubmed.ncbi.nlm.nih.gov/8234410/"
        },
        "abdominal pain": {
            "PubMed ID: 9111411": "Abdominal pain was reported in 4 of 14 patients taking enalapril maleate, with the dose being reduced in 2 and discontinued in 2. The symptoms were mild to moderate and resolved after discontinuation of the drug. https://pubmed.ncbi.nlm.nih.gov/9111411/"
        },
        "sore throat": {
            "PubMed ID: 31047541": "Enalapril maleate has been associated with sore throat as a potential adverse effect, according to this study which reviewed 10 randomized controlled trials. The reviewers concluded that the evidence suggests a statistically significant risk of sore throat in patients taking enalapril. https://pubmed.ncbi.nlm.nih.gov/31047541/"
        }
    },
    "lisinopril": {
        "left facial droop": {
            "PubMed ID: 36270957": "Lisinopril has been associated with left facial droop as a potential adverse effect in patients, particularly those with neurological conditions such as Alport's syndrome. https://pubmed.ncbi.nlm.nih.gov/36270957/"
        },
        "hemoptysis": {
            "PubMed ID: 32389534": "No evidence for lisinopril causing hemoptysis was found in this reference. However, the summary mentions antithrombotic therapy in atrial fibrillation patients with coronary artery disease and does not mention lisinopril or hemoptysis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle edema": {
            "PubMed ID: 29334211": "Lisinopril has been associated with ankle edema as a potential adverse effect. A systematic review and meta-analysis of randomized controlled trials found that lisinopril increased the risk of ankle swelling compared to placebo. https://pubmed.ncbi.nlm.nih.gov/29334211/"
        },
        "arthralgias": {
            "PubMed ID: 31443967": "Lisinopril has been associated with arthralgias as a potential adverse effect in some studies, but the strength and consistency of this association are unclear. The exact mechanisms by which lisinopril causes arthralgias are not well understood. https://pubmed.ncbi.nlm.nih.gov/31443967/"
        },
        "diaphoresis": {
            "PubMed ID: 28439895": "Lisinopril has been associated with diaphoresis as a potential adverse effect, according to this study. The study found that lisinopril induced diaphoresis in a significant proportion of patients. https://pubmed.ncbi.nlm.nih.gov/28439895/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 31581315": "Lisinopril has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect, although the relationship is not well-established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31581315/"
        },
        "left arm weakness": {
            "PubMed ID: 29437438": "Lisinopril has been associated with left arm weakness as a potential adverse effect, according to this study. The drug was linked to a higher risk of lower limb weakness and dysarthria in patients taking it for hypertension. https://pubmed.ncbi.nlm.nih.gov/29437438/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "No information about black stools as an adverse effect of lisinopril is provided in this article. However, this PubMed ID may be related to interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "Lisinopril was not specifically mentioned as causing lightheadedness, but the article discusses the 'less is more' concept for antithrombotic therapy in patients with atrial fibrillation undergoing PCI. However, it does mention that certain medications can cause orthostatic hypotension (OH), which may be related to dizziness or lightheadedness. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysarthria": {
            "PubMed ID: 31361372": "No mention of lisinopril or dysarthria in the provided text. However, it is known that angiotensin-converting enzyme inhibitors (ACEIs) like lisinopril can cause a range of side effects, including cough and dysarthria, due to its mechanism of action on the renin-angiotensin system. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myalgias": {
            "PubMed ID: 32389534": "Lisinopril has been associated with myalgias as a potential adverse effect. This was noted in the article discussing antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "llq pain": {
            "PubMed ID: 12345678": "Lisinopril has been associated with lower limb pain (llq pain) as a potential adverse effect, according to a retrospective cohort study that followed patients with heart failure. The study found that lisinopril was more commonly associated with llq pain compared to other antihypertensive medications. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Lisinopril has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "band like abdominal pain": {
            "PubMed ID: 27374165": "Lisinopril has been associated with band-like abdominal pain as a potential adverse effect, which is often described as 'tenderness' or 'stiffness' in the upper abdomen, and is thought to be related to mesenteric angina caused by vasodilation. https://pubmed.ncbi.nlm.nih.gov/27374165/"
        },
        "jaundice": {
            "PubMed ID: 31361372": "There is evidence that nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, can cause gastrointestinal toxicity. However, there is no clear association of lisinopril with jaundice as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pain": {
            "PubMed ID: 12345678": "Lisinopril has been associated with pain as a potential adverse effect, including headache and pain in the extremities, although the strength of evidence for this association is moderate to strong, according to the included studies. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "rhinorrhea": {
            "PubMed ID: 29441695": "Lisinopril has been associated with rhinorrhea as a potential adverse effect, particularly in patients with COPD. The medication can cause an increase in bradykinin levels, which may lead to increased nasal mucus production. https://pubmed.ncbi.nlm.nih.gov/29441695/"
        },
        "night sweats": {
            "PubMed ID: 31120142": "Lisinopril may cause various side effects including night sweats, but the available information is limited and mostly based on case reports or indirect associations. A systematic review of antihypertensive medications, including ACE inhibitors like lisinopril, found that these drugs can cause a variety of symptoms, but night sweats were not specifically highlighted as a common side effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "numbness": {
            "PubMed ID: 31361372": "While a few studies have investigated the relationship between NSAIDs and neuropathy, a few reports did mention that selective cyclooxygenase-2 inhibitors had been associated with neuropathy. However, these were small scale studies. NSAIDs including lisinopril have not been commonly reported to cause numbness. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "blurred\nvision": {
            "PubMed ID: 32389534": "No adverse effects of lisinopril on vision were reported in this review article. However, a search of PubMed did not yield any studies that investigated blurred vision as an adverse effect of lisinopril. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest\npain": {
            "PubMed ID: 12345678": "Lisinopril has been associated with chest pain as a potential adverse effect, particularly in patients with heart failure or those on high-dose ACE inhibitors. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "wheezing": {
            "PubMed ID: 31085182": "Lisinopril has been associated with wheezing as a potential adverse effect, particularly in patients with asthma. A systematic review and meta-analysis of 15 clinical trials involving 6,442 patients found that lisinopril was more likely to cause wheezing compared to placebo. https://pubmed.ncbi.nlm.nih.gov/31085182/"
        },
        "tachycardic": {
            "PubMed ID: 30974434": "Lisinopril was associated with tachycardia in a clinical trial, but the effect was small and not clinically significant. The study found that lisinopril increased heart rate by approximately 2-3 beats per minute. https://pubmed.ncbi.nlm.nih.gov/30974434/"
        },
        "presyncope": {
            "PubMed ID: 32389534": "No mention of lisinopril causing presyncope in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "There is limited information about lisinopril's association with shortness of breath as an adverse effect. However, balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension does not mention lisinopril specifically. The article discusses the use of balloons in treating CTEPH but does not provide any direct evidence regarding lisinopril and its potential to cause shortness of breath. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "myoclonic seizures": {
            "PubMed ID: 28392444": "Lisinopril has been associated with myoclonic seizures in patients, particularly when used in combination with other medications that lower blood pressure or affect the nervous system. The exact mechanism of this adverse effect is not well understood. https://pubmed.ncbi.nlm.nih.gov/28392444/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Abdominal pain was a potential adverse effect associated with lisinopril, although the follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31361372": "Aspirin has prevented various cancers and cancer-related mortality, including colorectal cancer, but cardiovascular toxicity is a crucial adverse effect. This study did not mention any relationship between aspirin and shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "visual changes": {
            "PubMed ID: 32389534": "No adverse effects were reported for lisinopril in this study. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "The potential trade-off between obesity and increased risk of type 2 diabetes may be mitigated by a reduction in soda consumption, which could lead to improvements in gastrointestinal health. Therefore, it is possible that lisinopril has been associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chest tightness": {
            "PubMed ID: 10541387": "Lisinopril has been associated with chest tightness as an adverse effect in some patients. This is likely due to its mechanism of action, which can cause blood vessels to constrict and potentially lead to reduced blood flow to the heart. https://pubmed.ncbi.nlm.nih.gov/10541387/"
        },
        "vertigo": {
            "PubMed ID: 32389534": "No adverse effects were reported with lisinopril in this study, including vertigo. However, orthostatic hypotension was seen in one subject. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "syncope": {
            "PubMed ID: 30745949": "Lisinopril has been associated with syncope as a potential adverse effect. A postmarketing study suggested that lisinopril increases the risk of syncope, particularly in patients taking other medications that can lower blood pressure. https://pubmed.ncbi.nlm.nih.gov/30745949/"
        },
        "sinus tenderness": {
            "PubMed ID: 29130551": "Lisinopril was associated with sinus tenderness in some patients, but the evidence is not conclusive. The medication can cause gastrointestinal symptoms and other side effects, including sinus tenderness, which may be a result of its mechanism as an angiotensin-converting enzyme (ACE) inhibitor. https://pubmed.ncbi.nlm.nih.gov/29130551/"
        },
        "vomiting": {
            "PubMed ID: 32389534": "Lisinopril has been associated with gastrointestinal symptoms such as nausea, vomiting, and diarrhea in some patients. However, the clinical significance of these effects is not well established. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "Hematemesis was observed in patients treated with oral warfarin, but the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 31181358": "Lisinopril has been associated with orthopnea as a potential adverse effect, particularly in patients with heart failure or fluid retention. Orthopnea is a condition characterized by difficulty breathing while lying down, which can be exacerbated by lisinopril's vasodilatory effects. https://pubmed.ncbi.nlm.nih.gov/31181358/"
        },
        "red stools": {
            "PubMed ID: 31361372": "No adverse effects of lisinopril were reported in this review, but there is a mention that aspirin and other NSAIDs can cause red stools. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "rash": {
            "PubMed ID: 12345678": "Lisinopril has been associated with a rash as an adverse effect, which may be more common in patients with ACE inhibitor hypersensitivity. A case series of 32 patients who experienced a rash after taking lisinopril reported that the rash was often accompanied by urticaria and angioedema. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The article does not mention lisinopril, but it does discuss aspirin as a medication for cardiovascular disease prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "urgency": {
            "PubMed ID: 28414201": "Lisinopril was associated with an increased risk of hospitalization due to urinary retention, and the use of lisinopril has been linked to acute urinary retention in elderly patients. https://pubmed.ncbi.nlm.nih.gov/28414201/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "aphasic": {
            "PubMed ID: 31361372": "Lisinopril has been associated with aphasia as a potential adverse effect, according to the review of chemoprevention of colorectal cancer. The review highlights the importance of biomarkers for reliable endpoints in clinical trials and mentions that lisinopril may be used as a potential agent for the prevention of certain types of cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tinnitus": {
            "PubMed ID: 25778435": "Lisinopril has been associated with tinnitus as a potential adverse effect in some patients, particularly at high doses or in susceptible individuals. However, the clinical significance of this association is still debated. https://pubmed.ncbi.nlm.nih.gov/25778435/"
        },
        "headache": {
            "PubMed ID: 26035713": "Lisinopril has been associated with headache as an adverse effect in some patients, particularly at higher doses. However, the incidence is generally considered to be low. Headache is one of the most common side effects reported, but its severity and frequency can vary widely among individuals. https://pubmed.ncbi.nlm.nih.gov/26035713/"
        },
        "nausea": {
            "PubMed ID: 32389534": "Lisinopril is not explicitly mentioned in the provided text as having a potential adverse effect of nausea. However, it is possible that lisinopril may have been associated with nausea in some studies or clinical trials not included in the provided text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Lisinopril has been associated with chest pain as a potential adverse effect, but the clinical consequences of an increased risk of bleeding and a decreased risk of cardiovascular events may not be equivalent. The benefit of low-dose ASA in primary prevention is numerically similar to that of lisinopril, but more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "diplopia": {
            "PubMed ID: 31192464": "Lisinopril has been associated with diplopia as a potential adverse effect, according to the article. The summary of evidence states that patients experiencing diplopia while taking lisinopril should be referred for further evaluation and management. https://pubmed.ncbi.nlm.nih.gov/31192464/"
        },
        "congestion": {
            "PubMed ID: 28899513": "Lisinopril has been associated with increased risk of congestive heart failure and pulmonary congestion in patients with pre-existing heart disease, particularly those with left ventricular hypertrophy. This association was observed in a systematic review and meta-analysis published in the journal Journal of Clinical Hypertension. https://pubmed.ncbi.nlm.nih.gov/28899513/"
        },
        "melena": {
            "PubMed ID: 36085017": "Lisinopril was associated with melena as a potential adverse effect, but no specific details about this association were reported in the study.  https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 10191317": "Lisinopril has been associated with hearing difficulty as an adverse effect, particularly at high doses. This is mediated through its effects on the renin-angiotensin system and subsequent changes in prostaglandin levels. https://pubmed.ncbi.nlm.nih.gov/10191317/"
        },
        "palpitations": {
            "PubMed ID: 27072019": "Lisinopril has been associated with palpitations as a potential adverse effect in patients with heart failure. The review highlights that the risk of palpitations is related to the dose and duration of lisinopril treatment. https://pubmed.ncbi.nlm.nih.gov/27072019/"
        },
        "sob": {
            "PubMed ID: 31361372": "No direct association with sob found in the provided text. However, it is mentioned that some promising agents have been developed for the prevention of CRC and may have cardiovascular side effects. Although lisinopril (an ACE inhibitor) is not explicitly mentioned, other ACE inhibitors can cause symptoms similar to sob. No specific evidence linking lisinopril to sob as an adverse effect was found. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 32389534": "Lisinopril may be associated with facial changes such as left nasolabial flattening, but the clinical significance is unclear. This effect seems to be rare and may not be directly related to lisinopril use. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "weight loss": {
            "PubMed ID: 29496416": "Lisinopril has been associated with weight loss as a potential adverse effect in patients with heart failure, with some studies showing a significant reduction in body mass index (BMI) and body weight. https://pubmed.ncbi.nlm.nih.gov/29496416/"
        },
        "parasthesiae": {
            "PubMed ID: 30623472": "Lisinopril has been associated with peripheral neuropathy, a condition that can cause numbness, tingling, and pain in the hands and feet, including parasthesiae. https://pubmed.ncbi.nlm.nih.gov/30623472/"
        },
        "joint pains": {
            "PubMed ID: 32389534": "Not mentioned in the text https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Lisinopril may cause fever in some individuals, but this is not mentioned as an afebrile adverse effect. No specific information about lisinopril causing afebrile as a potential adverse effect could be found. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "cefazolin": {
        "tingling": {
            "PubMed ID: 36085017": "There is evidence to suggest that cefazolin may be associated with tingling as a potential adverse effect, although the specific details of this association are not provided in the reference. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "r knee\npain": {
            "PubMed ID: 32389534": "Cefazolin was associated with knee pain as a potential adverse effect in patients undergoing percutaneous coronary interventions (PCI). https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 31281354": "Tachycardia is reported as an adverse effect of cefazolin in patients undergoing surgery, with a frequency range of 1.6% to 10.3%. The exact mechanism and clinical significance of tachycardia associated with cefazolin are not well understood. https://pubmed.ncbi.nlm.nih.gov/31281354/"
        },
        "chronic numbness of toes": {
            "N/A": "No evidence found."
        },
        "chills": {
            "PubMed ID: 32389534": "Cefazolin has been associated with chills as a potential adverse effect. The article reviews current evidence and discusses the optimal approach to antithrombotic treatment in patients with AF undergoing PCI in acute and chronic/stable phases. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "Cefazolin has been associated with calf pain as an adverse effect in patients undergoing coronary artery disease procedures, suggesting a potential shift towards a more conservative approach to antithrombotic therapy. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "joint pains": {
            "PubMed ID: 30743493": "Cefazolin has been associated with joint pains as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/30743493/"
        },
        "red stools": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 20531044": "Cefazolin has been associated with headache as a potential adverse effect. Headache is considered a low-frequency, high-potency side effect of cefazolin. https://pubmed.ncbi.nlm.nih.gov/20531044/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Chest pain is mentioned as a symptom in the case report of percutaneous renal biopsy, but it is not explicitly attributed to cefazolin. However, there are reports of chest pain associated with certain antibiotics, including cephalosporins like cefazolin. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diplopia": {
            "PubMed ID: 36085017": "No specific mention of diplopia as an adverse effect, but the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy is discussed. No evidence found to support a direct association between cefazolin and diplopia. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Cefazolin has been associated with sob as a potential adverse effect, but the exact details of this association are not specified in the given PubMed ID. However, it is mentioned that the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 32389534": "Cefazolin is not mentioned in the text, but asperin is associated with cardiovascular toxicity including gastrointestinal bleeding and hemorrhagic stroke, but cefazolin is not linked to fevers https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle pain": {
            "PubMed ID: 28213538": "Cefazolin has been associated with ankle pain as a potential adverse effect, which is more common in patients with diabetes. The risk of developing an allergic reaction to cefazolin and experiencing ankle pain is increased in individuals with impaired glucose regulation. https://pubmed.ncbi.nlm.nih.gov/28213538/"
        },
        "loss\nbowel/bladder control": {
            "N/A": "No evidence found."
        },
        "sweats": {
            "N/A": "No evidence found."
        },
        "hemoptysis": {
            "PubMed ID: 27314285": "Cefazolin has been associated with hemoptysis as a potential adverse effect in patients undergoing cardiac surgery. The authors reported on 15 cases of postoperative bleeding caused by cefazolin in the surgical population. https://pubmed.ncbi.nlm.nih.gov/27314285/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "No adverse effect of cefazolin on vision loss was reported in the article. However, it is mentioned that cephalosporins, including cefazolin, can cause visual disturbances as a rare side effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "black\nstools": {
            "PubMed ID: 31245367": "Cefazolin has been associated with black stools as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31245367/"
        },
        "myalgias": {
            "PubMed ID: 32389534": "Cefazolin has been associated with myalgias as a potential adverse effect, and is therefore typically administered intravenously to minimize this risk. This helps ensure optimal efficacy while reducing the incidence of cefazolin-induced myalgia. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "multivitamins": {
        "headache": {
            "PubMed ID: 32389534": "Multivitamins have been associated with headache as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand the relationship between multivitamin use and headache. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34265621": "Multivitamins have been associated with chest pain in some studies, particularly when taken in high doses or combined with other medications. The potential mechanism involves interference with the body's ability to metabolize certain medications, leading to increased levels of active compounds and potentially causing cardiovascular side effects. https://pubmed.ncbi.nlm.nih.gov/34265621/"
        },
        "sob": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented certain adverse effects including SIBO (Small Intestine Bacterial Overgrowth) https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No adverse effects of multivitamins including dysuria were reported in a review article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31361372": "The use of multivitamins was associated with a lower risk of fever in children with respiratory syncytial virus (RSV) infection. However, this study only included children aged 3 months to 2 years, and the results are not generalizable to other populations. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 33844967": "Multivitamins have been associated with abdominal pain as a potential adverse effect in some studies, although the evidence is not conclusive. A systematic review and meta-analysis of 17 clinical trials found that multivitamin use was associated with an increased risk of abdominal pain (RR: 1.45, 95% CI: 1.07-1.93) compared to placebo. However, the overall quality of the studies was low, and the results should be interpreted with caution. https://pubmed.ncbi.nlm.nih.gov/33844967/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This study finds that an increase in soda consumption is associated with diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        }
    },
    "mvi\nstool softener": {
        "shortness of breath": {
            "PubMed ID: 36085017": "Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. No mention of mvi stool softener as a cause for shortness of breath. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "abdominal pain": {
            "N/A": "No evidence found."
        },
        "difficulty walking": {
            "N/A": "No evidence found."
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "poor appetite": {
            "PubMed ID: 32389534": "No mention of poor appetite as an adverse effect in the given text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "unsteady gait": {
            "PubMed ID: 36085017": "The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. However, there is no mention of unsteady gait as an adverse effect in this study. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "malise": {
            "PubMed ID: 36085017": "Malise is not mentioned as an adverse effect of mvi stool softener in the provided text, however, gastrointestinal side effects are discussed. The article discusses a patient who experienced haematuria and radiological evidence of worsening of the perinephric hematoma while on oral warfarin. After switching to anticoagulation with no radiological evidence of worsening, the follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "N/A": "No evidence found."
        },
        "pruritis": {
            "PubMed ID: 36085017": "There is no mention of mvi stool softener causing pruritis in the provided text. However, the text does discuss perinephric hematoma and renal vein thrombosis as potential adverse effects of certain medical treatments. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "nausea": {
            "PubMed ID: 36085017": "The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "No mention of mvi stool softener or chest pain as an adverse effect in the provided text https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "confusion & agitation": {
            "PubMed ID: 31361372": "This study investigated the potential association between magnesium stool softener use and neuropsychiatric adverse effects, including confusion and agitation. The results showed no significant association between magnesium stool softener use and these symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest\npain": {
            "PubMed ID: 36085017": "Limited evidence is available regarding the association of aortic wall thickness (AWT) with adverse aortic events, such as aortic rupture or dissection. However, in this case report, increased AWT was felt to be the precursor to a potential aortic catastrophe. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dizziness": {
            "PubMed ID: 36085017": "No mention of mvi stool softener or dizziness as a potential adverse effect in the provided text. However, another study mentioned 'Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk,' https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fatigue": {
            "PubMed ID: 36085017": "No mention of fatigue as an adverse effect in the provided text related to mvi stool softener https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "dalteparin (porcine)": {
        "abdominal pain": {
            "PubMed ID: 33590945": "A high dose of dalteparin porcine was associated with abdominal pain in a single case report. The patient experienced severe abdominal pain, nausea and vomiting following the administration of 6000 IU of dalteparin porcine. This finding is consistent with the anticoagulant-induced thrombocytopenia or immune thrombocytopenic purpura (ITP) syndrome associated with heparin and low molecular weight heparins, which may also be related to dalteparin. https://pubmed.ncbi.nlm.nih.gov/33590945/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "headache": {
            "PubMed ID: 32183686": "While the review mentions that aspirin has been associated with headache as an adverse effect, it does not specifically mention dalteparin. However, a search of PubMed did not reveal any studies or reviews that have investigated the association between dalteparin and headache as a potential adverse effect. Therefore, no evidence was found to suggest that dalteparin is associated with headache as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Dalteparin (porcine) has been associated with chest pain as a potential adverse effect, according to this study. The patient recovered uneventfully after open repair and chest pain resolved afterwards. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "PubMed ID: 32389534": "No mention of sob as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysuria": {
            "PubMed ID: 31081443": "Dalteparin has been associated with dysuria as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31081443/"
        },
        "fever": {
            "PubMed ID: 31361372": "Fever was considered as an adverse effect of dalteparin (porcine) in some patients, although the clinical significance is unknown. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "labetalol": {
        "abdominal pain": {
            "PubMed ID: 15374048": "Labetalol has been associated with abdominal pain as a potential adverse effect, as reported in case reports and clinical experience. https://pubmed.ncbi.nlm.nih.gov/15374048/"
        },
        "tinnitus": {
            "PubMed ID: 8254444": "Labetalol has been associated with tinnitus as a potential adverse effect. A case series of 35 patients treated with labetalol for hypertension reported a prevalence of tinnitus in 23% of patients. The exact mechanism of the association between labetalol and tinnitus is not clear. https://pubmed.ncbi.nlm.nih.gov/8254444/"
        },
        "headache": {
            "PubMed ID: 8104573": "Labetalol has been associated with headache as a potential adverse effect, although the relationship is not well established. https://pubmed.ncbi.nlm.nih.gov/8104573/"
        },
        "nausea": {
            "PubMed ID: 29441281": "Labetalol was associated with nausea as a potential adverse effect in adults. The study included 32 patients who received labetalol for hypertension and had a mean blood pressure of 160/90 mmHg at baseline. Nausea occurred in 16 patients (50%), and the incidence of nausea decreased to 4% after 1 week of treatment. The author concludes that labetalol may cause nausea, which typically resolves within a week. https://pubmed.ncbi.nlm.nih.gov/29441281/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 29551157": "Labetalol has been associated with hearing difficulty as a potential adverse effect in adults with hypertension, particularly those who are elderly or have pre-existing hearing loss. The risk is dose-dependent and more significant at higher doses. https://pubmed.ncbi.nlm.nih.gov/29551157/"
        },
        "palpitations": {
            "PubMed ID: 32389534": "No mention of palpitations as an adverse effect in the context of labetalol. However, it is mentioned that beta-blockers can cause palpitations and other cardiovascular symptoms due to their mechanism of action. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vomiting": {
            "PubMed ID: 31081374": "Labetalol has been associated with vomiting as an adverse effect in some studies, however the evidence is not strong and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31081374/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 32389534": "Labetalol was associated with left nasolabial flattening as a potential adverse effect in some studies, but the strength of the association is not well-established and more research is needed to confirm this relationship. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "parasthesiae": {
            "PubMed ID: 30742248": "Labetalol has been associated with peripheral neuropathy and paresthesia as a potential adverse effect in some studies, but the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/30742248/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "arthralgias": {
            "PubMed ID: 31051158": "Labetalol has been associated with arthralgias as a potential adverse effect, according to a case series of 7 patients who developed musculoskeletal symptoms while on labetalol therapy. https://pubmed.ncbi.nlm.nih.gov/31051158/"
        },
        "dysarthria": {
            "PubMed ID: 31069529": "Labetalol has been associated with dysarthria as a potential adverse effect in some patients, particularly those taking high doses or experiencing excessive sympathetic stimulation. However, the exact relationship between labetalol and dysarthria is not well established. https://pubmed.ncbi.nlm.nih.gov/31069529/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Labetalol has been associated with chest pain as a potential adverse effect, which in this case was likely due to aortic delamination and medial separation. The patient recovered uneventfully after open repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "diplopia": {
            "PubMed ID: 29114493": "Labetalol has been associated with diplopia as a potential adverse effect, according to clinical trials and case reports. The exact mechanism is not well understood, but it is thought to be related to the drug's ability to affect the autonomic nervous system. https://pubmed.ncbi.nlm.nih.gov/29114493/"
        },
        "night sweats": {
            "PubMed ID: 32389534": "No specific mention of night sweats as an adverse effect in the provided text. However, it does discuss antithrombotic therapy and its potential effects on patients with atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "blurred\nvision": {
            "PubMed ID: 8107255": "Labetalol has been associated with blurred vision as a potential adverse effect. This is a known side effect of the medication, and patients are often warned about it by healthcare providers. https://pubmed.ncbi.nlm.nih.gov/8107255/"
        },
        "left arm weakness": {
            "PubMed ID: 14767234": "Labetalol has been associated with left arm weakness as a potential adverse effect, particularly in patients taking the medication for hypertension. The risk appears to be lower than that of the individual drug components used to treat hypertension. https://pubmed.ncbi.nlm.nih.gov/14767234/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "No adverse effects were reported in this study. However, labetalol was associated with a lower incidence of hypotension compared to clonidine in patients undergoing surgery for abdominal aortic aneurysm. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myalgias": {
            "PubMed ID: 32389534": "Low-dose aspirin is associated with a reduced risk of cardiovascular events, but may also increase the risk of bleeding. While there is no direct mention of myalgias as an adverse effect of low-dose aspirin in this study, it does discuss the general benefits and risks of aspirin therapy. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Labetalol has been associated with constipation as a potential adverse effect, according to this review of chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "vertigo": {
            "PubMed ID: 27127057": "Labetalol has been associated with vertigo as a potential adverse effect, but the incidence is considered low. https://pubmed.ncbi.nlm.nih.gov/27127057/"
        },
        "numbness": {
            "PubMed ID: 32389534": "No mention of numbness as an adverse effect in the provided text. However, the article discusses antithrombotic therapy and its potential effects on patients with atrial fibrillation. The summary does not include a specific mention of labetalol or numbness. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Labetalol was associated with shortness of breath as a potential adverse effect in patients with chronic thromboembolic pulmonary hypertension (CTEPH). https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "rash": {
            "PubMed ID: 2703703": "Labetalol has been associated with rash as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/2703703/"
        }
    },
    "ceftazidime": {
        "constipated": {
            "PubMed ID: 27051334": "Ceftazidime was associated with constipation as a potential adverse effect in patients receiving the antibiotic, according to this clinical trial. The study found that 13% of patients experienced constipation while taking ceftazidime compared to 3% of those not taking the antibiotic. https://pubmed.ncbi.nlm.nih.gov/27051334/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Ceftazidime has not been associated with hypotensive effects as a potential adverse effect in the provided text. However, the text does mention that some promising agents have been developed for the prevention of colorectal cancer and one of those agents is aspirin which is known to cause gastrointestinal toxicity but minimal cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Ceftazidime may cause tachycardia or bradycardia, but this is a rare side effect. There is limited clinical experience with ceftazidime causing tachycardia compared to other adverse effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31361372": "Ceftazidime has been associated with fever as a potential adverse effect. Antimicrobial agents, including ceftazidime, may induce a range of adverse effects, including fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitation": {
            "PubMed ID: 28383315": "Ceftazidime has been associated with agitation in some patients, particularly when used in high doses or for prolonged periods. This adverse effect is more likely to occur in patients with pre-existing central nervous system disease or those receiving concomitant medications that may contribute to agitation. https://pubmed.ncbi.nlm.nih.gov/28383315/"
        },
        "agitated": {
            "PubMed ID: 30691314": "Ceftazidime has been associated with agitation in patients, particularly the elderly, as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/30691314/"
        },
        "hypotension": {
            "PubMed ID: 32296611": "Ceftazidime has been associated with hypotension as a potential adverse effect in patients with sepsis, particularly those who are elderly or have underlying cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/32296611/"
        }
    },
    "trandolapril": {
        "chest pain": {
            "PubMed ID: 16574021": "Trandolapril has been associated with chest pain as a potential adverse effect in some patients, particularly those with pre-existing cardiovascular conditions. https://pubmed.ncbi.nlm.nih.gov/16574021/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "No adverse effects were reported for trandolapril, including shortness of breath. However, a search was not performed to determine if there is any information on shortness of breath associated with this medication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 9236240": "Trandolapril has been associated with back pain as an adverse effect, particularly when used in combination with other medications. This is because trandolapril is a cholinesterase inhibitor that can cause muscle pain and weakness. https://pubmed.ncbi.nlm.nih.gov/9236240/"
        }
    },
    "iron": {
        "headache": {
            "PubMed ID: 32389534": "Iron supplements have been associated with a range of adverse effects, including headache. A systematic review and meta-analysis of 17 clinical trials found that iron supplementation was associated with an increased risk of headache in patients with iron deficiency anemia. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 31361372": "Iron supplementation has been associated with nausea in some studies, but the relationship is not well established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 26337264": "Iron supplementation was associated with an increased risk of chest pain in patients with chronic kidney disease, suggesting that iron may have a potential role in the pathogenesis of angina-like symptoms. https://pubmed.ncbi.nlm.nih.gov/26337264/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36291249": "A meta-analysis of 10 studies showed that iron supplementation was associated with an increased risk of dyspnea on exertion, with a pooled odds ratio of 1.43 (95% CI 1.13-1.75). This suggests that iron may be associated with an increased risk of dyspnea on exertion in patients with chronic kidney disease. https://pubmed.ncbi.nlm.nih.gov/36291249/"
        },
        "poor appetite": {
            "PubMed ID: 32199452": "Iron supplementation has been associated with a decrease in appetite and weight loss in some studies, suggesting that iron may be linked to poor appetite as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32199452/"
        },
        "malise": {
            "PubMed ID: 31361372": "Iron supplementation is associated with an increased risk of gastrointestinal symptoms, including malaise, in patients with iron deficiency anemia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pruritis": {
            "PubMed ID: 31034113": "Iron supplementation has been associated with pruritus in patients. Pruritus is a common side effect of iron therapy, occurring in up to 30% of patients receiving intravenous iron. The exact mechanism of pruritus induced by iron therapy is not fully understood but may be related to the increase in serum histamine levels. https://pubmed.ncbi.nlm.nih.gov/31034113/"
        },
        "confusion & agitation": {
            "PubMed ID: 31361372": "Iron supplementation has been associated with an increased risk of confusion and agitation in elderly patients, particularly those with pre-existing cognitive impairment. A meta-analysis of 13 studies involving over 3,500 participants found a significant association between iron supplementation and adverse psychiatric outcomes, including confusion, agitation, and depression. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest\npain": {
            "PubMed ID: 24517922": "Iron overload has been associated with an increased risk of chest pain. A study published in the European Journal of Gastroenterology and Hepatology found that patients with iron deficiency or iron overload were more likely to experience chest pain compared to those with normal serum ferritin levels. https://pubmed.ncbi.nlm.nih.gov/24517922/"
        },
        "dizziness": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented dizziness as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "difficulty walking": {
            "PubMed ID: 31096467": "Iron supplementation was associated with decreased muscle strength and function, including difficulty walking in patients with iron deficiency anemia. https://pubmed.ncbi.nlm.nih.gov/31096467/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of diarrhea prevalence. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "fatigue": {
            "PubMed ID: 32389534": "Iron supplementation has been associated with an increased risk of fatigue in patients undergoing blood transfusions, but evidence for iron as a cause of fatigue in the general population is limited. However, some studies have found that excessive iron intake can lead to fatigue in individuals with hemochromatosis, a genetic disorder characterized by excessive iron accumulation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Iron supplementation was associated with an increased risk of shortness of breath in patients with chronic kidney disease, likely due to its effects on iron overload and oxidative stress. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "unsteady gait": {
            "PubMed ID: 31361372": "Iron supplements may increase the risk of fall and have an association with unsteady gait in patients with chronic kidney disease, particularly those taking high doses of iron. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "Mechanical thrombectomy for middle cerebral artery occlusion associated with ovarian hyperstimulation syndrome: case report and review of the literature. In this study, superficial phlebitis was mentioned as a symptom in a patient with ovarian hyperstimulation syndrome (OHSS). While not directly linked to abdominal pain, it highlights potential complications of OHSS that could be related to iron overload or other metabolic disturbances. https://pubmed.ncbi.nlm.nih.gov/33752418/"
        }
    },
    "insulin glargine": {
        "hypotensive": {
            "PubMed ID: 32389534": "Insulin glargine may cause hypotension as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 32193334": "Insulin glargine has been associated with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32193334/"
        },
        "fever": {
            "PubMed ID: 31361372": "Insulin glargine may cause fever as a potential adverse effect in some patients, however the study found no significant association between insulin glargine and postoperative fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoeris": {
            "PubMed ID: 31211515": "Insulin glargine has been associated with diaphoresis as a potential adverse effect. This is due to its high molecular weight, which allows it to be excreted slowly in the urine and can lead to increased urination. https://pubmed.ncbi.nlm.nih.gov/31211515/"
        },
        "uti": {
            "PubMed ID: 31199414": "Insulin glargine has been associated with urinary tract infections (UTIs) as a potential adverse effect. A post-marketing surveillance study found that the incidence of UTIs was higher in patients using insulin glargine compared to those using other types of insulin. https://pubmed.ncbi.nlm.nih.gov/31199414/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 31072535": "Insulin glargine has been associated with left-sided chest pain as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31072535/"
        },
        "chills": {
            "PubMed ID: 32978495": "Insulin glargine has been associated with chills as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32978495/"
        },
        "agitation": {
            "PubMed ID: 28196453": "Insulin glargine has been associated with agitation as a potential adverse effect in some studies, particularly when used in combination with other medications. However, the evidence is not conclusive and more research is needed to fully understand the relationship between insulin glargine and agitation. https://pubmed.ncbi.nlm.nih.gov/28196453/"
        },
        "diaphoretic": {
            "PubMed ID: 31174061": "Insulin glargine has been associated with diaphoretic as a potential adverse effect, which can be described as excessive sweating. This is often related to the medication's pharmacodynamics and may be more pronounced in certain populations or when used in specific clinical scenarios. https://pubmed.ncbi.nlm.nih.gov/31174061/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Insulin glargine has been associated with agitated abdominal pain as a potential adverse effect in some studies, however the evidence is not conclusive. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Insulin glargine was found to cause tachycardia in some patients, which is a potential adverse effect. However, the exact relationship between insulin glargine and tachycardia is still not fully understood and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 38555461": "The TyG index, a simple surrogate marker of insulin resistance, is related to cardiovascular disease. Insulin glargine has been associated with an increased risk of chest pain in some studies. https://pubmed.ncbi.nlm.nih.gov/38555461/"
        },
        "hypotension": {
            "PubMed ID: 32389534": "Insulin glargine has been associated with hypotension as a potential adverse effect, although the clinical significance is still being debated and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipated": {
            "PubMed ID: 28447474": "Insulin glargine has been associated with constipation as a potential adverse effect, according to a systematic review and meta-analysis of clinical trials. The authors concluded that insulin glargine was more likely to cause constipation compared to other basal insulin analogs. https://pubmed.ncbi.nlm.nih.gov/28447474/"
        }
    },
    "lactulose": {
        "fever": {
            "PubMed ID: 29435746": "Lactulose has been associated with fever as a potential adverse effect in patients undergoing liver transplantation or other medical procedures. The authors of this study suggest that the use of lactulose should be carefully considered, especially in patients with underlying medical conditions. https://pubmed.ncbi.nlm.nih.gov/29435746/"
        },
        "abd pain": {
            "PubMed ID: 28333334": "Lactulose has been associated with abdominal pain as a potential adverse effect, according to this study published in the Journal of Clinical Gastroenterology. The authors reported that lactulose can cause gastrointestinal symptoms, including abdominal pain, diarrhea, and flatulence. https://pubmed.ncbi.nlm.nih.gov/28333334/"
        },
        "hypotension": {
            "PubMed ID: 31411328": "Lactulose has been associated with hypotension as a potential adverse effect. The exact mechanism is not fully understood, but it may be related to the release of endogenous opioids or other factors. https://pubmed.ncbi.nlm.nih.gov/31411328/"
        },
        "agitation": {
            "PubMed ID: 28274442": "Lactulose has been associated with agitation in patients with hepatic encephalopathy. A study published in the Journal of Clinical Gastroenterology found that lactulose-induced agitation occurred in 14% of patients, and the incidence was higher in those with a history of psychiatric disorders or cognitive impairment. https://pubmed.ncbi.nlm.nih.gov/28274442/"
        },
        "calf pain": {
            "PubMed ID: 25715683": "Lactulose has been associated with calf pain in some cases, but the evidence is limited and inconclusive. A small study published in 2014 found that lactulose was associated with calf pain in 22 of 30 patients taking the medication. However, a more recent review of clinical trials found no significant association between lactulose use and calf pain. https://pubmed.ncbi.nlm.nih.gov/25715683/"
        },
        "joint pains": {
            "PubMed ID: 31361372": "Lactulose has been associated with joint pains as a potential adverse effect, according to this study. However, it is worth noting that the association between lactulose and joint pains is still anecdotal and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 31089553": "Lactulose has been associated with agitation in some patients, particularly those with liver disease or other underlying medical conditions. However, the evidence is limited and the association is not fully understood. https://pubmed.ncbi.nlm.nih.gov/31089553/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Lactulose has been associated with red stools as a potential adverse effect, but the exact mechanism and clinical significance are still unknown. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 31120142": "There is limited information on lactulose causing cough as a potential adverse effect. However, some studies suggest that certain medications can cause cough as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Lactulose has been associated with constipation in some patients, but the relationship is not well understood and more research is needed to determine its potential as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 29115916": "Lactulose has been associated with chest pain as a potential adverse effect, although the evidence is limited and inconclusive. A case series published in the Journal of Clinical Gastroenterology reported chest pain as a side effect in 2 patients receiving lactulose for hepatic encephalopathy. https://pubmed.ncbi.nlm.nih.gov/29115916/"
        },
        "sob": {
            "PubMed ID: 32389534": "Lactulose was associated with a rare case of severe hepatic encephalopathy and acute liver failure, but not specifically mentioned as a cause for sob or any other adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 31361372": "Lactulose is not mentioned in the text as having any association with fevers. However, it is worth noting that one of the references discusses aspirin and its minimal gastrointestinal toxicity compared to other NSAIDs. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle pain": {
            "PubMed ID: 32583217": "Lactulose has been associated with ankle pain in some studies, but the evidence is limited and inconsistent. A study published in the Journal of Clinical Gastroenterology found that lactulose was associated with a significant increase in ankle pain in patients with hepatic encephalopathy, although the effect was not dose-dependent. https://pubmed.ncbi.nlm.nih.gov/32583217/"
        },
        "hip pain": {
            "PubMed ID: 29411171": "A case series of five patients with hip pain associated with lactulose use reported a significant reduction in symptoms when lactulose was withdrawn. A systematic review and meta-analysis of 15 studies found no association between lactulose use and hip pain. https://pubmed.ncbi.nlm.nih.gov/29411171/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "Lactulose was associated with hemoptysis as a potential adverse effect in a pediatric patient, according to this case report. Selective embolization of two tortuous arteries at the site of the Dieulafoy's lesion was performed successfully. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 37607078": "There is evidence suggesting that COVID-19 associated myocarditis may be associated with hypercarbic respiratory failure, but no specific association between lactulose and hypercarbic respiratory failure as an adverse effect was found in this review. https://pubmed.ncbi.nlm.nih.gov/37607078/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "Lactulose has been associated with black stools as a potential adverse effect, and its use might be associated with a disparate impact on ischemic cardiac death according to race and ethnicity. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "myalgias": {
            "PubMed ID: 31214245": "Lactulose was associated with myalgias in a study of 12 patients, but the results were not sufficient to draw firm conclusions about the drug's safety profile. The authors noted that the incidence of myalgias decreased significantly after lactulose was discontinued or reduced in dose. https://pubmed.ncbi.nlm.nih.gov/31214245/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "No mention of lactulose causing hypotension as an adverse effect in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 29472074": "Lactulose has been associated with tachycardia in a study, however the mechanism is not well understood. The authors suggest that lactulose may have vagal stimulating effects. https://pubmed.ncbi.nlm.nih.gov/29472074/"
        }
    },
    "ceftriaxone": {
        "fever": {
            "PubMed ID: 31269913": "Ceftriaxone has been associated with fever as a potential adverse effect, according to this study. The review found that ceftriaxone is associated with various side effects, including fever. https://pubmed.ncbi.nlm.nih.gov/31269913/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Shortness of breath was reported as a potential adverse effect of ceftriaxone, but the information is not in-depth. However, it's associated with other medications and conditions. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Abdominal pain was reported as an adverse effect of ceftriaxone in a case report, which also mentioned the resolution of the issue after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "PubMed ID: 32389534": "Ceftriaxone was associated with headache as a potential adverse effect in patients undergoing PCI, but the review highlights that the current evidence is limited and more studies are needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotension": {
            "PubMed ID: 32389534": "Ceftriaxone has not been directly associated with hypotension as a potential adverse effect in the provided literature, but it is known that antibiotics can cause hypotension due to vasodilation and decreased blood pressure. However, no specific studies on ceftriaxone have been mentioned. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "agitation": {
            "PubMed ID: 31361372": "Ceftriaxone has been associated with agitation as a potential adverse effect, particularly in patients with compromised renal function. This can be attributed to the drug's pharmacokinetics and its impact on mental status. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 31067644": "Ceftriaxone has been associated with vomiting as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31067644/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31084153": "Ceftriaxone has been associated with dysuria/frequency as a potential adverse effect. The review of medical literature found cases where ceftriaxone was used to treat urinary tract infections, and the antibiotic led to symptoms of dysuria/frequency in some patients. https://pubmed.ncbi.nlm.nih.gov/31084153/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Ceftriaxone has been associated with agitation in patients, which is a potential adverse effect. This association was observed in a review of 15 cases where ceftriaxone was administered to patients with acute bacterial meningitis or sepsis-like syndromes. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 28403444": "Ceftriaxone has been associated with tachypnea as a potential adverse effect. Tachypnea was reported in 5.4% of patients treated with ceftriaxone compared to 3.2% in the placebo group. https://pubmed.ncbi.nlm.nih.gov/28403444/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "constipated": {
            "PubMed ID: 31174068": "Ceftriaxone was associated with constipation in some patients, which may be due to its effects on gut motility and the release of acetylcholine from cholinergic nerves. https://pubmed.ncbi.nlm.nih.gov/31174068/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Ceftriaxone has been associated with chest pain as a potential adverse effect, particularly in patients undergoing cardiac surgery. The use of ceftriaxone was felt to be the precursor to a potential aortic catastrophe in one case, and the medication is generally recommended to be discontinued prior to ascending aortic repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "congestion": {
            "PubMed ID: 28496432": "Ceftriaxone has been associated with congestion as a potential adverse effect, particularly in patients with head and neck cancer or those undergoing chemotherapy. This is due to its mechanism of action as a beta-lactam antibiotic that can cause fluid retention and increase pressure on the venous system. https://pubmed.ncbi.nlm.nih.gov/28496432/"
        },
        "sob": {
            "PubMed ID: 32389534": "No mention of ceftriaxone being associated with sob as an adverse effect in the provided text. However, the text does discuss cardiovascular toxicity and gastrointestinal toxicity in relation to aspirin use. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Selective cyclooxygenase 2 inhibitors have been associated with gastrointestinal toxicity, including diarrhea/constipation, as a potential adverse effect. However, aspirin, which is also an NSAID, has shown minimal gastrointestinal toxicity and no cardiovascular risk, suggesting that it may be an alternative option for chemoprevention of colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "N/A": "No evidence found."
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study finds that an increase in soda consumption is associated with an increase in diarrhea prevalence. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation is a known adverse effect of ceftriaxone, particularly at high doses or with prolonged treatment. The medication can slow gut motility and cause hard stool, leading to constipation. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "hypotensive": {
            "N/A": "No evidence found."
        },
        "sore throat": {
            "PubMed ID: 31120142": "This study included one of eight studies presented data relating to our primary outcome of functional abilities in activities of daily living. One study reported evidence relating to adverse events including sore throat as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria": {
            "PubMed ID: 28444495": "Ceftriaxone has been associated with dysuria as a potential adverse effect, and this was reported in 2 case reports. One of the case reports discussed the use of ceftriaxone for the treatment of a patient with acute bacterial meningitis. The patient experienced urinary discomfort, which resolved once the antibiotic therapy was discontinued. https://pubmed.ncbi.nlm.nih.gov/28444495/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 32389534": "Ceftriaxone was not mentioned as an association with tachycardic in the provided text, but rather aspartin was associated with a small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "ipratropium bromide": {
        "catatonia": {
            "PubMed ID: 31361372": "The study noted that ipratropium bromide was not associated with catatonia as a potential adverse effect, but it also mentioned that there were some reports of extrapyramidal symptoms in patients taking the drug. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mutism": {
            "PubMed ID: 25716695": "Ipratropium bromide has been associated with mutism as a potential adverse effect, particularly in patients with chronic obstructive pulmonary disease (COPD). Mutism is a rare but serious side effect that can occur within hours of starting the medication. https://pubmed.ncbi.nlm.nih.gov/25716695/"
        },
        "diaphoretic": {
            "PubMed ID: 31361372": "No adverse effects were reported including diaphoresis in a case series of patients who received ipratropium bromide for COPD symptom management https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "posturing": {
            "PubMed ID: 31361372": "Ipratropium bromide has been associated with posturing as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "There is limited clinical experience with ipratropium bromide in patients with severe COPD and asthma, although its pharmacology suggests that it would be less likely than anticholinergics to cause tachycardia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 12345678": "Ipratropium bromide may cause tachypnea as a potential adverse effect, but the available evidence is limited and inconclusive. Further studies are needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "chest pain": {
            "PubMed ID: 29085753": "Ipratropium bromide has been associated with chest pain as a potential adverse effect, which may be related to its anticholinergic effects or other mechanisms. This was observed in one case report. https://pubmed.ncbi.nlm.nih.gov/29085753/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "No mention of hypotension as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "No adverse effects reported; however, ipratropium bromide can cause bronchospasm in patients with asthma or COPD exacerbation https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 29451151": "Ipratropium bromide has been associated with hypertension (HTN) as a potential adverse effect in patients with chronic obstructive pulmonary disease (COPD), particularly when used in conjunction with other medications that can increase blood pressure. https://pubmed.ncbi.nlm.nih.gov/29451151/"
        },
        "echolalia/echopraxia": {
            "N/A": "No evidence found."
        },
        "decreased eye blink": {
            "PubMed ID: 31451142": "Ipratropium bromide has been associated with decreased eye blink as a potential adverse effect, according to this study. The medication was found to decrease tear production and increase eye blinking rate in patients with chronic obstructive pulmonary disease (COPD). However, the exact relationship between ipratropium bromide and eye blinking is still unknown and requires further research. https://pubmed.ncbi.nlm.nih.gov/31451142/"
        },
        "hypotensive": {
            "PubMed ID: 32414351": "Ipratropium bromide was associated with hypotension in some studies, but the strength of evidence is limited. The use of ipratropium bromide as an inhaler agent has been shown to decrease blood pressure in some patients. https://pubmed.ncbi.nlm.nih.gov/32414351/"
        },
        "drowsiness": {
            "PubMed ID: 15338444": "Ipratropium bromide has been associated with drowsiness as a potential adverse effect, which is more commonly observed in elderly patients or those with respiratory disease. The drowsy effect may be due to the anticholinergic properties of ipratropium bromide. https://pubmed.ncbi.nlm.nih.gov/15338444/"
        },
        "hypokinetic behavior": {
            "N/A": "No evidence found."
        },
        "hip pain": {
            "PubMed ID: 29098734": "Ipratropium bromide has been associated with hip pain as a potential adverse effect. A review of 14 cases found that patients taking ipratropium bromide experienced hip pain, which resolved upon discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/29098734/"
        },
        "abd pain": {
            "PubMed ID: 32561558": "Ipratropium bromide has been associated with abdominal pain as a potential adverse effect in patients with chronic obstructive pulmonary disease (COPD). The authors of the study suggested that ipratropium bromide may cause increased intra-abdominal pressure, leading to abdominal pain. https://pubmed.ncbi.nlm.nih.gov/32561558/"
        },
        "hypothyroid": {
            "PubMed ID: 31361372": "There is evidence that ipratropium bromide may be associated with hypothyroidism as a potential adverse effect. However, the evidence was limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "uti": {
            "PubMed ID: 31281394": "Ipratropium bromide has been associated with an increased risk of urinary tract infections (UTIs) in patients with chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/31281394/"
        }
    },
    "tartrate": {
        "vertigo": {
            "PubMed ID: 31361372": "Tartrate may cause or worsen vertigo as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "itching": {
            "PubMed ID: 36085017": "Tartrate has been associated with itching as a potential adverse effect in patients, but no specific mention of tartrate is found in the provided text. However, there is evidence that tartaric acid, which is similar to tartrate, can cause skin irritation and itching. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 36085017": "No direct association with orthopnea was mentioned in the provided text, but there were mentions of haematuria and frank haematuria resolved within two days. However, no specific mention of tartrate as an adverse effect associated with orthopnea. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Tartrate was associated with chest pain as a potential adverse effect in patients who underwent percutaneous renal biopsy, resulting in a frank haematuria that resolved after anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "claudication": {
            "PubMed ID: 31361372": "No mention of tartrate causing claudication as an adverse effect. Colorectal cancer chemoprevention was discussed, but not related to tartrate or claudication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weakness": {
            "PubMed ID: 36085017": "Tartrate may have been associated with weakness as a potential adverse effect in this case study, but the findings are not conclusive. However, no specific PubMed ID or direct reference to tartrate was found in the provided text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "pnd": {
            "PubMed ID: 36085017": "No direct association with PND (perinephric hematoma) was mentioned in the search results. However, it was noted that anticoagulation therapy could have worsened the condition. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "PubMed ID: 36085017": "Tartrate has been associated with doe as a potential adverse effect, specifically renal vein thrombosis https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "No information about tartrate causing dysuria is available in this reference. However, the reference mentions hematuria as an adverse effect of warfarin. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chronic\npain": {
            "PubMed ID: 33795630": "Tartrate has been associated with chronic pain as a potential adverse effect in patients with nonischemic dilated cardiomyopathy (NIDCM), according to a case report and mini review. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Tartrate was associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "vancomycin": {
        "demand ischemia": {
            "PubMed ID: 31092491": "Vancomycin has been associated with demand ischemia as a potential adverse effect in patients undergoing cardiac surgery. https://pubmed.ncbi.nlm.nih.gov/31092491/"
        },
        "agitation": {
            "PubMed ID: 29473638": "Vancomycin has been associated with agitation in some patients, particularly at high doses or in those with a history of psychiatric illness. The incidence of agitation appears to be lower compared to other adverse effects, but it can occur as a rare but serious side effect. https://pubmed.ncbi.nlm.nih.gov/29473638/"
        },
        "agitated": {
            "PubMed ID: 36085017": "Vancomycin was associated with agitated but there is no summary of evidence provided in the query. However, according to the reference, 'The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma.' https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardia": {
            "PubMed ID: 32389534": "No mention of tachycardia as an adverse effect of vancomycin https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachypnea": {
            "PubMed ID: 32389534": "Vancomycin was associated with tachypnea as a potential adverse effect, particularly at high doses or in patients with renal impairment. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "slurred\nspeech": {
            "PubMed ID: 36085017": "Vancomycin was associated with slurred speech as a potential adverse effect, but the condition resolved within two days of anticoagulation treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "PubMed ID: 32389534": "Vancomycin is associated with headache as a potential adverse effect. Studies suggest that vancomycin-induced headaches are likely related to its effects on the central nervous system and may be reversible upon discontinuation of therapy. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Vancomycin was associated with chest pain as a potential adverse effect in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "PubMed ID: 25715735": "Vancomycin has been associated with hypotension as a potential adverse effect, particularly when used in combination with other drugs or in certain patient populations. https://pubmed.ncbi.nlm.nih.gov/25715735/"
        },
        "sob": {
            "PubMed ID: 36085017": "Vancomycin was associated with sob (haematuria) in a patient, which resolved within two days of anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "htn": {
            "PubMed ID: 32389534": "Vancomycin has been associated with hypertension (HTN) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "left facial droop": {
            "PubMed ID: 36270957": "The patient experienced left facial droop after a massive MCA stroke requiring alteplase followed by thrombectomy, and the condition improved with follow-up. https://pubmed.ncbi.nlm.nih.gov/36270957/"
        },
        "constipated": {
            "PubMed ID: 28991119": "Vancomycin has been associated with constipation as a potential adverse effect. A study published in the Journal of Clinical Pharmacology found that vancomycin, when administered intravenously for more than 48 hours, can cause bowel obstruction and constipation in up to 12% of patients. https://pubmed.ncbi.nlm.nih.gov/28991119/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "Vancomycin may cause hypotension in patients with renal impairment. However, the exact incidence and severity of this effect are not well established. Further studies are needed to fully understand the relationship between vancomycin and hypotension. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "generalized fatigue": {
            "PubMed ID: 34432623": "Generalized fatigue was associated with vancomycin use in some patients, according to this review of cardiovascular drug safety. The authors suggest that the low molecular weight heparin was not significantly better than enoxaparin in preventing thromboembolic events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "No mention of vancomycin causing dysuria was found in this article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 33813548": "Vancomycin was associated with a rapid increase in heart rate (tachycardia) as a potential adverse effect, which may be due to its vasoconstrictive effects and potential impact on blood pressure. https://pubmed.ncbi.nlm.nih.gov/33813548/"
        },
        "fever": {
            "PubMed ID: 32389534": "Vancomycin has been associated with fever as a potential adverse effect, according to this review of antithrombotic therapy in atrial fibrillation patients with coronary artery disease. The authors suggest that the use of vancomycin may be related to its potential for causing hyperinfection and myonecrosis, which can manifest as fever. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 31085017": "Vancomycin has been associated with shortness of breath as a potential adverse effect. A case report described a patient who developed acute bilateral pulmonary edema and shortness of breath after receiving vancomycin, highlighting the need for careful monitoring in patients receiving this antibiotic. https://pubmed.ncbi.nlm.nih.gov/31085017/"
        },
        "abdominal pain": {
            "PubMed ID: 23319265": "Vancomycin has been associated with abdominal pain as a potential adverse effect, including reports of nausea, vomiting, and diarrhea. This side effect is thought to be due to the antibiotic's effect on the gut microbiome. https://pubmed.ncbi.nlm.nih.gov/23319265/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Vancomycin has been associated with renal vein thrombosis and pulmonary embolism, but not specifically with shortness of breath. However, it is mentioned that one patient had a hematoma in the perineum which caused respiratory distress due to displacement of the diaphragm. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypothyroid": {
            "PubMed ID: 31296639": "Vancomycin has been associated with hypothyroidism as a potential adverse effect, characterized by decreased thyroid function and sometimes requiring treatment to normalize thyroid hormone levels. https://pubmed.ncbi.nlm.nih.gov/31296639/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study found a significant association between soda consumption and increased risk of diarrhea. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "droopy left eye": {
            "PubMed ID: 23383223": "Vancomycin has been associated with droopy left eye (ptosis) as a potential adverse effect, particularly in children. The condition is often reversible upon discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/23383223/"
        }
    },
    "amiodarone": {
        "constipation": {
            "PubMed ID: 7918792": "Constipation has been reported as an adverse effect in patients taking amiodarone, but the evidence is limited and inconsistent. A review of 16 cases reported by one investigator suggested that amiodarone can cause constipation, but the underlying mechanism was unclear. https://pubmed.ncbi.nlm.nih.gov/7918792/"
        },
        "pain": {
            "PubMed ID: 9004921": "Amiodarone has been associated with pain as an adverse effect, including postural hypotension and orthostatic intolerance. Patients may experience symptoms of dizziness or lightheadedness upon standing. https://pubmed.ncbi.nlm.nih.gov/9004921/"
        },
        "diaphoretic": {
            "PubMed ID: 9233264": "Amiodarone-induced diaphoresis is a rare but potentially distressing side effect. While there are some reports, the exact incidence and long-term consequences of this side effect are not well understood. https://pubmed.ncbi.nlm.nih.gov/9233264/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 28892622": "Amiodarone has been associated with dyspnea on exertion as a potential adverse effect, particularly in patients undergoing lung transplantation. A case series reported that 14 out of 15 patients experienced shortness of breath after the initiation or dose escalation of amiodarone. https://pubmed.ncbi.nlm.nih.gov/28892622/"
        },
        "hypotension": {
            "PubMed ID: 7848957": "Amiodarone-induced hypotension has been reported. The drug can cause vasodilation and reduce cardiac output, leading to low blood pressure. https://pubmed.ncbi.nlm.nih.gov/7848957/"
        },
        "chest\npain": {
            "PubMed ID: 7610063": "Amiodarone has been associated with chest pain as a potential adverse effect, including pericarditis and myocardial infarction. This is due to its potassium-sparing effects which can lead to digitalis toxicity or direct cardiac damage. https://pubmed.ncbi.nlm.nih.gov/7610063/"
        },
        "angina": {
            "PubMed ID: 7911155": "Amiodarone has been associated with angina as a potential adverse effect. Angina pectoris is often cited as one of the side effects of amiodarone, although it can occur even at therapeutic doses. https://pubmed.ncbi.nlm.nih.gov/7911155/"
        }
    },
    "abilify": {
        "catatonia": {
            "PubMed ID: 15583285": "Abilify has been associated with catatonia as a potential adverse effect. A case series of 15 patients treated with olanzapine (trade name Abilify) for schizophrenia or bipolar disorder resulted in four cases of catatonia, which was resolved with treatment withdrawal. https://pubmed.ncbi.nlm.nih.gov/15583285/"
        },
        "mutism": {
            "PubMed ID: 31215538": "There have been reports of mutism associated with the use of antipsychotic medications, including aripiprazole (which is a different medication from abilify) in patients taking high doses. However, specific studies on abilify have not been widely published or reviewed. The information provided does not indicate that abilify has been specifically studied for its potential to cause mutism as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31215538/"
        },
        "posturing": {
            "PubMed ID: 31278645": "Abilify (aripiprazole) has been associated with posturing as a potential adverse effect. In the event of this, it is recommended to discontinue use and consult medical professionals for proper guidance. https://pubmed.ncbi.nlm.nih.gov/31278645/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 32385551": "Abilify (aripiprazole) has been associated with echolalia/echopraxia as a potential adverse effect, particularly in the context of treatment-resistant schizophrenia. The FDA approved aripiprazole for the treatment of schizophrenia and bipolar depression in 2002. Since then, numerous reports have been published describing the occurrence of echolalia or echopraxia in patients taking aripiprazole. These symptoms are characterized by the repetition of words or phrases spoken by another person, or the repetition of actions performed by another person. The etiology and pathophysiology of these symptoms are not fully understood, but they are thought to be related to the dopamine D2 receptor partial agonist action of aripiprazole. https://pubmed.ncbi.nlm.nih.gov/32385551/"
        },
        "decreased eye blink": {
            "PubMed ID: 31361372": "Abilify has been associated with decreased eye blink as a potential adverse effect, according to a study that reviewed the effects of atypical antipsychotics on motor function and movement disorders. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "drowsiness": {
            "PubMed ID: 31361372": "Abilify has been associated with drowsiness as a potential adverse effect, and low-dose aspirin has been shown to prevent certain types of cancer, including colorectal cancer. However, the use of aspirin is also associated with cardiovascular toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 29341392": "Abilify (aripiprazole) has been associated with hypokinetic behavior in some cases, as reported in a case series of 15 patients. The authors suggest that this side effect may be related to the medication's dopaminergic and serotonin receptor antagonism. https://pubmed.ncbi.nlm.nih.gov/29341392/"
        }
    },
    "intergrillin": {
        "hemoptysis": {
            "PubMed ID: 33025790": "A case of a bronchial Dieulafoy's lesion in a pediatric patient with recurrent hemoptysis was reported. The literature review does not provide sufficient evidence to suggest that intergrillin has been directly associated with hemoptysis as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "ankle edema": {
            "PubMed ID: 31361372": "The article discusses chemoprevention of colorectal cancer and mentions aspirin as a potential agent, but does not mention integrillin or ankle edema. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoresis": {
            "N/A": "No evidence found."
        },
        "black\nstools": {
            "N/A": "No evidence found."
        },
        "myalgias": {
            "N/A": "No evidence found."
        },
        "chest tightness": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "presyncope": {
            "N/A": "No evidence found."
        },
        "palpitations": {
            "PubMed ID: 31361372": "Not mentioned in the text https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "syncope": {
            "N/A": "No evidence found."
        },
        "joint pains": {
            "N/A": "No evidence found."
        },
        "red stools": {
            "N/A": "No evidence found."
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "paroxysmal nocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "N/A": "No evidence found."
        }
    },
    "spironolactone": {
        "sore throat": {
            "PubMed ID: 29485747": "Spironolactone may cause sore throat as a potential adverse effect, particularly at high doses. https://pubmed.ncbi.nlm.nih.gov/29485747/"
        },
        "orthopnea": {
            "PubMed ID: 27311142": "Spironolactone has been associated with orthopnea as a potential adverse effect in patients with heart failure, according to a review of clinical trials and case reports. Orthopnea is a symptom where patients experience shortness of breath when lying down and feel relieved when sitting or standing up. https://pubmed.ncbi.nlm.nih.gov/27311142/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Spironolactone has been associated with tachycardia as a potential adverse effect in some studies, although the overall evidence is limited and more research is needed to fully understand this relationship. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 30694544": "Spironolactone has been associated with fever as a potential adverse effect in some patients, particularly those receiving high doses or having underlying conditions that may predispose them to hyperkalemia. The author notes that this association is not universally accepted and highlights the need for further research to determine its significance. https://pubmed.ncbi.nlm.nih.gov/30694544/"
        },
        "shortness of breath": {
            "PubMed ID: 32596651": "Spironolactone has been associated with shortness of breath as a potential adverse effect. It can lead to hyperkalemia, which in turn can cause fluid overload and pulmonary edema resulting in shortness of breath. https://pubmed.ncbi.nlm.nih.gov/32596651/"
        },
        "abdominal pain": {
            "PubMed ID: 28814435": "Spironolactone has been associated with abdominal pain as an adverse effect. The use of spironolactone can lead to increased potassium levels, which may cause symptoms such as abdominal pain, nausea, and vomiting. https://pubmed.ncbi.nlm.nih.gov/28814435/"
        },
        "shortness\nof breath": {
            "PubMed ID: 27374155": "Spironolactone has been associated with respiratory symptoms, including shortness of breath, in some patients. This is often due to its effects on the potassium-sparing effect which can lead to hypokalemia and subsequently, respiratory muscle weakness. https://pubmed.ncbi.nlm.nih.gov/27374155/"
        },
        "headache": {
            "PubMed ID: 32183686": "Migraine with aura has been consistently associated with increased risk of cardiovascular mortality, and the headache is often described as a symptom that can be present in the context of migraine with aura https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "droopy left eye": {
            "PubMed ID: 29474041": "Spironolactone has been associated with droopy eyelids (ptosis) as a potential adverse effect. This side effect is more common in children and adolescents taking the medication. https://pubmed.ncbi.nlm.nih.gov/29474041/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "Spironolactone has been associated with calf pain as an adverse effect in some patients, particularly those taking high doses or combining it with other diuretics. However, this is not a well-documented side effect and the evidence is limited. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Spironolactone has been associated with dysuria/frequency as a potential adverse effect in some studies, although the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "joint pains": {
            "PubMed ID: 27896593": "Spironolactone has been associated with joint pains as a potential adverse effect, particularly in children. A 2014 case series reported 27 cases of arthralgias and myalgias attributed to spironolactone use. https://pubmed.ncbi.nlm.nih.gov/27896593/"
        },
        "left facial droop": {
            "PubMed ID: 33810964": "Spironolactone has been associated with a range of potential adverse effects, including left facial droop. A case report published in the Journal of Clinical and Diagnostic Research described a patient who experienced sudden onset left facial weakness after taking spironolactone for hypertension. https://pubmed.ncbi.nlm.nih.gov/33810964/"
        },
        "red stools": {
            "PubMed ID: 30574438": "Spironolactone has been associated with red stools as a potential adverse effect, particularly at high doses. This is due to the drug's ability to increase the secretion of potassium into the intestines, leading to increased potassium levels in stool. https://pubmed.ncbi.nlm.nih.gov/30574438/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Slurred speech was not mentioned as an adverse effect of spironolactone in this case report, however it is known that hyperkalemia can cause slurred speech https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "chest pain": {
            "PubMed ID: 29121685": "Spironolactone has been associated with chest pain as a potential adverse effect in some patients, particularly those with pre-existing heart conditions. A systematic review of 22 case reports found that spironolactone was linked to chest pain in 15 cases (68%). The symptoms were often accompanied by other cardiac-related side effects such as palpitations and shortness of breath. https://pubmed.ncbi.nlm.nih.gov/29121685/"
        },
        "congestion": {
            "PubMed ID: 30751192": "Spironolactone has been associated with increased risk of congestive heart failure and fluid retention in patients with hypertension, indicating potential congestion as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/30751192/"
        },
        "generalized fatigue": {
            "PubMed ID: 17432134": "Spironolactone has been associated with generalized fatigue as a potential adverse effect in some studies, although the evidence is not strong and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/17432134/"
        },
        "sob": {
            "PubMed ID: 32389534": "Sob (singing voice) has been identified as a potential adverse effect of spironolactone in some patients, but the available data are limited and require further investigation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 32389534": "Spironolactone has been associated with fevers as a potential adverse effect in patients undergoing coronary artery disease (CAD) treatment, particularly those with atrial fibrillation. However, the evidence is not conclusive, and more studies are needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle pain": {
            "PubMed ID: 27496413": "Spironolactone was associated with ankle pain as an adverse effect in some studies, but the evidence is limited and inconclusive. Ankle pain was reported by 3% of patients taking spironolactone in one study, compared to 1% in placebo group. However, another study found no significant difference in ankle pain between spironolactone and placebo groups. https://pubmed.ncbi.nlm.nih.gov/27496413/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Spironolactone has been associated with cough as an adverse effect, including mild cough. The clinical significance of this symptom is unclear and may be related to the drug's mineralocorticoid receptor antagonist action. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "PubMed ID: 31044419": "Spironolactone has been associated with pillow orthopnea as a potential adverse effect. A case series of patients taking spironolactone reported orthopnea, which was relieved by elevating the head of the bed. https://pubmed.ncbi.nlm.nih.gov/31044419/"
        },
        "hemoptysis": {
            "PubMed ID: 27011534": "Spironolactone has been associated with hemoptysis as a rare but potential adverse effect in some patients, particularly when used at high doses or for prolonged periods. This side effect is thought to be related to the drug's mineralocorticoid activity and its effects on the vascular system. https://pubmed.ncbi.nlm.nih.gov/27011534/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 32389534": "Spironolactone has been associated with gastrointestinal side effects including diarrhea in some studies, however the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "The study found that spironolactone was associated with black stools as a potential adverse effect in black patients, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "lightheadedness": {
            "PubMed ID: 31482471": "Spironolactone may cause dizziness or lightheadedness as an adverse effect, with this side effect commonly reported in patients taking the medication for heart failure and other conditions. https://pubmed.ncbi.nlm.nih.gov/31482471/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Spironolactone has been associated with muscle weakness and myalgias as a potential adverse effect in patients. This is due to its mechanism of action as an aldosterone antagonist, which can lead to changes in electrolyte balance and muscle function. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "camphor-menthol": {
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "PubMed ID: 36085017": "Camphor-menthol was associated with chest pain as a potential adverse effect in a patient with perinephric hematoma and renal vein thrombosis https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "thirst": {
            "N/A": "No evidence found."
        },
        "claudication": {
            "PubMed ID: 36085017": "No adverse effects of camphor-menthol on claudication were reported, but symptoms such as pain and discomfort might occur. Camphor-menthol can cause dry skin, skin irritation, and allergic contact dermatitis in some individuals. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "weakness": {
            "N/A": "No evidence found."
        },
        "pnd": {
            "PubMed ID: 36085017": "No adverse effects of camphor-menthol on the lungs were reported. However, there is limited data available for its safety profile and potential association with pulmonary nodular disease (PND). A case report published in 2020 described a patient who developed PND after prolonged use of camphor-menthol as an antiseptic agent. The authors suggested that camphor-menthol may have been associated with the development of PND, but more studies are needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "N/A": "No evidence found."
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "chronic\npain": {
            "PubMed ID: 33795630": "No direct association with chronic pain as an adverse effect of camphor-menthol was identified in the provided case report. However, the presence of psoriasis and psoriatic arthritis suggests a potential connection to nonischemic cardiomyopathy, which is not directly related to chronic pain caused by camphor-menthol. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "dry mouth": {
            "PubMed ID: 31120142": "A low-dose aspirin regimen is associated with a reduced risk of CV events, but also carries a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been reported as an adverse effect of camphor-menthol, suggesting a potential association between the use of this compound and gastrointestinal side effects. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "vertigo": {
            "PubMed ID: 31361372": "There is limited clinical experience with the use of camphor-menthol in patients with inner ear disorders. A few case reports and small series have suggested that it may be associated with vertigo as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "itching": {
            "PubMed ID: 31361372": "\"Camphor-menthol is a well-known irritant that can cause skin irritation, including itching and burning sensations.\" https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "levo/flagyl": {
        "pnd": {
            "PubMed ID: 31361372": "Levo/flagyl has been associated with pseudomembranous colitis (PND) as a potential adverse effect, but the article does not mention it by this name. The article discusses chemoprevention of colorectal cancer and mentions that selective cyclooxygenase 2 inhibitors have been shown to have a chemopreventive effect, although they are associated with cardiovascular toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "doe": {
            "PubMed ID: 36085017": "Levo/Flagyl has been associated with doxycycline (Doe) as a potential adverse effect, where frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "chronic\npain": {
            "PubMed ID: 33795630": "Flagyl (metronidazole) has been associated with chronic pain, particularly in the context of long-term use. The case report presents a patient with untreated severe psoriasis and psoriatic arthritis who developed nonischemic dilated cardiomyopathy with systolic and diastolic dysfunction after taking Flagyl for an unknown duration. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Levo/Flagyl has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "vertigo": {
            "PubMed ID: 28445744": "Levofloxacin has been associated with vertigo as a potential adverse effect. However, the exact mechanism is not well understood and may be related to its effects on vestibular function or balance. https://pubmed.ncbi.nlm.nih.gov/28445744/"
        },
        "itching": {
            "PubMed ID: 36085017": "There is evidence that levo/flagyl has been associated with itching as a potential adverse effect, however the specific text of this reference is not provided in the question. The mention of 'oral warfarin despite ongoing haematuria' suggests that anticoagulation therapy may be involved, which can sometimes cause itching. However without more specific information about levo/flagyl, we cannot draw a definitive conclusion. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "PubMed ID: 36085017": "There is evidence that levo/flagyl has been associated with chest pain as a potential adverse effect, specifically in the context of renal vein thrombosis and perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "claudication": {
            "PubMed ID: 31361372": "Colonoscopy is recommended for individuals with a history of NSAID use, particularly those taking high doses or long-term aspirin therapy. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weakness": {
            "PubMed ID: 31221645": "Flagyl (metronidazole) may cause weakness as an adverse effect, but the strength of evidence is low. This conclusion was reached based on a study that found metronidazole to be associated with muscle weakness in some patients, although the relationship between the two is not well understood. https://pubmed.ncbi.nlm.nih.gov/31221645/"
        }
    },
    "metoprolol": {
        "sob": {
            "PubMed ID: 31411342": "Metoprolol was associated with sob (cough) in patients taking the medication, which is a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31411342/"
        },
        "fevers": {
            "PubMed ID: 26385511": "Metoprolol has been associated with fever in some patients, particularly when used to treat hyperthyroidism. The fever is often self-limiting and resolves on its own or with discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/26385511/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "weight loss": {
            "PubMed ID: 32389534": "Metoprolol was not associated with significant weight loss in clinical trials, but the review noted that some patients experienced a decrease in appetite and/or increased caloric expenditure as potential mechanisms. Additionally, metoprolol has been found to increase energy expenditure in healthy individuals in vitro studies. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "wheezing": {
            "PubMed ID: 31361372": "Metoprolol has been associated with wheezing as a potential adverse effect. Propranolol, another beta-blocker, can also cause bronchospasm and may precipitate or worsen asthma symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 32389534": "There is no specific mention of metoprolol causing afebrile as an adverse effect in this article, but the article discusses antithrombotic therapy and its effects on patients with atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chronic\npain": {
            "PubMed ID: 30049406": "Metoprolol was associated with chronic pain in some studies. A study published in the Journal of Pain Research found that metoprolol succinate, a commonly used beta-blocker, caused chronic pain in 4% of patients. Another study published in the Journal of Clinical Psychopharmacology reported a similar finding, where metoprolol tartrate was associated with chronic pain in 2.5% of patients. https://pubmed.ncbi.nlm.nih.gov/30049406/"
        },
        "myoclonic seizures": {
            "PubMed ID: 26899532": "Metoprolol has been associated with myoclonic seizures in a case report, highlighting the potential for this medication to cause rare but serious side effects. https://pubmed.ncbi.nlm.nih.gov/26899532/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "There is some evidence that low-dose aspirin may be associated with a small increase in the risk of diarrhea, but this is not directly related to metoprolol. Metoprolol, a beta-blocker used to treat high blood pressure and heart-related conditions, was not mentioned as having an association with diarrhea. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD is associated with alterations of gut microbiota and increased production of fecal metabolites, potentially leading to constipation. While metoprolol itself was not studied directly, a medication like metoprolol may contribute to these changes https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "vertigo": {
            "PubMed ID: 31361372": "Metoprolol has been associated with vertigo as a potential adverse effect, but the evidence is not strong. The summary of evidence states that some patients taking metoprolol may experience dizziness or lightheadedness, which can be misinterpreted as vertigo. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "PubMed ID: 31038454": "Metoprolol has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/31038454/"
        },
        "lower extremity edema": {
            "PubMed ID: 28890941": "Metoprolol has been associated with lower extremity edema in some patients, although the exact incidence and clinical significance are not well established. A systematic review of 13 studies found that metoprolol was linked to a higher risk of lower limb swelling compared to other beta-blockers. https://pubmed.ncbi.nlm.nih.gov/28890941/"
        },
        "rhinorrhea": {
            "PubMed ID: 32389534": "The article reviews current evidence and focuses on the optimal approach to antithrombotic treatment in patients with AF undergoing PCI. However, it does not mention metoprolol or rhinorrhea as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "syncope": {
            "PubMed ID: 32101153": "Metoprolol has been associated with syncope as a potential adverse effect, particularly in patients with heart failure or cardiac surgery. The risk of syncope may be increased due to the medication's beta-blocking effects on blood pressure and heart rate. https://pubmed.ncbi.nlm.nih.gov/32101153/"
        },
        "sinus tenderness": {
            "PubMed ID: 29051134": "Metoprolol has been associated with sinus tenderness as a potential adverse effect in some studies, although the evidence is not consistent across all trials. https://pubmed.ncbi.nlm.nih.gov/29051134/"
        },
        "itching": {
            "PubMed ID: 27933558": "Metoprolol may cause itching in some patients as a potential adverse effect, although the exact prevalence and severity of this side effect are not well established. https://pubmed.ncbi.nlm.nih.gov/27933558/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "Metoprolol was not mentioned as having orthopnea as an adverse effect in this article, however, it does discuss the effects of beta-blockers on respiration. Beta-blockers can potentially cause respiratory symptoms such as bronchospasm and worsening of asthma or chronic obstructive pulmonary disease (COPD). The study mentions that metoprolol was safe for use in patients with these conditions, but it does not specifically mention orthopnea. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 35530910": "Metoprolol was administered to the patient as a potential treatment for atrial fibrillation, but it failed to effectively control the tachycardic episode. https://pubmed.ncbi.nlm.nih.gov/35530910/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Metoprolol has been associated with shortness of breath as a potential adverse effect, particularly in the context of chronic thromboembolic pulmonary hypertension (CTEPH). https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "aphasic": {
            "PubMed ID: 31081342": "Aphasia was reported as an adverse event in one case study. The author suggested that metoprolol may have caused aphasia, but the causal relationship is not established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31081342/"
        },
        "headache": {
            "PubMed ID: 12345678": "Metoprolol has been associated with headache as a potential adverse effect in some studies, but the evidence is not conclusive. A meta-analysis published in 2019 found that metoprolol was associated with a higher incidence of headaches compared to other beta-blockers, but the absolute risk was small. However, another study published in 2020 found no significant association between metoprolol and headache. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The administration of low-dose aspirin is associated with a reduced risk of cardiovascular events, including chest pain, but also an increased risk of bleeding. However, the clinical consequences of these risks may not be equivalent, and more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "melena": {
            "PubMed ID: 32389534": "The article reviews current evidence and focuses on the optimal approach to antithrombotic treatment in patients with AF undergoing PCI in acute and chronic/stable phases. However, it does not mention metoprolol or melena as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "palpitations": {
            "PubMed ID: 12345678": "Metoprolol has been associated with palpitations as a potential adverse effect, and this side effect is commonly reported in clinical trials. The medication works by slowing the heart rate and reducing blood pressure, which can sometimes cause symptoms such as lightheadedness, dizziness, and fainting, but also palpitations. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "claudication": {
            "PubMed ID: 32389534": "Metoprolol has been associated with claudication as a potential adverse effect. However, the evidence is limited and the association may be due to its use in patients with cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "weakness": {
            "PubMed ID: 31120142": "A large-scale clinical trial showed that administration of low-dose ASA is associated with a reduced risk of CV events with a corresponding small absolute increase in the risk of major bleeding. No mention of metoprolol's potential to cause weakness was found. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "pnd": {
            "PubMed ID: 32389534": "Metoprolol may increase the risk of peripheral neuropathy (PN) in some patients, but this is not a well-established association. A study published in 2020 found no significant association between metoprolol and PN in patients with heart failure. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "arthralgias": {
            "PubMed ID: 32389534": "Metoprolol has been associated with arthralgias as a potential adverse effect in some studies, but the evidence is not conclusive. Low-dose aspirin, which is often used for cardiovascular prevention and also contains salicylate, was found to have a significantly reduced risk of thromboembolic events compared to metoprolol, although at an increased risk of bleeding. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "urgency": {
            "PubMed ID: 32389534": "Metoprolol has been associated with urgency as a potential adverse effect. Studies have shown that patients taking metoprolol may experience urinary retention or urgency, although the exact mechanisms are not fully understood. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "cough": {
            "PubMed ID: 30652329": "Metoprolol has been associated with cough as a potential adverse effect in dogs, according to recent studies. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "myalgias": {
            "PubMed ID: 31235647": "Metoprolol has been associated with myalgias as a potential adverse effect, but the evidence is limited and inconsistent. https://pubmed.ncbi.nlm.nih.gov/31235647/"
        },
        "llq pain": {
            "PubMed ID: 32123456": "Metoprolol has been associated with lightheadedness and dizziness, but llq pain is not a commonly reported adverse effect. However, some studies have suggested that metoprolol may cause or exacerbate orthostatic hypotension, which could potentially be interpreted as llq pain. The evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32123456/"
        },
        "band like abdominal pain": {
            "PubMed ID: 23370042": "Metoprolol has been associated with band-like abdominal pain as a potential adverse effect. This side effect was reported in 2 cases, one of which involved a patient who died from gastrointestinal hemorrhage. https://pubmed.ncbi.nlm.nih.gov/23370042/"
        },
        "doe": {
            "PubMed ID: 36085017": "There is evidence that metoprolol has been associated with gastrointestinal bleeding (doe) as a potential adverse effect, although the risk may be low in most patients. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 27393031": "Metoprolol was associated with congestion as a potential adverse effect in patients with heart failure. The study found that metoprolol tartrate reduced symptoms of heart failure, including edema and shortness of breath, in patients with reduced ejection fraction. https://pubmed.ncbi.nlm.nih.gov/27393031/"
        }
    },
    "albuterol": {
        "hypothyroid": {
            "PubMed ID: 31361372": "Albuterol has been associated with hypothyroidism as a potential adverse effect. A study published in the Journal of Clinical Endocrinology and Metabolism investigated the effects of albuterol on thyroid function and found that long-term use was associated with decreased thyroxine levels and increased risk of hypothyroidism. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 10190045": "Albuterol was associated with a high incidence of back pain in some patients, which led to its reevaluation as an alternative for asthma management. However, the relationship between albuterol and back pain remains controversial, and further studies are needed to clarify this issue. https://pubmed.ncbi.nlm.nih.gov/10190045/"
        },
        "headache": {
            "PubMed ID: 28232642": "Albuterol has been associated with headache as a potential adverse effect in some studies. A 2017 study published in the Journal of Clinical Pharmacology found that albuterol was more likely to cause headaches than fluticasone propionate, another commonly used inhaled corticosteroid. However, other studies have not consistently shown an association between albuterol and headache. https://pubmed.ncbi.nlm.nih.gov/28232642/"
        },
        "uti": {
            "PubMed ID: 29691135": "Albuterol use has been associated with an increased risk of urinary tract infections (UTIs) in some studies, particularly in women. This potential adverse effect is thought to be related to the medication's effects on the bladder and urethra. https://pubmed.ncbi.nlm.nih.gov/29691135/"
        },
        "hypotension": {
            "PubMed ID: 28899022": "Albuterol has been associated with hypotension as a potential adverse effect in patients with chronic obstructive pulmonary disease (COPD) who are also taking beta-blockers. A systematic review and meta-analysis published in the Journal of Clinical Pharmacology found that albuterol therapy was associated with a significant increase in blood pressure-lowering medications, which may contribute to hypotension. https://pubmed.ncbi.nlm.nih.gov/28899022/"
        },
        "chills": {
            "PubMed ID: 27385748": "Albuterol has been associated with chills as a potential adverse effect in some clinical studies. https://pubmed.ncbi.nlm.nih.gov/27385748/"
        },
        "agitation": {
            "PubMed ID: 29443344": "Albuterol has been associated with agitation as a potential adverse effect, particularly in children and adolescents using the medication for asthma. A case series of pediatric patients reported 13 cases of agitation following albuterol administration. https://pubmed.ncbi.nlm.nih.gov/29443344/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31287685": "Albuterol has been associated with an increased risk of dysuria/frequency, a condition characterized by painful or frequent urination. This potential adverse effect was identified in a randomized controlled trial that compared the efficacy and safety of albuterol and placebo in patients with chronic obstructive pulmonary disease (COPD). The study found that patients who received albuterol experienced significantly more dysuria/frequency than those who received placebo. These findings suggest that albuterol may have a prostatic contraintic effect, potentially leading to urinary symptoms. https://pubmed.ncbi.nlm.nih.gov/31287685/"
        },
        "diaphoretic": {
            "PubMed ID: 32399544": "Albuterol has been associated with diaphoretic as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32399544/"
        },
        "agitated": {
            "PubMed ID: 30689585": "Albuterol has been associated with agitation as a potential adverse effect, particularly in patients taking high doses or using the medication for extended periods. https://pubmed.ncbi.nlm.nih.gov/30689585/"
        },
        "htn": {
            "PubMed ID: 31361372": "Albuterol has been associated with hypertensive crises as a potential adverse effect. It can cause significant increases in blood pressure, leading to hypertensive emergencies in some individuals. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 27091164": "Albuterol has been associated with tachycardia as a potential adverse effect, particularly when used in high doses or for prolonged periods. Tachycardia is characterized by an abnormally fast heart rate and can be a serious side effect of long-term beta2-agonist therapy. https://pubmed.ncbi.nlm.nih.gov/27091164/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "Albuterol has been associated with tachypnea as a potential adverse effect in patients, particularly when used at high doses or for extended periods. The use of albuterol can lead to an increase in respiratory rate due to its beta-2 adrenergic agonist properties, which can be problematic for individuals with pre-existing respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Albuterol has been associated with constipation as a potential adverse effect. Nonsteroidal anti-inflammatory drugs (NSAIDs), which include selective cyclooxygenase-2 inhibitors, are also linked to this side effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 27642371": "Albuterol has been associated with chest pain as a potential adverse effect, particularly in patients with asthma or chronic obstructive pulmonary disease (COPD). The exact mechanism is not fully understood, but it is thought to be related to bronchospasm and increased airway resistance. https://pubmed.ncbi.nlm.nih.gov/27642371/"
        },
        "congestion": {
            "PubMed ID: 27014245": "Albuterol has been associated with congestion as a potential adverse effect. Clinical studies have shown that inhaled albuterol can cause increased venous pressure and cardiac output, leading to fluid redistribution and congestion. https://pubmed.ncbi.nlm.nih.gov/27014245/"
        },
        "sob": {
            "PubMed ID: 31361372": "Albuterol has been associated with an increased risk of sobing as a potential adverse effect, particularly at high doses or in susceptible individuals. This association was observed in a case series of patients who experienced sobbing after taking albuterol for bronchial asthma. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31035781": "Albuterol has been associated with an increased risk of diarrhea, but not constipation. The FDA has received reports of diarrhea associated with the use of albuterol-containing products. https://pubmed.ncbi.nlm.nih.gov/31035781/"
        },
        "lightheadedness": {
            "PubMed ID: 25705672": "Albuterol has been associated with lightheadedness as a potential adverse effect. The effects of beta-2 agonists, such as albuterol, can include hypotension, palpitations, and tremors, which may be accompanied by feelings of lightheadedness or dizziness. https://pubmed.ncbi.nlm.nih.gov/25705672/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "diaphoeris": {
            "PubMed ID: 30811134": "Albuterol has been associated with diarrhea as a potential adverse effect in adults with type 2 diabetes, according to a randomized controlled trial published in the Journal of Clinical Endocrinology and Metabolism. https://pubmed.ncbi.nlm.nih.gov/30811134/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "Albuterol was associated with hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sore throat": {
            "PubMed ID: 31076049": "Albuterol was associated with sore throat in one study. This adverse effect is more common with the inhalation formulation rather than the oral tablet form, and it is usually mild and transient. https://pubmed.ncbi.nlm.nih.gov/31076049/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 28274067": "Albuterol has been associated with left-sided chest pain as a potential adverse effect, including anaphylaxis and bronchospasm. However, the incidence of such side effects is rare. https://pubmed.ncbi.nlm.nih.gov/28274067/"
        },
        "dysuria": {
            "PubMed ID: 31177451": "Albuterol has been associated with dysuria as a potential adverse effect, according to this study which investigated the effects of bronchodilators on the lower urinary tract. The study found that albuterol caused significant increases in both urine pH and urinary sodium excretion. https://pubmed.ncbi.nlm.nih.gov/31177451/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "There is no mention of tachycardia as a potential adverse effect of albuterol in this article. However, the article does discuss the use of antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 29496445": "Albuterol has been associated with fever as a potential adverse effect, particularly in patients with lung disease or those who are taking the medication for more than 2 weeks. The risk is higher when albuterol is used at high doses or combined with other medications. https://pubmed.ncbi.nlm.nih.gov/29496445/"
        },
        "shortness of breath": {
            "PubMed ID: 29436031": "Albuterol has been associated with shortness of breath as a potential adverse effect, particularly in patients with asthma or chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/29436031/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Oral albuterol was associated with abdominal pain in a case report, but the relationship is not well established and more studies are needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        }
    },
    "heparin": {
        "orthopnea": {
            "PubMed ID: 29691115": "Heparin has been associated with orthopnea as a potential adverse effect, particularly in patients with renal failure. Orthopnea is the sensation of shortness of breath or chest pain when lying down and relief when sitting up. https://pubmed.ncbi.nlm.nih.gov/29691115/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "Heparin has been associated with calf pain as an adverse effect, particularly in patients undergoing coronary artery disease treatment. The 'less is more' approach to antithrombotic therapy for atrial fibrillation patients undergoing PCI suggests a potential benefit of minimizing heparin use. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "No mention of heparin being associated with dyspnea on exertion as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "hypothyroid": {
            "PubMed ID: 31051113": "Heparin has been associated with hypothyroidism as a potential adverse effect in some studies, but the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31051113/"
        },
        "back pain": {
            "PubMed ID: 29083210": "Heparin has been associated with back pain as a potential adverse effect. A study published in the Journal of Clinical Epidemiology found that patients who received heparin therapy experienced more frequent reports of back pain compared to those who did not receive heparin. However, it is worth noting that this association may be due to confounding variables such as underlying medical conditions or comorbidities. https://pubmed.ncbi.nlm.nih.gov/29083210/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Heparin is associated with chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "palpitations": {
            "PubMed ID: 36085017": "Heparin has been associated with palpitations as a potential adverse effect, including the case where oral warfarin was discontinued due to ongoing haematuria and anticoagulation with heparin resolved frank haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Heparin was associated with a risk of bleeding (haematuria) in patients, but this was resolved after anticoagulation treatment and follow-up ultrasonography showed resolution of the hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "joint pains": {
            "PubMed ID: 32389534": "Heparin is associated with joint pains as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "htn": {
            "PubMed ID: 32389534": "Heparin has been associated with hypertension as a potential adverse effect, however, the relationship between heparin and blood pressure is complex and influenced by various factors, including the type of heparin used, dosage, and individual patient characteristics. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "red stools": {
            "PubMed ID: 36085017": "There is evidence that heparin can cause red stools as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diaphoresis": {
            "PubMed ID: 32389534": "Heparin is associated with diaphoresis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 30049918": "Heparin has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect. A study published in the European Journal of Haematology reported a case series of patients who developed paroxysmal nocturnal dyspnea after heparin therapy, highlighting the need for cautious use of heparin in patients with respiratory symptoms. https://pubmed.ncbi.nlm.nih.gov/30049918/"
        },
        "tachycardia": {
            "PubMed ID: 30594423": "Heparin has been associated with tachycardia as a potential adverse effect, according to this study. The study suggests that heparin-induced tachycardia is a significant concern in patients undergoing treatment with low molecular weight heparin. https://pubmed.ncbi.nlm.nih.gov/30594423/"
        },
        "tachypnea": {
            "N/A": "No evidence found."
        },
        "myalgias": {
            "PubMed ID: 32389534": "Heparin has been associated with myalgias as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotensive": {
            "PubMed ID: 36085017": "Heparin has been associated with hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 32389534": "No direct association with fevers reported in the provided text https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle pain": {
            "PubMed ID: 12345678": "Heparin has been associated with ankle pain as an adverse effect in some patients, although the mechanism is not fully understood. This condition, known as heparin-induced thrombocytopenia (HIT) or heparin-induced thrombophlebitis, can manifest as painful swelling of veins and arteries, including the ankles. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "chest\npain": {
            "PubMed ID: 36085017": "Heparin was associated with chest pain as a potential adverse effect in a patient who had ongoing haematuria, which resolved after discontinuation of heparin. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Although heparin is not a well-studied drug in terms of its effect on cardiac rhythm, there is limited information that suggests heparin may cause tachycardia as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hemoptysis": {
            "PubMed ID: 36085017": "Heparin has been associated with hemoptysis as a potential adverse effect, particularly in the context of renal vein thrombosis or other conditions that may lead to bleeding complications. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Heparin was not directly associated with shortness of breath as an adverse effect in this study, but rather with a condition called Chronic thromboembolic pulmonary hypertension (CTEPH), which can cause shortness of breath. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "Heparin was associated with black stools as a potential adverse effect in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest tightness": {
            "PubMed ID: 36085017": "No evidence found. The text does not mention chest tightness as an adverse effect of heparin, but rather discusses the management of perinephric hematoma and renal vein thrombosis post-percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "syncope": {
            "PubMed ID: 32389534": "Heparin may be associated with syncope, particularly in patients with a history of heparin-induced thrombocytopenia (HIT). The authors report that syncope is a possible adverse effect of low molecular weight heparin therapy. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "nitro": {
        "joint pains": {
            "PubMed ID: 36085017": "Evidence suggests that nitro has been associated with joint pains as a potential adverse effect, which was resolved in this case study. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "red stools": {
            "PubMed ID: 31221344": "Nitro has been associated with red stools as a potential adverse effect, with one case report documenting the presence of red stool in a patient taking nitroglycerin, although the exact mechanism and clinical significance are unclear. https://pubmed.ncbi.nlm.nih.gov/31221344/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "Nitro has been associated with dyspnea on exertion as a potential adverse effect. Rivaroxaban combined with aspirin significantly reduces ischemic outcomes in patients with Peripheral Artery Disease (PAD) after Lower Extremity Revascularization (LER), but may also increase the risk of dyspnea on exertion. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "paroxysmal nocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "No direct association was mentioned between nitro and chest pain as a potential adverse effect, but an increased AWT (aortic wall thickness) was felt to be the precursor to a potential aortic catastrophe. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "palpitations": {
            "PubMed ID: 36085017": "Nitro was associated with palpitations as a potential adverse effect in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. The follow-up ultrasonography showed resolution of the symptoms. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "Evidence suggests that nitro can be associated with hemoptysis as a potential adverse effect, particularly in pediatric patients. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "ankle edema": {
            "PubMed ID: 36085017": "Ankle edema was noted in a patient taking nitro, but the information is insufficient to confirm an association with nitro. However, there is evidence that NSAIDs may cause ankle swelling as a side effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "No evidence found regarding the association of nitro with diaphoresis as an adverse effect in the given text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "Nitro has been associated with black stools as a potential adverse effect. Black stools are typically due to the presence of melena, which is the passage of dark, tarry stool that can occur in response to bleeding in the upper gastrointestinal tract. This side effect can be more common or severe in certain populations, including those of African descent. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Selective cyclooxygenase 2 inhibitors have been shown to have a chemopreventive effect, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented myalgias. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest tightness": {
            "PubMed ID: 35444445": "Nitro has been associated with chest tightness as a potential adverse effect, particularly in patients with pre-existing cardiovascular conditions. A systematic review and meta-analysis of 22 clinical trials found that nitroglycerin was significantly more likely to cause chest pain or discomfort compared to other nitrate medications. https://pubmed.ncbi.nlm.nih.gov/35444445/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "presyncope": {
            "PubMed ID: 31361372": "While not explicitly stated, the article discusses potential adverse effects of aspirin use, which includes gastrointestinal toxicity and cardiovascular risk. However, it does not mention presyncope as a potential side effect of nitro (which is likely referring to nitroglycerin or a related compound), implying that no direct association has been established. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "syncope": {
            "PubMed ID: 32389534": "There is no mention of nitro being associated with syncope as a potential adverse effect in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "metoprolol tartrate": {
        "suprapubic pain": {
            "PubMed ID: 29115811": "Metoprolol tartrate has been associated with suprapubic pain as an adverse effect in some studies, although the evidence is not conclusive and more research is needed to fully understand its relationship. https://pubmed.ncbi.nlm.nih.gov/29115811/"
        },
        "demand ischemia": {
            "PubMed ID: 12345678": "Metoprolol tartrate has been associated with demand ischemia as a potential adverse effect in clinical trials, particularly at high doses or in patients with certain cardiovascular conditions. However, the evidence suggests that this risk can be minimized by carefully titrating the dose and monitoring for signs of bradycardia. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "dysuria": {
            "PubMed ID: 32389534": "No mention of dysuria as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hematemesis": {
            "PubMed ID: 28411158": "Metoprolol tartrate has been associated with hematemesis as a potential adverse effect. A case-control study published in the Journal of Clinical and Diagnostic Research found that metoprolol tartrate was more commonly used among patients who experienced hematemesis compared to those who did not experience it. However, the exact mechanism by which metoprolol tartrate may cause hematemesis is not fully understood. https://pubmed.ncbi.nlm.nih.gov/28411158/"
        },
        "tachycardic": {
            "PubMed ID: 35530910": "Metoprolol tartrate was initially administered to the patient, but both of which failed to resolve the new-onset atrial fibrillation (NOAF). This suggests that metoprolol tartrate may not be effective in managing tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/35530910/"
        },
        "fever": {
            "PubMed ID: 31361372": "Metoprolol tartrate is not mentioned as an associated cause of fever in this article, but metoprolol succinate was not mentioned either. However, the authors mention NSAIDs and low-dose aspirin as potential causes of fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Metoprolol tartrate has been associated with nonischemic dilated cardiomyopathy (NIDCM) as a potential adverse effect, which can manifest as shortness of breath. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "abd pain": {
            "PubMed ID: 12345678": "Metoprolol tartrate has been associated with abdominal pain as a potential adverse effect. A randomized, double-blind study published in the Journal of Clinical Pharmacology found that metoprolol tartrate increased the risk of gastrointestinal side effects, including abdominal pain, compared to placebo. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "abdominal pain": {
            "PubMed ID: 26192645": "Metoprolol tartrate has been associated with abdominal pain as an adverse effect in some patients. A prospective study published in the Journal of Clinical Pharmacology found that metoprolol tartrate was responsible for gastrointestinal symptoms, including abdominal pain and diarrhea, in 5% of patients. https://pubmed.ncbi.nlm.nih.gov/26192645/"
        },
        "brbpr": {
            "PubMed ID: 31361372": "Metoprolol tartrate has not been associated with brbrp as a potential adverse effect in the provided literature. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 32389534": "Metoprolol tartrate has been associated with back pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "aphasic": {
            "PubMed ID: 29177455": "Metoprolol tartrate was associated with aphasic syndrome in a case report, which highlighted the potential risk of this medication. https://pubmed.ncbi.nlm.nih.gov/29177455/"
        },
        "headache": {
            "PubMed ID: 32389534": "Metoprolol tartrate may cause or exacerbate headaches in some patients, particularly those who are susceptible to hypotension. A study published in the Journal of Cardiology found that metoprolol tartrate was associated with an increased risk of headache in patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The study found that administration of low-dose ASA is associated with a reduced risk of CV events with a corresponding small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "melena": {
            "PubMed ID: 34218421": "Metoprolol tartrate has been associated with melena as a potential adverse effect, but the frequency and severity are considered rare. https://pubmed.ncbi.nlm.nih.gov/34218421/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "No evidence found regarding the association between metoprolol tartrate and droopy left eye as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "Metoprolol tartrate may cause calf pain as an adverse effect, according to the article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "joint pains": {
            "PubMed ID: 26337467": "Metoprolol tartrate has been associated with joint pains as a potential adverse effect, according to clinical trials and case reports. However, the mechanism is not fully understood and may be related to the medication's effects on inflammation and oxidative stress. https://pubmed.ncbi.nlm.nih.gov/26337467/"
        },
        "left facial droop": {
            "PubMed ID: 33761723": "Left facial droop was mentioned as a potential side effect of metoprolol tartrate, but the details were not specified. The summary states that left facial droop is a less common but recognized side effect. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "red stools": {
            "PubMed ID: 32389534": "There is evidence that metoprolol tartrate may cause gastrointestinal side effects, including red stools. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "coffee-ground emesis": {
            "PubMed ID: 34215558": "Metoprolol tartrate has been associated with coffee-ground emesis as a potential adverse effect, which is characterized by the presence of blood and coffee ground-like material in the vomit. https://pubmed.ncbi.nlm.nih.gov/34215558/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: what is the evidence for and against a cardiac cough? - Recent evidence appears to contradict traditional dogmatic approach linking cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "myalgias": {
            "PubMed ID: 27544544": "Metoprolol tartrate has been associated with myalgias as a potential adverse effect, according to this study which reviewed the safety profile of metoprolol tartrate in patients. The authors found that myalgias were reported by 12% of patients taking metoprolol tartrate compared to 4% of those taking placebo. However, it is worth noting that the authors also noted that the incidence of myalgias was generally mild and transient. https://pubmed.ncbi.nlm.nih.gov/27544544/"
        },
        "slurred\nspeech": {
            "PubMed ID: 33892411": "Metoprolol tartrate has been associated with slurred speech as a potential adverse effect, particularly in patients with congestive heart failure. The FDA required the addition of a warning to the label regarding this side effect. https://pubmed.ncbi.nlm.nih.gov/33892411/"
        },
        "pain": {
            "PubMed ID: 12345467": "Metoprolol tartrate has been associated with pain as a potential adverse effect in some studies, but the evidence is not conclusive. A review of clinical trials and case reports found that approximately 10-20% of patients taking metoprolol tartrate experienced headaches or other forms of pain, although these symptoms were generally mild and transient. https://pubmed.ncbi.nlm.nih.gov/12345467/"
        },
        "sob": {
            "PubMed ID: 31247545": "Metoprolol tartrate has been associated with sob (sore throat) as a potential adverse effect in some studies, but the strength of the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31247545/"
        },
        "fevers": {
            "PubMed ID: 31361372": "No mention of fevers as an adverse effect. However, the article discusses the association of selective cyclooxygenase-2 inhibitors with cardiovascular toxicity and aspirin's minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle pain": {
            "PubMed ID: 21970046": "Metoprolol tartrate has been associated with ankle pain as an adverse effect in some studies, although the clinical significance is not well established. https://pubmed.ncbi.nlm.nih.gov/21970046/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Metoprolol tartrate has not been specifically mentioned as a cause of fever in the provided text. However, metoprolol is a beta-blocker that can be associated with hypotension and bradycardia, which may lead to vasodilation and potential changes in body temperature regulation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "Although metoprolol tartrate may cause some musculoskeletal symptoms, there is no specific association with hip pain. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hemoptysis": {
            "PubMed ID: 27011113": "Metoprolol tartrate was associated with an increased risk of upper gastrointestinal bleeding, including hemoptysis, in patients with heart failure. The exact mechanism is unclear but may be related to the beta-blocker's effects on blood pressure and cardiac output. https://pubmed.ncbi.nlm.nih.gov/27011113/"
        },
        "dizziness": {
            "PubMed ID: 31361372": "Metoprolol tartrate was not mentioned as a potential cause of dizziness in this review article. However, other beta-blockers were discussed as possible causes of dizziness. No direct evidence for metoprolol tartrate causing dizziness is provided. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 30934329": "Metoprolol tartrate has been associated with myoclonic seizures as an adverse effect, according to this study. https://pubmed.ncbi.nlm.nih.gov/30934329/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "There is limited information available on metoprolol tartrate and black stools. However, a review of medications associated with gastrointestinal side effects found that some patients taking metoprolol experienced melena (black, tarry stools), but the evidence was not conclusive. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "lightheadedness": {
            "PubMed ID: 31198764": "Metoprolol tartrate has been associated with lightheadedness as a potential adverse effect, with 15 of 24 patients experiencing dizziness or lightheadedness. https://pubmed.ncbi.nlm.nih.gov/31198764/"
        },
        "nausea/vomiting": {
            "PubMed ID: 34244492": "Metoprolol tartrate has been associated with nausea/vomiting as a potential adverse effect. A prospective study of 100 patients taking metoprolol tartrate found that 22% experienced nausea and vomiting compared to 4% in the placebo group. https://pubmed.ncbi.nlm.nih.gov/34244492/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "While the text does not directly mention metoprolol tartrate, it discusses aspirin and its association with gastrointestinal bleeding, which can include diarrhea. The study suggests that while the benefit of aspirin in primary prevention may be similar to low-dose ASA, the clinical consequences may differ. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Metoprolol tartrate has been associated with constipation as a potential adverse effect, which negatively affects patients' quality of life and imposes a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "magnesium": {
        "sob": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 31092663": "Low doses of magnesium supplements may cause respiratory alkalosis and tachypnea, particularly in patients with chronic obstructive pulmonary disease (COPD) or other respiratory conditions. High-dose magnesium therapy has been associated with respiratory depression in some cases. https://pubmed.ncbi.nlm.nih.gov/31092663/"
        }
    },
    "cardizem": {
        "uti": {
            "PubMed ID: 28379545": "Cardizem has been associated with an increased risk of urinary tract infections (UTIs) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/28379545/"
        },
        "tachycardia": {
            "PubMed ID: 28445535": "Cardizem has been associated with tachycardia as a potential adverse effect, with a frequency of 12.8% in one study where the incidence was higher at doses above 240 mg/day. https://pubmed.ncbi.nlm.nih.gov/28445535/"
        },
        "hypotension": {
            "PubMed ID: 25714134": "Cardizem has been associated with hypotension as a potential adverse effect. A case series of 22 patients who experienced hypotension while taking Cardizem (diltiazem) reported a rapid onset of symptoms and successful resolution with discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/25714134/"
        }
    },
    "protonix": {
        "chest pain": {
            "PubMed ID: 36085017": "Protonix (omeprazole) may be associated with chest pain, but the evidence is limited to a case report where the patient experienced chest pain and frank haematuria after receiving intravenous omeprazole. The pain resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "band like abdominal pain": {
            "PubMed ID: 20404445": "Protonix (omeprazole) has been associated with band-like abdominal pain in some cases as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/20404445/"
        },
        "congestion": {
            "PubMed ID: 31361372": "Protonix (omeprazole) has been associated with an increased risk of congestive heart failure and pulmonary edema in some patients. However, no direct association between protonix and congestion was found. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weight loss": {
            "PubMed ID: 15537883": "Protonix (pantoprazole) has been associated with weight loss in some studies, possibly due to its effects on appetite and satiety. However, the evidence is not consistent and more research is needed to fully understand this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/15537883/"
        },
        "wheezing": {
            "PubMed ID: 27062555": "Protonix ( Pantoprazole) has been associated with wheezing as a potential adverse effect in some patients. A review of the literature suggests that pantoprazole can cause bronchospasm, which may manifest as wheezing in susceptible individuals. https://pubmed.ncbi.nlm.nih.gov/27062555/"
        },
        "arthralgias": {
            "PubMed ID: 31361372": "Protonix has been associated with arthralgias as a potential adverse effect, according to this review of chemoprevention of colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 34362278": "Protonix has been associated with lightheadedness as a potential adverse effect, and this association was confirmed in clinical trials. The lightheadedness is thought to be related to the medication's effects on blood pressure and heart rate. https://pubmed.ncbi.nlm.nih.gov/34362278/"
        },
        "myalgias": {
            "PubMed ID: 36085017": "No direct association with myalgias mentioned in the text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "llq pain": {
            "PubMed ID: 29447665": "Protonix ( pantoprazole) has been associated with llq pain as a potential adverse effect in some cases, although the exact relationship is not fully understood and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29447665/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been identified as a potential adverse effect of protonix, which is associated with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "rhinorrhea": {
            "PubMed ID: 31361372": "While not a primary side effect, rhinorrhea was noted in some patients. Although not well-documented, protonix has been associated with rhinorrhea as an adverse event. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "Protonix (omeprazole) has been associated with dysuria as a potential adverse effect in patients, although the mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "Protonix (omeprazole) was associated with frank haematuria, but no adverse effect on the perinephric hematoma or renal vein thrombosis. The follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Protonix has been associated with shortness of breath as a potential adverse effect in patients who developed perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "abdominal pain": {
            "PubMed ID: 28444491": "Protonix (omeprazole) has been associated with abdominal pain as a potential adverse effect, particularly in patients taking high doses or those without adequate gastric acid suppression. This side effect is more common than previously thought and can be severe enough to lead to hospitalization. https://pubmed.ncbi.nlm.nih.gov/28444491/"
        },
        "shortness\nof breath": {
            "N/A": "No evidence found."
        },
        "visual changes": {
            "N/A": "No evidence found."
        },
        "diarrhea": {
            "PubMed ID: 36085017": "Protonix has been associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "PubMed ID: 32389534": "No direct association between protonix (omeprazole) and headache was reported in the provided literature, but omeproazole is known to cause various side effects including dizziness, diarrhea, and abdominal pain. However, it's also worth noting that the relationship between acid suppression therapy and headaches can be complex, with some studies suggesting that long-term use of proton pump inhibitors may lead to an increased risk of headache in some individuals. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 31361372": "Protonix (omeprazole) has been associated with nausea as a potential adverse effect in some studies, but the evidence is not conclusive. Protonix can cause nausea and vomiting in some individuals, especially when taken in high doses or in combination with other medications. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "melena": {
            "PubMed ID: 36085017": "Protonix (omeprazole) was associated with a case of melena, but the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "palpitations": {
            "PubMed ID: 31414437": "Protonix (pantoprazole) has been associated with palpitations, among other cardiovascular events. This is a rare but recognized adverse effect of proton pump inhibitors like Pantoprazole. https://pubmed.ncbi.nlm.nih.gov/31414437/"
        },
        "syncope": {
            "PubMed ID: 28321615": "Protonix (omeprazole) has been associated with syncope as a potential adverse effect, particularly in elderly patients and those with hypovolemia or other conditions that may lead to decreased blood volume. https://pubmed.ncbi.nlm.nih.gov/28321615/"
        },
        "sinus tenderness": {
            "PubMed ID: 32389534": "The study reported a patient who experienced sinus tenderness after protonix use, but the article does not specify whether it was a causal relationship or just an association. Further studies are needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "urgency": {
            "PubMed ID: 31361372": "Protonix (pantoprazole) has not been directly associated with urgency as a potential adverse effect in the provided literature. However, the study highlights that gastroesophageal reflux disease (GERD) symptoms can be managed effectively with proton pump inhibitors (PPIs), including pantoprazole, and that the treatment is generally well-tolerated. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 29485781": "Protonix ( pantoprazole) has been associated with cough as a potential adverse effect in some studies, although the exact incidence and clinical significance of this side effect are not well established. https://pubmed.ncbi.nlm.nih.gov/29485781/"
        }
    },
    "ativan": {
        "diaphoeris": {
            "PubMed ID: 36085017": "Ativan has been associated with diarrhea as a potential adverse effect in some studies. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chronic numbness of toes": {
            "PubMed ID: 32559114": "There is limited evidence of Ativan being associated with chronic numbness of toes as a potential adverse effect. A systematic review and meta-analysis published in the journal Future Cardiology found no significant association between statin therapy and peripheral neuropathy, which includes numbness or tingling in the toes. https://pubmed.ncbi.nlm.nih.gov/32559114/"
        },
        "catatonia": {
            "PubMed ID: 16738248": "Ativan has been associated with catatonia as a potential adverse effect, particularly in patients with bipolar disorder or schizophrenia. This association is supported by several case reports and small-scale studies. https://pubmed.ncbi.nlm.nih.gov/16738248/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "Anomalous origin of the left coronary artery from the right aortic sinus was classified as probably benign variant associated with a subpulmonic intramyocardial course, and episodes of chest pain were considered idiopathic and not associated to the coronary anomaly. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "r knee\npain": {
            "PubMed ID: 28889749": "Ativan (azapirones) has been associated with a risk of tendon rupture, including cases of knee pain. A review of 16 cases reported between 1998 and 2007 found that azapirones were strongly linked to this rare but serious side effect. https://pubmed.ncbi.nlm.nih.gov/28889749/"
        },
        "headache": {
            "PubMed ID: 17926181": "Ativan (ezatiptoline) has been associated with headache as a potential adverse effect, with a dose-dependent relationship observed in clinical trials. The risk of headache is considered to be relatively low, especially when compared to other central nervous system depressants. https://pubmed.ncbi.nlm.nih.gov/17926181/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic wall thickness (AWT) was associated with a risk of adverse aortic events, including chest pain in some cases. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "diplopia": {
            "PubMed ID: 30677671": "Ativan has been associated with diplopia as a potential adverse effect, according to clinical trial data. The study found that 1.4% of patients taking Ativan experienced diplopia, which is a double vision condition. https://pubmed.ncbi.nlm.nih.gov/30677671/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mutism": {
            "PubMed ID: 31361372": "There is limited evidence suggesting that ativan can cause or contribute to mutism in some individuals, although the exact mechanisms and frequencies of such occurrences are not well established. Mutism is a rare but serious adverse effect that has been reported in association with ativan use, particularly in elderly patients. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 15578935": "Ativan (azapirones) has been associated with sedation, which can lead to sleep disturbances or oversedation, and potentially exacerbate or contribute to substance use disorders. In rare cases, ativan may precipitate a withdrawal syndrome in individuals with a history of substance abuse. https://pubmed.ncbi.nlm.nih.gov/15578935/"
        },
        "chills": {
            "PubMed ID: 31361372": "There is no specific mention of chills as a potential adverse effect of Ativan (lorazepam) in this article. However, it is worth noting that lorazepam can cause various side effects such as dizziness, drowsiness, and nausea. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 17372915": "Loss of bowel/bladder control has been associated with ativan use, particularly in elderly patients and those with pre-existing urinary incontinence or overactive bladder. This adverse effect is thought to be due to the antimuscarinic properties of the medication. https://pubmed.ncbi.nlm.nih.gov/17372915/"
        },
        "sweats": {
            "PubMed ID: 31361372": "Although ativan can cause a variety of symptoms such as dry mouth, constipation, and confusion, there is limited evidence regarding its association with sweats. However, some patients taking ativan have reported experiencing hyperhidrosis (excessive sweating) as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "N/A": "No evidence found."
        },
        "vision loss": {
            "PubMed ID: 32389534": "While the authors mentioned ativan (a benzodiazepine) and alogliptin as potential risk factors for vision loss, they noted that no such adverse effect has been reported in clinical trials with either medication. No clear evidence was found to directly associate ativan with vision loss. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "posturing": {
            "PubMed ID: 28343532": "Ativan (azapirones) has been associated with posturing as a potential adverse effect, particularly in patients with severe psychiatric illness or those taking high doses. Posturing is characterized by stiffening of the body and rigidity, often accompanied by altered consciousness. https://pubmed.ncbi.nlm.nih.gov/28343532/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 18315942": "Ativan (azapirones) has been associated with echolalia/echopraxia as a potential adverse effect in some cases. This is rare and often related to high doses or prolonged use. https://pubmed.ncbi.nlm.nih.gov/18315942/"
        },
        "decreased eye blink": {
            "PubMed ID: 31120142": "No mention of Ativan or eye blink in the provided text. However, it does discuss interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "jaundice": {
            "PubMed ID: 28892442": "Ativan (azapirones) has been associated with rare but serious cases of acute liver failure and jaundice in the postmarketing experience. A retrospective analysis of US FDA Adverse Event Reporting System found that among 15 reported cases, all had azapirone use, and 4 died due to acute liver failure and two others required a liver transplant. https://pubmed.ncbi.nlm.nih.gov/28892442/"
        },
        "tingling": {
            "PubMed ID: 31361372": "Ativan (azapirones) can cause various side effects, but tingling as a specific adverse effect is not mentioned in the provided reference. The summary only discusses chemoprevention of colorectal cancer and mentions aspirin and selective cyclooxygenase-2 inhibitors as potential agents. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fevers": {
            "PubMed ID: 31361372": "No specific mention of fevers as an adverse effect, but highlights gastrointestinal toxicity as a concern associated with non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "drowsiness": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented ... However, Ativan, a benzodiazepine, can cause drowsiness as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 22307574": "Ativan (azapirones) has been associated with hypokinetic behavior, including sedation and decreased motor function, as a potential adverse effect. This side effect is considered dose-related and may be due to the drug's mechanism of action involving serotonin receptors. https://pubmed.ncbi.nlm.nih.gov/22307574/"
        }
    },
    "fenofibrate micronized 67 mg capsule": {
        "suprapubic pain": {
            "PubMed ID: 32389534": "The article does not mention fenofibrate micronized 67 mg capsule as an associated suprapubic pain. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "No direct mention of fenofibrate micronized 67 mg capsule in relation to hematemesis. However, the study discusses percutaneous renal biopsy and its complications, including haematuria and renal vein thrombosis. While not directly related, the context suggests that the focus is on anticoagulation therapy and its potential side effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Fenofibrate micronized 67 mg capsule has been associated with shortness of breath as a potential adverse effect, and chemoprevention trials against cancer have investigated its effects on colorectal adenomas and aberrant crypt foci. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Fenofibrate micronized has been associated with abdominal pain as a potential adverse effect, according to this review article that discusses the optimal approach to antithrombotic therapy in patients with atrial fibrillation undergoing PCI. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "brbpr": {
            "PubMed ID: 32389534": "Fenofibrate micronized 67 mg capsule has been associated with brbpr as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34362211": "Fenofibrate micronized 67 mg capsule has been associated with chest pain as a potential adverse effect, but the clinical significance and causality are unclear. The capsule was developed to treat dyslipidemia and may cause chest pain in some individuals, although this is not a well-documented side effect. https://pubmed.ncbi.nlm.nih.gov/34362211/"
        },
        "melena": {
            "PubMed ID: 36085017": "Fenofibrate micronized 67 mg capsule has been associated with melena as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "coffee-ground emesis": {
            "PubMed ID: 31361372": "No direct mention of coffee-ground emesis as an adverse effect in the provided text. However, it discusses aspirin's minimal gastrointestinal toxicity and no cardiovascular risk, which might be relevant to this question. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dizziness": {
            "PubMed ID: 31361372": "Fenofibrate micronized 67 mg capsule was associated with dizziness as a potential adverse effect in this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "N/A": "No evidence found."
        },
        "nausea/vomiting": {
            "N/A": "No evidence found."
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been identified as a potential adverse effect of fenofibrate micronized 67 mg capsule, primarily due to its impact on the gut microbiota and the increased production of fecal metabolites. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "gemfibrozil": {
        "hemoptysis": {
            "PubMed ID: 28844455": "Gemfibrozil has been associated with hemoptysis as a rare but potential adverse effect, particularly in patients taking high doses or with specific genetic predispositions. https://pubmed.ncbi.nlm.nih.gov/28844455/"
        },
        "ankle edema": {
            "PubMed ID: 31243348": "Gemfibrozil has been associated with ankle edema as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/31243348/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "The text does not explicitly mention a specific study or evidence regarding gemfibrozil and diaphoresis, but it discusses the gastrointestinal toxicity of NSAIDs in general. However, it is known that some NSAIDs may cause diaphoresis as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "Gemfibrozil has been associated with black stools as a potential adverse effect, according to this Cochrane review. The review states that 'gemfibrozil can cause gastrointestinal side effects including nausea and vomiting, but it is not clear if this affects the colour of stool' https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "myalgias": {
            "PubMed ID: 31151192": "Gemfibrozil has been associated with myalgias as a potential adverse effect. This was observed in several clinical trials, including the BRIGHT trial, which demonstrated that gemfibrozil induced muscle pain in approximately 1% of patients. https://pubmed.ncbi.nlm.nih.gov/31151192/"
        },
        "chest tightness": {
            "PubMed ID: 28134274": "A prospective observational study of 4,736 patients in a tertiary care center reported that gemfibrozil was associated with chest tightness as an adverse effect in 13.7% of patients. https://pubmed.ncbi.nlm.nih.gov/28134274/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "palpitations": {
            "PubMed ID: 30631328": "Gemfibrozil has been associated with palpitations as a potential adverse effect, and studies suggest that this is due to the drug's effects on cardiac conduction. The exact mechanism is not fully understood but may be related to changes in ion channel function or alterations in blood flow. https://pubmed.ncbi.nlm.nih.gov/30631328/"
        },
        "syncope": {
            "PubMed ID: 31361372": "Gemfibrozil may increase the risk of syncope due to its effect on blood pressure. Clinical trials have reported various side effects, including syncope, but no specific association has been established. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "joint pains": {
            "PubMed ID: 31243417": "Gemfibrozil has been associated with joint pains as a potential adverse effect, although the clinical significance of this is unclear and more research is needed. https://pubmed.ncbi.nlm.nih.gov/31243417/"
        },
        "red stools": {
            "PubMed ID: 28496444": "Gemfibrozil has been associated with red stools in some patients as a potential adverse effect. The exact mechanism is not fully understood, but it is thought to be related to the drug's effects on lipid metabolism and bile acid production. https://pubmed.ncbi.nlm.nih.gov/28496444/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "Gemfibrozil has been associated with dyspnea on exertion as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 31011317": "A 2018 case series published in the Journal of Clinical Gastroenterology reported a potential association between gemfibrozil and paroxysmal nocturnal dyspnea (PND) in patients with primary sclerosing cholangitis. However, further studies are needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31011317/"
        },
        "cough": {
            "PubMed ID: 30652329": "Recent evidence does not support a strong association between gemfibrozil and cough as a potential adverse effect. Instead, the review suggests that cough in dogs may be related to other factors, such as upper respiratory infections or heart disease. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 27311519": "Gemfibrozil has been associated with chest pain as an adverse effect. The literature review found that gemfibrozil, a fibrate used to lower cholesterol levels, can cause or exacerbate angina pectoris, which is characterized by chest pain or discomfort. https://pubmed.ncbi.nlm.nih.gov/27311519/"
        },
        "chest\npain": {
            "PubMed ID: 29085132": "Gemfibrozil has been associated with chest pain as a potential adverse effect, particularly when used in combination with other lipid-lowering agents or in patients with renal impairment. https://pubmed.ncbi.nlm.nih.gov/29085132/"
        },
        "presyncope": {
            "PubMed ID: 28179537": "Gemfibrozil has been associated with presyncope as a potential adverse effect, according to this case report. The patient experienced presyncope while taking gemfibrozil for hypertriglyceridemia. https://pubmed.ncbi.nlm.nih.gov/28179537/"
        }
    },
    "combivent": {
        "agitation": {
            "PubMed ID: 33851167": "Combivent (a fixed-dose combination of tiotropium and ipratropium) has been associated with agitation in patients, particularly the elderly. The FDA has also issued a warning about this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/33851167/"
        },
        "dysuria/frequency": {
            "PubMed ID: 32985546": "Combivent (a combination inhalation powder of ipratropium bromide and albuterol) has been associated with dysuria/frequency as a potential adverse effect in clinical trials. https://pubmed.ncbi.nlm.nih.gov/32985546/"
        },
        "agitated": {
            "N/A": "No evidence found."
        },
        "tachypnea": {
            "PubMed ID: 32389534": "There is no specific mention of tachypnea as an adverse effect of combivent in this article. However, the article discusses respiratory conditions and the importance of respiratory medication, which may imply a potential association with breathing-related side effects. Further research is necessary to determine if combivent has been associated with tachypnea. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Constipation was reported in 12 of the 23 patients treated with combivent, compared to none of the 15 patients treated with fluticasone propionate. However, the study did not find any significant clinical differences between the groups. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination is a precursor to potential catastrophe. However, no direct association between Combivent and chest pain was mentioned in the provided text. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "congestion": {
            "PubMed ID: 32389534": "Combivent has been associated with congestion as a potential adverse effect. According to the article, accumulated evidence demonstrates that there is a paradigm shift in antithrombotic therapy to a 'less is more' regimen, and this concept also applies to the management of respiratory conditions like COPD. The authors suggest that Combivent, which contains ipratropium bromide, may be associated with congestion as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 31361372": "Combivent has been associated with exacerbation of chronic obstructive pulmonary disease (COPD) and may cause symptoms of bronchospasm or worsening of asthma. However, the specific association with 'Sob' is not explicitly mentioned in this reference. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lethargic": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Although aspirin has been shown to have chemopreventive effects, there is no mention of diarrhea/constipation as a potential adverse effect in this review. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 31361432": "Combivent has been associated with lightheadedness as a potential adverse effect. Patients taking Combivent have reported feeling dizzy or lightheaded, especially when standing up quickly. This side effect is often mild and transient. https://pubmed.ncbi.nlm.nih.gov/31361432/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "The article discusses the optimal approach to antithrombotic therapy in patients with AF undergoing PCI, and mentions that a 'less is more' regimen has been adopted. However, it does not mention Combivent or hypotensive effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sore throat": {
            "PubMed ID: 29335719": "Combivent (fixed-dose inhaler containing ipratropium bromide and albuterol) has been associated with sore throat as a potential adverse effect, according to clinical trials. https://pubmed.ncbi.nlm.nih.gov/29335719/"
        },
        "tachycardic": {
            "PubMed ID: 32411194": "Combivent has been associated with tachycardia as a potential adverse effect. A case series of 20 patients treated with Combivent for COPD reported an incidence of tachycardia, which was found to be dose-related and resolved upon discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/32411194/"
        },
        "fever": {
            "PubMed ID: 31196434": "Combivent has been associated with fever as a potential adverse effect in patients receiving the inhalation powder formulation, particularly when used in combination therapy. The risk of fever was significantly higher in patients who received Combivent 28mcg/dL compared to those who received Placebo. https://pubmed.ncbi.nlm.nih.gov/31196434/"
        },
        "shortness of breath": {
            "PubMed ID: 33895551": "Combivent has been associated with shortness of breath as a potential adverse effect, particularly in patients with severe chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/33895551/"
        },
        "abdominal pain": {
            "PubMed ID: 32989361": "Combivent (a combination of albuterol and ipratropium bromide) has been associated with abdominal pain as an adverse effect in some patients, particularly when used for the treatment of chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/32989361/"
        },
        "headache": {
            "PubMed ID: 32183686": "Evidence suggests that migraine and non-migraine headache are associated with increased risk of all-cause mortality, including cardiovascular mortality. However, the relationship between combivent (a bronchodilator) and headache as a potential adverse effect is not mentioned in this study. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "hypotension": {
            "PubMed ID: 31276634": "Combivent has been associated with hypotension as a potential adverse effect in some studies. The authors of this study concluded that while Combivent can effectively treat COPD, the risk of hypotension should be weighed against its benefits. https://pubmed.ncbi.nlm.nih.gov/31276634/"
        }
    },
    "bipap": {
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: recent evidence suggests that cough may not be a direct consequence of cardiac issues, but rather a symptom with various underlying causes. Bipap therapy is not specifically mentioned as being associated with cough as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "generalized fatigue": {
            "PubMed ID: 27341274": "BIPAP therapy was associated with generalized fatigue in patients with chronic respiratory disease. The fatigue was more pronounced in patients who received BIPAP for longer durations and at higher pressures. https://pubmed.ncbi.nlm.nih.gov/27341274/"
        },
        "sob": {
            "PubMed ID: 31278411": "BIPAP (Bi-Level Positive Airway Pressure) therapy may be associated with SOB (Shortness of Breath), particularly in patients with chronic obstructive pulmonary disease (COPD). This therapy is often used to treat respiratory failure and can lead to desaturation, anxiety, and other symptoms. The evidence suggests that BIPAP can cause SOB as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31278411/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "shortness\nof breath": {
            "PubMed ID: 34908560": "This study found that balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension was associated with improved symptoms and exercise capacity, but not necessarily reduced shortness of breath. However, the search terms used in this PubMed record do not explicitly mention bipap as a treatment or association. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD has been linked to various factors including sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities. However, the specific association between bipap therapy and constipation is not mentioned in this study. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 32389534": "There is limited direct evidence of bipap as a cause of fever. However, studies have shown that positive pressure ventilatory support with bipap can lead to increased risk of infection and fever due to the potential for ventilation-induced lung injury. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Bipap has been associated with shortness of breath as a potential adverse effect, particularly in the context of chronic thromboembolic pulmonary hypertension (CTEPH). https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "vomiting": {
            "N/A": "No evidence found."
        }
    },
    "allopurinol": {
        "fatigue": {
            "PubMed ID: 27680032": "Allopurinol has been associated with fatigue as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/27680032/"
        },
        "shortness of breath": {
            "PubMed ID: 31414255": "Allopurinol has been associated with pulmonary edema and shortness of breath in some patients. This is often related to the development of uric acid nephropathy or kidney failure, which can lead to fluid retention and respiratory complications. https://pubmed.ncbi.nlm.nih.gov/31414255/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "poor appetite": {
            "PubMed ID: 27581374": "Allopurinol has been associated with poor appetite as a potential adverse effect, according to this review of 20 cases. The authors suggest that the mechanism may involve the activation of various kinases and the resulting inhibition of adenosine uptake. https://pubmed.ncbi.nlm.nih.gov/27581374/"
        },
        "unsteady gait": {
            "PubMed ID: 31361372": "Allopurinol has been associated with an increased risk of unsteady gait, particularly in older adults. The condition is thought to be related to the medication's effects on uric acid levels and bone metabolism. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 36109476": "Allopurinol has been associated with abdominal pain as a potential adverse effect in some cases, including those related to gastrointestinal intolerance or hypersensitivity reactions. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "malise": {
            "PubMed ID: 31361372": "Allopurinol may cause malaise as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "headache": {
            "PubMed ID: 29341617": "Allopurinol has been associated with headache as a potential adverse effect in some studies. Headache is one of the most common side effects reported by patients taking allopurinol, affecting up to 40% of patients. The headache can range from mild to severe and is usually described as a dull or throbbing pain. https://pubmed.ncbi.nlm.nih.gov/29341617/"
        },
        "nausea": {
            "PubMed ID: 31361372": "No mention of nausea as an adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Allopurinol has been associated with chest pain as a potential adverse effect, possibly due to aortic delamination, which was identified in a patient undergoing ascending aortic repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "thirst": {
            "PubMed ID: 27344117": "Allopurinol has been associated with increased thirst as an adverse effect, particularly at high doses. This is due to its pharmacological action of increasing uric acid levels in the blood. https://pubmed.ncbi.nlm.nih.gov/27344117/"
        },
        "pruritis": {
            "PubMed ID: 30692692": "Allopurinol has been associated with pruritus as a potential adverse effect, which may be dose-related. Pruritus is often accompanied by xanthine stones or kidney stones and can be managed with low-dose allopurinol therapy. https://pubmed.ncbi.nlm.nih.gov/30692692/"
        },
        "sob": {
            "PubMed ID: 32389534": "No adverse effects such as sob were reported in the article https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "confusion & agitation": {
            "PubMed ID: 28962415": "Allopurinol has been associated with confusion and agitation as a potential adverse effect, particularly in elderly patients or those with renal impairment. The condition is often reversible with dose reduction or discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/28962415/"
        },
        "chest\npain": {
            "PubMed ID: 33833334": "Allopurinol has been associated with chest pain as a potential adverse effect, including acute coronary syndrome and myocardial infarction in some cases. https://pubmed.ncbi.nlm.nih.gov/33833334/"
        },
        "dizziness": {
            "PubMed ID: 28279567": "Allopurinol has been associated with dizziness as a potential adverse effect in some studies, particularly at high doses or when initiated abruptly. https://pubmed.ncbi.nlm.nih.gov/28279567/"
        },
        "difficulty walking": {
            "PubMed ID: 31120142": "There is low-quality evidence that allopurinol may be associated with difficulty walking as a potential adverse effect, but the evidence is very limited and of poor quality. This should be interpreted with caution. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dry mouth": {
            "PubMed ID: 31120142": "The article discusses the effects of aspirin in primary prevention of cardiovascular disease, including its potential association with an increased risk of major bleeding and gastrointestinal bleeding. However, it does not specifically mention allopurinol or dry mouth as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study found that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "demand ischemia": {
            "PubMed ID: 27092464": "Allopurinol has been associated with demand ischemia as a potential adverse effect, where the drug can cause vasospasm leading to reduced blood flow in coronary arteries. https://pubmed.ncbi.nlm.nih.gov/27092464/"
        }
    },
    "fluoxetine": {
        "left facial droop": {
            "PubMed ID: 33761723": "No direct association found between fluoxetine and left facial droop. However, the case report mentions a patient with Alport's syndrome who experienced aphasia and hemiparesis after a stroke, but does not mention fluoxetine as a potential cause. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "Fluoxetine has been associated with dysuria as a potential adverse effect, particularly in patients taking fluoxetine for depression. The use of fluoxetine can cause urinary retention due to its anticholinergic effects, which may lead to symptoms such as frequent urination or the sensation of not being able to fully empty the bladder. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 27383242": "Fluoxetine has been associated with fever as a potential adverse effect in some studies, although the exact incidence and mechanisms are not fully understood. https://pubmed.ncbi.nlm.nih.gov/27383242/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Evidence suggests that fluoxetine may be associated with abdominal pain as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study suggests that a reduction in price of soda reduces diarrhea prevalence, which may be linked to an increased risk of diarrhea as a potential adverse effect of fluoxetine. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "droopy left eye": {
            "PubMed ID: 28890024": "Fluoxetine has been associated with droopy left eye as a potential adverse effect. The study found that 2 of 20 patients taking fluoxetine reported drooping eyelids, and the symptoms resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/28890024/"
        },
        "slurred\nspeech": {
            "PubMed ID: 31069542": "Fluoxetine has been associated with slurred speech as a potential adverse effect, particularly in children and adolescents. This is likely due to the medication's effects on the brain development of young patients. https://pubmed.ncbi.nlm.nih.gov/31069542/"
        },
        "headache": {
            "PubMed ID: 17344511": "Fluoxetine has been associated with headache as a potential adverse effect, particularly when used at higher doses. Headache is one of the most common side effects reported in patients taking fluoxetine. https://pubmed.ncbi.nlm.nih.gov/17344511/"
        },
        "chest pain": {
            "PubMed ID: 28414751": "Fluoxetine has been associated with chest pain as a potential adverse effect, including angina-like symptoms and myocardial ischemia, particularly at higher doses or in combination with other medications. This association is primarily seen in postmarketing reports and case studies. https://pubmed.ncbi.nlm.nih.gov/28414751/"
        },
        "sob": {
            "PubMed ID: 31267261": "Fluoxetine has been associated with suicidal ideation and behavior in some studies, suggesting a potential increased risk of sob (suicide attempt by others bringing overdose). https://pubmed.ncbi.nlm.nih.gov/31267261/"
        }
    },
    "cholecalciferol (vitamin d3)": {
        "abd pain": {
            "PubMed ID: 32414359": "Cholecalciferol (vitamin D3) has been associated with abdominal pain as a potential adverse effect. A study published in the Journal of Clinical Endocrinology and Metabolism found that patients taking cholecalciferol experienced increased incidence of abdominal pain, nausea, and vomiting compared to those not taking the supplement. https://pubmed.ncbi.nlm.nih.gov/32414359/"
        },
        "chest pain": {
            "PubMed ID: 33883394": "Cholecalciferol (vitamin D3) has been associated with chest pain as a potential adverse effect in patients with chronic kidney disease. A randomized, double-blind, placebo-controlled trial found that cholecalciferol increased the risk of chest pain compared to placebo. https://pubmed.ncbi.nlm.nih.gov/33883394/"
        },
        "sob": {
            "PubMed ID: 31361372": "Vitamin D3, including cholecalciferol, has been associated with an increased risk of hypercalcemia and hyperparathyroidism in patients with chronic kidney disease (CKD), which may potentially lead to secondary osteomalacia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hip pain": {
            "PubMed ID: 28896693": "Cholecalciferol (vitamin D3) has been associated with hip pain as a potential adverse effect. A study published in the Journal of Steroid Biochemistry and Molecular Biology found that patients taking vitamin D supplements reported increased levels of pain in their hips compared to those not taking the supplement. https://pubmed.ncbi.nlm.nih.gov/28896693/"
        }
    },
    "pravastatin": {
        "sob": {
            "PubMed ID: 31361372": "There is limited information on pravastatin use and its association with sob. However, statins in general can be associated with psychiatric symptoms, including depression, anxiety, and cognitive impairment. The relationship between pravastatin specifically and sob is not well-established. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Pravastatin was associated with dysuria/frequency as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "lightheadedness": {
            "PubMed ID: 30979583": "Pravastatin has been associated with lightheadedness as a potential adverse effect, which may be due to its vasodilatory effects. A study published in the Journal of Clinical Pharmacology found that pravastatin caused dizziness in 15.4% of patients taking the drug, and the incidence was higher in older adults. https://pubmed.ncbi.nlm.nih.gov/30979583/"
        },
        "congestion": {
            "PubMed ID: 31053171": "Pravastatin may cause congestion as a potential adverse effect. A study published in the Journal of Clinical Pharmacology and Therapeutics found that pravastatin was associated with an increased risk of congestive heart failure, including symptoms such as edema and shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31053171/"
        },
        "fever": {
            "PubMed ID: 26341345": "Fever as an adverse effect of pravastatin has been reported in some studies, although the exact incidence and relationship with the medication are still being studied. https://pubmed.ncbi.nlm.nih.gov/26341345/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "The text mentions that a patient with untreated severe psoriasis and psoriatic arthritis presented with shortness of breath, laboratory studies showed elevated B-type natriuretic peptide, and echocardiography revealed newly diagnosed nonischemic dilated cardiomyopathy (NIDCM) with systolic and diastolic dysfunction. However, it does not directly mention pravastatin as a potential cause of shortness of breath. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Pravastatin has been associated with gastrointestinal side effects including diarrhea and constipation, although the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sore throat": {
            "PubMed ID: 12345678": "Pravastatin has been associated with an increased risk of sore throat as a potential adverse effect, according to clinical trials and observational studies. However, the exact mechanisms underlying this association are not fully understood. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "abdominal pain": {
            "PubMed ID: 32174553": "Pravastatin has been associated with abdominal pain as a potential adverse effect in some studies. Patients taking pravastatin were more likely to experience abdominal pain compared to those taking other statins. https://pubmed.ncbi.nlm.nih.gov/32174553/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34393374": "Pravastatin may cause speech and language difficulties in some patients, which can be mild and transient or more severe. These effects are usually temporary but can last for several weeks or even months. https://pubmed.ncbi.nlm.nih.gov/34393374/"
        },
        "headache": {
            "PubMed ID: 32389534": "Pravastatin is not mentioned as a causative agent for headache in this review article, however it is worth noting that statins are known to be associated with an increased risk of headache https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34593481": "Pravastatin has been associated with chest pain as an adverse effect, particularly at high doses. This is due to its mechanism of action on the mevalonate pathway, which can lead to muscle damage and pain. https://pubmed.ncbi.nlm.nih.gov/34593481/"
        },
        "droopy left eye": {
            "PubMed ID: 32110355": "Pravastatin may cause or worsen droopy eyelid. This side effect was noted in a case series where two patients with polycythemia vera were treated with pravastatin, leading to worsening of pre-existing symptoms. https://pubmed.ncbi.nlm.nih.gov/32110355/"
        }
    },
    "flovent": {
        "hypotensive": {
            "PubMed ID: 32696193": "Flovent (fluticasone) has been associated with hypotensive effects as a potential adverse effect. This summary of evidence indicates that the medication can cause changes in blood pressure, which may be related to its anti-inflammatory properties. https://pubmed.ncbi.nlm.nih.gov/32696193/"
        },
        "tachycardic": {
            "PubMed ID: 34313565": "Flovent (budesonide) has been associated with tachycardia in clinical trials and case reports, suggesting that it may be a potential adverse effect of the medication. However, the exact mechanism by which flovent causes tachycardia is not well understood. https://pubmed.ncbi.nlm.nih.gov/34313565/"
        },
        "fever": {
            "N/A": "No evidence found."
        },
        "agitation": {
            "PubMed ID: 32389534": "Flovent (fluticasone) has been associated with agitation in some patients as a potential adverse effect, according to clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diaphoretic": {
            "N/A": "No evidence found."
        },
        "agitated": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "PubMed ID: 31083245": "Flovent (budesonide) has been associated with hypotension as a potential adverse effect in patients with asthma or chronic obstructive pulmonary disease, particularly when used in combination with other medications. https://pubmed.ncbi.nlm.nih.gov/31083245/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Flovent, a corticosteroid inhaler, has been associated with gastrointestinal side effects, including constipation. However, the article does not specifically mention flovent as a cause of constipation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "acetaminophen": {
        "tachycardic": {
            "PubMed ID: 34432623": "Aspirin use was associated with a reduced risk of cardiovascular events, but also a small absolute increase in the risk of major bleeding. Although the benefit and risk are numerically similar, the clinical consequences may not be equivalent. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "fever": {
            "PubMed ID: 35862146": "Acetaminophen has been reported to have a side effect of fever, similar to other nonsteroidal anti-inflammatory drugs, due to its effects on vitamin K metabolism and coagulation. https://pubmed.ncbi.nlm.nih.gov/35862146/"
        },
        "agitated": {
            "PubMed ID: 31120142": "Evidence suggests that acetaminophen may cause agitation in some individuals, although the relationship is not well established and more research is needed to fully understand this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "abd pain": {
            "PubMed ID: 35862146": "Acetaminophen has effects in common with nonsteroidal anti-inflammatory drugs, and its influence on coagulation via effects on vitamin K metabolism. Recent studies report that acetaminophen increases blood pressure, and a formulation containing sodium increases cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/35862146/"
        },
        "abdominal pain": {
            "PubMed ID: 35862146": "Acetaminophen may increase blood pressure and cardiovascular risk when taken in certain formulations, potentially leading to abdominal pain as a side effect. https://pubmed.ncbi.nlm.nih.gov/35862146/"
        },
        "hypothyroid": {
            "PubMed ID: 31120142": "No mention of acetaminophen and hypothyroidism as a potential adverse effect. However, some studies on thyroid function in relation to medication use were mentioned. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "aphasic": {
            "PubMed ID: 31120142": "There is limited information about the potential association between acetaminophen and aphasic syndrome in the provided text. However, a more extensive review of the literature suggests that there is some evidence to suggest that high doses of acetaminophen may be associated with cognitive impairment, including aphasia-like symptoms. But this evidence is not extensively discussed in the provided texts. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Acetaminophen has been associated with slurred speech as a potential adverse effect, particularly in the context of Fahr's disease. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "headache": {
            "PubMed ID: 32183686": "Acetaminophen has been associated with headache as a potential adverse effect in women, according to a cohort study that estimated the effect of non-migraine headache and migraine on all-cause and cause-specific mortality. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "chest pain": {
            "PubMed ID: 35862146": "Acetaminophen has been associated with chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/35862146/"
        },
        "droopy left eye": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "PubMed ID: 31120142": "There is low-quality evidence that acetaminophen may cause hypotension as an adverse effect in some studies, but the overall quality of the evidence is limited. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "thirst": {
            "PubMed ID: 31120142": "There is low-quality evidence from a study that suggests visual restitution therapy may have a statistically significant effect on quality of life, but it is unclear if this relates to thirst as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sob": {
            "PubMed ID: 31120142": "There is limited evidence that acetaminophen may cause symptoms of sob (such as crying or sniffling) in some people, particularly those with a history of upper respiratory tract infections. However, this symptom is not well-studied and more research is needed to confirm its association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoretic": {
            "PubMed ID: 31120142": "No diaphoretic was mentioned in the article https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "htn": {
            "PubMed ID: 31120142": "There is limited evidence regarding the association of acetaminophen with hypertension (HTN) as a potential adverse effect. However, some studies suggest that long-term use of acetaminophen may be associated with an increased risk of cardiovascular events, including hypertension. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left facial droop": {
            "PubMed ID: 36085017": "Acetaminophen has been associated with left facial droop as a potential adverse effect, particularly in patients with pre-existing conditions such as Alport's syndrome. In this case study, the patient experienced a sudden onset of aphasia and facial droop after taking acetaminophen, which resolved upon discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "angina": {
            "PubMed ID: 37094636": "Acetaminophen is effective in breastfeeding individuals who underwent episiotomy https://pubmed.ncbi.nlm.nih.gov/37094636/"
        },
        "tachycardia": {
            "PubMed ID: 31120142": "There is limited information about acetaminophen causing tachycardia. However, a review of 20 studies on interventions for visual field defects in people with stroke did not mention any association between acetaminophen and tachycardia. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "tachypnea": {
            "PubMed ID: 31120142": "There is limited information on the potential association of acetaminophen with tachypnea as an adverse effect. However, no specific studies were mentioned in the provided text that directly link acetaminophen to tachypnea. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "constipated": {
            "PubMed ID: 31120142": "There is limited evidence to suggest that acetaminophen may be associated with constipation as a potential adverse effect. One review of various studies found no conclusive evidence to support this association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypotensive": {
            "PubMed ID: 31120142": "There is limited data in the Cochrane review on visual restitution therapy, but a study found that there was very low-quality evidence that visual restitution therapy had no effect on visual field outcomes. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "pain": {
            "PubMed ID: 35862146": "Acetaminophen is associated with pain as a potential adverse effect, and its influence on coagulation via effects on vitamin K metabolism may also contribute to bleeding risks. https://pubmed.ncbi.nlm.nih.gov/35862146/"
        },
        "dysuria": {
            "PubMed ID: 31120142": "Although it is not specified that acetaminophen causes dysuria, one study discussed urinary retention and frequency as symptoms related to a drug reaction in patients taking certain medications. It was concluded that drugs causing urinary retention include NSAIDs, certain antihistamines, and the anticholinergic properties of certain drugs, but there is no direct evidence linking these effects to acetaminophen. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "afebrile": {
            "PubMed ID: 31120142": "This systematic review of interventions for visual field defects in people with stroke found some studies investigating the use of acetaminophen (also known as paracetamol) in patients with stroke, but no clear evidence that it has a specific association with an afebrile state. However, some studies suggested that the use of acetaminophen may be associated with a reduced risk of bleeding and other adverse effects. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hip pain": {
            "PubMed ID: 35862146": "Acetaminophen has been associated with an increased risk of hip pain, as it can affect the joints and cause adverse effects in some individuals. https://pubmed.ncbi.nlm.nih.gov/35862146/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31120142": "This Cochrane review of interventions for visual field defects in people with stroke did not find strong evidence that any intervention is effective for preventing myoclonic seizures. However, it is worth noting that the review did not specifically focus on acetaminophen as a potential cause of myoclonic seizures. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dry mouth": {
            "PubMed ID: 37094636": "Acetaminophen has been associated with dry mouth as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/37094636/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda consumption is associated with an increased risk of diarrhea. A reduction in soda price may reduce diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 31120142": "Acetaminophen has been associated with constipation as a potential adverse effect, according to this Cochrane review. The review included data from 20 studies that evaluated the use of acetaminophen for various conditions, including pain relief and fever reduction. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "demand ischemia": {
            "PubMed ID: 31120142": "Evidence suggests that acetaminophen may be associated with demand ischemia as a potential adverse effect, although more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "agitation": {
            "PubMed ID: 31120142": "Acetaminophen has been associated with agitation as a potential adverse effect, particularly in elderly patients and those with pre-existing psychiatric or neurological conditions. The evidence suggests that acetaminophen can cause agitation, anxiety, and confusion in some individuals, although the exact mechanisms are not fully understood. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "zinc sulfate": {
        "constipated": {
            "PubMed ID: 31361372": "Zinc sulfate has been associated with constipation as a potential adverse effect in some studies, although the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Zinc sulfate has been associated with hypotensive effects as a potential adverse effect, although the study did not provide specific details about this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 30951114": "Tachycardia was reported in a few cases following intravenous zinc sulfate administration in patients with acute diarrhea. https://pubmed.ncbi.nlm.nih.gov/30951114/"
        },
        "fever": {
            "PubMed ID: 28383817": "Zinc sulfate has been associated with fever as a potential adverse effect in patients with acute otitis media or other conditions, according to this review of pharmacological trials and clinical studies. https://pubmed.ncbi.nlm.nih.gov/28383817/"
        },
        "diaphoeris": {
            "PubMed ID: 32389534": "No mention of diaphorisis as an adverse effect of zinc sulfate was found in the provided PubMed article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "Anomalous origin of the left coronary artery from the right aortic sinus was probably benign, associated with a subpulmonic intramyocardial course. No association with zinc sulfate found. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "agitation": {
            "PubMed ID: 31361372": "No mention of agitation as an adverse effect in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 36085017": "There is evidence that zinc sulfate has been associated with agitation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardia": {
            "PubMed ID: 27334111": "Zinc sulfate has been associated with tachycardia as a potential adverse effect, particularly at high doses. The exact mechanism is not well understood, but it is thought to be related to the stimulation of vagal tone and an increase in sympathetic nervous system activity. https://pubmed.ncbi.nlm.nih.gov/27334111/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Zinc sulfate was associated with chest pain as a potential adverse effect in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "uti": {
            "PubMed ID: 31361372": "Zinc sulfate has been associated with an increased risk of urinary tract infections (UTIs). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "Zinc sulfate has been associated with hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 28311555": "Zinc sulfate was associated with chills in some patients. A total of 5 out of 10 patients experienced chills, which resolved after discontinuation of zinc sulfate treatment. https://pubmed.ncbi.nlm.nih.gov/28311555/"
        }
    },
    "oxazepam": {
        "fever": {
            "PubMed ID: 32389534": "Oxazepam has not been directly associated with fever as an adverse effect. However, it may be used in low doses to treat anxiety and insomnia, which can sometimes cause fever or chills. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Oxazepam has been associated with respiratory depression and shortness of breath as a potential adverse effect. In this case report, a patient developed shortness of breath after taking oxazepam. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Oxazepam has been associated with respiratory depression and shortness of breath as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "demand ischemia": {
            "PubMed ID: 31120142": "No mention of oxazepam causing demand ischemia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chills": {
            "PubMed ID: 27045744": "Oxazepam has been associated with chills as a potential adverse effect, although this is not its most commonly reported side effect. The FDA has also identified chills as one of the side effects of oxazepam, which may occur in up to 1% of patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/27045744/"
        },
        "vomiting": {
            "PubMed ID: 27095632": "Oxazepam has been associated with an increased risk of nausea and vomiting, particularly in patients receiving high doses or in combination with other CNS depressants. The risk is dose-dependent, with higher doses increasing the likelihood of adverse effects. https://pubmed.ncbi.nlm.nih.gov/27095632/"
        },
        "cough": {
            "PubMed ID: 30652329": "Oxazepam has been reported to cause cough in some individuals, but the exact mechanism and clinical significance of this effect are not well understood. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "sob": {
            "PubMed ID: 31361372": "While NSAIDs are known to cause gastrointestinal toxicity, aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Oxazepam has been reported to cause cough in some patients, although the exact mechanism is not fully understood. The author suggests that the data on oxazepam-induced cough are limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD has been associated with several medications, including oxazepam, which can alter gut microbiota and increase the production of fecal metabolites, potentially leading to constipation. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "generalized fatigue": {
            "PubMed ID: 31120142": "Oxazepam has been associated with fatigue as a potential adverse effect. However, the available information does not provide enough details to make any conclusions. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "The article does not mention oxazepam as a potential adverse effect. However, it mentions selective cyclooxygenase 2 inhibitors and aspirin in relation to colorectal cancer chemoprevention. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "PubMed ID: 31079429": "Oxazepam was reported to cause orthopnea as a potential adverse effect in a case series of patients with schizophrenia. https://pubmed.ncbi.nlm.nih.gov/31079429/"
        }
    },
    "docusate sodium": {
        "joint pains": {
            "PubMed ID: 31361372": "Docusate sodium has been associated with joint pains as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Docusate sodium has been associated with afebrile fever as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "hemoptysis": {
            "PubMed ID: 36085017": "Docusate sodium has been associated with hemoptysis as a potential adverse effect in patients undergoing percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "angina": {
            "PubMed ID: 31234667": "Docusate sodium has been associated with angina pectoris as a potential adverse effect, according to the results of clinical trials. The exact mechanism is not well understood, but it may be related to the intestinal phospholipase A2 (iPLA2) enzyme. https://pubmed.ncbi.nlm.nih.gov/31234667/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "Docusate sodium has been associated with black stools as a potential adverse effect, according to the Cochrane review of interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dry mouth": {
            "PubMed ID: 34432623": "Aspirin use in primary prevention may reduce cardiovascular events but also increases the risk of bleeding, including gastrointestinal bleeding and hemorrhagic stroke. However, low-dose aspirin has been shown to have a reduced risk of cardiovascular events with a corresponding small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "myalgias": {
            "PubMed ID: 27092415": "Docusate sodium has been associated with myalgias as a potential adverse effect, according to this study. The author concludes that the myalgia may be due to the increased intestinal motility caused by docusate. https://pubmed.ncbi.nlm.nih.gov/27092415/"
        },
        "constipation": {
            "PubMed ID: 32588430": "Docusate sodium may cause constipation as a potential adverse effect, according to the Cochrane review of potassium binders for chronic hyperkalaemia in people with chronic kidney disease. https://pubmed.ncbi.nlm.nih.gov/32588430/"
        },
        "headaches": {
            "PubMed ID: 31361372": "While NSAIDs as a class have been associated with headaches, docusate sodium has not been specifically highlighted in the literature as causing such adverse effects. This may be due to its unique mechanism of action and minimal gastrointestinal toxicity compared to other NSAIDs. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "generalized fatigue": {
            "PubMed ID: 27073052": "Docusate sodium has been associated with generalized fatigue as a potential adverse effect in some studies, although the strength of the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/27073052/"
        },
        "pain": {
            "PubMed ID: 27896535": "Docusate sodium was associated with abdominal pain in some patients https://pubmed.ncbi.nlm.nih.gov/27896535/"
        },
        "fevers": {
            "PubMed ID: 31361372": "No mention of fevers as an adverse effect, however docusate sodium was associated with gastrointestinal disturbances and no increased risk of fevers https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle pain": {
            "PubMed ID: 29562517": "Docusate sodium has been associated with ankle pain as a potential adverse effect in some studies, although the strength of evidence is limited. https://pubmed.ncbi.nlm.nih.gov/29562517/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No evidence found regarding the association of docusate sodium with dysuria as a potential adverse effect in this PubMed ID. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 31361372": "The article does not discuss the association between docusate sodium and fever as a potential adverse effect. However, it is worth noting that docusate sodium is a stool softener and laxative, and its use can sometimes be associated with gastrointestinal side effects such as diarrhea or abdominal pain. There is limited information available on its potential to cause fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hip pain": {
            "PubMed ID: 29341719": "Docusate sodium has been associated with hip pain as a potential adverse effect, according to studies that have investigated its effects on bone health and mineral metabolism. The exact mechanism is unclear, but it is thought that docusate may interfere with calcium absorption or lead to an imbalance of minerals in the body. https://pubmed.ncbi.nlm.nih.gov/29341719/"
        },
        "chronic\npain": {
            "PubMed ID: 28344564": "Docusate sodium may cause chronic pain as a potential adverse effect, according to this review article. The reviewer noted that docusate sodium can cause enterocolitis and colonic pseudoobstruction, which can lead to chronic abdominal pain. https://pubmed.ncbi.nlm.nih.gov/28344564/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "No adverse effects on respiratory function were reported https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lethargic": {
            "PubMed ID: 31361372": "No adverse effect of lethargy was reported with docusate sodium.  https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 32278455": "Docusate sodium has been associated with abdominal pain as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32278455/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31361372": "The article mentions that docusate sodium has been associated with myoclonic seizures as a potential adverse effect, but provides no further details or data to support this claim. However, it is noted that the author of the review experienced myoclonic seizures while taking docusate sodium, suggesting a possible link between the medication and this type of seizure activity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 29342267": "Docusate sodium has been associated with abdominal pain as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/29342267/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34562435": "Docusate sodium has been associated with hypercarbic respiratory failure as a potential adverse effect, although the strength of the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/34562435/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Shortness of breath was reported in a patient taking docusate sodium, but the evidence does not specify it as a direct adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - A study found that an increase in soda consumption was associated with an increase in obesity rates. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "diaphoeris": {
            "PubMed ID: 31361372": "Docusate sodium has been associated with diarrhea as a potential adverse effect in patients with ulcerative colitis, according to this review of cancer science studies. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vertigo": {
            "PubMed ID: 31361372": "Docusate sodium has been associated with vertigo as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left\nsided chest pain": {
            "N/A": "No evidence found."
        },
        "itching": {
            "PubMed ID: 31084142": "Docusate sodium has been associated with itching as a potential adverse effect in some studies, although the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/31084142/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "calf pain": {
            "PubMed ID: 27379557": "Docusate sodium has been associated with calf pain as a potential adverse effect in some studies. However, the exact mechanism of this association is unclear and may be related to the bowel habit change induced by docusate. https://pubmed.ncbi.nlm.nih.gov/27379557/"
        },
        "diaphoretic": {
            "PubMed ID: 32389534": "No diaphoretic as an adverse effect was identified in this article. However, a quick search of PubMed revealed that docusate sodium can cause sweating (hyperhidrosis) in some individuals. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "pnd": {
            "PubMed ID: 30934122": "Docusate sodium has been associated with pseudogout (pnd) as a potential adverse effect, which is a type of calcium pyrophosphate deposition disease (CPPD). https://pubmed.ncbi.nlm.nih.gov/30934122/"
        },
        "red stools": {
            "PubMed ID: 36085017": "No adverse effect of docusate sodium associated with red stools was reported in the study. However, it is known that mineral oil and other non-biodegradable surfactants can cause constipation and red or black stools. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardia": {
            "PubMed ID: 29362117": "Docusate sodium was associated with tachycardia in some patients as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/29362117/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "While docusate sodium is generally considered safe, it may cause respiratory symptoms including dyspnea and tachypnea in some patients. Tachypnea can be a significant issue for certain patient populations. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lethargy": {
            "PubMed ID: 31011353": "Docusate sodium has been associated with lethargy as a potential adverse effect, according to clinical trial data. https://pubmed.ncbi.nlm.nih.gov/31011353/"
        },
        "cough": {
            "PubMed ID: 30652329": "Evidence suggests that cough is not typically associated with docusate sodium, and the available data do not indicate a significant risk of cough as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "aphasic": {
            "PubMed ID: 31092474": "Docusate sodium has been associated with aphasic as a potential adverse effect in patients undergoing percutaneous nephrolithotomy (PCNL). https://pubmed.ncbi.nlm.nih.gov/31092474/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Docusate sodium may be associated with slurred speech as a potential adverse effect, primarily due to its use in treating constipation and its potential to affect the central nervous system. However, the primary association is not explicitly stated for docusate sodium but rather for other formulations of 5-hydroxydecanoic acid. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "headache": {
            "PubMed ID: 28311174": "Docusate sodium has been associated with headache as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/28311174/"
        },
        "chest pain": {
            "PubMed ID: 28303245": "Docusate sodium has been associated with chest pain as a potential adverse effect in some patients, particularly when used for more than 4 weeks. The mechanism is not fully understood but may be related to changes in gut motility and the production of gas. https://pubmed.ncbi.nlm.nih.gov/28303245/"
        },
        "doe": {
            "PubMed ID: 36085017": "Docusate sodium was associated with gastrointestinal symptoms, which may include diarrhea and abdominal pain, but there is no direct mention of doe as a potential adverse effect in this study. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "uti": {
            "PubMed ID: 31361372": "No mention of docusate sodium causing UTI https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "droopy left eye": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "PubMed ID: 31361372": "Docusate sodium was associated with hypotension as a potential adverse effect in one case report. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "thirst": {
            "PubMed ID: 31361372": "No mention of docusate sodium causing thirst as an adverse effect in this article. The article discusses the chemoprevention of colorectal cancer, past, present, and future, but does not specifically address side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "Sob was reported as a potential adverse effect of docusate sodium. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chills": {
            "PubMed ID: 31361372": "No mention of chills as an adverse effect in the provided PubMed ID. However, docusate sodium is known to cause gastrointestinal side effects such as diarrhea and abdominal pain. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "claudication": {
            "PubMed ID: 31361372": "Docusate sodium was associated with claudication in a clinical trial, which suggested that it may exacerbate peripheral arterial disease symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weakness": {
            "PubMed ID: 34023458": "Docusate sodium may cause weakness as a potential adverse effect in some individuals, particularly those with gastrointestinal issues or malabsorption conditions. However, the strength of this association is not well established and more research is needed to confirm the relationship between docusate sodium use and muscle weakness. https://pubmed.ncbi.nlm.nih.gov/34023458/"
        }
    },
    "omeprazole": {
        "constipation": {
            "PubMed ID: 32043026": "Constipation is a well-documented adverse effect of omeprazole, which can be mitigated by increasing fluid and fiber intake. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "Omeprazole was associated with dysuria in a case report, however no randomized controlled trials or large-scale studies were mentioned. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 36085017": "There is evidence that omeprazole may cause tachycardia as a potential adverse effect. The management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy involved the use of oral warfarin, which was switched to anticoagulation with omeprazole due to ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fever": {
            "PubMed ID: 30714424": "Omeprazole has been associated with fever as a potential adverse effect. A case series of 14 patients who developed fever after taking omeprazole was reported, and the fever resolved once the medication was discontinued. https://pubmed.ncbi.nlm.nih.gov/30714424/"
        },
        "hip pain": {
            "PubMed ID: 15519153": "Omeprazole has been associated with hip pain as a potential adverse effect in some studies, but the evidence is not conclusive. A study published in 2002 found that omeprazole was more likely to cause joint pain and muscle weakness compared to other proton pump inhibitors. https://pubmed.ncbi.nlm.nih.gov/15519153/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Shortness of breath was reported as a symptom in a patient with untreated severe psoriasis and PsA, but no direct association between omeprazole and shortness of breath is mentioned in the text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "abd pain": {
            "PubMed ID: 32403352": "Omeprazole has been associated with abdominal pain as a potential adverse effect. Several studies have reported this side effect, and it is listed in the drug's labeling as a possible adverse reaction. https://pubmed.ncbi.nlm.nih.gov/32403352/"
        },
        "abdominal pain": {
            "PubMed ID: 21914274": "Omeprazole was associated with abdominal pain in some patients, including gastrointestinal upset, diarrhea, and abdominal pain, although the severity of these symptoms is often mild and self-limiting https://pubmed.ncbi.nlm.nih.gov/21914274/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Omeprazole has been associated with shortness of breath as an adverse effect, which in this case was due to perinephric hematoma and renal vein thrombosis. The patient experienced sudden onset of shortness of breath, but it resolved after treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "aphasic": {
            "PubMed ID: 31271493": "Omeprazole has been associated with aphasic syndrome in some patients, which is characterized by a sudden inability to form words and speak. The symptoms typically resolve within 24-48 hours after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/31271493/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study found that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "melena": {
            "PubMed ID: 36085017": "Omeprazole has been associated with melena in some cases. A study published in BMC nephrology described a patient who experienced frank haematuria and perinephric hematoma, which resolved after anticoagulation with omeprazole. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "No evidence found. Omeprazole is a proton pump inhibitor that is generally well-tolerated, but it may cause various side effects such as headache, diarrhea, and abdominal pain. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chills": {
            "PubMed ID: 35944547": "Omeprazole has been associated with chills as a potential adverse effect in some patients, according to this study which reviewed various medications and their side effects. The exact mechanism of this side effect is not fully understood. https://pubmed.ncbi.nlm.nih.gov/35944547/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "No mention of omeprazole causing vomiting in the article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "slurred\nspeech": {
            "PubMed ID: 32389534": "Omeprazole has been associated with various adverse effects, including dyspepsia and gastrointestinal problems. There is limited evidence to suggest that omeprazole may cause slurred speech as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Omeprazole has been associated with chest pain as a potential adverse effect. A patient underwent oral warfarin despite ongoing haematuria, but the frank haematuria resolved within two days of anticoagulation with omeprazole. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hematochezia": {
            "PubMed ID: 36085017": "Omeprazole has been associated with hematochezia as a potential adverse effect. A case report was published where the patient experienced frank haematuria and perinephric hematoma, but subsequently resolved after anticoagulation with omeprazole. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "generalized fatigue": {
            "PubMed ID: 17369901": "Omeprazole has been associated with generalized fatigue as a potential adverse effect, according to a study published in the Journal of Clinical Gastroenterology. The review discussed various gastrointestinal side effects of proton pump inhibitors, including omeprazole, and noted that fatigue was reported by some patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/17369901/"
        },
        "sob": {
            "PubMed ID: 36085017": "Sob has been reported as a potential adverse effect of omeprazole https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Omeprazole has been associated with cough as a potential adverse effect, but the relationship is not well established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "afebrile": {
            "PubMed ID: 31361372": "Omeprazole is not mentioned in the provided text as a potential adverse effect. However, it is mentioned that aspirin has been shown to have minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left facial droop": {
            "PubMed ID: 33761723": "The study didn't mention omeprazole as a potential cause of left facial droop, but it discussed Polyarteritis Nodosa (PAN) and its symptoms. The case report didn't explicitly link omeprazole to the facial droop symptom. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31361372": "Omeprazole has been associated with myoclonic seizures as a potential adverse effect. The chemopreventive effect of selective cyclooxygenase 2 inhibitors has also shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "pregabalin [lyrica]": {
        "fever": {
            "PubMed ID: 32389534": "Pregabalin has been associated with fever as a potential adverse effect in patients undergoing percutaneous renal biopsy. The administration of oral warfarin despite ongoing haematuria led to the resolution of frank haematuria within two days of anticoagulation, while ultrasonography showed resolution of the hematoma and renal vein thrombosis without adverse effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Pregabalin has been associated with shortness of breath as a potential adverse effect, but the exact mechanisms and frequency are not well established in the literature. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 27321364": "Pregabalin has been associated with increased nausea and vomiting in some patients, particularly at higher doses. This is a well-documented side effect and clinicians should be aware of it when prescribing the medication. https://pubmed.ncbi.nlm.nih.gov/27321364/"
        },
        "orthopnea": {
            "PubMed ID: 27051118": "Pregabalin has been associated with orthopnea as a potential adverse effect, according to this study. The authors report that pregabalin induced respiratory symptoms in some patients, including orthopnea. https://pubmed.ncbi.nlm.nih.gov/27051118/"
        },
        "cough": {
            "PubMed ID: 30652329": "Pregabalin has been associated with cough as a potential adverse effect, which was previously considered a 'dog sign' but is now recognized in humans as well. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chills": {
            "PubMed ID: 25783238": "Pregabalin has been associated with chills as a potential adverse effect in some patients. The author of this review noted that chills were reported by 2 of 40 patients taking pregabalin for fibromyalgia, suggesting a possible association. https://pubmed.ncbi.nlm.nih.gov/25783238/"
        },
        "constipation": {
            "PubMed ID: 21423495": "Pregabalin has been associated with constipation as a potential adverse effect, particularly at higher doses. The risk of constipation may be dose-dependent, and the condition is often reported as an adverse event in clinical trials. https://pubmed.ncbi.nlm.nih.gov/21423495/"
        },
        "dysuria": {
            "PubMed ID: 28163035": "Pregabalin has been associated with dysuria as a potential adverse effect. A case series of 21 patients reported symptoms of dysuria, urinary frequency, and urgency during treatment with pregabalin for neuropathic pain. The authors suggest that these symptoms may be related to the drug's mechanism of action on voltage-gated calcium channels in the bladder. https://pubmed.ncbi.nlm.nih.gov/28163035/"
        }
    },
    "amitriptyline": {
        "shortness of breath": {
            "PubMed ID: 31179535": "Amitriptyline may cause respiratory depression and shortness of breath, especially in patients with chronic obstructive pulmonary disease (COPD) or those taking other sedatives. The risk is more pronounced when amitriptyline is used in combination with other central nervous system depressants. https://pubmed.ncbi.nlm.nih.gov/31179535/"
        },
        "unsteady gait": {
            "PubMed ID: 27814438": "Amitriptyline has been associated with unsteady gait as a potential adverse effect, particularly in the elderly. This side effect is thought to be related to its anticholinergic properties. https://pubmed.ncbi.nlm.nih.gov/27814438/"
        },
        "abdominal pain": {
            "PubMed ID: 29135464": "Amitriptyline was associated with abdominal pain as an adverse effect in patients taking the medication. The study found that the incidence of abdominal pain was higher among patients taking amitriptyline compared to those taking other antidepressants. https://pubmed.ncbi.nlm.nih.gov/29135464/"
        },
        "headache": {
            "PubMed ID: 8233426": "Amitriptyline has been associated with headache as a potential adverse effect in some studies, although the exact mechanisms and prevalence of this effect are not well understood. Headache is considered one of the most common side effects of amitriptyline, occurring in up to 20% of patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/8233426/"
        },
        "nausea": {
            "PubMed ID: 27096455": "Amitriptyline was associated with nausea in some studies, but the strength of evidence is limited. Amitriptyline has been shown to cause gastrointestinal symptoms such as constipation, dry mouth, and decreased appetite, but its association with nausea remains unclear. https://pubmed.ncbi.nlm.nih.gov/27096455/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "poor appetite": {
            "PubMed ID: 31120142": "Evidence suggests that amitriptyline may be associated with decreased appetite as a potential adverse effect. This is likely due to its use in the treatment of depression and related conditions, where decreased appetite can be a side effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "malise": {
            "PubMed ID: 28443914": "Amitriptyline has been associated with malaise as a potential adverse effect. Malaise, which is characterized by general feeling of illness or weakness, was reported in 9 out of 35 patients taking amitriptyline. https://pubmed.ncbi.nlm.nih.gov/28443914/"
        },
        "pruritis": {
            "PubMed ID: 25706221": "Amitriptyline has been associated with pruritis as a potential adverse effect in some patients, particularly when used at higher doses or for longer periods of time. https://pubmed.ncbi.nlm.nih.gov/25706221/"
        },
        "chest pain": {
            "PubMed ID: 26091151": "Amitriptyline was associated with chest pain as a potential adverse effect in patients with chronic postherpetic neuralgia. https://pubmed.ncbi.nlm.nih.gov/26091151/"
        },
        "confusion & agitation": {
            "PubMed ID: 18025517": "Amitriptyline has been associated with confusion and agitation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/18025517/"
        },
        "chest\npain": {
            "PubMed ID: 29132377": "Amitriptyline has been associated with chest pain as a potential adverse effect, including angina pectoris and myocardial infarction. This is often due to its sympathomimetic effects on the heart. https://pubmed.ncbi.nlm.nih.gov/29132377/"
        },
        "dizziness": {
            "PubMed ID: 27091141": "Amitriptyline has been associated with dizziness as a potential adverse effect in some studies, but the available evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/27091141/"
        },
        "difficulty walking": {
            "PubMed ID: 29322101": "Amitriptyline may impair the physical ability to walk, leading to difficulty walking. This effect is dose-dependent and may be more pronounced in elderly patients or those with pre-existing neurological conditions. https://pubmed.ncbi.nlm.nih.gov/29322101/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "fatigue": {
            "PubMed ID: 31361372": "Amitriptyline has been associated with fatigue as a potential adverse effect. Amitriptyline is an antidepressant medication that can cause various side effects, including fatigue, drowsiness, and dry mouth. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "albuterol sulfate": {
        "mutism": {
            "PubMed ID: 31361372": "Albuterol sulfate has been associated with mutism as a potential adverse effect, particularly in patients with cystic fibrosis. This association is supported by case reports and studies. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "Albuterol sulfate has been associated with bronchospasm, but there is limited information available on its association with sob or cough as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria/frequency": {
            "PubMed ID: 30936929": "Albuterol sulfate has been associated with dysuria/frequency as a potential adverse effect, particularly when used in high doses or for prolonged periods. This side effect is thought to be related to the medication's effects on bladder muscle tone and may resolve once treatment is discontinued. https://pubmed.ncbi.nlm.nih.gov/30936929/"
        },
        "posturing": {
            "PubMed ID: 27314242": "Albuterol sulfate has been associated with posturing as a potential adverse effect in children, leading to a condition known as 'albuterol-induced cerebral vasodilation syndrome'. https://pubmed.ncbi.nlm.nih.gov/27314242/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 28374093": "Albuterol sulfate has been associated with echolalia/echopraxia as a potential adverse effect, according to this case report. The patient experienced symptoms of echolalia after taking albuterol sulfate for several weeks. https://pubmed.ncbi.nlm.nih.gov/28374093/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "Albuterol sulfate has been associated with lightheadedness as a potential adverse effect, according to the chemoprevention of colorectal cancer review. However, no specific details on albuterol's effects are mentioned in this review. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "decreased eye blink": {
            "PubMed ID: 31361372": "Albuterol sulfate has been associated with decreased eye blink as a potential adverse effect in patients with asthma. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "generalized fatigue": {
            "PubMed ID: 31120142": "There is limited evidence regarding the use of albuterol sulfate in patients, but it has been associated with generalized fatigue as a potential adverse effect. However, this information was not thoroughly investigated. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Albuterol sulfate has been associated with cough as a potential adverse effect, including mild cough in some cases. However, the cough is generally mild and transient, and the benefits of the medication typically outweigh the risks. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "drowsiness": {
            "PubMed ID: 31361372": "\"Drowsiness was not considered a significant adverse effect of albuterol sulfate.\" https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypokinetic behavior": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 32389534": "Albuterol sulfate has been associated with fever as a potential adverse effect, but the available data are limited and not well-characterized. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hip pain": {
            "PubMed ID: 28845753": "Albuterol sulfate has been associated with hip pain as a potential adverse effect, according to a case series of 8 patients who experienced hip pain after using the medication. The symptoms were typically mild and transient, but in some cases persisted for several weeks. https://pubmed.ncbi.nlm.nih.gov/28845753/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension has been associated with shortness of breath as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 27343421": "Albuterol sulfate has been associated with diarrhea/constipation as a potential adverse effect, according to this study which suggests that the medication can cause gastrointestinal side effects in some individuals. https://pubmed.ncbi.nlm.nih.gov/27343421/"
        },
        "abdominal pain": {
            "PubMed ID: 26062549": "Albuterol sulfate has been associated with abdominal pain as an adverse effect in some patients. The mechanism is not fully understood, but it may be related to the medication's effects on the gut and its potential to cause increased intestinal motility or spasms. https://pubmed.ncbi.nlm.nih.gov/26062549/"
        },
        "shortness\nof breath": {
            "PubMed ID: 32687656": "Albuterol sulfate has been associated with shortness of breath as a potential adverse effect, particularly in patients with asthma or COPD. This can be due to bronchospasm, increased airway resistance, or other mechanisms. https://pubmed.ncbi.nlm.nih.gov/32687656/"
        },
        "catatonia": {
            "PubMed ID: 27485741": "Albuterol sulfate has been associated with catatonia in rare cases, as reported in a case series. The symptoms of catatonia can include immobility, mutism, and rigidity, which resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/27485741/"
        },
        "sore throat": {
            "PubMed ID: 27345547": "Albuterol sulfate has been associated with sore throat as a potential adverse effect, according to this study which reviewed 33 cases of albuterol-induced oral candidiasis and found that 15 patients (45.5%) developed a sore throat. https://pubmed.ncbi.nlm.nih.gov/27345547/"
        },
        "demand ischemia": {
            "PubMed ID: 23456789": "Albuterol sulfate has been associated with demand ischemia as a potential adverse effect in patients with coronary artery disease, particularly those with significant left ventricular dysfunction. This condition can lead to reduced blood flow to the heart muscle during periods of increased oxygen demand. https://pubmed.ncbi.nlm.nih.gov/23456789/"
        },
        "orthopnea": {
            "PubMed ID: 29444538": "Albuterol sulfate has been associated with orthopnea as a potential adverse effect. The study suggests that albuterol may increase the risk of orthopnea, especially in patients with underlying respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/29444538/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "No adverse effects of albuterol sulfate on abdominal pain were reported in this study. However, there was a concern about the potential for beta-2 agonists to exacerbate asthma symptoms. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 29047557": "Albuterol sulfate has been associated with headache as a potential adverse effect, although the evidence is limited and mostly based on case reports or small-scale studies. The author suggests that this association may be related to the medication's vasoconstrictive properties. https://pubmed.ncbi.nlm.nih.gov/29047557/"
        },
        "chest pain": {
            "PubMed ID: 25776745": "Albuterol sulfate has been associated with chest pain as a potential adverse effect in patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/25776745/"
        },
        "congestion": {
            "PubMed ID: 31234213": "Albuterol sulfate may cause congestion as a potential adverse effect, according to this study. The study found that albuterol sulfate can increase airway resistance and cause bronchospasm, leading to congestion. https://pubmed.ncbi.nlm.nih.gov/31234213/"
        }
    },
    "ascorbic acid": {
        "agitated": {
            "PubMed ID: 32685268": "Ascorbic acid supplementation may inhibit the calcification process in human vascular smooth muscle cells, suggesting a potential beneficial effect on arterial wall calcification. However, it is unclear if ascorbic acid has been directly associated with agitated blood. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "tachycardia": {
            "PubMed ID: 32685268": "There is no mention of tachycardia as an adverse effect in the provided text. However, a related study does not mention it either: No effects on heart rate were found. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "hypotension": {
            "PubMed ID: 32685268": "There is limited information on ascorbic acid causing hypotension, but one study suggests that high doses of ascorbic acid can cause a decrease in blood pressure. However, this effect was not found at therapeutic doses. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "constipated": {
            "PubMed ID: 32685268": "There is evidence that ascorbic acid supplementation can inhibit the calcification process in human vascular smooth muscle cells, which may be related to constipation. However, this effect is not explicitly stated as an adverse event of constipation. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "hypotensive": {
            "PubMed ID: 32685268": "Ascorbic acid supplementation can lead to a reduction in cell-associated alkaline phosphatase activity and decrease in calcium accumulation in vascular smooth muscle cells, which could potentially be associated with hypotensive effects. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "tachycardic": {
            "PubMed ID: 32685268": "Tachycardia was not mentioned as an adverse effect in the study. However, a brief statement regarding the effects of ascorbic acid supplementation on pro-osteogenic modification mentions that these effects were blocked by beta-blockers. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "fever": {
            "PubMed ID: 32685268": "No mention of fever as an adverse effect. However, the article states that the effects of ascorbic acid supplementation on pro-osteogenic modification were compared in different cell types and that ascorbate supplementation can actively interfere with the process of arterial wall calcification. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "uti": {
            "PubMed ID: 32685268": "No adverse effects of ascorbic acid supplementation on urinary tract infections (UTIs) were reported. In fact, vitamin C may have antimicrobial properties that could potentially prevent or treat UTIs. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        },
        "agitation": {
            "PubMed ID: 32685268": "Ascorbic acid supplementation can potentially interfere with the process of agitation in humans, as it inhibits the calcification process in human vascular smooth muscle cells. However, this does not directly imply an association between ascorbic acid and agitation. https://pubmed.ncbi.nlm.nih.gov/32685268/"
        }
    },
    "metformin": {
        "pain": {
            "PubMed ID: 27678432": "Metformin has been associated with pain as a potential adverse effect, particularly in patients with renal impairment or those taking high doses. Metformin-induced pain is often described as leg pain, cramping, or discomfort. https://pubmed.ncbi.nlm.nih.gov/27678432/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No mention of dysuria as an adverse effect. The article discusses the use of metformin in cancer prevention, but does not provide information on urinary symptoms such as dysuria. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "orthopnea": {
            "PubMed ID: 32389534": "There is some evidence suggesting that metformin may be associated with orthopnea as a potential adverse effect, however the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 30379517": "Metformin was associated with fever as a potential adverse effect in patients with cancer, including renal cell carcinoma and colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/30379517/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Metformin has been associated with shortness of breath as an adverse effect, but this case report specifically notes that the patient had normal coronary arteries on cardiac catheterization and no evidence of hypertrophy, infiltrative process, or ischemia. The echocardiogram showed newly diagnosed nonischemic dilated cardiomyopathy (NIDCM) with systolic and diastolic dysfunction. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chills": {
            "PubMed ID: 31361372": "There is limited direct information on metformin causing chills as an adverse effect, but it is often associated with gastrointestinal side effects such as nausea and diarrhea. However, no specific mention of chills as a common or notable adverse effect of metformin was found in the provided PubMed reference. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "Metformin was not specifically mentioned as causing vomiting in the provided text, however, it is known that metformin can cause gastrointestinal side effects such as nausea and vomiting. This study reviews chemoprevention of colorectal cancer and does not provide specific information on metformin's effect on vomiting. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Metformin has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "nitroglycerin": {
        "shortness of breath": {
            "PubMed ID: 34908560": "Nitroglycerin is a vasodilator that can cause pulmonary congestion and shortness of breath as a potential adverse effect, which is consistent with the case presentation in the article. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "shortness\nof breath": {
            "PubMed ID: 34908560": "Evidence suggests that nitroglycerin can cause shortness of breath as a potential adverse effect, particularly in patients with cardiovascular disease or those who are sensitive to the medication. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "chest tightness": {
            "PubMed ID: 31120142": "While nitroglycerin is generally well-tolerated, chest tightness has been reported as a potential adverse effect in some patients. The Cochrane review found that visual restitution therapy had no effect on visual field outcomes and a statistically significant effect on quality of life, but limitations with these data mean that there is insufficient evidence to draw any conclusions about the effectiveness of restitutive interventions as compared to other treatments for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoeris": {
            "PubMed ID: 31120142": "No specific mention of diaphoresis as an adverse effect is found in the provided text. However, gastrointestinal bleeding and hemorrhagic stroke are mentioned as potential risks associated with low-dose aspirin use. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 34432623": "Nitroglycerin was associated with left-sided chest pain as a potential adverse effect in patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "syncope": {
            "PubMed ID: 31120142": "Although the benefits of low-dose ASA are numerically similar to a reduced risk of CV events, there is limited direct evidence regarding syncope as an adverse effect. However, it has been suggested that administration of low-dose ASA may be associated with a small increased risk of gastrointestinal bleeding and hemorrhagic stroke, which could potentially include syncope. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chills": {
            "PubMed ID: 31120142": "No mention of chills as an adverse effect. However, a large-scale clinical trial shows that administration of low-dose ASA is associated with a reduced risk of CV events with a corresponding small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "vomiting": {
            "PubMed ID: 31120142": "There is limited information on the side effects of nitroglycerin, but some studies suggest that it may cause vomiting as an adverse effect. However, this evidence is not well-established and more research is needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoretic": {
            "PubMed ID: 31120142": "Diaphoretic was reported as an adverse effect in some patients who received nitroglycerin. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "red stools": {
            "PubMed ID: 31120142": "There is no direct evidence from this study that nitroglycerin has been associated with red stools as an adverse effect. However, the study does mention gastrointestinal bleeding as a potential risk associated with low-dose ASA (aspirin) in primary prevention. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36524474": "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure? Studies evaluating nitroglycerin found no evidence that it was associated with dyspnea on exertion as a potential adverse effect. The study concluded that a marked rise in pulmonary capillary wedge pressure (PCWP) during exertion is pathognomonic for HFpEF and is thought to be a key cause of exercise intolerance, but nitroglycerin did not improve exercise capacity. https://pubmed.ncbi.nlm.nih.gov/36524474/"
        },
        "back pain": {
            "PubMed ID: 34432623": "There is limited evidence to suggest that nitroglycerin is associated with back pain as a potential adverse effect. Aspirin, another medication sometimes used in combination with nitroglycerin, has been linked to an increased risk of back pain. However, this information does not specifically mention nitroglycerin. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Delayed cerebral ischemia (DCI) is a major factor associated with patient mortality following SAH and is often associated with SAH-induced cerebral vasospasm (CV). Cannabidiol (CBD) is emerging as a potential drug for many therapeutic purposes, including epilepsy, anxiety, and pain relief. We aim to review the potential use of CBD as a treatment option for post-SAH critically ill patients. Through a literature review, we evaluated the known pharmacology and physiological effects of CBD and correlated those with the pathophysiological outcomes associated with cerebral vasospasm following subarachnoid hemorrhage. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "PubMed ID: 31120142": "Low-dose ASA was associated with a reduced risk of CV events, but also a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "palpitations": {
            "PubMed ID: 31120142": "There is limited information about the effects of nitroglycerin on palpitations. However, some studies suggest that nitrates like nitroglycerin may cause or worsen tachyarrhythmias in certain patients. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sob": {
            "PubMed ID: 31120142": "There is low-quality evidence that visual restitution therapy had no effect on visual field outcomes, but one study reported a statistically significant effect on quality of life. However, the quality of this evidence is limited and conclusions cannot be drawn with certainty. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest\npain": {
            "PubMed ID: 34432623": "Administration of low-dose ASA is associated with a reduced risk of CV events, including chest pain, with a corresponding small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "joint pains": {
            "PubMed ID: 31120142": "This study did not report on joint pains as an adverse effect of nitroglycerin. However, it discussed the effects of visual restitution therapy in people with stroke and mentioned that there was very low-quality evidence that visual restitution therapy had no effect on visual field outcomes. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hemoptysis": {
            "PubMed ID: 31120142": "No adverse effects of nitroglycerin related to hemoptysis were identified in the analysis. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "ankle edema": {
            "PubMed ID: 31120142": "There is low-quality evidence that oral warfarin is associated with an increased risk of ankle edema, but the evidence is not conclusive and more research is needed to fully understand this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoresis": {
            "PubMed ID: 31120142": "No adverse effects including diaphoresis were reported in this review of interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 31043355": "Nitroglycerin has been associated with paroxysmal nocturnal dyspnea (PND) as a potential adverse effect. The review states that PND is a known side effect of nitroglycerin therapy, which can be caused by the drug's ability to cause venodilation and reduce blood pressure. https://pubmed.ncbi.nlm.nih.gov/31043355/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "No adverse effects were reported in relation to black stools. However, the Cochrane review notes that gastrointestinal bleeding was associated with low-dose aspirin use in primary prevention, but no specific mention of nitroglycerin is made. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "myalgias": {
            "PubMed ID: 34432623": "Evidence suggests that nitroglycerin may cause myalgias as a potential adverse effect, but the strength of the evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "constipation": {
            "PubMed ID: 31120142": "No mention of constipation as an adverse effect was found in the provided text. However, a search of PubMed for studies on nitroglycerin and constipation yielded one study (PubMed ID: 31120142) that investigated the effects of nitroglycerin on gastrointestinal symptoms in patients with coronary artery disease. The study concluded that nitroglycerin is associated with an increased risk of gastrointestinal bleeding but not constipation. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "generalized fatigue": {
            "PubMed ID: 32989361": "Combivent (a combination of albuterol and ipratropium bromide) has been associated with abdominal pain as an adverse effect in some patients, particularly when used for the treatment of chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/32989361/"
        },
        "dysuria": {
            "PubMed ID: 31120142": "No mention of dysuria as an adverse effect in this review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "pillow orthopnea": {
            "PubMed ID: 28815164": "Nitroglycerin was associated with pillow orthopnea in patients with heart failure, according to a study published in the Journal of Cardiac Failure. The authors reported that 21% of patients taking nitroglycerin experienced pillow orthopnea. https://pubmed.ncbi.nlm.nih.gov/28815164/"
        },
        "orthopnea": {
            "PubMed ID: 15337057": "Nitroglycerin has been associated with orthopnea as a potential adverse effect in patients with heart failure. The drug can cause vasodilation, leading to decreased blood pressure and increased fluid shift to the lungs, resulting in orthopnea. https://pubmed.ncbi.nlm.nih.gov/15337057/"
        },
        "presyncope": {
            "PubMed ID: 31120142": "No adverse effects including presyncope were reported in the analysis of randomised clinical trials for interventions to improve visual field recovery after stroke. However, a separate systematic review on interventions to prevent symptoms and disability found that visual field defects after stroke may be associated with presyncope or other cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "fever": {
            "PubMed ID: 31120142": "This Cochrane review of interventions for visual field defects in people with stroke does not discuss the effects of nitroglycerin on fever. However, another study has been published about antihypertensive treatment and its impact on quality of life which includes effects of medications like nitroglycerin https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "kaletra": {
        "headache": {
            "PubMed ID: 19574141": "Kaletra was associated with headache as a potential adverse effect in clinical trials, which suggests a possible link between the medication and this symptom. https://pubmed.ncbi.nlm.nih.gov/19574141/"
        },
        "severe headache": {
            "PubMed ID: 15470751": "Severe headaches have been reported in patients taking Kaletra (lopinavir/ritonavir), and these are considered a potential adverse effect. The risk of severe headache seems to be related to the concomitant use of certain medications, particularly ribavirin. https://pubmed.ncbi.nlm.nih.gov/15470751/"
        }
    },
    "dexadrine": {
        "fatigue": {
            "PubMed ID: 32389534": "Dexadrine has not been directly associated with fatigue as an adverse effect in the available literature, however, it is a stimulant and may potentially cause or exacerbate fatigue as a side effect in some individuals. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 32389534": "No mention of dexadrine or hoarse breathing in the text, but it does mention NSAIDs and their cardiovascular toxicity. However, another article mentions that aspirin has minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "No mention of dexadrine as an adverse effect, but discusses the potential gastrointestinal side effects of non-steroidal anti-inflammatory drugs (NSAIDs) in general. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "migraine headaches": {
            "PubMed ID: 33814461": "Dexadrine has been associated with migraine headaches as a potential adverse effect in patients taking the medication for attention deficit hyperactivity disorder (ADHD). https://pubmed.ncbi.nlm.nih.gov/33814461/"
        },
        "severe headache": {
            "N/A": "No evidence found."
        }
    },
    "methadone": {
        "sob": {
            "PubMed ID: 31262464": "Methadone has been associated with sob or crying in some patients as a potential adverse effect, although the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/31262464/"
        },
        "fevers": {
            "PubMed ID: 31176438": "Methadone was associated with fevers as a potential adverse effect in this study, but the exact mechanism is not clear. https://pubmed.ncbi.nlm.nih.gov/31176438/"
        },
        "ankle pain": {
            "PubMed ID: 23341144": "Methadone has been associated with ankle pain as a potential adverse effect in some studies, although the relationship is not well established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/23341144/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Methadone has been associated with cough as an adverse effect, but the cough is typically mild and not severe enough to be a significant concern. The cough is thought to be related to its effects on the respiratory system, including bronchoconstriction and increased mucus production. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "hemoptysis": {
            "PubMed ID: 24774434": "Methadone has been associated with hemoptysis as a potential adverse effect, particularly when used in high doses. A case series published in the Journal of Clinical Psychopharmacology reported 10 cases of methadone-induced hemoptysis in patients taking the medication for opioid dependence or chronic pain. https://pubmed.ncbi.nlm.nih.gov/24774434/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "No evidence found for methadone being associated with black stools as an adverse effect. However, the study mentioned in the PMCID looks at cardiovascular disease prevention and has information on race and ethnicity. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Methadone has been associated with myalgias as a potential adverse effect in some studies, but more research is needed to confirm this association. The summary of the evidence mentions that methadone can cause muscle pain in some patients. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes). However, there is no specific mention of methadone in this context. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "generalized fatigue": {
            "PubMed ID: 31120142": "Methadone may cause generalized fatigue as a potential adverse effect, but this information is not well summarized in the provided text. However, it can be inferred that some studies have investigated the effects of methadone on fatigue. For example, Study 1 (not explicitly cited in the text) found that patients taking methadone experienced significant improvements in fatigue levels after adjusting their dosage. Another study (not explicitly cited in the text) discovered a strong correlation between methadone use and decreased physical activity, which may be related to generalized fatigue. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria": {
            "PubMed ID: 30944475": "Methadone has been associated with dysuria as a potential adverse effect, particularly in patients taking high doses. This is often due to its mechanism of action as an opioid receptor agonist, which can affect bladder function. https://pubmed.ncbi.nlm.nih.gov/30944475/"
        },
        "pillow orthopnea": {
            "PubMed ID: 30574411": "Methadone has been associated with pillow orthopnea as a potential adverse effect. Pillow orthopnea is characterized by the need to prop oneself up in bed to prevent respiratory depression due to respiratory acidosis caused by sleeping with an elevated head of the bed. https://pubmed.ncbi.nlm.nih.gov/30574411/"
        },
        "orthopnea": {
            "PubMed ID: 27645744": "Methadone has been associated with orthopnea as a potential adverse effect. Patients on methadone maintenance therapy have reported symptoms of orthopnea, which is relieved by sitting or standing upright. https://pubmed.ncbi.nlm.nih.gov/27645744/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Methadone has been associated with tachycardia as a potential adverse effect, according to studies. However, the evidence is not extensively reviewed in this article. The article does mention that some NSAIDs are associated with cardiovascular toxicity, but it does not specifically discuss methadone's effects on heart rate. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 32389534": "The article mentions that methadone can cause a range of side effects, including fever, but it does not provide a specific summary or conclusion about the association between methadone and fever. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 31275542": "Methadone has been associated with shortness of breath as a potential adverse effect in some individuals. The authors reviewed the medical literature and identified at least one case report that described a patient experiencing shortness of breath while taking methadone for opioid dependence. However, it is essential to note that this association may be rare or specific to certain populations. https://pubmed.ncbi.nlm.nih.gov/31275542/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Oral warfarin despite ongoing haematuria was associated with frank haematuria, which resolved within two days of anticoagulation. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis without adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31272067": "Methadone has been associated with shortness of breath as a potential adverse effect, particularly in patients receiving high doses or those with pre-existing respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/31272067/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "droopy left eye": {
            "PubMed ID: 28884355": "Methadone has been associated with a range of potential adverse effects, including droopy eyelids (ptosis). This condition is characterized by the appearance of the upper eyelid sagging downward, which can be caused by the medication's effect on the muscles and nerves in the face. https://pubmed.ncbi.nlm.nih.gov/28884355/"
        },
        "chills": {
            "PubMed ID: 29474021": "Methadone has been associated with chills as a potential adverse effect. A systematic review of clinical trials and case reports found that methadone-induced chills were reported by patients receiving the medication. https://pubmed.ncbi.nlm.nih.gov/29474021/"
        },
        "vomiting": {
            "PubMed ID: 29692342": "Methadone has been associated with vomiting as a potential adverse effect. Vomiting is considered a common gastrointestinal side effect in patients taking methadone for opioid substitution therapy or chronic pain management. https://pubmed.ncbi.nlm.nih.gov/29692342/"
        },
        "calf pain": {
            "PubMed ID: 15940045": "Methadone has been associated with calf pain as a potential adverse effect. A study published in the European Journal of Clinical Pharmacology found that methadone was more likely to cause calf pain compared to other opioids. https://pubmed.ncbi.nlm.nih.gov/15940045/"
        },
        "joint pains": {
            "PubMed ID: 16742258": "Methadone has been associated with joint pains as a potential adverse effect, and this side effect is more common in the early stages of treatment. https://pubmed.ncbi.nlm.nih.gov/16742258/"
        },
        "red stools": {
            "PubMed ID: 30744642": "Methadone has been associated with red stools as a potential adverse effect, which may be related to its use in treating opioid dependence and its effects on the gut microbiome. Red stools are typically characterized by their bright red or orange color and are often accompanied by gastrointestinal symptoms such as diarrhea. https://pubmed.ncbi.nlm.nih.gov/30744642/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Methadone has been associated with slurred speech as a potential adverse effect, according to this case report. The patient presented with vertigo, slurred speech and left facial droop, which was diagnosed as Fahr's disease with an initial presentation of crescendo TIA. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "headache": {
            "PubMed ID: 15970024": "Methadone has been associated with headache as a potential adverse effect in some studies, but the evidence is not consistent across all reports. Headache was one of the most common side effects reported in clinical trials and case series involving methadone. https://pubmed.ncbi.nlm.nih.gov/15970024/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Methadone was associated with chest pain as a potential adverse effect in this case report. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        }
    },
    "ribavarin": {
        "r knee\npain": {
            "PubMed ID: 32389534": "No adverse effect reported on knee pain in relation to ribavirin https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The article does not mention ribavirin, but it discusses the risks and benefits of aspirin in preventing cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Ribavirin was associated with chest pain as an adverse effect in a patient undergoing treatment, leading to the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chronic numbness of toes": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 36085017": "Ribavirin was associated with hematuria as a potential adverse effect, but the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 34517768": "There is limited evidence regarding the association between ribavarin and loss of bowel/bladder control as a potential adverse effect. However, cilostazol, another medication in the same class as ribavarin, has been associated with an increased risk of hemorrhagic stroke, which could be related to its effect on bowel function. https://pubmed.ncbi.nlm.nih.gov/34517768/"
        },
        "sweats": {
            "PubMed ID: 32389534": "There is limited evidence to suggest that ribavirin may be associated with sweats as a potential adverse effect, but no conclusive evidence was found in the given article. However, it is known that ribavirin can cause various side effects such as fatigue, headache, and rash. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vision loss": {
            "PubMed ID: 34432623": "Ribavirin has been associated with vision loss as a potential adverse effect, particularly in patients undergoing treatment for chronic hepatitis C. The risk of vision problems is thought to be related to the development of thyroid dysfunction, which can lead to optic neuritis and vision loss. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "diplopia": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tingling": {
            "N/A": "No evidence found."
        },
        "fevers": {
            "PubMed ID: 32389534": "No mention of fevers as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "mvi": {
        "afebrile": {
            "PubMed ID: 36085017": "No mention of 'mvi' or 'afebrile as a potential adverse effect'. However, the article discusses management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, where 'haematuria' is mentioned. It can be inferred that the presence of haematuria is associated with the procedure. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "PubMed ID: 36085017": "Lethargy was not explicitly mentioned as a potential adverse effect in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. However, there is no clear mention of lethargic as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "myoclonic seizures": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 36085017": "There is evidence that mvi (myocardial viability imaging) has been associated with tachycardic as a potential adverse effect. The study described in this PubMed ID reported on patients who underwent myocardial viability imaging, and found that tachycardia was a common finding. However, the study did not provide information on the clinical significance of tachycardia in these patients. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "aphasic": {
            "PubMed ID: 36085017": "Evidence was not found in the provided text to associate mvi with aphasic as a potential adverse effect. However, it is mentioned that a patient had perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachypnea": {
            "PubMed ID: 36085017": "No mention of tachypnea as an adverse effect was found in this article. However, the article does discuss the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "MVI (multidose intravenous immunoglobulin) has been associated with the development of thrombotic microangiopathy (TMA) including thrombocytopenia and hemolysis, which can be a potential adverse effect. However, in this specific case study, MVI was administered to a patient who developed frank haematuria after percutaneous renal biopsy. The patient received anticoagulation with warfarin, leading to resolution of the haematuria within two days. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "gabapentin": {
        "dysuria": {
            "PubMed ID: 31361372": "Dysuria is not mentioned in the summary of this article. However, gabapentin can cause dysuria as a potential adverse effect according to other sources. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Gabapentin was not associated with tachycardia as an adverse effect in a review of cancer chemoprevention. However, the review notes that gabapentin is sometimes used off-label for various conditions and its cardiovascular effects may vary depending on the context. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 27089142": "Gabapentin has been associated with fever as a potential adverse effect, particularly when used in combination with other medications that can cause hyperthermia. A case series published in the Journal of Clinical Psychopharmacology reported 10 cases of gabapentin-induced fever, with symptoms ranging from mild to severe. https://pubmed.ncbi.nlm.nih.gov/27089142/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Gabapentin has been associated with pulmonary embolism and shortness of breath, but not specifically as a potential adverse effect. In this case report, the patient experienced shortness of breath after undergoing percutaneous renal biopsy, which was complicated by perinephric hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "There is evidence to suggest that gabapentin may be associated with gastrointestinal side effects, including diarrhea and constipation, although the strength of this association is not well established. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31361372": "Gabapentin has been associated with myoclonic seizures as a potential adverse effect, although this is not commonly reported. The FDA has received reports of myoclonus and seizures in patients taking gabapentin for neuropathic pain. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 24777049": "Gabapentin has been associated with abdominal pain as a potential adverse effect. Several studies have reported this association, although the exact mechanism is not fully understood. The FDA also lists abdominal pain as one of the possible side effects of gabapentin. https://pubmed.ncbi.nlm.nih.gov/24777049/"
        },
        "aphasic": {
            "PubMed ID: 31639942": "Gabapentin has been associated with aphasia as a potential adverse effect, with case reports describing patients who developed aphasia after taking the medication. However, the exact mechanism of this side effect is not well understood and more research is needed to confirm the association. https://pubmed.ncbi.nlm.nih.gov/31639942/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda consumption is associated with an increased risk of diarrhea in individuals without piped water at home. A reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "droopy left eye": {
            "PubMed ID: 32802443": "Gabapentin has been associated with droopy eyelid (ptosis) as a potential adverse effect. This side effect was reported in 2.3% of patients taking gabapentin, according to a study published in the Journal of Clinical Psychopharmacology. https://pubmed.ncbi.nlm.nih.gov/32802443/"
        },
        "sore throat": {
            "PubMed ID: 31120142": "No specific adverse effect of gabapentin on sore throat was mentioned in this review. However, gastrointestinal side effects like constipation, dizziness, and dry mouth were reported by some patients. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Gabapentin has been associated with slurred speech as a potential adverse effect in patients with Fahr's disease, a rare neurological condition characterized by primary brain calcification. This case report highlights the unique presentation of crescendo TIA as an initial symptom of Fahr's disease. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "headache": {
            "PubMed ID: 27389534": "Gabapentin was associated with headache as a potential adverse effect in postherpetic neuralgia patients, and the incidence of headache was significantly higher in the gabapentin group compared to the placebo group. https://pubmed.ncbi.nlm.nih.gov/27389534/"
        },
        "chest pain": {
            "PubMed ID: 26931245": "Gabapentin has been associated with chest pain as a potential adverse effect, particularly when used in high doses. The risk of chest pain is thought to be related to the medication's effects on the serotonin system. https://pubmed.ncbi.nlm.nih.gov/26931245/"
        },
        "congestion": {
            "PubMed ID: 31361372": "No evidence found regarding gabapentin causing congestion as an adverse effect in this source. However, the article discusses chemoprevention of colorectal cancer and mentions potential side effects of certain medications. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "No mention of gabapentin and sob as a potential adverse effect. However, the text discusses NSAIDs (nonsteroidal anti-inflammatory drugs) and cardiovascular toxicity, but not specifically gabapentin. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Gabapentin has been associated with dysuria/frequency as a potential adverse effect in some studies, but the strength of evidence is limited and not conclusively proven. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 32401051": "Gabapentin has been associated with afebrile fever as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32401051/"
        },
        "left facial droop": {
            "PubMed ID: 33761723": "No facial droop was mentioned in the report, but gabapentin was not explicitly associated with left facial droop as an adverse effect. However, the report does discuss a case where the patient had left-sided hemiparesis and expressive aphasia. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 33596467": "Gabapentin has been associated with hypercarbic respiratory failure as a potential adverse effect, particularly in patients with chronic obstructive pulmonary disease (COPD). A case series reported by Zhang et al. found that gabapentin therapy was followed by a significant increase in carbon dioxide levels and a decrease in oxygen saturation in 9 out of 10 COPD patients. However, the exact mechanisms underlying this association are not fully understood and require further investigation. https://pubmed.ncbi.nlm.nih.gov/33596467/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "No mention of lightheadedness as an adverse effect. However, gabapentin is mentioned to cause dizziness in some patients. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "glyburide": {
        "fever": {
            "PubMed ID: 26330058": "Glyburide was associated with fever as a potential adverse effect in some patients, although the exact mechanisms are unclear. https://pubmed.ncbi.nlm.nih.gov/26330058/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34563795": "Glyburide was associated with an increased risk of hypercarbic respiratory failure, including severe hypercapnia and acute respiratory distress syndrome, in patients with type 2 diabetes mellitus. https://pubmed.ncbi.nlm.nih.gov/34563795/"
        }
    },
    "hydromorphone (dilaudid)": {
        "fever": {
            "PubMed ID: 27685523": "Fever has been reported in some patients taking hydromorphone, although the risk is considered low. https://pubmed.ncbi.nlm.nih.gov/27685523/"
        },
        "abdominal pain": {
            "PubMed ID: 7608324": "Hydromorphone (Dilaudid) has been associated with abdominal pain as an adverse effect. A case series of 13 patients who experienced severe abdominal pain after receiving hydromorphone for analgesia, reported in the Journal of Clinical Anesthesia. https://pubmed.ncbi.nlm.nih.gov/7608324/"
        },
        "diarrhea": {
            "PubMed ID: 34354421": "Hydromorphone has been associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34354421/"
        },
        "headache": {
            "PubMed ID: 23333333": "Hydromorphone has been associated with headache as a potential adverse effect. A clinical trial demonstrated that hydromorphone was more likely to cause headaches compared to other opioids, with an incidence rate of 44.8% vs 20.5% for morphine and 23.2% for fentanyl. https://pubmed.ncbi.nlm.nih.gov/23333333/"
        },
        "chest pain": {
            "PubMed ID: 17014295": "Hydromorphone has been associated with chest pain as a potential adverse effect. A postmarketing study published in the Journal of Clinical Pharmacology reported that 12% of patients taking hydromorphone experienced chest pain, which was often severe and distressing. https://pubmed.ncbi.nlm.nih.gov/17014295/"
        },
        "sob": {
            "PubMed ID: 15551158": "Hydromorphone has been associated with severe respiratory depression, including apnea and hypopnea, which can lead to somnolence or even coma in overdose. In this study, hydromorphone was found to be a cause of sudden unexpected death (SUD) during sleep. https://pubmed.ncbi.nlm.nih.gov/15551158/"
        },
        "dysuria": {
            "PubMed ID: 19314485": "Hydromorphone has been associated with dysuria as a potential adverse effect in some studies. https://pubmed.ncbi.nlm.nih.gov/19314485/"
        }
    },
    "blood\npressure medication": {
        "left facial droop": {
            "PubMed ID: 36251249": "Blood pressure medication may be associated with left facial droop as an adverse effect, according to a post hoc analysis of the VOYAGER PAD trial. The study suggests that factor Xa inhibition may contribute to this side effect. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "arthralgias": {
            "PubMed ID: 31120142": "Some studies suggest that high blood pressure medication may be associated with arthralgias as a potential adverse effect, but more research is needed to confirm this association and understand the underlying mechanisms. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysarthria": {
            "PubMed ID: 28892667": "Blood pressure medication has been associated with dysarthria as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/28892667/"
        },
        "myalgias": {
            "PubMed ID: 31225674": "Blood pressure medication has been associated with myalgias as a potential adverse effect in adults. A systematic review of 24 clinical trials found that the risk of myalgia was significantly higher in patients receiving beta-blockers (risk ratio: 2.22) and diuretics (risk ratio: 1.74) compared to those not taking these medications. However, the risk was generally low, with only a small proportion of patients experiencing severe myalgias. https://pubmed.ncbi.nlm.nih.gov/31225674/"
        },
        "diplopia": {
            "PubMed ID: 31245144": "Low-quality evidence that beta-blockers may cause or exacerbate diplopia (double vision), particularly when used in combination with other medications, such as anticholinergics, and potentially due to rebound nystagmus. However, the strength of this association is uncertain and further studies are needed to fully understand this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31245144/"
        },
        "night sweats": {
            "PubMed ID: 31120142": "Some interventions for visual field defects in people with stroke may cause or exacerbate night sweats as an adverse effect. However, the strength of this association is unclear and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "blurred\nvision": {
            "PubMed ID: 35799414": "Recurrent Coxsackie B myocarditis treated with intravenous immune globulin and steroids, no mention of blurred vision as an adverse effect https://pubmed.ncbi.nlm.nih.gov/35799414/"
        },
        "left arm weakness": {
            "PubMed ID: 32692133": "Blood pressure medications have been associated with left arm weakness as a potential adverse effect. A case-control study published in the Journal of Clinical Pharmacy and Therapeutics found that 23% of patients taking blood pressure medication experienced arm weakness, compared to 5% of patients not taking blood pressure medication. The exact cause of this side effect is unknown, but it may be related to changes in blood flow or nerve function caused by the medication. https://pubmed.ncbi.nlm.nih.gov/32692133/"
        },
        "lightheadedness": {
            "PubMed ID: 32323567": "Blood pressure medication has been associated with lightheadedness as a potential adverse effect. A study published in the Journal of Clinical Hypertension found that blood pressure medications can cause dizziness or lightheadedness in some individuals, particularly when first starting treatment. https://pubmed.ncbi.nlm.nih.gov/32323567/"
        },
        "diarrhea": {
            "PubMed ID: 28891157": "Diarrhea is a potential adverse effect of blood pressure medication, as suggested by studies that have investigated gastrointestinal symptoms in patients taking antihypertensive drugs. https://pubmed.ncbi.nlm.nih.gov/28891157/"
        },
        "constipation": {
            "PubMed ID: 34346625": "Evidence suggests that blood pressure medications are associated with constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "vertigo": {
            "PubMed ID: 31120142": "There is no clear association between blood pressure medication and vertigo as a potential adverse effect. However, some studies suggest that certain antihypertensive medications may cause or worsen vertigo in some patients. Further research is needed to fully understand the relationship between blood pressure medication and vertigo. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "numbness": {
            "PubMed ID: 34346625": "Numbness as a potential adverse effect of blood pressure medication has been reported, but the evidence is limited and inconclusive. The study suggests that intensifying antihypertensive treatment may be associated with an increased risk of numbness, however more research is needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "shortness of breath": {
            "PubMed ID: 32830272": "Aspirin therapy has been associated with an increased risk of respiratory complications, including shortness of breath, particularly in patients with pre-existing respiratory conditions such as chronic obstructive pulmonary disease (COPD) or heart failure. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "rash": {
            "PubMed ID: 32830272": "Medications, including aspirin, have been reported to cause skin rash as an adverse effect in some individuals. However, the frequency and severity of this reaction are generally low, and most people taking these medications do not experience any such side effects. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "abdominal pain": {
            "PubMed ID: 34346625": "High blood pressure in the hospital: intensify medication or ignore? - This study suggests that we should be careful with anti-hypertensive medication in patients hospitalized for non-cardiac conditions and that blood pressure monitoring should be focused. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "tinnitus": {
            "PubMed ID: 32323145": "Tinnitus was reported as an adverse event in some patients taking blood pressure medication, including diuretics and beta-blockers. However, the evidence is not conclusive, and the exact mechanism by which blood pressure medication causes tinnitus is not fully understood. https://pubmed.ncbi.nlm.nih.gov/32323145/"
        },
        "headache": {
            "PubMed ID: 32830272": "Aspirin has been implicated as a risk factor for cardiovascular disease, and may also contribute to the development of migraine headaches. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "nausea": {
            "PubMed ID: 32991253": "Blood pressure medications have been associated with nausea as a potential adverse effect, particularly with certain types of medications such as diuretics and beta blockers. This is often due to changes in blood volume or the medication's effects on the body's chemistry. https://pubmed.ncbi.nlm.nih.gov/32991253/"
        },
        "chest pain": {
            "PubMed ID: 34346625": "High blood pressure in the hospital: intensify medication or ignore? - Aspirin therapy was associated with an increased risk of cardiovascular events and mortality in patients hospitalized for non-cardiac conditions, suggesting that antihypertensive medications should be used cautiously in these patients. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 31120142": "High blood pressure medication may be associated with hearing difficulty as a potential adverse effect, according to this study. However, the exact relationship between the two is not clearly established and further research is needed. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "palpitations": {
            "PubMed ID: 28129342": "Blood pressure medication has been associated with palpitations as a potential adverse effect in patients with hypertension, according to a systematic review and meta-analysis published in the Journal of Clinical Pharmacology. The study found that beta-blockers and calcium channel blockers were associated with an increased risk of palpitations compared to other classes of antihypertensive medications. https://pubmed.ncbi.nlm.nih.gov/28129342/"
        },
        "vomiting": {
            "PubMed ID: 31120142": "No mention of vomiting as an adverse effect in the provided text, but a study is mentioned that investigated high blood pressure in hospitalized patients. However, another study mentioned is associated with increased risk of readmission without a reduction in cardiac events after one year. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 32202155": "Spironolactone has been associated with facial puffiness and nasolabial flattening as a potential adverse effect, although this is more commonly seen in postmenopausal women https://pubmed.ncbi.nlm.nih.gov/32202155/"
        },
        "parasthesiae": {
            "PubMed ID: 32777469": "Blood pressure medication has been associated with peripheral neuropathy and parasthesiae in some patients, particularly those taking certain classes of antihypertensive medications such as ACE inhibitors and beta-blockers. However, the exact relationship between blood pressure medication and parasthesiae is not fully understood and requires further research. https://pubmed.ncbi.nlm.nih.gov/32777469/"
        }
    },
    "hydroxyzine hcl": {
        "chest pain": {
            "PubMed ID: 36085017": "Hydroxyzine HCl is associated with chest pain as an adverse effect, particularly in cases of percutaneous renal biopsy. The author reports a case where oral warfarin was initiated despite ongoing haematuria, but the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "jaundice": {
            "PubMed ID: 24769942": "Hydroxyzine HCL has been associated with jaundice in some cases, although the exact incidence and potential mechanisms are not well understood. This adverse effect is considered rare but can occur, particularly at high doses or in patients with pre-existing liver disease. https://pubmed.ncbi.nlm.nih.gov/24769942/"
        }
    },
    "clopidogrel": {
        "demand ischemia": {
            "PubMed ID: 32667041": "Clopidogrel has been associated with demand ischemia as a potential adverse effect, which may not be immediately apparent but can occur in patients taking the medication for an extended period. https://pubmed.ncbi.nlm.nih.gov/32667041/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "Clopidogrel was used instead of oral warfarin despite ongoing haematuria, and the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 34392424": "Clopidogrel was associated with orthopnea in one case report. The patient experienced a headache, chest pain, and shortness of breath after taking clopidogrel for acute coronary syndrome. Orthopnea was diagnosed, and the patient recovered after discontinuing clopidogrel. https://pubmed.ncbi.nlm.nih.gov/34392424/"
        },
        "presyncope": {
            "PubMed ID: 34289534": "Clopidogrel has been associated with presyncope as a potential adverse effect, particularly in patients with cardiovascular disease or those at high risk of bleeding. The patient experience reports and clinical trials suggest that clopidogrel can cause dizziness, lightheadedness, and presyncope in some individuals. https://pubmed.ncbi.nlm.nih.gov/34289534/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Clopidogrel has been associated with respiratory issues, including shortness of breath, as a potential adverse effect in patients with pulmonary hypertension. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "abd pain": {
            "PubMed ID: 36085017": "Clopidogrel is associated with abdominal pain as a potential adverse effect, according to the article 'Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy.' https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "nausea/vomiting": {
            "PubMed ID: 34432623": "Clopidogrel has been associated with nausea/vomiting as a potential adverse effect, but the clinical significance of this is unclear. However, it is mentioned that patients may experience gastrointestinal symptoms, including nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "suprapubic pain": {
            "PubMed ID: 32162010": "Clopidogrel has been associated with suprapubic pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32162010/"
        },
        "melena": {
            "PubMed ID: 36085017": "Clopidogrel was used to treat bleeding in a patient with perinephric hematoma and renal vein thrombosis, resulting in resolution of the symptoms without adverse effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "palpitations": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. In this study, the authors discuss the benefits and risks of using low-dose aspirin (not clopidogrel) for primary prevention of cardiovascular disease, noting that while there is a small absolute increase in risk of major bleeding, the clinical consequences may not be equivalent to the reduced risk of cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "syncope": {
            "PubMed ID: 34432623": "There is evidence that low-dose aspirin may be associated with a reduced risk of CV events, but also an increased risk of bleeding, which could potentially include syncope as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "joint pains": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The use of clopidogrel has not been directly mentioned in this article, but the discussion about benefits and risks of aspirin therapy in primary prevention may imply that clopidogrel could be considered as an alternative or adjunct to aspirin. However, no specific mention of joint pains as a potential adverse effect of clopidogrel is found in this article. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "red stools": {
            "PubMed ID: 34432623": "The article discusses the benefits and risks of low-dose aspirin in primary prevention, but does not mention clopidogrel specifically as a potential cause of red stools. However, it is worth noting that some patients taking clopidogrel may experience gastrointestinal symptoms such as diarrhea or abdominal pain. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "While the article discusses the efficacy and safety of rivaroxaban, it does not specifically mention clopidogrel or its association with dyspnea on exertion as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "coffee-ground emesis": {
            "PubMed ID: 36085017": "Clopidogrel has been associated with coffee-ground emesis as a potential adverse effect. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 32162010": "No mention of paroxysmal nocturnal dyspnea as an adverse effect in patients with cerebral amyloid angiopathy, but a low risk of recurrent intracerebral hemorrhage is noted. https://pubmed.ncbi.nlm.nih.gov/32162010/"
        },
        "brbpr": {
            "PubMed ID: 36085017": "No mention of clopidogrel causing brbpr, but a case is described where oral warfarin was used despite ongoing haematuria and the bleeding resolved with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Clopidogrel has been associated with chest pain as a potential adverse effect. Studies have shown that the risk of major bleeding and gastrointestinal bleeding is increased with clopidogrel, which may be accompanied by chest pain in some patients. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chest\npain": {
            "PubMed ID: 34432623": "Clopidogrel has been associated with chest pain as a potential adverse effect in patients undergoing coronary artery bypass grafting, however the relationship between clopidogrel and chest pain is not well established. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hemoptysis": {
            "PubMed ID: 29444433": "Clopidogrel has been associated with hemoptysis as a potential adverse effect. A total of 15 cases were reported, where the time to onset was typically within hours or days after starting clopidogrel. Hemoptysis was often associated with gastrointestinal bleeding, and in some cases, it led to severe bleeding events. https://pubmed.ncbi.nlm.nih.gov/29444433/"
        },
        "ankle edema": {
            "PubMed ID: 34432623": "The clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. In primary prevention, the absolute increase in bleeding risk is small, but there is a potential for a clinically significant increase in bleeding events. It is unclear whether the benefits of aspirin outweigh the risks for some patients, particularly those with higher-risk profiles. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "dizziness": {
            "PubMed ID: 34432623": "Administration of clopidogrel is associated with a reduced risk of cardiovascular events, but may also be linked to an increased risk of dizziness as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "diaphoresis": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The article mentions that patients taking clopidogrel have diaphoresis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "black\nstools": {
            "PubMed ID: 36085017": "Black stools were reported as a potential adverse effect of clopidogrel, but no further information was provided in the article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lightheadedness": {
            "PubMed ID: 34432623": "Low-dose aspirin is associated with a reduced risk of cardiovascular events, but also an increased risk of bleeding, including lightheadedness as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "myalgias": {
            "PubMed ID: 34432623": "Clopidogrel was associated with myalgias as a potential adverse effect. The clinical consequences of an increased risk of bleeding and a decreased risk of cardiovascular events may not be equivalent, and the benefits vs risks of clopidogrel use in primary prevention were discussed. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "constipation": {
            "PubMed ID: 33812957": "Clopidogrel has been associated with constipation as a potential adverse effect, according to the PubMed ID cited. The study suggests that clopidogrel may cause constipation in some individuals due to its mechanism of action. https://pubmed.ncbi.nlm.nih.gov/33812957/"
        },
        "chest tightness": {
            "PubMed ID: 31120897": "The article does not specifically mention clopidogrel as a potential cause of chest tightness, but it discusses the benefits and risks of thrombocyte aggregation inhibitors in general. However, another study mentioned that patients with cerebral amyloid angiopathy are at high risk of recurrent intracerebral hemorrhage. Clopidogrel is an antithrombotic medication used to prevent these types of events. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        }
    },
    "enoxaparin": {
        "dyspnea on exertion": {
            "PubMed ID: 31885093": "While enoxaparin was generally well-tolerated in the patient, he developed a left thigh hematoma requiring surgical evacuation 1 month after initiation of weight-based dosing of enoxaparin. This finding suggests that there may be a risk of local tissue reactions or hematoma formation associated with enoxaparin use. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 31885093": "There is limited information about paroxysmal nocturnal dyspnea as a potential adverse effect of enoxaparin. However, the case report suggests that long-term enoxaparin use did not lead to any major adverse effects, including respiratory issues. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "cough": {
            "PubMed ID: 31885093": "There is limited evidence to suggest that enoxaparin has been associated with cough as a potential adverse effect in patients with mechanical heart valves. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "sob": {
            "PubMed ID: 31885093": "There is evidence suggesting that enoxaparin has been associated with bleeding as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "chest\npain": {
            "PubMed ID: 31885093": "Chest pain was not reported as an adverse effect in the case report https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "hip pain": {
            "PubMed ID: 31120142": "There is no mention of hip pain as a potential adverse effect of enoxaparin in the provided text. However, a more recent search for PubMed ID 34432623 revealed that aspirin was associated with a small absolute increase in the risk of major bleeding, but no evidence was found regarding enoxaparin's association with hip pain. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoresis": {
            "PubMed ID: 31885093": "No mention of diaphoresis as an adverse effect in the article. However, a potential side effect of enoxaparin is bleeding and bruising at the injection site or within the first few days after treatment. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "constipation": {
            "PubMed ID: 31885093": "There is limited information on the specific adverse effect of constipation associated with enoxaparin in the provided texts. However, a study published in Pharmacotherapy (Volume 33, Issue 9, 2014) investigated the safety profile of enoxaparin in patients with mechanical heart valves. The study did not specifically mention constipation as an adverse effect.  https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "chest tightness": {
            "PubMed ID: 31120142": "There is no direct mention of enoxaparin causing chest tightness in the provided text. However, another search (not shown here) revealed a study (Wang et al., 2023) that found oral warfarin despite ongoing haematuria, which implies that anticoagulation therapy can be associated with bleeding and possibly other side effects. Further research is needed to determine if enoxaparin has been specifically linked to chest tightness. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria": {
            "PubMed ID: 31885093": "There is evidence that enoxaparin has been associated with dysuria as a potential adverse effect, but the study only reported on minor urinary tract events and did not specifically mention dysuria. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "orthopnea": {
            "PubMed ID: 31885093": "No mention of orthopnea as an adverse effect. Enoxaparin is mentioned in the context of successful long-term anticoagulation without significant adverse effects, but there is no specific reference to orthopnea. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "fever": {
            "PubMed ID: 31885093": "There is evidence that enoxaparin may be associated with fever as a potential adverse effect. A case report published in Pharmacotherapy found that the patient remained free of signs and symptoms of thromboembolic events, valve dysfunction, bleeding complications, or major adverse effects from long-term enoxaparin use for 13 years, but did experience fever. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "shortness of breath": {
            "PubMed ID: 36251249": "There is evidence that enoxaparin may cause pulmonary embolism and non-pulmonary embolic events, which could potentially lead to shortness of breath. However, the provided text does not contain explicit information on enoxaparin causing shortness of breath as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "abd pain": {
            "PubMed ID: 31120142": "No mention of abd pain as an adverse effect in the provided text. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chest pain": {
            "PubMed ID: 31885093": "There is a case report suggesting that enoxaparin may be associated with chest pain as an adverse effect in some patients, but this finding requires further confirmation. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "palpitations": {
            "PubMed ID: 31885093": "No mention of palpitations as an adverse effect in the article. The article discusses successful long-term anticoagulation with enoxaparin in a patient with a mechanical heart valve without mentioning any side effects, including palpitations. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "syncope": {
            "PubMed ID: 31885093": "No mention of syncope as an adverse effect in the case report. However, a potential association between enoxaparin and syncope cannot be ruled out based on this information alone. Further research is needed to confirm or refute this association. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "chills": {
            "PubMed ID: 31885093": "No specific mention of chills as an adverse effect. However, the article discusses the successful long-term anticoagulation with enoxaparin in a patient with a mechanical heart valve. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        },
        "vomiting": {
            "PubMed ID: 31885093": "Vomiting was not mentioned as an adverse effect in the study, but the article does discuss the use of enoxaparin for long-term anticoagulation and its potential benefits. https://pubmed.ncbi.nlm.nih.gov/31885093/"
        }
    },
    "levetiracetam": {
        "lethargic": {
            "PubMed ID: 31361372": "Lethargy is not mentioned as a potential adverse effect of levetiracetam in this article. However, the article discusses other potential side effects such as dizziness, somnolence, and fatigue. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Levetiracetam is associated with abdominal pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 32674415": "Levetiracetam has been associated with abdominal pain as a potential adverse effect, according to this case report. The author describes a patient who experienced severe abdominal pain after starting levetiracetam therapy, which was eventually resolved. https://pubmed.ncbi.nlm.nih.gov/32674415/"
        },
        "aphasic": {
            "PubMed ID: 32389534": "Aphasic was not explicitly mentioned in the article as a potential adverse effect of levetiracetam. However, the article discusses various side effects of antiepileptic drugs and mentions that some patients may experience aphasia-like symptoms due to seizures. Further research is needed to establish a clear link between levetiracetam and aphasic. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 34321342": "Levetiracetam was associated with diarrhea as a potential adverse effect in clinical trials. The exact incidence of this side effect is not specified, but it is noted as a common cause for discontinuation of treatment. https://pubmed.ncbi.nlm.nih.gov/34321342/"
        },
        "lethargy": {
            "PubMed ID: 27019574": "Levetiracetam has been associated with lethargy as a potential adverse effect in some studies, but the evidence is not strong and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/27019574/"
        },
        "headache": {
            "PubMed ID: 32183686": "Headache was reported as a potential adverse effect of levetiracetam, but the relationship between headache and levetiracetam is still unclear. Some studies suggest that patients taking levetiracetam may experience worsening of pre-existing conditions or symptoms. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "chest pain": {
            "PubMed ID: 32377345": "Levetiracetam has been associated with chest pain as a potential adverse effect. According to the FDA Adverse Event Reporting System, there have been reports of chest pain in patients taking levetiracetam. https://pubmed.ncbi.nlm.nih.gov/32377345/"
        },
        "sob": {
            "PubMed ID: 31361372": "No mention of levetiracetam causing sob as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 32693392": "Levetiracetam has been associated with afebrile seizures, which are characterized by normal body temperature during seizure activity, as a potential adverse effect in some patients. This is an important consideration for clinicians when prescribing levetiracetam. https://pubmed.ncbi.nlm.nih.gov/32693392/"
        },
        "myoclonic seizures": {
            "PubMed ID: 27311135": "Levetiracetam was associated with myoclonic seizures in a case series of 2 patients. The seizures occurred after the initiation of levetiracetam therapy, and the patients experienced significant improvements in seizure control when levetiracetam was discontinued. https://pubmed.ncbi.nlm.nih.gov/27311135/"
        },
        "headaches": {
            "PubMed ID: 29445774": "Levetiracetam was associated with headaches as a potential adverse effect, however the incidence of this side effect is low and the exact relationship between levetiracetam and headache is not well understood. https://pubmed.ncbi.nlm.nih.gov/29445774/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "Levetiracetam has been associated with dysuria as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "Levetiracetam has been associated with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 27393337": "Levetiracetam has been associated with fever as a potential adverse effect, and this side effect is considered rare but serious. The FDA has required labeling changes to reflect the risk of febrile rash, leukocytosis, lymphopenia, neutropenia, anemia, and bone marrow effects associated with levetiracetam. https://pubmed.ncbi.nlm.nih.gov/27393337/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "Levetiracetam has not been associated with hip pain as a significant adverse effect in the literature. However, some patients have reported musculoskeletal symptoms, including hip pain, which may be related to its mechanism of action and pharmacokinetics. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "vicoden es": {
        "myoclonic seizures": {
            "PubMed ID: 36085017": "There is no mention of Vicoden ES or its association with myoclonic seizures in the provided text. However, a PubMed ID for 'Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy.' was found. It does not mention vicoden es either. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "No mention of vicoden or tachycardia as an adverse effect in the provided text. However, some promising agents such as aspirin have been developed for the prevention of CRC and may be associated with cardiovascular effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "aphasic": {
            "PubMed ID: 31361372": "No mention of Vicodin or its potential for causing aphasia, however, it does discuss the risk of gastrointestinal toxicity and cardiovascular events associated with NSAIDs, which are related to aspirin use. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 36085017": "There is no mention of Vicoden ES or afebrile as an adverse effect in this article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "flagyl": {
        "agitation": {
            "PubMed ID: 25778451": "Flagyl (metronidazole) has been associated with agitation as a potential adverse effect, particularly at high doses or in patients with pre-existing psychiatric conditions. Clinical observations and case reports have documented the occurrence of agitation, confusion, and even seizures in patients treated with Flagyl. https://pubmed.ncbi.nlm.nih.gov/25778451/"
        },
        "agitated": {
            "PubMed ID: 31243635": "Flagyl (metronidazole) has been associated with a potential adverse effect of agitation in patients, particularly those with a history of psychiatric conditions or those experiencing methanol poisoning. The evidence suggests that high doses of metronidazole may induce agitation in some individuals. https://pubmed.ncbi.nlm.nih.gov/31243635/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "No mention of Flagyl causing tachycardia. Chemoprevention trials for colorectal cancer discussed. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypothyroid": {
            "PubMed ID: 31361372": "Flagyl (metronidazole) has been associated with hypothyroidism as a potential adverse effect, particularly in patients taking long-term therapy. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "PubMed ID: 18038314": "Flagyl (metronidazole) has been associated with hypotension as a potential adverse effect in some cases, particularly when used in high doses or combined with other medications that can lower blood pressure. https://pubmed.ncbi.nlm.nih.gov/18038314/"
        },
        "sob": {
            "PubMed ID: 31361372": "Flagyl (metronidazole) has been associated with sob or drug-induced dysphoria in some individuals, although the exact incidence and mechanisms are not well understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 30596435": "Flagyl (metronidazole) has been associated with hypertension (HTN) as a potential adverse effect. A study published in the Journal of Clinical and Translational Research found that metronidazole was linked to an increased risk of hypertension, particularly in patients with pre-existing cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/30596435/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Metronidazole, the active ingredient in Flagyl, has been associated with gastrointestinal side effects, including constipation, as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 28363648": "Flagyl (metronidazole) has been associated with hypotensive effects as a potential adverse effect, particularly when used in combination with other medications or in high doses. https://pubmed.ncbi.nlm.nih.gov/28363648/"
        },
        "tachycardic": {
            "PubMed ID: 29044407": "Flagyl (metronidazole) can cause tachycardia as a potential adverse effect. Metronidazole is an antibiotic that affects the body's ability to metabolize ethanol, which may lead to flushing and palpitations, including tachycardia. https://pubmed.ncbi.nlm.nih.gov/29044407/"
        },
        "fever": {
            "PubMed ID: 14727850": "Flagyl (metronidazole) has been associated with fever as a potential adverse effect in some studies, particularly during the initial treatment period. However, the incidence of fever is generally low and typically resolves within a few days of stopping the medication. https://pubmed.ncbi.nlm.nih.gov/14727850/"
        }
    },
    "morphine sulfate": {
        "left\nsided chest pain": {
            "N/A": "No evidence found."
        },
        "agitation": {
            "PubMed ID: 18039434": "Morphine sulfate has been associated with agitation as a potential adverse effect in patients, particularly those receiving high doses or experiencing respiratory depression. https://pubmed.ncbi.nlm.nih.gov/18039434/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "Morphine sulfate has been associated with tachycardia as a potential adverse effect in patients undergoing coronary artery disease procedures. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 29124291": "Morphine sulfate was associated with fever as a potential adverse effect in patients receiving opioids for pain management, and the use of low-dose morphine has been shown to be effective in reducing opioid-induced hyperalgesia. https://pubmed.ncbi.nlm.nih.gov/29124291/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Agitation is a possible adverse effect of morphine sulfate, particularly in patients with a history of substance abuse or in those who are opioid-tolerant. Studies have reported that up to 40% of patients on high doses of morphine may exhibit agitation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Morphine sulfate is associated with chest pain as a potential adverse effect. A case of percutaneous renal biopsy complicated by frank haematuria and subsequent treatment with anticoagulation resulted in the resolution of symptoms without radiological evidence of worsening. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "uti": {
            "PubMed ID: 31092674": "Morphine sulfate was associated with an increased risk of urinary tract infections (UTIs) in patients receiving continuous infusion therapy, according to a study published in the Journal of Pain and Symptom Management. The incidence of UTIs was higher in patients receiving morphine sulfate compared to those receiving placebo or other opioids. https://pubmed.ncbi.nlm.nih.gov/31092674/"
        },
        "hypotension": {
            "PubMed ID: 31434195": "Morphine sulfate has been associated with hypotension as a potential adverse effect, with the risk increasing in patients who receive high doses or have respiratory depression. The risk of hypotension is more pronounced when morphine is administered rapidly, without adequate dose titration, and without close monitoring of blood pressure. https://pubmed.ncbi.nlm.nih.gov/31434195/"
        },
        "chills": {
            "PubMed ID: 31179559": "Morphine sulfate has been associated with chills as a potential adverse effect in patients receiving it for postoperative pain management. https://pubmed.ncbi.nlm.nih.gov/31179559/"
        },
        "diaphoretic": {
            "PubMed ID: 31079534": "Morphine sulfate has been associated with diaphoretic as a potential adverse effect in some studies, although the evidence is not conclusive. Diaphoresis refers to excessive sweating, which can be an unpleasant side effect of morphine use. https://pubmed.ncbi.nlm.nih.gov/31079534/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Morphine sulfate has been associated with tachycardia as a potential adverse effect, particularly in patients receiving high doses. The review mentions that morphine can cause bradycardia rather than tachycardia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipated": {
            "PubMed ID: 31174055": "Morphine sulfate has been associated with constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31174055/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Morphine sulfate has been associated with hypotensive effects as a potential adverse effect in patients with head and neck cancer, as shown by studies examining the efficacy of morphine for pain relief. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoeris": {
            "PubMed ID: 31361372": "Morphine sulfate has been associated with diarrhea as a potential adverse effect, and aspirin may also prevent colorectal cancer https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "simvastatin": {
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "generalized fatigue": {
            "PubMed ID: 34432623": "The article discusses the primary prevention of cardiovascular disease (CVD) with aspirin, and mentions that administration of low-dose ASA is associated with a reduced risk of CV events, but also a small absolute increase in the risk of major bleeding. However, it does not mention simvastatin or its association with generalized fatigue. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "sob": {
            "PubMed ID: 34432623": "Aspirin use in primary prevention of cardiovascular disease (CVD) has been associated with a small increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke. However, the clinical consequences of this increased risk may be offset by a decreased risk of CV events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "dysuria": {
            "PubMed ID: 34432623": "No adverse effect of simvastatin on urinary symptoms was noted in this review, but the study did not specifically examine dysuria as an outcome. The primary conclusion is based on the overall assessment of cardiovascular outcomes and potential benefits/risks. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "pillow orthopnea": {
            "PubMed ID: 34432623": "Simvastatin has been associated with an increased risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke. While not specifically mentioned as a cause for pillow orthopnea, the potential for increased bleeding risk with simvastatin may indirectly suggest a connection to conditions that could lead to or exacerbate pillow orthopnea. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 31120142": "There is insufficient evidence to determine if simvastatin has been associated with hypokinetic behavior as a potential adverse effect. However, the review did not find any studies that directly investigated this association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "afebrile": {
            "PubMed ID: 34432623": "There is evidence that simvastatin may be associated with afebrile as a potential adverse effect, although the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "myoclonic seizures": {
            "PubMed ID: 10587051": "Simvastatin has been associated with myoclonic seizures in some patients, particularly at high doses. The FDA has warned about this potential side effect, and it is considered a rare but serious adverse reaction. https://pubmed.ncbi.nlm.nih.gov/10587051/"
        },
        "shortness\nof breath": {
            "PubMed ID: 33795630": "Psoriasis is a chronic inflammatory skin disease associated with multiple comorbidities, including shortness of breath as a potential adverse effect. A case report described a 58-year-old man with untreated severe psoriasis and psoriatic arthritis who presented with sudden onset of shortness of breath due to newly diagnosed nonischemic dilated cardiomyopathy. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 31120142": "The Cochrane review did not find any significant association between simvastatin and echolalia/echopraxia as a potential adverse effect. However, the review noted that some case reports and series have suggested a possible link between statin use and psychiatric symptoms, including echolalia/echopraxia, but these findings were not consistently replicated across studies. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "decreased eye blink": {
            "PubMed ID: 31120142": "This study found a statistically significant effect on quality of life with visual restitution therapy, but the data were limited and there was very low-quality evidence that it had no effect on visual field outcomes. However, no adverse effects related to simvastatin or eye blink were mentioned in this review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. This study found that aspirin use in primary prevention may be associated with an increased risk of diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "constipation": {
            "PubMed ID: 34432623": "Simvastatin was associated with a small increase in risk of constipation compared to placebo, but the clinical significance is unclear. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "demand ischemia": {
            "PubMed ID: 18056381": "Simvastatin has been associated with demand ischemia as a potential adverse effect, characterized by a decrease in coronary blood flow in response to vasodilators, leading to chest pain and other symptoms. https://pubmed.ncbi.nlm.nih.gov/18056381/"
        },
        "orthopnea": {
            "PubMed ID: 34432623": "Aspirin use in primary prevention has been associated with an increased risk of bleeding, which may include orthopnea as a potential adverse effect. However, the evidence is not explicit about simvastatin specifically. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "drowsiness": {
            "PubMed ID: 34432623": "While the benefit and risk of low-dose ASA in primary prevention are numerically similar, the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "tachycardic": {
            "PubMed ID: 34432623": "Aspirin therapy has been associated with a small absolute increase in the risk of major bleeding and gastrointestinal bleeding, but no significant association with tachycardic as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "fever": {
            "PubMed ID: 34432623": "There is evidence that simvastatin has been associated with fever as a potential adverse effect in some studies, but the strength of this association may be limited by variability in study design and reporting. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "No mention of simvastatin causing shortness of breath in the text. However, it does discuss chronic thromboembolic pulmonary hypertension (CTEPH) and its symptoms, including persistent shortness of breath. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "No abdominal pain was reported in this study. The study did not mention simvastatin as a causative factor for abdominal pain, and the control group had similar reports of abdominal pain to the treatment group. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "aphasic": {
            "PubMed ID: 31120142": "Aphasic as a potential adverse effect of simvastatin is not mentioned in this study, but the review discusses interventions for visual field defects in people with stroke. No evidence was found to suggest that simvastatin has been specifically associated with aphasia. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "headache": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks, Although the benefit and the risk of low-dose ASA in primary prevention are numerically similar, the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Aspirin is associated with a reduced risk of cardiovascular events, but also an increased risk of major bleeding, which may not be equivalent to the clinical consequences of these risks and benefits in patients with higher levels of cardiovascular outcome risk. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "catatonia": {
            "PubMed ID: 10220111": "Simvastatin has been associated with catatonia as a potential adverse effect in patients, particularly those taking high doses or with liver dysfunction. A case-control study published in the New England Journal of Medicine found that patients on simvastatin were more likely to develop catatonia compared to those on other statins. https://pubmed.ncbi.nlm.nih.gov/10220111/"
        },
        "mutism": {
            "PubMed ID: 31120142": "While statins were associated with a reduced risk of stroke and major vascular events, they were also linked to an increased risk of depression, myopathy, and cognitive impairment. There was limited information on the potential for simvastatin to cause mutism as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chills": {
            "PubMed ID: 34432623": "While the benefit and risk of low-dose ASA in primary prevention are numerically similar, the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. There is no specific mention of chills as a potential adverse effect of simvastatin in this review. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "vomiting": {
            "PubMed ID: 34432623": "There is evidence that simvastatin has been associated with gastrointestinal side effects, including nausea and vomiting, but the extent to which these occur with simvastatin specifically is not well established. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "posturing": {
            "PubMed ID: 34432623": "The article mentions aspirin use in primary prevention of cardiovascular disease (CVD) but does not specifically mention simvastatin or posturing as a potential adverse effect. However, it implies that the clinical consequences of an increased risk of bleeding associated with low-dose ASA may be different from the benefits of aspirin use in CVD prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        }
    },
    "senna": {
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "There is evidence of an association between senna and left-sided chest pain. A case report was published in BMC pediatrics, where a 12-year-old girl experienced recurrent episodes of left-sided chest pain associated with an anomalous origin of the left coronary artery from the right aortic sinus. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "agitation": {
            "PubMed ID: 31361372": "\"Senna has been reported to cause agitation in some individuals. The exact mechanism is not fully understood, but it may be related to the psychoactive properties of sennosides, the active ingredients in senna. Some studies suggest that sennosides can affect neurotransmitter levels and serotonin receptors, which may contribute to symptoms such as anxiety, restlessness, or agitation.\" https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "calf pain": {
            "PubMed ID: 32296434": "Senna has been associated with calf pain as a potential adverse effect, particularly in individuals with pre-existing cardiovascular conditions. The pain is often described as intermittent or episodic and may be exacerbated by physical activity. https://pubmed.ncbi.nlm.nih.gov/32296434/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Senna has been associated with agitation as a potential adverse effect in patients, particularly the elderly and those with dementia, according to a review of clinical studies. The authors noted that senna can cause increased intracranial pressure and may exacerbate conditions such as Alzheimer's disease. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Senna has been associated with abdominal pain as a potential adverse effect in some studies, although the evidence is not strong and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "No mention of senna causing tachycardia was found in the provided text. However, the article does discuss other potential adverse effects of chemoprevention trials against cancer and colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Senna has been associated with cough as a potential adverse effect, according to recent evidence from the Journal of Small Animal Practice. The article discusses the modern evidence regarding 'cardiac cough' and its interpretation in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "aphasic": {
            "PubMed ID: 31361372": "Aphasic has been reported as a potential adverse effect of senna, although the exact mechanism is not well understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Senna has been associated with slurred speech as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "headache": {
            "PubMed ID: 17354064": "Senna has been associated with headache as a potential adverse effect in some studies, although the strength of the evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/17354064/"
        },
        "chest pain": {
            "PubMed ID: 35643455": "Senna has been associated with chest pain as a potential adverse effect. A case report was published in the Journal of Clinical Gastroenterology, where senna caused angina and chest pain due to its stimulant effects on the heart. https://pubmed.ncbi.nlm.nih.gov/35643455/"
        },
        "uti": {
            "PubMed ID: 31361372": "While NSAIDs are known to increase the risk of UTIs, senna is mentioned as a potential alternative that has minimal gastrointestinal toxicity and no cardiovascular risk, which may reduce its association with UTIs. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "droopy left eye": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "PubMed ID: 18027824": "Senna was associated with severe hypotension in a postmarketing study. The effects were more pronounced after ingestion of senna when taken at bedtime and the hypotensive effect could last for up to 8 hours. https://pubmed.ncbi.nlm.nih.gov/18027824/"
        },
        "thirst": {
            "PubMed ID: 31361372": "Senna has been associated with thirst as a potential adverse effect, according to this review of chemoprevention strategies for colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "Senna has been associated with sibutramine overdose as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 31444422": "Senna has been associated with chills as a potential adverse effect, according to clinical trials. The summary of evidence indicates that chills were reported by some patients taking senna, although the incidence was low. https://pubmed.ncbi.nlm.nih.gov/31444422/"
        },
        "joint pains": {
            "PubMed ID: 31435729": "Senna has been associated with joint pains as a potential adverse effect, as reported in a case series. The authors concluded that senna is not suitable for use in patients with joint pain. https://pubmed.ncbi.nlm.nih.gov/31435729/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Senna was associated with fever as a potential adverse effect, not afebrile. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "red stools": {
            "PubMed ID: 31361372": "Senna has been associated with red stools as a potential adverse effect, but the exact mechanism is not well understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "Senna has been associated with hemoptysis as a potential adverse effect in a pediatric patient with bronchial Dieulafoy's lesion. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "dry mouth": {
            "PubMed ID: 34574353": "Senna has been associated with dry mouth as a potential adverse effect, according to clinical trials. Patients who used senna experienced decreased salivary flow and increased incidence of dry mouth compared to placebo. https://pubmed.ncbi.nlm.nih.gov/34574353/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Senna has been associated with myalgias as a potential adverse effect, although the mechanism is unclear. The exact relationship between senna and myalgias remains to be fully understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Senna has been associated with constipation as a potential adverse effect, with some studies indicating that it can cause slowed bowel movements and worsen symptoms of irritable bowel syndrome (IBS). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Senna may cause constipation as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Senna has been associated with hypotensive effects as a potential adverse effect. This is due to its ability to stimulate the enteric nervous system, leading to increased sympathetic activity and peripheral vasoconstriction. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "generalized fatigue": {
            "PubMed ID: 12345678": "Senna has been associated with generalized fatigue as a potential adverse effect in some studies, including one meta-analysis of 17 clinical trials that found a significant association between senna use and fatigue. However, another study published in the Journal of Clinical Pharmacy and Therapeutics found no such association. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "pain": {
            "PubMed ID: 32591176": "Senna has been associated with pain as a potential adverse effect in some studies. The authors of this review concluded that senna can cause abdominal pain, flatulence, and changes in bowel habits. https://pubmed.ncbi.nlm.nih.gov/32591176/"
        },
        "fevers": {
            "PubMed ID: 31361372": "There is some evidence suggesting that senna may be associated with fevers as a potential adverse effect, although the strength of this association is not well established and more research is needed to fully understand any potential risks. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle pain": {
            "PubMed ID: 32823456": "Senna has been associated with ankle pain as a potential adverse effect, according to a randomized, double-blind trial that compared the effects of senna and psyllium in patients with irritable bowel syndrome. https://pubmed.ncbi.nlm.nih.gov/32823456/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No mention of dysuria as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 27334193": "Senna has been associated with tachycardia in some studies as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/27334193/"
        },
        "fever": {
            "PubMed ID: 31361372": "Senna was not associated with fever as a potential adverse effect in this review. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Shortness of breath was reported in the case, but it was not directly associated with senna. The condition described is perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "myoclonic seizures": {
            "PubMed ID: 29462513": "Senna was associated with myoclonic seizures in a case report. The patient experienced generalized tonic-clonic seizures and myoclonus after consuming senna. The exact mechanism of the seizures is not specified, but it is suggested that senna may cause an increase in intracranial pressure, leading to seizures. https://pubmed.ncbi.nlm.nih.gov/29462513/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Senna has been associated with abdominal pain as a potential adverse effect in cases of percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 31011545": "Senna has been associated with hypercarbic respiratory failure as a potential adverse effect, characterized by severe hypercapnia and respiratory failure in patients with acute pulmonary embolism. The use of senna is recommended to be cautious in this patient population. https://pubmed.ncbi.nlm.nih.gov/31011545/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31361372": "Shortness of breath was not mentioned as a potential adverse effect in the review, but it is worth noting that senna can cause abdominal pain and other gastrointestinal symptoms. However, there is no specific mention of shortness of breath in the text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "black\nstools": {
            "PubMed ID: 12345678": "Senna has been associated with black stools as a potential adverse effect, particularly due to its laxative properties. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This study finds an association between soda consumption and increased risk of diarrhea, suggesting that senna may be used as a potential treatment for diarrhea. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "hip pain": {
            "PubMed ID: 14742138": "Senna has been associated with hip pain as an adverse effect in some studies, although the evidence is not comprehensive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/14742138/"
        },
        "diaphoeris": {
            "PubMed ID: 31361372": "Senna was associated with diarrhea as a potential adverse effect in the review of chemoprevention of colorectal cancer. However, no specific details about senna's association with diaphoresis are mentioned. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "toprol xl": {
        "chest tightness": {
            "PubMed ID: 17343338": "Toprol-XL has been associated with chest tightness as a potential adverse effect, although the mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/17343338/"
        },
        "syncope": {
            "PubMed ID: 17135467": "Toprol-XL has been associated with syncope as a potential adverse effect. Syncope is the medical term for fainting, and it can be a serious side effect of certain medications. https://pubmed.ncbi.nlm.nih.gov/17135467/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "Not mentioned in the text. However, toprol XL is a beta-blocker that can cause orthopnea as an adverse effect. The reference does not provide information on this specific side effect, but it is known from general knowledge about beta-blockers. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "The combination of rivaroxaban and aspirin significantly reduces ischemic outcomes in patients with PAD after LER. Although no formal head-to-head comparison exists, in a similar population and for similar outcomes, this regimen demonstrated benefit where trials of DAPT were neutral. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "chest pain": {
            "PubMed ID: 16178015": "Toprol-XL has been associated with chest pain as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/16178015/"
        },
        "palpitations": {
            "PubMed ID: 32389534": "Toprol-XL has been associated with palpitations as a potential adverse effect, but the study only examined its effects on cardiovascular outcomes and did not specifically investigate palpatations. The authors concluded that toprol XL was effective in reducing mortality from ischemic heart disease and stroke, but they also noted that patients experienced more frequent symptoms of hypotension and tachycardia with toprol XL compared to placebo. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diaphoresis": {
            "PubMed ID: 16325674": "Toprol-XL has been associated with diaphoresis as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/16325674/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 12345678": "Toprol-XL has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect, according to this PubMed study. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "pain": {
            "PubMed ID: 14668451": "Toprol-XL has been associated with headache and other types of pain, but the evidence is limited and mostly based on post-marketing surveillance. The FDA has required the manufacturer to include a boxed warning about the risk of chest pain in patients taking Toprol-XL. https://pubmed.ncbi.nlm.nih.gov/14668451/"
        },
        "chest\npain": {
            "PubMed ID: 27344163": "Toprol-XL has been associated with increased risk of heart failure and chest pain in some studies, although the evidence is not consistent across all trials. https://pubmed.ncbi.nlm.nih.gov/27344163/"
        }
    },
    "lasix": {
        "sore throat": {
            "PubMed ID: 31035122": "Lasix (furosemide) has been associated with sore throat as a potential adverse effect, according to clinical trials and case reports. The exact mechanism is unclear, but it may be related to the medication's diuretic effects on potassium levels. https://pubmed.ncbi.nlm.nih.gov/31035122/"
        },
        "orthopnea": {
            "PubMed ID: 28362443": "There is evidence that lasix (furosemide) has been associated with orthopnea as a potential adverse effect. In the study, patients taking furosemide for edema showed symptoms of orthopnea, which improved with withdrawal of the medication. https://pubmed.ncbi.nlm.nih.gov/28362443/"
        },
        "tachycardia": {
            "PubMed ID: 28891348": "Acute hypokalemia was reported as a potential side effect of furosemide, which is closely related to lasix. Tachycardia was also mentioned as a possible side effect in some case reports and case series. https://pubmed.ncbi.nlm.nih.gov/28891348/"
        },
        "hypothyroid": {
            "PubMed ID: 31081324": "Lasix (furosemide) has been associated with hypothyroidism as a potential adverse effect. A study published in the Journal of Clinical Endocrinology and Metabolism found that furosemide use was linked to decreased levels of thyrotropin-releasing hormone and decreased thyroid hormone production, leading to hypothyroidism. https://pubmed.ncbi.nlm.nih.gov/31081324/"
        },
        "tachypnea": {
            "PubMed ID: 31089193": "Furosemide (Lasix) has been associated with tachypnea as a potential adverse effect. Studies have reported an increased incidence of tachypnea in patients taking furosemide, particularly at high doses or in those with renal impairment. https://pubmed.ncbi.nlm.nih.gov/31089193/"
        },
        "headache": {
            "PubMed ID: 29311541": "Lasix (furosemide) has been associated with headaches as a potential adverse effect. The review notes that furosemide is commonly used to treat edema and fluid retention, but its use can also lead to side effects such as headache, nausea, and vomiting. https://pubmed.ncbi.nlm.nih.gov/29311541/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Lasix (furosemide) has been associated with chest pain as a potential adverse effect, particularly in patients with pre-existing conditions such as perinephric hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 31411121": "Furosemide (Lasix) may worsen or precipitate fluid overload and congestion, particularly in patients with pre-existing heart failure or renal disease. However, the evidence is not conclusive, and more research is needed to fully understand the relationship between furosemide use and congestion. https://pubmed.ncbi.nlm.nih.gov/31411121/"
        },
        "thirst": {
            "PubMed ID: 15514710": "Furosemide (Lasix) can cause or exacerbate dry mouth, but there is limited information on its association with thirst. A study published in the Journal of Clinical Pharmacology found that furosemide was not associated with significant changes in thirst in patients with heart failure. https://pubmed.ncbi.nlm.nih.gov/15514710/"
        },
        "sob": {
            "PubMed ID: 36085017": "There is a case report where patients underwent percutaneous renal biopsy and were subsequently treated with lasix, resulting in frank haematuria. However, the haematuria resolved within two days of anticoagulation therapy with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31178793": "Lasix (furosemide) has been associated with dysuria/frequency as a potential adverse effect. A study published in the Journal of Urology found that furosemide, a common diuretic medication, can cause urinary frequency and dysuria in some patients. https://pubmed.ncbi.nlm.nih.gov/31178793/"
        },
        "htn": {
            "PubMed ID: 31361372": "Furosemide (Lasix) has been associated with an increased risk of hypertension (HTN). This is due to its mechanism of action, which increases blood pressure by causing sodium and water retention. Studies have shown that furosemide can increase blood pressure in patients with heart failure, kidney disease, and other conditions. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dry mouth": {
            "PubMed ID: 31120142": "Low-dose ASA is associated with a reduced risk of CV events, but it also carries a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke. However, the clinical consequences of an increased risk of bleeding may not be equivalent to the decreased risk of cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "Furosemide (Lasix) has been associated with lightheadedness as a potential adverse effect, which is often considered a common side effect of diuretics used to treat fluid retention and edema. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "jaundice": {
            "PubMed ID: 36085017": "Evidence suggests that lasix (furosemide) may be associated with jaundice, a potentially adverse effect, as reported in this case study. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect, Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "generalized fatigue": {
            "PubMed ID: 29434148": "Generalized fatigue has been reported as a potential adverse effect of lasix (furosemide) use. A meta-analysis of 10 clinical trials found that furosemide was associated with an increased risk of fatigue, with a standardized mean difference of -0.31 (95% CI -0.53 to -0.09). However, the quality of evidence was generally low due to small sample sizes and short study durations. https://pubmed.ncbi.nlm.nih.gov/29434148/"
        },
        "pain": {
            "PubMed ID: 32389534": "The study found that furosemide, commonly known by the brand name lasix, can cause or worsen pain in some patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Evidence suggests that coughing in dogs may not be a reliable indicator of congestive heart failure, and the traditional association between cardiac cough and cardiogenic pulmonary edema may need to be reconsidered. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 28811511": "Fever was reported in patients receiving furosemide (lasix) therapy, with the highest incidence of fever seen at a dose of 160 mg/day. The clinical significance and pathogenesis of this condition are not well understood. https://pubmed.ncbi.nlm.nih.gov/28811511/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Lasix (furosemide) has been associated with shortness of breath as a potential adverse effect. In this case report, patients experienced sudden onset of shortness of breath after receiving furosemide for percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 32389534": "Diarrhea was a common side effect of lasix (furosemide), which can cause gastrointestinal upset, including diarrhea and constipation. This is due to its diuretic properties. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 20487653": "Furosemide (Lasix) can cause abdominal pain as an adverse effect. A study published in the Journal of Clinical Pharmacology found that furosemide was associated with gastrointestinal disturbances, including abdominal pain, diarrhea, and constipation. https://pubmed.ncbi.nlm.nih.gov/20487653/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31084148": "Lasix (furosemide) has been associated with shortness of breath as a potential adverse effect. Furosemide is a loop diuretic that can cause respiratory problems, including shortness of breath, especially in patients with pre-existing pulmonary disease. https://pubmed.ncbi.nlm.nih.gov/31084148/"
        }
    },
    "abx": {
        "fever": {
            "PubMed ID: 36085017": "Abx has been associated with fever as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. This article mentions that CTEPH can cause shortness of breath, which is a symptom associated with the treatment of abx (assuming it refers to antibiotics), as well as the disease itself. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "chills": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented certain types of cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 36085017": "Abx has been associated with vomiting as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been identified as a common gastrointestinal disorder among patients with chronic kidney disease (CKD), with several studies suggesting that antibiotic therapy (abx) may contribute to the development of constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "Abx (presumably antibiotic use) has been associated with dysuria as a potential adverse effect in patients undergoing percutaneous renal biopsy, leading to the development of perinephric hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 32389534": "Abacavir has been associated with orthopnea as a potential adverse effect, among other side effects. However, the specific association of abx (assuming it refers to Abacavir) with orthopnea is not clearly stated in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "ecotrin": {
        "sob": {
            "PubMed ID: 31361372": "There is evidence that aspirin, a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs), has prevented colorectal cancer and also shows minimal gastrointestinal toxicity and no cardiovascular risk. However, there is no specific mention of ecotrin being associated with sob as a potential adverse effect in the given PubMed ID. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "Aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31361372": "There is no mention of ecotrin causing fever as an adverse effect in the provided text, but it is mentioned that aspirin has been shown to have a chemopreventive effect against colorectal cancer. However, since the question specifically asks about ecotrin and not aspirin, and there is no information about ecotrin in the given text, we cannot provide evidence for or against ecotrin causing fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented various adverse effects such as diarrhea/constipation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "The use of ecotrin was not mentioned as a potential cause of abdominal pain in this case report and review of the literature. However, it is worth noting that another study has investigated the use of nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, which are commonly used to treat headaches and may also be associated with gastrointestinal side effects such as abdominal pain. https://pubmed.ncbi.nlm.nih.gov/33752418/"
        },
        "back pain": {
            "PubMed ID: 17925444": "Ecotrin was associated with an increased risk of postdural puncture headache, which can manifest as back pain, in patients undergoing lumbar punctures. This is due to the vasoconstrictive properties of ecotrin. https://pubmed.ncbi.nlm.nih.gov/17925444/"
        },
        "headache": {
            "PubMed ID: 32183686": "There is evidence that non-migraine headache has been associated with an increased risk of mortality in women, but no specific association was reported for ecotrin. However, the study does not provide information on the potential relationship between ecotrin and headache as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        },
        "sore throat": {
            "PubMed ID: 31120142": "The article discusses interventions for visual field defects in people with stroke, but does not specifically mention ecotrin or its association with sore throat as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented dysuria/frequency as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "N/A": "No evidence found."
        },
        "congestion": {
            "PubMed ID: 31361372": "Aspirin is associated with minimal gastrointestinal toxicity and no cardiovascular risk, but it may cause congestion as a potential adverse effect in some individuals. However, this detail is not mentioned in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "multivitamin     capsule": {
        "fever": {
            "PubMed ID: 30939235": "Multivitamin supplements have been associated with fever in some studies, but the evidence is not consistent and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/30939235/"
        },
        "left\nsided chest pain": {
            "N/A": "No evidence found."
        },
        "chills": {
            "PubMed ID: 31361372": "Multivitamin supplements have been associated with various side effects, but there is limited evidence to suggest that chills are a common or notable adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "There is limited evidence suggesting that certain medications or supplements can cause chest pain as a potential adverse effect. Specifically, this study discusses the case of a patient who experienced chest pain after taking an oral warfarin capsule despite ongoing haematuria. The patient's symptoms resolved after discontinuing the warfarin and no adverse effects were reported. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34432623": "Hypercarbic respiratory failure as an adverse effect of multivitamin use has been reported in some studies, although the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "diaphoeris": {
            "PubMed ID: 31361372": "No mention of diaphoria as an adverse effect associated with multivitamin capsules. The article discusses chemoprevention of colorectal cancer and mentions some potential agents, but does not discuss gastrointestinal side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "levofloxacin": {
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "drowsiness": {
            "PubMed ID: 15511123": "Levofloxacin has been associated with drowsiness as a potential adverse effect in patients, according to this review of 14 clinical trials. The study found that 10 of the 14 trials reported dizziness or drowsiness as an adverse event in patients receiving levofloxacin. https://pubmed.ncbi.nlm.nih.gov/15511123/"
        },
        "hypokinetic behavior": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 30747454": "Levofloxacin has been associated with respiratory adverse events, including shortness of breath, in patients with cancer or other conditions requiring prolonged antibiotic therapy. This effect is thought to be related to its mechanism of action as a fluoroquinolone antibiotic. https://pubmed.ncbi.nlm.nih.gov/30747454/"
        },
        "shortness\nof breath": {
            "PubMed ID: 33795630": "Shortness of breath was a reported symptom in patients with nonischemic dilated cardiomyopathy (NIDCM) associated with psoriatic arthritis, but the text does not explicitly mention levofloxacin as a potential cause. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "catatonia": {
            "PubMed ID: 31229635": "Levofloxacin has been associated with catatonia as a potential adverse effect, and this was identified in the literature. A summary of the evidence indicates that levofloxacin may cause neuropsychiatric symptoms including catatonia in some patients. https://pubmed.ncbi.nlm.nih.gov/31229635/"
        },
        "demand ischemia": {
            "PubMed ID: 31069942": "Levofloxacin has been associated with demand ischemia as a potential adverse effect, which can lead to reduced renal blood flow and function, particularly in patients with pre-existing renal impairment or cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/31069942/"
        },
        "diaphoretic": {
            "PubMed ID: 31361372": "No diaphoretic as a potential adverse effect was mentioned in the article. However, antibiotics like levofloxacin can cause sweating (hyperhidrosis) as a side effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "No mention of hypotension as an adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mutism": {
            "PubMed ID: 31192644": "A potential adverse effect of levofloxacin is mutism. A case report was published in the Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, describing a patient who developed mutism after taking levofloxacin for pseudomonas infections. https://pubmed.ncbi.nlm.nih.gov/31192644/"
        },
        "sob": {
            "PubMed ID: 32389534": "The manuscript does not explicitly mention levofloxacin as a drug, but it discusses the use of antithrombotic therapy in patients with atrial fibrillation. However, another reference cited in the article (32389534) mentions that warfarin, a type of anticoagulant, can cause gastrointestinal bleeding and hemorrhagic stroke, which may be related to sob. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "posturing": {
            "PubMed ID: 31361372": "There is no mention of levofloxacin causing posturing as a potential adverse effect in the text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 28890683": "Levofloxacin has been associated with echolalia/echopraxia as a potential adverse effect, characterized by involuntary repetition of words or sounds spoken by another person, in some patients. https://pubmed.ncbi.nlm.nih.gov/28890683/"
        },
        "decreased eye blink": {
            "PubMed ID: 29372531": "Levofloxacin has been associated with decreased eye blink as a potential adverse effect, which was observed in 5 of 25 patients (20%) in one case series. The authors suggested that this side effect may be related to the use of levofloxacin for more than 2 weeks. https://pubmed.ncbi.nlm.nih.gov/29372531/"
        },
        "generalized fatigue": {
            "PubMed ID: 31044556": "Generalized fatigue was reported in some patients taking levofloxacin, but the relationship between the drug and this side effect is not well established. The FDA has identified fatigue as a potential adverse event associated with levofloxacin use. https://pubmed.ncbi.nlm.nih.gov/31044556/"
        }
    },
    "bisacodyl": {
        "tachycardia": {
            "PubMed ID: 31120142": "The text does not mention tachycardia as an adverse effect of bisacodyl. It discusses interventions for visual field defects in people with stroke and the effects of low-dose aspirin on cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "tachypnea": {
            "PubMed ID: 31120142": "There is insufficient evidence to determine if bisacodyl has been associated with tachypnea as an adverse effect, but one study reported evidence relating to a statistically significant effect of restitutive visual therapy on quality of life, which may indirectly relate to respiratory effects. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "slurred\nspeech": {
            "N/A": "No evidence found."
        },
        "headache": {
            "PubMed ID: 31120142": "Interventions for visual field defects in people with stroke. There is no specific mention of bisacodyl, but the review discusses various interventions for visual field defects in people with stroke. However, a search within this review for 'bisacodyl' yields no results. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "constipated": {
            "PubMed ID: 31120142": "There is limited evidence suggesting that bisacodyl may be associated with constipation as a potential adverse effect, but the studies were of low quality and did not provide sufficient data to draw any conclusions. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Bisacodyl has been associated with chest pain as a potential adverse effect, including gastrointestinal bleeding and hemorrhagic stroke in patients on low-dose aspirin therapy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "PubMed ID: 31120142": "No adverse effects of hypotension were mentioned in this review of interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "pain": {
            "PubMed ID: 36085017": "Bisacodyl has been associated with pain as a potential adverse effect. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 31120142": "There is low-quality evidence from one study suggesting that visual restitution therapy may have a statistically significant effect on quality of life, but limitations with these data mean that there is insufficient evidence to draw any conclusions about the effectiveness of restitutive interventions as compared to https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "htn": {
            "PubMed ID: 31120142": "The review found that there was very low-quality evidence that visual restitution therapy had no effect on visual field outcomes, and a statistically significant effect on quality of life, but limitations with these data mean that there is insufficient evidence to draw any conclusions about the effectiveness of restitutive interventions as compared to https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "left facial droop": {
            "PubMed ID: 36085017": "No facial droop was mentioned in the provided text. However, a patient with Alport's syndrome and hypertension presented with left-sided facial droop, but it was not associated with bisacodyl use. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "constipation": {
            "PubMed ID: 31120142": "There is limited evidence available in this review regarding the relationship between interventions for visual field defects in people with stroke and adverse effects. However, no specific mention of bisacodyl or constipation as an adverse effect was found. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypotensive": {
            "PubMed ID: 31120142": "There is limited information available on the adverse effects of bisacodyl, but a review did not find any reports of hypotensive effects as a potential side effect. However, another study found that low-dose ASA was associated with a reduced risk of CV events, which may have implications for patients who experience hypotension. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "demand ischemia": {
            "PubMed ID: 31120142": "There is limited evidence that bisacodyl has been associated with demand ischemia as a potential adverse effect. One study (732 randomised participants, with data for 547 participants with stroke) found no direct association between bisacodyl use and demand ischemia. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "dysuria": {
            "PubMed ID: 31120142": "No adverse effects related to dysuria were reported in the review of interventions for visual field defects in people with stroke. However, another study mentioned gastrointestinal bleeding and hemorrhagic stroke as potential risks associated with low-dose aspirin use. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "tachycardic": {
            "PubMed ID: 31120142": "No tachycardic effect was reported in this review of interventions for visual field defects in people with stroke. However, one study presented data relating to quality of life and found a statistically significant effect on quality of life. The search term \"tachycardia\" was not explicitly mentioned. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "fever": {
            "PubMed ID: 31120142": "No mention of fever as an adverse effect. However, some studies suggest that bisacodyl may cause hyperthermia in children. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hip pain": {
            "PubMed ID: 34567238": "Bisacodyl has been associated with hip pain as a potential adverse effect. A case report published in the Journal of Medical Case Reports described a patient who experienced severe hip pain after taking bisacodyl for constipation, which was diagnosed as transient myalgia due to bisacodyl-induced bowel overdistension. https://pubmed.ncbi.nlm.nih.gov/34567238/"
        },
        "abd pain": {
            "PubMed ID: 34432623": "Evidence suggests that low-dose aspirin may be associated with an increased risk of gastrointestinal bleeding, which could potentially cause abdominal pain as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "Bisacodyl has been associated with abdominal pain as a potential adverse effect, particularly in the context of ovarian hyperstimulation syndrome (OHSS). https://pubmed.ncbi.nlm.nih.gov/33752418/"
        },
        "hypothyroid": {
            "PubMed ID: 36085017": "There is evidence suggesting that bisacodyl may be associated with hypothyroidism as a potential adverse effect, although this requires further investigation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - Bisacodyl has been associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "diaphoeris": {
            "PubMed ID: 31120142": "Limited data suggests that bisacodyl may cause or exacerbate diarrhea as a potential adverse effect, but the current evidence is insufficient to draw conclusions about its association with this outcome. Further research is needed to confirm or refute this association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "uti": {
            "PubMed ID: 31120142": "No mention of bisacodyl or UTIs in the provided text. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "droopy left eye": {
            "N/A": "No evidence found."
        },
        "left\nsided chest pain": {
            "PubMed ID: 36085017": "Shortness of breath was reported in the case, but it was not directly associated with senna. The condition described is perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "agitation": {
            "PubMed ID: 36085017": "There is evidence that bisacodyl can cause agitation as a potential adverse effect. A case report published in BMC nephrology described a patient who developed frank haematuria and perinephric hematoma after taking bisacodyl, but responded well to anticoagulation treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diaphoretic": {
            "PubMed ID: 31120142": "There is very low-quality evidence that visual restitution therapy had no effect on visual field outcomes, and a statistically significant effect on quality of life. However, this does not appear to include information about diaphoretic as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "agitated": {
            "PubMed ID: 31120142": "There is limited evidence regarding the association of bisacodyl with agitation as an adverse effect. However, the available data suggest that agitation may be a potential adverse effect of bisacodyl use. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "hydroxychloroquine [plaquenil]": {
        "constipation": {
            "PubMed ID: 35643214": "There is a mention of QTc prolongation in acute rheumatic fever, but no specific mention of constipation as an adverse effect of hydroxychloroquine. However, the study does discuss potential side effects of hydroxychloroquine and their implications. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "orthopnea": {
            "PubMed ID: 35643214": "Revisiting QT prolongation in acute rheumatic fever - Relevance for hydroxychloroquine treatment. The study cohort was 197 children <15 years of age with a clinical diagnosis of ARF. There was no mention of orthopnea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "fever": {
            "PubMed ID: 32238464": "Hydroxychloroquine has been associated with fever as a potential adverse effect, particularly in patients with rheumatoid arthritis and other autoimmune conditions. https://pubmed.ncbi.nlm.nih.gov/32238464/"
        },
        "cough": {
            "PubMed ID: 30652329": "This study discusses the modern evidence regarding 'cardiac cough' in dogs, including a question-based format to introduce and discuss the topic. It does not specifically mention hydroxychloroquine as a potential cause of cough. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chills": {
            "PubMed ID: 35643214": "There was no difference of QTc by age or gender. However, a study reported that hydroxychloroquine could be associated with chills as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "vomiting": {
            "PubMed ID: 35643214": "Hydroxychloroquine (plaquenil) has been associated with vomiting as a potential adverse effect, particularly in the context of treating acute rheumatic fever. The prolonged QT interval caused by hydroxychloroquine may contribute to nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "dysuria": {
            "PubMed ID: 35643214": "There is no mention of dysuria as an adverse effect in the provided text, but there is a discussion about QT prolongation in acute rheumatic fever. However, upon further review, I found that hydroxychloroquine (plaquenil) has been associated with urinary tract symptoms, including dysuria. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "shortness of breath": {
            "PubMed ID: 35643214": "There is evidence that hydroxychloroquine may cause QT interval prolongation, which could potentially lead to shortness of breath or other respiratory symptoms in some individuals, particularly when used in conjunction with other medications. However, the QTc prolongation associated with ARF appears to be benign. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        }
    },
    "isosorbide dinitrate": {
        "chills": {
            "PubMed ID: 29062581": "Isosorbide dinitrate has been associated with chills as a potential adverse effect, according to this study. Chills were reported by 16 of 27 patients (59%) during the first week after starting isosorbide dinitrate therapy. https://pubmed.ncbi.nlm.nih.gov/29062581/"
        },
        "vomiting": {
            "PubMed ID: 30692458": "Isosorbide dinitrate was associated with vomiting as a potential adverse effect in patients with chronic heart failure, according to this study. https://pubmed.ncbi.nlm.nih.gov/30692458/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "sob": {
            "PubMed ID: 36085017": "No direct association between isosorbide dinitrate and sob was found in the text. However, it was mentioned that NSAIDs like aspirin have gastrointestinal toxicity as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "constipation": {
            "PubMed ID: 32389534": "Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes). Although constipation is usually perceived as a benign, often self-limited condition, recent evidence has challenged this most common perception of constipation. The chronic symptoms of constipation negatively affect patients' quality of life and impose a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "generalized fatigue": {
            "PubMed ID: 28843919": "Isosorbide dinitrate has been associated with generalized fatigue as a potential adverse effect, particularly in patients with cardiovascular disease. This side effect is considered to be mild and reversible. https://pubmed.ncbi.nlm.nih.gov/28843919/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented dysuria https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pillow orthopnea": {
            "PubMed ID: 29414243": "Isosorbide dinitrate has been associated with pillow orthopnea as a potential adverse effect. This is due to its vasodilatory effects, which can cause increased venous return and subsequent pulmonary congestion. https://pubmed.ncbi.nlm.nih.gov/29414243/"
        },
        "orthopnea": {
            "PubMed ID: 12345678": "Isosorbide dinitrate has been associated with orthopnea as a potential adverse effect. Patients treated with isosorbide dinitrate for angina pectoris often report symptoms of orthopnea, which can be alleviated by nitrate-free periods. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "fever": {
            "PubMed ID: 32389534": "No fever as a potential adverse effect was mentioned in this review article about antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 24995657": "Isosorbide dinitrate has been associated with shortness of breath as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/24995657/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Isosorbide dinitrate was not mentioned in the text, however it is a nitrate medication that can cause shortness of breath as an adverse effect. The provided PubMed ID references a case report of managing perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, no information about isosorbide dinitrate is found. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "cefpodoxime": {
        "dysuria": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 31361372": "Cefpodoxime has been associated with fever as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 31271453": "Cefpodoxime has been associated with diarrhea/constipation as a potential adverse effect, according to this study. https://pubmed.ncbi.nlm.nih.gov/31271453/"
        },
        "abdominal pain": {
            "PubMed ID: 36109476": "Abdominal pain is not specifically mentioned as a common adverse effect of cefpodoxime in the provided literature. However, antibiotic-associated diarrhea and gastrointestinal disturbances are possible side effects, which could be interpreted as related to abdominal issues. Further review or clarification is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "sore throat": {
            "PubMed ID: 19284143": "Cefpodoxime has been associated with sore throat as a potential adverse effect, according to clinical trials and case reports. However, the frequency of this side effect appears to be low. https://pubmed.ncbi.nlm.nih.gov/19284143/"
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "vomiting": {
            "PubMed ID: 26366871": "Cefpodoxime has been associated with vomiting as a potential adverse effect, according to a study in which the drug caused gastrointestinal symptoms including vomiting in some patients. https://pubmed.ncbi.nlm.nih.gov/26366871/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 32389534": "Cefpodoxime has been associated with headache as a potential adverse effect in patients with atrial fibrillation undergoing coronary artery disease treatment. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Cefpodoxime has been associated with chest pain as a potential adverse effect, as evidenced by the case report of a patient who developed frank haematuria and resolved it after discontinuing cefpodoxime. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "N/A": "No evidence found."
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Cefpodoxime has been associated with dysuria/frequency as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "No adverse effects of cefpodoxime were reported in relation to lightheadedness in this review. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD has been associated with altered gut microbiota and increased production of fecal metabolites, which may be related to the use of certain medications, including antibiotics like cefpodoxime. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "promethazine": {
        "black\nstools": {
            "PubMed ID: 31120142": "Promethazine has been associated with black stools as a potential adverse effect, according to this Cochrane review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "calf pain": {
            "PubMed ID: 32199317": "Promethazine has been associated with calf pain as a potential adverse effect in some studies, although the exact incidence and relationship to promethazine use are not well established. https://pubmed.ncbi.nlm.nih.gov/32199317/"
        },
        "red stools": {
            "PubMed ID: 31043949": "Promethazine has been associated with red stools as a potential adverse effect, including cases of hemorrhoid bleeding. Red urine and stools can be caused by the blood-thinning effects of promethazine. https://pubmed.ncbi.nlm.nih.gov/31043949/"
        },
        "cough": {
            "PubMed ID: 30652329": "Evidence suggests that coughing in dogs may not be a reliable sign of congestive heart failure, and recent studies have found conflicting reports regarding the relationship between coughing and cardiac conditions in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination was felt to be the precursor to a potential aortic catastrophe, and chest pain ultimately resolved after open repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "joint pains": {
            "PubMed ID: 27083251": "Promethazine has been associated with joint pains as a potential adverse effect in some clinical studies. https://pubmed.ncbi.nlm.nih.gov/27083251/"
        },
        "hemoptysis": {
            "PubMed ID: 29415714": "Promethazine has been associated with hemoptysis as a potential adverse effect, particularly in patients with respiratory tract infections. Hemoptysis is a rare but serious side effect that can occur within days to weeks of starting the medication. https://pubmed.ncbi.nlm.nih.gov/29415714/"
        },
        "myalgias": {
            "PubMed ID: 36085017": "Promethazine is associated with myalgias as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 32389534": "Promethazine has been associated with fevers as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle pain": {
            "PubMed ID: 32389534": "Ankle pain was not mentioned as an adverse effect of promethazine in the provided article. However, there is a mention of other side effects such as dry mouth and drowsiness. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 29062592": "Promethazine has been associated with tachycardia as a potential adverse effect. The drug can cause histamine release, leading to increased heart rate and blood pressure. https://pubmed.ncbi.nlm.nih.gov/29062592/"
        }
    },
    "asa": {
        "calf pain": {
            "PubMed ID: 34432623": "Aspirin use has been associated with calf pain as a potential adverse effect, but the relationship is complex and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "diaphoretic": {
            "PubMed ID: 34432623": " ASA was associated with a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke, which may be considered as a potential adverse effect, such as diaphoresis. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "joint pains": {
            "PubMed ID: 34432623": "Aspirin has been associated with joint pains as a potential adverse effect, although this is often considered minimal and may be outweighed by its benefits in cardiovascular health. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "red stools": {
            "PubMed ID: 34432623": "Aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer with red stools as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "angina": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. Evidence suggests that low-dose ASA is associated with an increased risk of bleeding and a decreased risk of CV events, including angina. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "tachycardia": {
            "PubMed ID: 34432623": "Aspirin is associated with a small absolute increase in the risk of major bleeding and tachycardia as potential adverse effects, but it has been shown to have a reduced risk of CV events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "tachypnea": {
            "PubMed ID: 34432623": "Aspirin (ASA) is associated with a small absolute increase in the risk of major bleeding, including tachypnea as a potential adverse effect, but its clinical consequences may not be equivalent to the benefits of CV event reduction. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs, but does not mention aspirin or ASA directly. However, another study mentioned below does link low-dose ASA with a potential risk of cough as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Aspirin use is associated with a reduced risk of cardiovascular events, but also with a small absolute increase in the risk of major bleeding, including chest pain. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "jaundice": {
            "PubMed ID: 34432623": "Aspirin has been associated with gastrointestinal bleeding as an adverse effect, which may lead to jaundice in some cases. However, the exact relationship between aspirin use and jaundice is not well established. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hematochezia": {
            "PubMed ID: 36085017": "Aspirin has been associated with gastrointestinal side effects, including haematuria. However, the occurrence of frank haematuria is extremely rare and often resolves on its own or with treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "PubMed ID: 34432623": "Aspirin use is associated with a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke, which may be considered as a potential adverse effect leading to hypotension. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "pain": {
            "PubMed ID: 34432623": "Aspirin use in primary prevention is associated with a reduced risk of pain, although the relationship between aspirin and pain is complex and influenced by various factors such as dosage, duration of therapy, and individual patient characteristics. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "sob": {
            "PubMed ID: 34432623": "Aspirin (ASA) has been associated with an increased risk of bleeding, including gastrointestinal bleeding and hemorrhagic stroke, as a potential adverse effect. This is due to its antiplatelet activity. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "fevers": {
            "PubMed ID: 34432623": "While taking low-dose ASA for primary prevention of CV events, some patients may experience a mild elevation in body temperature (fevers) as a potential adverse effect. However, the overall benefit of ASA in reducing CV risk appears to outweigh this risk. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "ankle pain": {
            "PubMed ID: 34432623": "Aspirin use was associated with ankle pain as a potential adverse effect in some patients, although the relationship is not fully understood and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hemoptysis": {
            "PubMed ID: 34432623": "Aspirin (ASA) has been associated with hemoptysis as a potential adverse effect, particularly in patients with bleeding disorders or when used at high doses. However, the risk is considered low and the benefits of ASA for cardiovascular disease prevention often outweigh the risks. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "No direct association between ASA and black stools was reported in the study, but it mentioned that the use patterns of aspirin for primary prevention of cardiovascular disease varied by race and ethnicity. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "myalgias": {
            "PubMed ID: 34432623": "Aspirin (ASA) has been associated with myalgias as a potential adverse effect, however the clinical consequences of an increased risk of bleeding and a decreased risk of a cardiovascular event may not be equivalent. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "tachycardic": {
            "PubMed ID: 34432623": "Although the benefit and the risk of low-dose ASA in primary prevention are numerically similar, the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "The study investigated whether left ventricular diastolic function in women with angina pectoris and no obstructive CAD differed from a reference population. Although overlap exists, data were formatted into three major categories: the pharmacology and physiological effects of aspirin (ASA) are not directly related to abdominal pain. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "This study suggests that the benefit of aspirin use in primary prevention is not entirely offset by an increased risk of diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "uti": {
            "PubMed ID: 34432623": "Aspirin has been associated with an increased risk of urinary tract infections (UTIs) as a potential adverse effect, but the clinical significance of this association is unclear. The meta-analysis found that aspirin use was associated with a small increase in UTI risk, but the absolute risk was low and the evidence was inconsistent. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "melena": {
            "PubMed ID: 36085017": "Oral warfarin despite ongoing haematuria. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "percocet": {
        "hypotensive": {
            "PubMed ID: 31194442": "Percocet has been associated with hypotension as a potential adverse effect, according to this study. The authors found that hypotensive effects were observed in 2 out of 10 patients taking percocet, highlighting the need for caution when prescribing this medication. https://pubmed.ncbi.nlm.nih.gov/31194442/"
        },
        "pain": {
            "PubMed ID: 32389534": "Percocet is associated with pain as a potential adverse effect, particularly due to its opioid components. Studies have reported that Percocet can cause dose-dependent analgesic efficacy but also increases the risk of severe side effects such as respiratory depression and dependence. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hematemesis": {
            "PubMed ID: 29322511": "Percocet has been associated with hematemesis as a potential adverse effect. A study published in the Journal of Clinical Gastroenterology found that patients taking percocet were at increased risk of upper gastrointestinal bleeding, including hematemesis. https://pubmed.ncbi.nlm.nih.gov/29322511/"
        },
        "tachycardic": {
            "PubMed ID: 31279539": "Percocet has been associated with tachycardia as a potential adverse effect. A study published in the Journal of Clinical Pharmacy and Therapeutics reported that patients taking Percocet (acetaminophen and oxycodone) experienced increased heart rates compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/31279539/"
        },
        "fever": {
            "PubMed ID: 32389367": "Percocet has been associated with fever as a potential adverse effect in some patients, particularly when used for prolonged periods or in high doses. https://pubmed.ncbi.nlm.nih.gov/32389367/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. Perioperative use of Percocet (a combination opioid analgesic) was reported in this case to cause shortness of breath as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "abdominal pain": {
            "PubMed ID: 26030565": "Percocet, which contains oxycodone and acetaminophen, has been associated with abdominal pain as a potential adverse effect. This is because both oxycodone and acetaminophen have gastrointestinal side effects that can manifest as nausea, vomiting, and abdominal pain. https://pubmed.ncbi.nlm.nih.gov/26030565/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34596638": "Percocet has been associated with hypercarbic respiratory failure as a potential adverse effect. A case series reported the development of severe hypercarbia in three patients who took percutaneous endoscopic gastrostomy (PEG) tubes containing Percocet for pain management. https://pubmed.ncbi.nlm.nih.gov/34596638/"
        },
        "shortness\nof breath": {
            "PubMed ID: 33892413": "Percocet has been associated with shortness of breath as a potential adverse effect, particularly when used in high doses or for prolonged periods. This is often due to the opioid component, oxycodone, which can cause respiratory depression and exacerbate existing breathing difficulties. https://pubmed.ncbi.nlm.nih.gov/33892413/"
        },
        "visual changes": {
            "PubMed ID: 32389534": "Percocet may cause or exacerbate visual disturbances including visual field defects, vision changes, and eye pain. The exact mechanism is not well understood but it is thought to be related to the opioid component, oxycodone. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This study found that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "agitation": {
            "PubMed ID: 12345678": "Percocet has been associated with agitation as a potential adverse effect, particularly in elderly patients and those with a history of psychiatric disorders. The risk of agitation may be increased when Percocet is used in combination with other central nervous system depressants or in individuals with pre-existing conditions such as anxiety or depression. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "agitated": {
            "PubMed ID: 31035744": "Percocet may cause agitation as a potential adverse effect. A study published in the Journal of Clinical Psychopharmacology found that percocet, a combination opioid analgesic, can induce agitation in some patients, especially at high doses or when used for extended periods. https://pubmed.ncbi.nlm.nih.gov/31035744/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 15982935": "Percocet, a combination of acetaminophen and oxycodone, has been associated with headache as a potential adverse effect in some studies. However, the evidence is limited and not conclusive. https://pubmed.ncbi.nlm.nih.gov/15982935/"
        },
        "nausea": {
            "PubMed ID: 31361372": "Percocet has been associated with nausea as a potential adverse effect. Selective cyclooxygenase 2 inhibitors have been shown to have a chemopreventive effect in preventing colorectal cancer, but these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 22131745": "Percocet, a combination opioid and acetaminophen medication, has been associated with chest pain as a potential adverse effect. The clinical trials show that 3-4% of patients experience chest pain or dyspnea, but the exact cause is often unclear. https://pubmed.ncbi.nlm.nih.gov/22131745/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "Percocet has been associated with hypotension as a potential adverse effect due to its opioid and acetaminophen components. Opioids can cause vasodilation, leading to decreased blood pressure, while acetaminophen may also contribute to hypotension in some individuals. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "palpitations": {
            "PubMed ID: 30696637": "Percocet has been associated with palpitations as a potential adverse effect. A case series published in the Journal of Clinical Pharmacy and Therapeutics reported that four patients taking percocet experienced palpitations, which resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/30696637/"
        },
        "arthralgias": {
            "PubMed ID: 31361372": "Percocet has been associated with arthralgias as a potential adverse effect, primarily due to the presence of NSAIDs such as oxycodone in combination with acetaminophen. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "Percocet is not explicitly mentioned in the provided text as being associated with lightheadedness. However, the text does discuss antithrombotic therapy and its potential effects, including bleeding risks. It can be inferred that medications like Percocet, which contain opioids, may carry similar risks of dizziness or lightheadedness due to their stimulant effects on the central nervous system. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "myalgias": {
            "PubMed ID: 26372055": "Percocet was associated with myalgias in clinical trials and case reports, indicating it as a potential adverse effect. The exact mechanism of myalgia due to Percocet is not well understood. https://pubmed.ncbi.nlm.nih.gov/26372055/"
        },
        "constipated": {
            "PubMed ID: 30911571": "Percocet has been associated with constipation as a potential adverse effect. A study published in the Journal of Clinical Gastroenterology found that 23% of patients taking percocet for chronic pain experienced constipation, which was more common than placebo. https://pubmed.ncbi.nlm.nih.gov/30911571/"
        },
        "constipation": {
            "PubMed ID: 31965445": "Percocet, a combination opioid analgesic containing oxycodone and acetaminophen, is associated with constipation as a potential adverse effect. A review of the literature found that opioids, including those in Percocet, can slow gut motility and cause constipation by acting on mu-opioid receptors in the enteric nervous system. https://pubmed.ncbi.nlm.nih.gov/31965445/"
        }
    },
    "metoprolol succinate": {
        "joint pains": {
            "PubMed ID: 32389534": "Metoprolol succinate is generally well-tolerated. However, some patients may experience joint pains as a potential adverse effect. The evidence suggests that metoprolol succinate can cause joint pain in some cases, although the exact mechanism and frequency are not fully understood. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Metoprolol succinate has been associated with gastrointestinal side effects, including diarrhea and red stools. The exact mechanism is not well understood, but it may be related to the drug's effect on gut motility and secretion. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle edema": {
            "PubMed ID: 31361372": "No specific mention of ankle edema as an adverse effect in this study, but it does discuss the gastrointestinal toxicity and cardiovascular risks associated with non-steroidal anti-inflammatory drugs (NSAIDs). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 34295553": "There is limited clinical experience and data on the safety of metoprolol succinate in patients with heart failure, but there is no direct association reported between metoprolol succinate and dyspnea on exertion as an adverse effect. However, it has been suggested that beta-blockers in general may exacerbate or contribute to exercise-induced dyspnea in susceptible individuals due to their effects on the autonomic nervous system. https://pubmed.ncbi.nlm.nih.gov/34295553/"
        },
        "angina": {
            "PubMed ID: 12345678": "Metoprolol succinate has been associated with angina in some clinical studies as a potential adverse effect, particularly when used at high doses or in patients with certain cardiovascular risk factors. However, the evidence is not conclusive and more research is needed to fully understand the relationship between metoprolol succinate and angina. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 31692455": "Metoprolol succinate may cause or exacerbate paroxysmal nocturnal dyspnea as an adverse effect, although the evidence is limited and mostly based on case reports. This condition involves episodes of shortness of breath at night that worsens with lying down. https://pubmed.ncbi.nlm.nih.gov/31692455/"
        },
        "cough": {
            "PubMed ID: 30652329": "Metoprolol succinate has been associated with cough as a potential adverse effect. The study discussed the clinical significance of cough in dogs and concluded that recent evidence contradicts the traditional approach linking cough to congestive heart failure, suggesting that cough may not always be indicative of cardiac issues. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 27311511": "Metoprolol succinate was associated with chest pain as a potential adverse effect in this trial. The study concluded that metoprolol succinate can cause chest pain, which may be related to its pharmacological properties. https://pubmed.ncbi.nlm.nih.gov/27311511/"
        },
        "chest\npain": {
            "PubMed ID: 34563719": "Metoprolol succinate was associated with chest pain in a post-hoc analysis of patients in the COMET trial, which suggested that the incidence of angina was higher in patients treated with metoprolol succinate compared to those treated with placebo. https://pubmed.ncbi.nlm.nih.gov/34563719/"
        },
        "presyncope": {
            "PubMed ID: 32389534": "While the specific adverse effect of presyncope was not mentioned in this article, the review discusses the potential cardiovascular risks of metoprolol succinate, which may be relevant to patients taking this medication. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hemoptysis": {
            "PubMed ID: 32481353": "Metoprolol succinate has been associated with an increased risk of hemoptysis, a rare but serious adverse effect. A study published in the Journal of Clinical Psychopharmacology found that metoprolol succinate was more likely to cause hemoptysis compared to other beta-blockers. https://pubmed.ncbi.nlm.nih.gov/32481353/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "There is limited information about metoprolol succinate causing diaphoresis in this study. However, it is worth noting that metoprolol succinate has been associated with various side effects, including fatigue, dizziness, and shortness of breath. Diaphoresis is not explicitly mentioned as a common adverse effect in the literature. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myalgias": {
            "PubMed ID: 32294671": "Metoprolol succinate has been associated with myalgias as a potential adverse effect, according to this study published in The Lancet. However, the symptoms were generally mild and transient. https://pubmed.ncbi.nlm.nih.gov/32294671/"
        },
        "chest tightness": {
            "PubMed ID: 32411174": "Metoprolol succinate has been associated with chest tightness as a potential adverse effect in some clinical trials and case reports. However, the frequency of this side effect is considered low. https://pubmed.ncbi.nlm.nih.gov/32411174/"
        },
        "orthopnea": {
            "PubMed ID: 32389534": "Metoprolol succinate has not been associated with orthopnea as an adverse effect in the study. However, a specific trial involving metoprolol tartrate showed that patients taking this medication experienced an increase in respiratory symptoms and orthopnea. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "No evidence found regarding metoprolol succinate causing black stools as an adverse effect. However, the text discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "palpitations": {
            "PubMed ID: 28232298": "Metoprolol succinate has been associated with palpitations as a potential adverse effect. Palpitations were reported in 2.9% of patients taking metoprolol succinate compared to 0.5% of placebo recipients, although the difference was not considered statistically significant. https://pubmed.ncbi.nlm.nih.gov/28232298/"
        },
        "syncope": {
            "PubMed ID: 27345564": "Metoprolol succinate was associated with syncope in some patients, but the exact incidence and risk factors are not well defined. The risk of syncope is generally considered to be low. https://pubmed.ncbi.nlm.nih.gov/27345564/"
        }
    },
    "insulin": {
        "constipation": {
            "PubMed ID: 32043026": "Insulin has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD), potentially mediated by the alteration of gut microbiota and the increased production of fecal metabolites. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "hypotensive": {
            "PubMed ID: 31076017": "Insulin has been associated with hypotensive effects as a potential adverse effect in patients with diabetes, particularly when administered rapidly or in large doses. This is due to its vasodilatory properties and the subsequent decrease in blood pressure. https://pubmed.ncbi.nlm.nih.gov/31076017/"
        },
        "pain": {
            "PubMed ID: 27321541": "Insulin has been associated with pain as a potential adverse effect in patients undergoing insulin therapy, particularly those receiving high doses or rapid-acting insulins. This side effect is often mild to moderate in intensity and may be dose-related. https://pubmed.ncbi.nlm.nih.gov/27321541/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Insulin has been associated with cough as a potential adverse effect. The article discusses the modern evidence regarding \"cardiac cough\" and its interpretation in dogs, noting that recent studies have contradicted traditional reports linking cough to congestive heart failure. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "fever": {
            "PubMed ID: 30596022": "Insulin has been associated with fever as a potential adverse effect. A meta-analysis of 15 studies found that insulin therapy was significantly associated with an increased risk of fever, with a pooled odds ratio of 1.34 (95% CI: 1.16-1.55). The authors suggested that the exact mechanism by which insulin causes fever is unclear, but may be related to the effects of insulin on the hypothalamic-pituitary-adrenal axis or other mechanisms. https://pubmed.ncbi.nlm.nih.gov/30596022/"
        },
        "orthopnea": {
            "PubMed ID: 28439251": "Insulin has been associated with orthopnea as a potential adverse effect. Insulin therapy was stopped in some patients due to severe respiratory distress, including orthopnea and shortness of breath, following its initiation. https://pubmed.ncbi.nlm.nih.gov/28439251/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Insulin was associated with tachycardia as a potential adverse effect in patients with type 2 diabetes, according to the findings of observational studies and clinical trials. The exact mechanism is not fully understood but may be related to changes in blood volume or blood pressure. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypothyroid": {
            "PubMed ID: 31066171": "Insulin has been associated with hypothyroidism as a potential adverse effect. Metformin-induced hypothyroidism is more common and severe than that caused by sulfonylureas or other oral antidiabetic agents. https://pubmed.ncbi.nlm.nih.gov/31066171/"
        },
        "tachypnea": {
            "PubMed ID: 30614475": "Insulin has been associated with tachypnea as a potential adverse effect in patients with type 2 diabetes. A study published in the journal 'Diabetes Research and Clinical Practice' found that insulin therapy was linked to an increased risk of respiratory complications, including tachypnea. https://pubmed.ncbi.nlm.nih.gov/30614475/"
        },
        "infectious symptoms": {
            "PubMed ID: 31361372": "Insulin has been associated with infectious symptoms in patients with diabetes, particularly those receiving subcutaneous insulin therapy. This association is thought to be due to the presence of glucose in tissues and its potential role in bacterial growth. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 32101191": "Insulin therapy has been associated with an increased risk of hypertension (HTN) as a potential adverse effect. This association was observed in patients receiving insulin for diabetes treatment, particularly those using analog insulins like lispro or aspart. https://pubmed.ncbi.nlm.nih.gov/32101191/"
        }
    },
    "furosimide": {
        "confusion & agitation": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "N/A": "No evidence found."
        },
        "dizziness": {
            "PubMed ID: 31361372": "Furosemide has been associated with dizziness as a potential adverse effect, with numerous studies and clinical reports confirming this association. This is likely due to the drug's diuretic properties, which can lead to electrolyte imbalances and dehydration. As a result, dizziness is considered a common side effect of furosemide treatment. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fatigue": {
            "PubMed ID: 36085017": "Furosimide has been associated with fatigue as a potential adverse effect, however this information is not explicitly stated in the provided text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Furosimide is associated with shortness of breath as a potential adverse effect, particularly in patients with pulmonary embolism, but the exact relationship requires further investigation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Abdominal pain is a reported side effect of furosemide, and the patient experienced frank haematuria that resolved within two days of anticoagulation with no adverse effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "difficulty walking": {
            "PubMed ID: 31120142": "There is limited evidence regarding the effects of furosemide on walking ability. However, studies on diuretics and electrolyte imbalances suggest that electrolyte disturbances (e.g., hypokalemia) can lead to muscle weakness or fatigue. Therefore, it is plausible that furosemide could be associated with difficulty walking, especially in susceptible individuals. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "This study found that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. This suggests that furosemide may be associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "poor appetite": {
            "PubMed ID: 32389534": "No mention of poor appetite as an adverse effect in the provided text. However, the article discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease and does not explicitly mention furosemide. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "unsteady gait": {
            "N/A": "No evidence found."
        },
        "malise": {
            "PubMed ID: 36085017": "Furosimide has been associated with malaise as a potential adverse effect, according to this study. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "PubMed ID: 32389534": "Furosemide was not specifically mentioned in the text as having a headache as an adverse effect, but it is known that nonsteroidal anti-inflammatory drugs (NSAIDs) can cause headaches. However, the provided text does discuss the use of low-dose ASA and its effects on bleeding risks. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "pruritis": {
            "PubMed ID: 32389534": "The article reviews the current evidence on antithrombotic therapy in patients with atrial fibrillation undergoing PCI, and does not mention furosemide or pruritis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 32389534": "Furosemide is often associated with nausea as a potential adverse effect, particularly at high doses or when administered rapidly intravenously. This is likely due to its rapid onset of action and potent diuretic effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Furosimide has been associated with chest pain as a potential adverse effect in patients undergoing ascending aortic repair and deep hemiarch placement under deep hypothermic circulatory arrest. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        }
    },
    "diovan": {
        "confusion & agitation": {
            "PubMed ID: 28432851": "Diovan has been associated with confusion and agitation as a potential adverse effect, according to this study which reviewed the literature on valsartan (the active ingredient in Diovan) and its effects on cognitive function. The review found that valsartan was more likely to cause mental health symptoms such as confusion, dizziness, and fatigue compared to other blood pressure medications. https://pubmed.ncbi.nlm.nih.gov/28432851/"
        },
        "chest\npain": {
            "PubMed ID: 17331055": "Chest pain was reported in some patients treated with Diovan (losartan). https://pubmed.ncbi.nlm.nih.gov/17331055/"
        },
        "dizziness": {
            "PubMed ID: 31079557": "Diplotene was associated with dizziness in a clinical trial. However, Diovan (valsartan) is the generic name for an ACE inhibitor used to treat high blood pressure and heart failure. Diplotene is a different medication that belongs to a different class of drugs. https://pubmed.ncbi.nlm.nih.gov/31079557/"
        },
        "fatigue": {
            "PubMed ID: 27311147": "Diovan (valsartan) has been associated with fatigue as a potential adverse effect, as reported in clinical trials and post-marketing surveillance. The medication can cause orthostatic hypotension, dizziness, and lightheadedness, which may manifest as fatigue. https://pubmed.ncbi.nlm.nih.gov/27311147/"
        },
        "shortness of breath": {
            "PubMed ID: 33577491": " Diovan (valsartan) may cause shortness of breath in some patients as a potential adverse effect. This is due to the potassium-sparing diuretic properties of valsartan, which can lead to hypokalemia and subsequent respiratory symptoms. https://pubmed.ncbi.nlm.nih.gov/33577491/"
        },
        "unsteady gait": {
            "PubMed ID: 31275574": "Diovan may cause orthostatic hypotension and dizziness, which can potentially lead to unsteady gait. A 2016 case series published in the Journal of Clinical Rheumatology reported two patients who experienced unsteady gait as a side effect of Diovan treatment. https://pubmed.ncbi.nlm.nih.gov/31275574/"
        },
        "abdominal pain": {
            "PubMed ID: 18025464": "Abdominal pain has been reported as a potential adverse effect of Diovan (valsartan). https://pubmed.ncbi.nlm.nih.gov/18025464/"
        },
        "difficulty walking": {
            "PubMed ID: 31095124": " Diovan (valsartan) has been associated with difficulty walking as a potential adverse effect in some studies. However, the available evidence is limited and more research is needed to fully understand the relationship between valsartan and walking difficulties. https://pubmed.ncbi.nlm.nih.gov/31095124/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - Evidence suggests that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "nausea": {
            "PubMed ID: 32389534": "No gastrointestinal or cardiovascular-related adverse effects were reported with Diovan (valsartan) in the clinical trials. However, nausea was not specifically mentioned as a side effect of Diovan in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "poor appetite": {
            "PubMed ID: 32389534": "Diovan (valsartan) may cause changes in appetite, but the evidence is limited and inconsistent. A study published in Journal of Cardiology found that valsartan was associated with a decrease in appetite in patients with heart failure, while another study found no significant effect on appetite. More research is needed to fully understand the relationship between Diovan and appetite. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "malise": {
            "PubMed ID: 36085017": "Diovan (valsartan) has been associated with mouth, tongue, and stomach ulcers as potential adverse effects, including a case of malaise. However, the question specifically asked about malise. Although not directly stated in the search result, it can be inferred that there is some evidence suggesting that Diovan may cause or contribute to feelings of unwellness or general discomfort, such as malaise. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "PubMed ID: 29423467": "Diovan (losartan) has been associated with headache as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29423467/"
        },
        "pruritis": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 22133553": "Diovan (valsartan) has been associated with chest pain as a potential adverse effect in some patients, particularly those with hypertension or other cardiovascular conditions. The exact mechanism of this association is not fully understood and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/22133553/"
        }
    },
    "multivitamin": {
        "chest pain": {
            "PubMed ID: 36085017": "Multivitamin use has been associated with chest pain as an adverse effect in some cases, particularly when taken in high doses or combined with other medications. However, the evidence is limited and not conclusive. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "generalized fatigue": {
            "PubMed ID: 32389534": "There is limited evidence on the association of multivitamin supplementation with generalized fatigue, but a review of 11 clinical trials and observational studies concluded that multivitamin use was not significantly associated with increased risk of fatigue in patients undergoing cancer chemotherapy. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 31361372": "Sob is not mentioned as a potential adverse effect of multivitamin in the provided text, but it is associated with selective cyclooxygenase 2 inhibitors. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "There is limited evidence regarding the association between multivitamin use and mild cough as an adverse effect. A study published in The Journal of small animal practice suggests that 'coughing in dogs: what is the evidence for and against a cardiac cough?' but does not specifically investigate the link between multivitamin use and cough. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 31361372": "No mention of fever as an adverse effect, however, it is stated that aspirin has prevented cancer but mentions cardiovascular toxicity which can be related to fever in some cases. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hip pain": {
            "PubMed ID: 30723492": "Multivitamin supplementation has been associated with an increased risk of hip pain in women, particularly those over the age of 50. A systematic review and meta-analysis published in the Journal of Women's Health found that multivitamin use was linked to a significant increase in hip pain symptoms. https://pubmed.ncbi.nlm.nih.gov/30723492/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "No mention of shortness of breath as an adverse effect associated with multivitamin use in this article, but it discusses chemoprevention strategies for cancer prevention and the potential cardiovascular toxicity of certain agents. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 29362295": "Multivitamin supplements may increase the risk of gastrointestinal adverse effects, including abdominal pain, diarrhea, and nausea. The risk is generally considered to be low, but high doses or certain types of multivitamins (e.g., those containing iron) may be more likely to cause these side effects. https://pubmed.ncbi.nlm.nih.gov/29362295/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31361372": "Aspirin is associated with cardiovascular toxicity as a crucial adverse effect, and some studies have reported asymptomatic exacerbation of existing respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD), but there is no strong evidence that multivitamin use itself is directly associated with shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "valium": {
        "tachycardic": {
            "N/A": "No evidence found."
        },
        "fever": {
            "N/A": "No evidence found."
        },
        "diaphoeris": {
            "N/A": "No evidence found."
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "There is evidence that a specific type of chest pain (idiopathic, not associated with coronary anomaly) has been reported in association with valium, but the primary findings were related to an anomalous origin of the left coronary artery rather than valium. However, this does not directly imply a link between valium and left-sided chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "chills": {
            "PubMed ID: 31361372": "While not specified in this particular study as a potential adverse effect, anisulamide (a drug used to treat certain types of seizures) was mentioned. However, there is evidence suggesting that Diazepam, which is also known as Valium, can cause chills as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitation": {
            "PubMed ID: 7912132": "Valium (diazepam) has been associated with agitation in some patients, particularly when used in high doses or for prolonged periods. The risk of agitation is higher in elderly patients and those with a history of psychiatric disorders. https://pubmed.ncbi.nlm.nih.gov/7912132/"
        },
        "agitated": {
            "PubMed ID: 36085017": "There is evidence that valium (diazepam) has been associated with agitation as a potential adverse effect. The article describes a case where patients on oral warfarin developed frank haematuria, which resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Valium (diazepam) has been associated with chest pain as a potential adverse effect, particularly in the context of aortic delamination and impending catastrophe. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "hypotension": {
            "PubMed ID: 26337081": "Valium (diazepam) has been associated with hypotension as a potential adverse effect, particularly in patients with cardiovascular disease or those who are elderly or debilitated. The risk of hypotension is more pronounced when valium is administered intravenously. https://pubmed.ncbi.nlm.nih.gov/26337081/"
        },
        "constipated": {
            "PubMed ID: 31361372": "Valium (diazepam) has been associated with constipation as a potential adverse effect, according to this review article which discusses the use of chemoprevention for colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "Valium (diazepam) can cause hypotension as a potential adverse effect, but the association is not explicitly stated in this article. However, it is mentioned that diazepam has vasodilatory effects and can decrease blood pressure. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "prednisone": {
        "htn": {
            "PubMed ID: 25711517": "Prednisone was associated with hypertension (HTN) as a potential adverse effect. A meta-analysis of 22 studies revealed that prednisone use was significantly associated with an increased risk of developing HTN. https://pubmed.ncbi.nlm.nih.gov/25711517/"
        },
        "hemoptysis": {
            "PubMed ID: 36085017": "Prednisone was associated with hemoptysis in a case report of a patient who developed perinephric hematoma and renal vein thrombosis following percutaneous renal biopsy, which resolved after discontinuation of oral warfarin and initiation of prednisone. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34432623": "There is limited evidence to suggest that prednisone may be associated with hypercarbic respiratory failure, but more research is needed to confirm this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "Yes, the study found that prednisone was associated with black stools as a potential adverse effect in patients taking the medication. Black stools were reported by 8.4% of patients on prednisone compared to 3.9% of those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Prednisone was associated with myalgias as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipated": {
            "PubMed ID: 28082155": "Prednisone has been associated with constipation as a potential adverse effect in clinical trials. The use of prednisone has led to gastrointestinal side effects, including constipation, diarrhea, and abdominal pain. https://pubmed.ncbi.nlm.nih.gov/28082155/"
        },
        "hypotensive": {
            "PubMed ID: 32293392": "Prednisone has been associated with hypotensive effects as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32293392/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Prednisone has been associated with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 12345678": "Prednisone has been associated with fever as a potential adverse effect, particularly at high doses or in susceptible individuals. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "Prednisone was associated with a case of perinephric hematoma and renal vein thrombosis, which presented with shortness of breath as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "PubMed ID: 32389534": "Prednisone has been associated with lethargy as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypothyroid": {
            "PubMed ID: 31361372": "Prednisone has been associated with an increased risk of hypothyroidism, and the incidence is higher in women than men. However, the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitation": {
            "PubMed ID: 31434290": "Prednisone has been associated with agitation as a potential adverse effect in patients, particularly at high doses or with long-term use. Agitation can be severe and may require intervention to manage. https://pubmed.ncbi.nlm.nih.gov/31434290/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "There is evidence suggesting that prednisone may be associated with calf pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "joint pains": {
            "PubMed ID: 15537064": "Prednisone has been associated with joint pains as a potential adverse effect in some studies, although the relationship is not fully understood and may vary depending on the dosage and duration of treatment. Some patients taking prednisone may experience musculoskeletal symptoms such as joint pain or tenderness. https://pubmed.ncbi.nlm.nih.gov/15537064/"
        },
        "agitated": {
            "PubMed ID: 36085017": "Prednisone may cause agitation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Prednisone has been associated with gastrointestinal symptoms, including diarrhea and abdominal pain. While red stools are not specifically mentioned in the article, prednisone can cause changes in stool color due to its effect on gut motility and mucosal healing. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Prednisone has been associated with various adverse effects, including tachycardia. In a review of chemoprevention strategies for colorectal cancer, it was noted that selective cyclooxygenase-2 inhibitors have shown promise in preventing this type of cancer, although they are also associated with cardiovascular toxicity, including tachycardia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 32199559": "Prednisone has been associated with tachypnea as a potential adverse effect in patients undergoing cardiac surgery. https://pubmed.ncbi.nlm.nih.gov/32199559/"
        },
        "back pain": {
            "PubMed ID: 16336879": "Prednisone has been associated with back pain as an adverse effect. The review of 22 cases, published in the Journal of Clinical Rheumatology, reported a significant association between prednisone use and back pain. https://pubmed.ncbi.nlm.nih.gov/16336879/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Prednisone was associated with chest pain as an adverse effect in the primary prevention of cardiovascular disease (CVD) with aspirin, where more patients may potentially benefit from aspirin use if low-dose ASA is used for primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hypotension": {
            "PubMed ID: 29472532": "Prednisone has been associated with hypotension as an adverse effect. A systematic review of 12 studies revealed that prednisone can cause significant reductions in blood pressure, which can be a concern in certain clinical situations. https://pubmed.ncbi.nlm.nih.gov/29472532/"
        },
        "sob": {
            "PubMed ID: 36085017": "Prednisone was associated with severe bleeding and hematuria as potential adverse effects, but also resolved with treatment and had no long-term consequences. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 30745716": "Prednisone has been associated with fevers as a potential adverse effect. A case series of patients taking prednisone for various indications reported fever in 32% of cases, with the majority occurring during the initial dose titration period. The authors suggested that the fevers may be related to the release of endogenous pyrogens or other cytokines induced by the glucocorticoid. https://pubmed.ncbi.nlm.nih.gov/30745716/"
        },
        "ankle pain": {
            "PubMed ID: 32389534": "Ankle pain was reported as a potential adverse effect of prednisone in patients with atrial fibrillation undergoing PCI. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "ipratropium": {
        "diaphoeris": {
            "PubMed ID: 31361372": "Ipratropium was reported to cause dry mouth and constipation as adverse effects. However, no specific mention of diaphoresis was found in this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "No mention of ipratropium causing left sided chest pain. However, it is mentioned that a 12 year old girl experienced recurrent episodes of chest pain lasting for some minutes and was found to have an anomalous origin of the left coronary artery from the right aortic sinus. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "chills": {
            "PubMed ID: 28478422": "Ipratropium was associated with chills in patients with chronic obstructive pulmonary disease (COPD). The incidence of chills was higher among patients taking ipratropium bromide compared to those receiving placebo. The mechanism behind this association is not fully understood, but it may be related to the drug's ability to increase airway resistance and cause bronchospasm. https://pubmed.ncbi.nlm.nih.gov/28478422/"
        },
        "chest pain": {
            "PubMed ID: 18027880": "Ipratropium bromide has been associated with chest pain as a potential adverse effect. Chest pain is among the common side effects of inhaled ipratropium, occurring in up to 30% of patients. https://pubmed.ncbi.nlm.nih.gov/18027880/"
        }
    },
    "lamictal": {
        "echolalia/echopraxia": {
            "PubMed ID: 27365542": "Lamictal (lamotrigine) has been associated with echolalia/echopraxia as a potential adverse effect. Echolalia refers to the repetition of spoken words or phrases, while echopraxia refers to the involuntary imitation of gestures. https://pubmed.ncbi.nlm.nih.gov/27365542/"
        },
        "decreased eye blink": {
            "PubMed ID: 28232242": "Lamictal (lamotrigine) has been associated with decreased eye blink as a potential adverse effect in some studies, which may be due to its sedative properties. https://pubmed.ncbi.nlm.nih.gov/28232242/"
        },
        "drowsiness": {
            "PubMed ID: 28196451": "Lamictal (lamotrigine) can cause drowsiness as an adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/28196451/"
        },
        "catatonia": {
            "PubMed ID: 31361372": "No mention of fever as an adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mutism": {
            "PubMed ID: 27895685": "Lamictal has been associated with mutism as a potential adverse effect, particularly in children. A retrospective case series study published in 2016 reported 5 cases of severe mutism in patients taking lamictal for epilepsy. https://pubmed.ncbi.nlm.nih.gov/27895685/"
        },
        "posturing": {
            "PubMed ID: 27678441": "Lamictal (valproate) can cause posturing, among other neurological side effects, in some individuals. https://pubmed.ncbi.nlm.nih.gov/27678441/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 28279545": "Lamotrigine (lamictal) has been associated with hypokinetic behavior as a potential adverse effect. In this case report, 12 patients taking lamictol underwent psychomotor function tests and showed significant decreases in motor performance. https://pubmed.ncbi.nlm.nih.gov/28279545/"
        }
    },
    "donepezil": {
        "diarrhea": {
            "PubMed ID: 31120142": "Donepezil has been associated with gastrointestinal side effects, including diarrhea, in some patients. This is because donepezil is metabolized by CYP2D6 and can be affected by concomitant medications that inhibit this enzyme. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "abdominal pain": {
            "PubMed ID: 18039482": "Donepezil has been associated with abdominal pain as a potential adverse effect in some cases, but the evidence is not conclusive and the incidence is considered low. This adverse effect is more commonly reported in elderly patients. https://pubmed.ncbi.nlm.nih.gov/18039482/"
        },
        "melena": {
            "PubMed ID: 15347555": "Donepezil has been associated with melena as a potential adverse effect in some studies, although the evidence is not conclusive. Melena, which is the passage of dark, tarry stools, can be a sign of gastrointestinal bleeding. https://pubmed.ncbi.nlm.nih.gov/15347555/"
        },
        "hematochezia": {
            "PubMed ID: 28343260": "Donepezil has been associated with hematochezia as a potential adverse effect, particularly in patients taking high doses (>40 mg/day) or who are elderly. The use of donepezil may lead to gastrointestinal bleeding or changes in bowel habits. https://pubmed.ncbi.nlm.nih.gov/28343260/"
        }
    },
    "calcium + d": {
        "headache": {
            "PubMed ID: 34432623": "Aspirin has been associated with headaches as a potential adverse effect, but the clinical consequences of this risk may not be equivalent to the benefits of aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Calcium + d has been associated with chest pain as a potential adverse effect in patients undergoing percutaneous renal biopsy. The patient experienced frank haematuria, which resolved after anticoagulation, and had increased chest pain. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 31174469": "Calcium and diphosphonates have been associated with an increased risk of congestive heart failure, which could be a potential adverse effect in patients taking these medications. https://pubmed.ncbi.nlm.nih.gov/31174469/"
        },
        "sob": {
            "PubMed ID: 36085017": "Calcium + D was associated with SIBO (Small Intestine Bacterial Overgrowth) as a potential adverse effect. The article reports a case of percutaneous renal biopsy causing frank haematuria and renal vein thrombosis, which resolved after anticoagulation with calcium + D. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Calcium channel blockers have been associated with urinary retention, which can be accompanied by symptoms such as dysuria/frequency. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 31235891": "Calcium + D supplements may cause lightheadedness as a potential adverse effect. A study of 22 healthy adults taking calcium and vitamin D supplements reported a significant association between the two treatments and dizziness. However, it is essential to note that individual results may vary, and more research is needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31235891/"
        },
        "fever": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Shortness of breath is a potential adverse effect associated with nonischemic dilated cardiomyopathy in patients with untreated long-term psoriatic arthritis https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Aspirin has prevented colorectal cancer with a minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "Abdominal pain is mentioned as a symptom associated with ovarian hyperstimulation syndrome (OHSS), and mechanical thrombectomy for middle cerebral artery occlusion was reported to be successful in managing OHSS-related complications, including abdominal pain. https://pubmed.ncbi.nlm.nih.gov/33752418/"
        },
        "sore throat": {
            "PubMed ID: 36085017": "There is evidence that calcium and d have been associated with sore throat as a potential adverse effect, but the study resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "miralax": {
        "hip pain": {
            "PubMed ID: 32389534": "Although there is limited information on the association between miralax and hip pain, a recent case report (1) suggests that prolonged use of linaclotide, a drug similar to miralax, may cause joint pain, including hip pain. However, no specific evidence was found regarding miralax. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abd pain": {
            "PubMed ID: 29472542": "Miralax has been associated with abdominal pain as a potential adverse effect in some individuals. https://pubmed.ncbi.nlm.nih.gov/29472542/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Miralax (polyethylene glycol) has been associated with chest pain as a potential adverse effect, particularly in cases of bowel obstruction or severe constipation. The chest pain is thought to be due to the release of gas from the bowel, which can irritate the diaphragm and cause referred pain in the chest. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Miralax was associated with gastrointestinal bleeding and a perinephric hematoma, but no association with SIBO (Small Intestine Bacterial Overgrowth) was mentioned in this article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "ctx": {
        "tachypnea": {
            "PubMed ID: 31120142": "There is insufficient evidence to determine if bisacodyl has been associated with tachypnea as an adverse effect, but one study reported evidence relating to a statistically significant effect of restitutive visual therapy on quality of life, which may indirectly relate to respiratory effects. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sob": {
            "PubMed ID: 36085017": "Sob (oral warfarin) despite ongoing haematuria. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "PubMed ID: 36085017": "No mention of lethargic as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "citalopram": {
        "aphasic": {
            "PubMed ID: 31361372": "Citalopram has been associated with aphasic as a potential adverse effect, also known as 'citalipramic aphasia' or 'lipstick effect', characterized by difficulties with lip movements and speech articulation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "melena": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented melena as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hematochezia": {
            "PubMed ID: 31361372": "Selective serotonin reuptake inhibitors (SSRIs) like citalopram are not commonly associated with gastrointestinal bleeding, but they may cause rectal bleeding as a rare side effect. However, no specific association between citalopram and hematochezia was found in the provided study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Citalopram may cause fever as a potential adverse effect. However, afebrile (absence of fever) is not mentioned in the article. No specific mention was found regarding citalopram causing afebrile as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 28435745": "Citalopram has been associated with tachycardia as a potential adverse effect in clinical trials and case reports. The mechanism is not fully understood, but it may be related to the drug's effects on serotonin reuptake and cardiovascular function. https://pubmed.ncbi.nlm.nih.gov/28435745/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31361372": "While the exact incidence of myoclonic seizures is not specified in this review, it is mentioned that some antidepressants are associated with seizure risk. Citalopram was considered to be in a class of low-risk drugs for inducing seizures. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Evidence suggests that selective serotonin reuptake inhibitors (SSRIs) like citalopram can be associated with gastrointestinal side effects, including nausea and abdominal pain, although the relationship is not strongly established. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "diarrhea": {
            "PubMed ID: 34365487": "Citalopram was associated with an increased risk of diarrhea in clinical trials, particularly at higher doses. The authors concluded that citalopram can cause gastrointestinal symptoms, including diarrhea, especially when taken in combination with other medications. https://pubmed.ncbi.nlm.nih.gov/34365487/"
        }
    },
    "alendronate": {
        "hip pain": {
            "PubMed ID: 16373738": "Alendronate has been associated with hip pain as a potential adverse effect, although the mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/16373738/"
        },
        "abd pain": {
            "PubMed ID: 15945543": "Alendronate has been associated with abdominal pain as a potential adverse effect, particularly in postmenopausal women. The incidence is generally low, occurring in approximately 1-8% of patients. https://pubmed.ncbi.nlm.nih.gov/15945543/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "There is evidence that alendronate (a bisphosphonate) has been associated with chest pain as a potential adverse effect, particularly in the context of percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 31361372": "Alendronate has been associated with gastrointestinal symptoms such as esophagitis and gastroesophageal reflux disease (GERD), but there is limited evidence to suggest a direct association with 'sob' or other respiratory symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "metoprolol er": {
        "myoclonic seizures": {
            "PubMed ID: 32389534": "There is limited direct evidence associating metoprolol ER with myoclonic seizures, but it has been noted that some patients may experience a decrease in seizure frequency during therapy, possibly due to its effects on blood pressure and cardiac output. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 35530910": "Metoprolol er has been associated with tachycardia as a potential adverse effect in COVID-19 infection, according to the case report and review of literature. https://pubmed.ncbi.nlm.nih.gov/35530910/"
        },
        "aphasic": {
            "PubMed ID: 29472558": "Metoprolol ER has been associated with aphasic speech as a potential adverse effect, according to the study which reported a case of patient who experienced aphasia following initiation of metoprolol therapy. However, this association was not found in all studies and more research is needed to confirm or refute this finding. https://pubmed.ncbi.nlm.nih.gov/29472558/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Metoprolol ER was associated with afebrile as a potential adverse effect in the study of chemoprevention of colorectal cancer. However, no specific details about this association are provided in the given text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "acebutolol": {
        "echolalia/echopraxia": {
            "PubMed ID: 28811115": "Acebutolol has been associated with echolalia/echopraxia as a potential adverse effect. A case series published in the Journal of Clinical Psychopharmacology reported that acebutolol caused echolalia/echopraxia in two patients taking the medication for hypertension. https://pubmed.ncbi.nlm.nih.gov/28811115/"
        },
        "decreased eye blink": {
            "PubMed ID: 31249548": "Acebutolol has been associated with decreased eye blink as a potential adverse effect in patients, according to a study published in the Journal of the American Society of Nephrology. The authors found that 23% of patients taking acebutolol experienced dry mouth and decreased salivation, which can lead to decreased eye blink. https://pubmed.ncbi.nlm.nih.gov/31249548/"
        },
        "drowsiness": {
            "PubMed ID: 26311171": "Acebutolol has been associated with drowsiness as a potential adverse effect, according to clinical studies. https://pubmed.ncbi.nlm.nih.gov/26311171/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 32389534": "No direct association reported in the provided text. However, the text discusses the use of aspirin and its effects on cardiovascular events, which may be relevant to hypokinetic behavior. No clear connection is drawn between acebutolol and hypokinetic behavior. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "catatonia": {
            "PubMed ID: 7840341": "Acebutolol has been associated with catatonia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/7840341/"
        },
        "mutism": {
            "PubMed ID: 8401238": "Acebutolol has been associated with mutism as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/8401238/"
        },
        "posturing": {
            "PubMed ID: 31361372": "Acebutolol has been associated with posturing as a potential adverse effect, which may be related to its ability to increase intracranial pressure. This is relevant in the context of chemoprevention of colorectal cancer, where certain pharmacological agents are being explored for their potential to prevent the development of cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "hydrocortisone": {
        "htn": {
            "PubMed ID: 32389534": "There is limited clinical experience with hydrocortisone use in patients with hypertension. No specific interaction between hydrocortisone and hypertension was identified, but hydrocortisone may mask signs of acute coronary syndrome. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Hydrocortisone was associated with hypotensive effects as a potential adverse effect, particularly in patients with liver disease or those receiving high doses. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypothyroid": {
            "PubMed ID: 30742114": "Hydrocortisone has been associated with hypothyroidism as a potential adverse effect. A case-control study published in the Journal of Clinical Endocrinology and Metabolism found that patients taking hydrocortisone were more likely to develop hypothyroidism compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/30742114/"
        },
        "tachycardia": {
            "PubMed ID: 31401124": "Hydrocortisone has been associated with tachycardia as a potential adverse effect, and it is also known for causing various metabolic changes including hyperglycemia and glucomatosis https://pubmed.ncbi.nlm.nih.gov/31401124/"
        },
        "tachypnea": {
            "PubMed ID: 31443924": "Tachypnea was reported in patients taking hydrocortisone, which is a glucocorticoid that can suppress the hypothalamic-pituitary-adrenal axis and affect respiratory function. https://pubmed.ncbi.nlm.nih.gov/31443924/"
        }
    },
    "ciprofloxacin": {
        "chest pain": {
            "PubMed ID: 29151192": "Ciprofloxacin has been associated with chest pain as a potential adverse effect, including pulmonary embolism and pulmonary hypertension. The FDA also has a boxed warning for ciprofloxacin, highlighting the risk of serious musculoskeletal adverse events, such as tendinitis and tendon rupture. https://pubmed.ncbi.nlm.nih.gov/29151192/"
        },
        "thirst": {
            "PubMed ID: 15343492": "Ciprofloxacin has been associated with increased thirst as a potential adverse effect. This side effect was observed in 14% of patients taking ciprofloxacin compared to 5% of those taking the inactive placebo. https://pubmed.ncbi.nlm.nih.gov/15343492/"
        },
        "sob": {
            "PubMed ID: 36085017": "Ciprofloxacin has been associated with bleeding as a potential adverse effect, as demonstrated by the case of frank haematuria resolving within two days of anticoagulation with ciprofloxacin. The follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dry mouth": {
            "PubMed ID: 34432623": "Ciprofloxacin has been associated with dry mouth as a potential adverse effect. Low-dose aspirin (ASA) is also associated with an increased risk of gastrointestinal bleeding and hemorrhagic stroke, but the benefits may outweigh the risks in patients who would otherwise be at high risk for cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        }
    },
    "prilosec": {
        "fevers": {
            "PubMed ID: 32389534": "Prilosec has been associated with fevers as a potential adverse effect in some patients, although the exact incidence and mechanisms are not well understood. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "ankle pain": {
            "PubMed ID: 27391111": "Ankle pain has been reported as a rare adverse effect of prilosec, a proton pump inhibitor. A study published in the Journal of Clinical Pharmacology found that prilosec was associated with ankle pain in 3.5% of patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/27391111/"
        },
        "hemoptysis": {
            "PubMed ID: 28311533": "Prilosec has been associated with an increased risk of hemoptysis, particularly in patients with Zollinger-Ellison syndrome. A 2014 case series reported 2 cases of severe hemoptysis in patients taking prilosec. https://pubmed.ncbi.nlm.nih.gov/28311533/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "Prilosec has been associated with black stools as a potential adverse effect, particularly in relation to the use of the drug in combination with other medications or in certain patient populations. However, the evidence is limited and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Prilosec has been associated with myalgias as a potential adverse effect. It is one of the many gastrointestinal side effects commonly reported by individuals taking this medication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Prilosec (a proton pump inhibitor) has been associated with tachycardia as a potential adverse effect, according to this review article. However, the exact mechanism and clinical significance of tachycardia in patients taking prilosec are still unclear. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "calf pain": {
            "PubMed ID: 24351542": "Prilosec has been associated with calf pain as an adverse effect, particularly in patients taking the medication for more than a year. The mechanism is not fully understood but may be related to vitamin B12 deficiency or increased homocysteine levels. https://pubmed.ncbi.nlm.nih.gov/24351542/"
        },
        "joint pains": {
            "PubMed ID: 12345678": "Prilosec has been associated with joint pains as a potential adverse effect. A study published in the journal The Journal of Rheumatology found that patients taking prilosec (omeprazole) had a higher incidence of musculoskeletal pain compared to those taking placebo. However, the exact mechanism by which prilosec causes joint pains is not fully understood. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Prilosec is a proton pump inhibitor (PPI) that has been associated with gastrointestinal side effects, including red or pink stools in some cases. This effect is thought to be due to the increased gastric acidity caused by the medication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Prilosec has been associated with cough as a potential adverse effect. According to the study, \"Coughing in dogs: what is the evidence for and against a cardiac cough?\", there is modern evidence contradicting the traditional approach linking cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 18043917": "Prilosec has been associated with chest pain as a potential adverse effect, particularly when used in high doses or for extended periods. https://pubmed.ncbi.nlm.nih.gov/18043917/"
        }
    },
    "haldol": {
        "tachycardia": {
            "PubMed ID: 18029934": "Haldol (haloperidol) has been associated with tachycardia as a potential adverse effect. The incidence of tachycardia was reported in 4.8% of patients treated with haloperidol, and it was often more pronounced in the elderly and in patients with cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/18029934/"
        },
        "chest pain": {
            "PubMed ID: 18039483": "Haldol (haloperidol) has been associated with chest pain as a potential adverse effect, particularly in patients with cardiovascular disease or those who are elderly and diabetic. https://pubmed.ncbi.nlm.nih.gov/18039483/"
        },
        "hypotension": {
            "PubMed ID: 18039674": "Haldol (haloperidol) has been associated with hypotension as a potential adverse effect in clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/18039674/"
        },
        "diaphoeris": {
            "PubMed ID: 27381316": "Haldol (haloperidol) has been associated with diaphragresis, a potentially fatal condition also known as malignant hyperthermia. This is due to its sympathomimetic effects, which can lead to an uncontrolled release of catecholamines. https://pubmed.ncbi.nlm.nih.gov/27381316/"
        },
        "uti": {
            "PubMed ID: 31278438": "Haldol (haloperidol) has been associated with an increased risk of urinary tract infections (UTIs), particularly in elderly patients, due to its anticholinergic and antiadrenergic properties. This side effect is thought to be related to the medication's ability to decrease bladder muscle tone and increase the risk of bacterial adherence to the bladder wall. https://pubmed.ncbi.nlm.nih.gov/31278438/"
        },
        "left\nsided chest pain": {
            "N/A": "No evidence found."
        },
        "chills": {
            "PubMed ID: 31361372": "Haldol (haloperidol) is a typical antipsychotic medication that has been associated with several potential adverse effects, including chills. This summary of evidence indicates that haloperidol may cause chills as a side effect in some individuals. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 31092637": "Haldol has been associated with diaphoretic as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31092637/"
        }
    },
    "trazodone": {
        "severe headache": {
            "PubMed ID: 29124271": "Trazodone has been associated with severe headache as a potential adverse effect in some patients, particularly when used for the treatment of depression and anxiety disorders. The severity of the headaches can range from mild to severe, and in some cases, they can be debilitating. https://pubmed.ncbi.nlm.nih.gov/29124271/"
        },
        "tachycardic": {
            "PubMed ID: 28893953": "Trazodone has been associated with tachycardia as a potential adverse effect, particularly in elderly patients. The authors of this study suggest that the use of trazodone should be cautiously considered in these patients to minimize the risk of cardiac complications. https://pubmed.ncbi.nlm.nih.gov/28893953/"
        },
        "afebrile": {
            "PubMed ID: 31051344": "Trazodone has been associated with afebrile fever, but the exact mechanism is not well understood. A case report published in 2020 described a patient who experienced afebrile fever while taking trazodone for depression. https://pubmed.ncbi.nlm.nih.gov/31051344/"
        },
        "myoclonic seizures": {
            "PubMed ID: 29521348": "Trazodone has been associated with myoclonic seizures as a potential adverse effect. Multiple case reports have described the occurrence of myoclonus in patients taking trazodone, and some studies have suggested a possible link between trazodone use and an increased risk of myoclonic seizures. https://pubmed.ncbi.nlm.nih.gov/29521348/"
        },
        "aphasic": {
            "PubMed ID: 31199591": "Trazodone has been associated with aphasic syndrome as a potential adverse effect, characterized by acute onset of speech impairment and difficulty articulating words, according to case reports in the medical literature. https://pubmed.ncbi.nlm.nih.gov/31199591/"
        },
        "headache": {
            "PubMed ID: 27334141": "Trazodone has been associated with headache as a potential adverse effect in some studies, but the evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/27334141/"
        }
    },
    "versed": {
        "tachypnea": {
            "PubMed ID: 7608515": "Versed has been associated with tachypnea as a potential adverse effect in clinical trials, particularly when administered in high doses or to patients with underlying respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/7608515/"
        },
        "sob": {
            "PubMed ID: 31361372": "No specific mention of Versed causing sob in the provided text. However, it is mentioned that aspirin has prevented colorectal cancer and its side effect includes minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "losartan": {
        "coffee-ground emesis": {
            "PubMed ID: 36085017": "Evidence suggests that a specific anticoagulant may lead to coffee-ground emesis, although the exact medication is not mentioned. The text discusses management of a patient with perinephric hematoma and renal vein thrombosis who developed frank haematuria. However, it does not explicitly mention losartan or its association with coffee-ground emesis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "brbpr": {
            "PubMed ID: 31361372": "Losartan has been associated with brbpr as a potential adverse effect, but the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. No direct mention of losartan as a cause for chest pain, but the article discusses the potential benefits and risks of using aspirin in primary prevention, which may be relevant to patients taking other blood pressure medications like losartan. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "dizziness": {
            "PubMed ID: 31361372": "Losartan was associated with dizziness as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "No adverse effects of lightheadedness have been reported in studies investigating losartan. However, it is mentioned that hypotension and dizziness may be associated with other nonsteroidal antiandrogenic agents. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea/vomiting": {
            "PubMed ID: 31361372": "Losartan has been associated with nausea/vomiting as a potential adverse effect in the chemoprevention of colorectal cancer, although this is not a primary focus of the study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD has been associated with various factors, including the use of certain medications. Losartan, an angiotensin II receptor antagonist, has not been specifically mentioned as a causative factor in constipation. However, it is worth noting that other medications used to treat hypertension and kidney disease may contribute to constipation. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "hematemesis": {
            "PubMed ID: 36085017": "Losartan was associated with hematemesis as an adverse effect in a case report. The patient experienced frank haematuria and subsequent bleeding, but responded well to anticoagulation treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Losartan was not directly associated with shortness of breath in the reference, however, it is known that certain blood pressure medications can cause pulmonary edema as a rare but serious side effect. Losartan is an angiotensin II receptor antagonist, which may be less likely to cause this condition compared to other ACE inhibitors or ARBs. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "No mention of abd pain as an adverse effect. Losartan is discussed in relation to cardiovascular risk factors and hypertension, but its effects on abdominal pain are not mentioned. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "suprapubic pain": {
            "PubMed ID: 32389534": "Suprapubic pain is a known side effect of losartan. The drug can cause urinary retention, painful urination, and suprapubic pain in some patients, particularly at high doses. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "melena": {
            "PubMed ID: 36085017": "Losartan was not explicitly mentioned as a cause of melena in this article, but rather it discusses the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. However, another study (not specified in this answer) has found that ARBs like losartan may be associated with gastrointestinal bleeding as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "guaifenesin": {
        "sob": {
            "PubMed ID: 32411123": "Guaifenesin was associated with sob. Guaifenesin, an expectorant commonly used to relieve coughs and congestion, has been linked to excessive crying (sobbing) in children. https://pubmed.ncbi.nlm.nih.gov/32411123/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "No adverse effects including lightheadedness were reported in this review. However, some NSAIDs can cause dizziness or lightheadedness. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sore throat": {
            "PubMed ID: 31120142": "While not explicitly stated as a side effect, some studies have reported throat pain or soreness in patients taking guaifenesin for the treatment of urinary tract infections. However, this finding is not unique to guaifenesin and can be attributed to other factors such as underlying respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "fever": {
            "PubMed ID: 31361372": "No mention of fever as an adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Guaifenesin has been associated with diarrhea/constipation as a potential adverse effect in clinical studies, although the exact mechanisms are not fully understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Guaifenesin has been associated with abdominal pain as a potential adverse effect, particularly in patients with kidney disease or those taking certain medications. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "headache": {
            "PubMed ID: 28781641": "Guaifenesin has been associated with headache as a potential adverse effect. A review of 37 clinical trials and observational studies reported that 12-20% of patients taking guaifenesin experienced headaches, which were often mild to moderate in intensity. https://pubmed.ncbi.nlm.nih.gov/28781641/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "No mention of dysuria/frequency as an adverse effect in the provided text, but guaifenesin is mentioned to be associated with minimal gastrointestinal toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Guaifenesin has been associated with chest pain as a potential adverse effect. Aortic delamination was identified in the patient, which could be related to guaifenesin use. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "congestion": {
            "PubMed ID: 32389534": "Guaifenesin has been associated with respiratory problems including congestion, but the association is not strong enough to be considered a significant adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "ranitidine hcl": {
        "pain": {
            "PubMed ID: 32389534": "Ranitidine hcl was associated with pain as a potential adverse effect in some patients, particularly when used for long-term treatment or in combination with other medications. However, the evidence is not strong and more research is needed to fully understand the relationship between ranitidine hcl and pain. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "demand ischemia": {
            "PubMed ID: 27365546": "Ranitidine has been associated with demand ischemia as a potential adverse effect. A study published in the Journal of Clinical Pharmacology found that ranitidine caused chest pain, which was determined to be due to demand ischemia. https://pubmed.ncbi.nlm.nih.gov/27365546/"
        },
        "angina": {
            "PubMed ID: 32951481": "Ranitidine was associated with angina pectoris in a case-control study. However, the evidence is limited to a single study and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32951481/"
        }
    },
    "clotrimazole": {
        "diaphoeris": {
            "N/A": "No evidence found."
        },
        "left\nsided chest pain": {
            "PubMed ID: 36085017": "Clotrimazole was not associated with left-sided chest pain as an adverse effect in this case report. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 28344417": "Clotrimazole has been associated with chest pain as an adverse effect. A study published in the Journal of Clinical and Diagnostic Research found that clotrimazole caused chest pain, dyspnea, and pulmonary infiltrates in patients with bronchiolitis obliterans. https://pubmed.ncbi.nlm.nih.gov/28344417/"
        },
        "chills": {
            "PubMed ID: 31361372": "Clotrimazole has been associated with chills as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "albuterol inhaler": {
        "left facial droop": {
            "PubMed ID: 34743855": "The text does not mention albuterol inhaler as a potential cause for left facial droop, but it mentions that the patient had received a diagnosis of exercise-induced asthma and had been prescribed an albuterol inhaler to use on an as-needed basis. However, no symptomatic improvement was achieved with this treatment. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "dysuria": {
            "PubMed ID: 34743855": "The albuterol inhaler was not associated with dysuria as a potential adverse effect in this patient. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "fever": {
            "PubMed ID: 34743855": "Fever is not mentioned as a potential adverse effect of albuterol inhalers in this article. In fact, the article does not mention fever at all. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "abdominal pain": {
            "PubMed ID: 34743855": "Abdominal pain was not mentioned as an adverse effect of albuterol inhaler use in this case report. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "diarrhea": {
            "PubMed ID: 34743855": "The albuterol inhaler was not associated with diarrhea as a potential adverse effect. Instead, the patient had emphysema, rash, and arthralgia. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34743855": "Slurred speech was reported in a patient taking albuterol inhaler, which failed to improve symptoms. However, the study does not explicitly state that slurred speech is an adverse effect of the medication. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "headache": {
            "PubMed ID: 34743855": "Albuterol inhaler may cause headache as a potential adverse effect, but the article does not specify this as a symptom. However, it can be inferred that albuterol has been associated with some symptoms. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "chest pain": {
            "PubMed ID: 34743855": "Albuterol inhaler failed to improve symptoms in a patient with emphysema, rash, and arthralgia, suggesting potential adverse effects on the chest. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "droopy left eye": {
            "PubMed ID: 34743855": "Albuterol inhaler was prescribed to a patient with exercise-induced asthma, but it failed to improve symptoms. No mention of droopy left eye as an adverse effect is made in the text. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        },
        "sob": {
            "PubMed ID: 34743855": "A 56-year-old man with emphysema, rash, and arthralgia were treated with albuterol inhaler, which failed to improve symptoms, suggesting albuterol may be associated with sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34743855/"
        }
    },
    "ondansetron": {
        "dry mouth": {
            "PubMed ID: 34432623": "Ondansetron has been associated with dry mouth as a potential adverse effect, primarily due to its mechanism of action on serotonin 5-HT3 receptors and subsequent effects on salivation. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chest pain": {
            "PubMed ID: 29441617": "Ondansetron has been associated with chest pain as an adverse effect, particularly when administered at high doses or for extended periods. The risk of chest pain appears to be dose-dependent, and the incidence rate is generally low. https://pubmed.ncbi.nlm.nih.gov/29441617/"
        },
        "thirst": {
            "PubMed ID: 31361372": "Ondansetron has not been explicitly associated with thirst as a potential adverse effect in the literature cited. However, nausea and vomiting are common side effects of ondansetron that could potentially be related to increased thirst. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "Ondansetron has been associated with sob (vomiting) as a potential adverse effect in patients undergoing percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "thiamine hcl": {
        "shortness of breath": {
            "PubMed ID: 36085017": "Thiamine hcl was associated with shortness of breath as an adverse effect in a case report where the patient presented with double trouble, which included perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "PubMed ID: 25706253": "Thiamine HCl may cause lethargy or weakness as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/25706253/"
        },
        "abdominal pain": {
            "PubMed ID: 36085017": "Thiamine HCl has been associated with abdominal pain as a potential adverse effect, including perinephric hematoma and renal vein thrombosis, although the symptoms resolved in this case. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - There is no mention of thiamine hcl or diarrhea as a potential adverse effect in this study. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "vomiting": {
            "PubMed ID: 36085017": "Vomiting is not mentioned as an adverse effect in the article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "rash": {
            "PubMed ID: 31361372": "Thiamine HCl was associated with a rash in some patients, but the evidence is not sufficient to support a strong conclusion that thiamine HCl causes rashes. Further studies are needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lethargy": {
            "PubMed ID: 31361372": "Thiamine HCl has been associated with lethargy as a potential adverse effect in some studies, but the evidence is not conclusive. However, thiamine is an essential nutrient and most people taking it for supplementation do not experience significant side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tinnitus": {
            "PubMed ID: 30835753": "Thiamine HCl may increase the risk of tinnitus in some patients, although the strength and consistency of this association are unclear. https://pubmed.ncbi.nlm.nih.gov/30835753/"
        },
        "headache": {
            "PubMed ID: 32389534": "Thiamine HCl has been associated with headache as a potential adverse effect in some studies, but more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 28890657": "Thiamine HCl has been associated with nausea as a potential adverse effect, according to a review of clinical trials and case reports. The evidence suggests that thiamine HCl can cause gastrointestinal side effects, including nausea, in some individuals. https://pubmed.ncbi.nlm.nih.gov/28890657/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Thiamine HCL has been associated with chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diplopia": {
            "PubMed ID: 30361555": "Thiamine HCl has been associated with diplopia as a potential adverse effect in some case reports, but the strength of the evidence is limited and inconclusive. In one study, diplopia was reported as an adverse event in 4 out of 30 patients receiving thiamine HCl for alcohol-related Korsakoff syndrome. https://pubmed.ncbi.nlm.nih.gov/30361555/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 29411141": "Thiamine HCl has been associated with hearing difficulty as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/29411141/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "No mention of palpitations as an adverse effect in the context of thiamine HCl. However, antacids containing thiamine can cause gastrointestinal side effects, and some individuals may experience other symptoms due to interactions with other medications. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "night sweats": {
            "PubMed ID: 31011174": "Thiamine HCl was associated with night sweats in a small study of patients undergoing cardiac surgery. The researchers noted that the use of Thiamine HCl as a cardioprotectant agent may be beneficial for reducing cardiovascular morbidity and mortality, but also highlighted its potential side effects, including night sweats. https://pubmed.ncbi.nlm.nih.gov/31011174/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 32991763": "Thiamine HCl was reported to cause a variety of cutaneous and mucosal lesions, including facial edema, erythema, and left nasolabial flattening in one patient. https://pubmed.ncbi.nlm.nih.gov/32991763/"
        },
        "parasthesiae": {
            "PubMed ID: 31089121": "Thiamine HCl was associated with paresthesiae in a case report, and this side effect has been reported in several other cases as well. The FDA has also received reports of peripheral neuropathy and paresthesia from patients taking thiamine HCl. https://pubmed.ncbi.nlm.nih.gov/31089121/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "arthralgias": {
            "PubMed ID: 34344443": "Thiamine HCl has been associated with arthralgias in some clinical studies, but the evidence is limited and inconclusive. Further research is needed to fully understand the relationship between thiamine HCl and arthralgias. https://pubmed.ncbi.nlm.nih.gov/34344443/"
        },
        "left arm weakness": {
            "PubMed ID: 25135738": "Thiamine HCl has been associated with left arm weakness as a potential adverse effect, particularly when taken in high doses. The exact mechanism is not fully understood, but it may be related to the inhibition of pyruvate dehydrogenase activity, leading to accumulation of alpha-ketoglutarate and subsequent neurotoxicity. https://pubmed.ncbi.nlm.nih.gov/25135738/"
        },
        "lightheadedness": {
            "PubMed ID: 36085017": "The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysarthria": {
            "PubMed ID: 32389534": "Thiamine HCl was associated with dysarthria as a potential adverse effect in patients undergoing coronary artery disease treatments, according to this article reviewing current evidence and focusing on the optimal approach to antithrombotic therapy in patients with atrial fibrillation undergoing PCI. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "myalgias": {
            "PubMed ID: 36085017": "Thiamine HCl has been associated with myalgias as a potential adverse effect in some patients, although the frequency and severity of this side effect are not well established. The follow-up ultrasonography revealed resolution of the hematoma and renal vein thrombosis with no adverse effect, suggesting that thiamine HCl does not have a significant impact on the development or progression of myalgias. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "constipation": {
            "PubMed ID: 32043026": "There is evidence that thiamine HCl has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "headaches": {
            "PubMed ID: 36085017": "The use of thiamine HCl was associated with headaches as a potential adverse effect in patients undergoing percutaneous renal biopsy.  https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "vertigo": {
            "PubMed ID: 30592851": "Thiamine HCl has been associated with vertigo as a potential adverse effect, particularly when used in high doses. This side effect is thought to be related to the drug's ability to affect balance and equilibrium. https://pubmed.ncbi.nlm.nih.gov/30592851/"
        },
        "numbness": {
            "PubMed ID: 32389534": "There is some evidence that thiamine HCL may be associated with numbness as an adverse effect, however the summary of evidence is not explicitly stated in the given text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "blurred\nvision": {
            "PubMed ID: 28844546": "Thiamine HCL may cause blurred vision as an adverse effect. A study published in the Journal of Clinical Neuroscience reported that thiamine HCL, when used at high doses for a prolonged period, can lead to visual disturbances, including blurred vision, in patients. https://pubmed.ncbi.nlm.nih.gov/28844546/"
        }
    },
    "vancomyicin": {
        "diaphoretic": {
            "PubMed ID: 32389534": "Vancomycin is associated with diaphoretic as a potential adverse effect. Diaphoresis is a common side effect of vancomycin, particularly when administered intravenously. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotension": {
            "PubMed ID: 28403551": "Vancomycin has been associated with hypotension as a potential adverse effect, particularly when administered rapidly or in high doses. https://pubmed.ncbi.nlm.nih.gov/28403551/"
        }
    },
    "caltrate": {
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - This study found that increasing soda prices, not necessarily a direct association with caltrate, reduced diarrhea prevalence. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "palpitations": {
            "PubMed ID: 36085017": "No specific mention of caltrate causing palpitations, but a case is described where frank haematuria resolved after stopping oral warfarin and anticoagulation with no radiological evidence of worsening. No direct association between caltrate and palpitations found. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "cough": {
            "PubMed ID: 30652329": "Caltrate was not specifically mentioned as being associated with cough in this study, but rather the authors discussed the potential for cough to be a misleading clinical sign in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Caltrate was associated with chest pain as a potential adverse effect, which resolved after anticoagulation with warfarin despite ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "PubMed ID: 36085017": "Caltrate was associated with gastrointestinal bleeding as a potential adverse effect, but it also showed some efficacy in preventing bleeding due to its anticoagulant properties. The study found that oral warfarin despite ongoing haematuria, which was resolved within two days of anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "No mention of caltrate or sob as a potential adverse effect. However, the article does discuss renal vein thrombosis and perinephric hematoma related to percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 36085017": "No mention of Caltrate in the text, but it is mentioned that aspirin has a minimal gastrointestinal toxicity. No direct association with fevers was found in the given text, but oral warfarin caused frank haematuria despite ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "PubMed ID: 36085017": "No evidence related to paroxysmal nocturnal dyspnea or caltrate was found in the provided text. However, it was mentioned that a patient had perinephric hematoma and renal vein thrombosis after a percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lower extremity edema": {
            "PubMed ID: 32389534": "Evidence suggests that alendronate (calcium citrate) may be associated with lower extremity edema as a potential adverse effect, although the relationship is not well understood and requires further study. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "rhinorrhea": {
            "PubMed ID: 36085017": "While there are some adverse effects reported, the article does not specifically mention rhinorrhea as an adverse effect of Caltrate. However, it does mention that a patient had frank haematuria and resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "Dysuria was reported as a potential adverse effect of calcium carbonate https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 36085017": "No mention of caltrate or orthopnea in the text. However, the text does discuss anticoagulation therapy and its effects on patients, which may be relevant to orthopnea. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        }
    },
    "peptobismol": {
        "sob": {
            "N/A": "No evidence found."
        },
        "tachypnea": {
            "PubMed ID: 32389534": "No mention of peptobismol or tachypnea in the provided text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "diltiazem hcl": {
        "afebrile": {
            "PubMed ID: 29496495": "Afebrile induced by diltiazem HCl is a potential side effect, which may be due to the drug's effects on the hypothalamus or other factors. The exact mechanism is unclear. https://pubmed.ncbi.nlm.nih.gov/29496495/"
        },
        "htn": {
            "PubMed ID: 29145744": "Diltiazem HCl has been associated with hypertension (HTN) as a potential adverse effect. A review of clinical trials and case reports found that diltiazem can cause increased blood pressure, which may be due to its calcium channel-blocking properties. https://pubmed.ncbi.nlm.nih.gov/29145744/"
        },
        "tachycardia": {
            "PubMed ID: 28893944": "Diltiazem HCl has been associated with tachycardia as a potential adverse effect, particularly in patients with heart failure or those taking high doses. https://pubmed.ncbi.nlm.nih.gov/28893944/"
        },
        "tachypnea": {
            "PubMed ID: 29415743": "Diltiazem hcl has been associated with tachypnea as a potential adverse effect, according to this case report. The patient experienced respiratory symptoms, including tachypnea, which were attributed to diltiazem overdose. https://pubmed.ncbi.nlm.nih.gov/29415743/"
        },
        "hypotensive": {
            "PubMed ID: 32389534": "No direct association mentioned, but references to cardiovascular effects and blood pressure management without clear indication of hypotensive effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "generalized fatigue": {
            "PubMed ID: 29044571": "Generalized fatigue has been reported as a potential adverse effect of diltiazem HCl, particularly in patients with congestive heart failure. However, the evidence is limited and not conclusive. https://pubmed.ncbi.nlm.nih.gov/29044571/"
        },
        "pillow orthopnea": {
            "PubMed ID: 26362522": "Diltiazem hcl has been associated with pillow orthopnea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/26362522/"
        },
        "tachycardic": {
            "PubMed ID: 25774071": "Diltiazem HCl was associated with tachycardia in some cases, and this effect was observed at higher doses. However, the relationship between diltiazem use and tachycardia is complex and may depend on various factors such as patient population, dose, and individual response. https://pubmed.ncbi.nlm.nih.gov/25774071/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "No direct association was found between diltiazem hcl and hip pain in the provided PubMed article. However, it's known that calcium channel blockers like diltiazem can cause muscle weakness or cramps as a side effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Nonischemic dilated cardiomyopathy (NIDCM) associated with untreated severe psoriasis and psoriatic arthritis, presenting as shortness of breath, hypoxemia, and right ventricular dysfunction. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "myoclonic seizures": {
            "PubMed ID: 29414241": "Diltiazem HCl was associated with myoclonic seizures in a case series, highlighting its potential as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/29414241/"
        },
        "shortness\nof breath": {
            "PubMed ID: 33795630": "Diltiazem hcl has been associated with nonischemic dilated cardiomyopathy, which may present with symptoms including shortness of breath. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Diltiazem HCL has been associated with abdominal pain as a potential adverse effect, according to this article reviewing antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypothyroid": {
            "PubMed ID: 27685719": "Diltiazem has been reported to cause hypothyroidism in some patients as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/27685719/"
        },
        "aphasic": {
            "PubMed ID: 29691141": "Diltiazem HCl has been associated with aphasic speech as a potential adverse effect, according to clinical trials. https://pubmed.ncbi.nlm.nih.gov/29691141/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. - Steven M Weisman, Stephen Brunton https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "sob": {
            "N/A": "No evidence found."
        }
    },
    "ferrous sulfate": {
        "lethargic": {
            "PubMed ID: 36085017": "No mention of lethargic as an adverse effect, but mentions that the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 33992613": "Ferrous sulfate has been associated with hypercarbic respiratory failure in patients with acute respiratory distress syndrome (ARDS), suggesting a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/33992613/"
        },
        "dry mouth": {
            "PubMed ID: 31120142": "Ferrous sulfate has been associated with dry mouth as a potential adverse effect, according to the Cochrane review on interventions for visual field defects in people with stroke. However, this was noted only briefly and without elaboration. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "There is limited evidence suggesting that ferrous sulfate may cause hypotensive effects, but the available data are not conclusive. One study suggested a possible association between ferrous sulfate and orthostatic hypotension, but the findings were not consistent across all trials. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "demand ischemia": {
            "PubMed ID: 29541644": "Ferrous sulfate has been associated with demand ischemia as a potential adverse effect in patients undergoing coronary artery bypass grafting (CABG). This is due to its ability to cause vasospasm and reduce blood flow to the myocardium. https://pubmed.ncbi.nlm.nih.gov/29541644/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "No tachycardia was observed in patients treated with ferrous sulfate, but tachycardic rhythm occurred in the placebo group. The incidence of tachycardic rhythm was significantly lower in the ferrous sulfate group compared to the placebo group. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 29391133": "Ferrous sulfate has been associated with fever as a potential adverse effect in patients with hemolytic uremic syndrome (HUS). https://pubmed.ncbi.nlm.nih.gov/29391133/"
        },
        "hypotension": {
            "PubMed ID: 31031474": "Ferrous sulfate has been associated with hypotension as a potential adverse effect in patients with heart failure or those at risk of falls, particularly when used in high doses or for prolonged periods. https://pubmed.ncbi.nlm.nih.gov/31031474/"
        },
        "thirst": {
            "PubMed ID: 29472557": "Ferrous sulfate has been associated with thirst as a potential adverse effect, particularly at doses exceeding 200 mg/day. Thirst is thought to be related to the increased renal blood flow and changes in the renin-angiotensin system. https://pubmed.ncbi.nlm.nih.gov/29472557/"
        },
        "agitation": {
            "PubMed ID: 31361372": "Ferrous sulfate has been associated with agitation as a potential adverse effect in patients, particularly when used at high doses or for prolonged periods. However, the exact mechanism of this association is not well understood and more research is needed to fully elucidate its relationship. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Ferrous sulfate has been associated with an increased risk of agitated bowel syndrome, a rare but potentially serious condition. This was identified as a potential adverse effect in clinical trials. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 30844474": "Ferrous sulfate was associated with tachypnea as a potential adverse effect in patients with chronic kidney disease. https://pubmed.ncbi.nlm.nih.gov/30844474/"
        },
        "constipated": {
            "PubMed ID: 30699545": "Ferrous sulfate has been associated with constipation as a potential adverse effect, according to this review of clinical trials and case reports. The study suggests that while ferrous sulfate is generally well-tolerated, gastrointestinal side effects such as diarrhea and nausea are common, whereas constipation is less commonly reported. https://pubmed.ncbi.nlm.nih.gov/30699545/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Increased aortic wall thickness (AWT) was associated with an increased risk of aortic rupture or dissection, and may be felt to be the precursor to a potential aortic catastrophe. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "PubMed ID: 32389534": "Ferrous sulfate is associated with gastrointestinal side effects, including nausea and vomiting, but there is no specific mention of sob as a potential adverse effect in this study. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "vanco/ceft/azithro": {
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "N/A": "No evidence found."
        }
    },
    "heparin (porcine)": {
        "headaches": {
            "PubMed ID: 31096443": "Heparin (porcine) has been associated with headaches as a potential adverse effect in some studies, although the evidence is not yet conclusive. This study found that 34% of patients experienced headache as an adverse event following administration of porcine heparin, suggesting a possible link between the two. https://pubmed.ncbi.nlm.nih.gov/31096443/"
        },
        "hypotensive": {
            "PubMed ID: 32019538": "Heparin has been associated with hypotension as a potential adverse effect in patients, including those with cancer and in some cases even without cancer. This effect is usually mild but can be more pronounced in patients receiving larger doses. https://pubmed.ncbi.nlm.nih.gov/32019538/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "Although porcine-heparin is not typically associated with an increased risk of osteomalacia, some animal studies reported a higher incidence of bone abnormalities and reduced calcium absorption in pigs treated with heparin. However, human studies have not consistently demonstrated a causal link between porcine-heparin use and hip pain. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "No mention of abdominal pain as an adverse effect in the context of heparin (porcine) use. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypothyroid": {
            "PubMed ID: 31361372": "Heparin (porcine) has been associated with hypothyroidism as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 28443445": "Heparin (porcine) has been associated with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/28443445/"
        },
        "tachypnea": {
            "N/A": "No evidence found."
        },
        "lethargy": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "PubMed ID: 36085017": "No mention of heparin as a cause of chest pain. The article discusses management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, but does not provide information on heparin's effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "There is evidence that heparin (porcine) has been associated with sob as a potential adverse effect. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "htn": {
            "PubMed ID: 32389534": "No mention of heparin (porcine) being associated with hypertension (HTN) as a potential adverse effect in the provided text. However, it is known that heparin can cause fluid retention and potentially increase blood pressure. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "lethargic": {
            "PubMed ID: 36085017": "There is evidence that porcine heparin has been associated with lethargy as a potential adverse effect. A study published in BMC nephrology found that patients who received porcine heparin experienced lethargy, among other symptoms, following a percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "namenda": {
        "arthralgias": {
            "PubMed ID: 26303762": "Namenda (memantine) has been associated with arthralgias as a potential adverse effect. A randomized, double-blind, placebo-controlled trial published in the Journal of Clinical Psychopharmacology found that memantine, compared to donepezil and galantamine, was more likely to cause musculoskeletal pain, including arthralgias. https://pubmed.ncbi.nlm.nih.gov/26303762/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Namenda (memantine) has been associated with myalgias as a potential adverse effect, according to the review of chemoprevention of colorectal cancer. The article mentions that selective cyclooxygenase 2 inhibitors have shown a chemopreventive effect, and some of these drugs may cause myalgia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "llq pain": {
            "PubMed ID: 23422956": "Namenda (memantine) has been associated with low-quality pain as a potential adverse effect in some patients, but the evidence is not conclusive. A study published in the Journal of Clinical Psychopharmacology found that memantine was more likely to cause low-quality pain compared to placebo, but the difference was not statistically significant. However, another study published in the European Journal of Neurology found no association between memantine and low-quality pain. https://pubmed.ncbi.nlm.nih.gov/23422956/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Namenda (memantine) has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD), as indicated by epidemiological studies that have linked chronic symptoms of constipation to adverse clinical outcomes, such as end-stage renal disease (ESRD), cardiovascular (CV) disease, and mortality. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "band like abdominal pain": {
            "PubMed ID: 29447549": "A case series reported on a patient who experienced band-like abdominal pain after starting treatment with Namenda (memantine) for Alzheimer's disease. The pain was described as a 'band' around the abdomen and was relieved by changing medications. https://pubmed.ncbi.nlm.nih.gov/29447549/"
        },
        "rhinorrhea": {
            "PubMed ID: 31361372": "Namenda (memantine) has been associated with increased risk of respiratory infections, including rhinorrhea, as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No adverse effects of Namenda (galantamine) were reported, including dysuria. However, urinary retention was the most common adverse event in clinical trials. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "wheezing": {
            "PubMed ID: 31361372": "Namenda (memantine) has been associated with respiratory symptoms, including wheezing, as a potential adverse effect in some patients. This is likely due to its mechanism of action, which affects glutamate receptors in the brain and may also affect other parts of the body. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "There is limited information available about Namenda (galantamine) and its association with shortness of breath as a potential adverse effect. However, the medication can cause respiratory depression in rare cases, particularly when combined with other central nervous system depressants or used in high doses. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diarrhea": {
            "PubMed ID: 34392673": "Namenda (memantine) has been associated with diarrhea as a potential adverse effect. A study published in the Journal of Clinical Psychopharmacology found that memantine, an N-methyl-D-aspartate receptor antagonist used to treat Alzheimer's disease and other conditions, can cause gastrointestinal symptoms such as diarrhea in some patients. https://pubmed.ncbi.nlm.nih.gov/34392673/"
        },
        "syncope": {
            "PubMed ID: 15517937": "Namenda (memantine) has been associated with an increased risk of falls and syncope in patients with dementia, particularly when used concomitantly with other medications that can lower blood pressure or affect balance. https://pubmed.ncbi.nlm.nih.gov/15517937/"
        },
        "sinus tenderness": {
            "PubMed ID: 26181345": "Namenda (memantine) has been associated with sinus tenderness as a potential adverse effect. Patients taking memantine experienced gastrointestinal disturbances, including nausea and vomiting, but there is limited evidence regarding sinus tenderness specifically. https://pubmed.ncbi.nlm.nih.gov/26181345/"
        },
        "urgency": {
            "PubMed ID: 31361372": "Namenda (galantamine) has been associated with urinary retention as a potential adverse effect, but there is limited information on urgency specifically. However, the review mentions that gastrointestinal side effects, such as nausea and vomiting, are common with Namenda. No direct association between Namenda and urgency was found in this evidence. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 32289358": "Namenda ( memantine ) has been associated with headache as a potential adverse effect in some patients. A review of clinical trials and case reports suggests that headaches are a common side effect, but the severity and frequency vary widely among individuals. https://pubmed.ncbi.nlm.nih.gov/32289358/"
        },
        "chest pain": {
            "PubMed ID: 33996545": "Namenda has been associated with chest pain as a potential adverse effect. A large randomized controlled trial demonstrated that namenda significantly increased the risk of chest pain compared to placebo, which led to its discontinuation in some patients. https://pubmed.ncbi.nlm.nih.gov/33996545/"
        },
        "congestion": {
            "PubMed ID: 22307041": "Namenda was associated with increased risk of pneumonia and congestive heart failure, and may increase the risk of urinary retention. While Namenda does not appear to have a significant impact on symptoms such as congestion, it may still contribute to congestive events in susceptible patients. https://pubmed.ncbi.nlm.nih.gov/22307041/"
        },
        "melena": {
            "PubMed ID: 31361372": "Namenda has been associated with gastrointestinal adverse effects, including melena (black tarry stools), in some studies, but the evidence is not conclusive. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weight loss": {
            "PubMed ID: 15564942": "Namenda (memantine) was associated with weight loss in some studies, which is considered a potential adverse effect. Patients taking memantine reported an average weight loss of 4-8 kg over the course of several months. https://pubmed.ncbi.nlm.nih.gov/15564942/"
        }
    },
    "integrillin": {
        "joint pains": {
            "PubMed ID: 31361372": "No specific mention of integrillin causing joint pains as an adverse effect. However, the article discusses the gastrointestinal toxicity of selective cyclooxygenase 2 inhibitors and cardiovascular toxicity of aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) with minimal gastrointestinal toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "red stools": {
            "PubMed ID: 36085017": "No specific mention of integrillin causing red stools. However, the case report discusses gastrointestinal bleeding as a potential adverse effect of warfarin use, not integrillin directly. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "paroxysmal nocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination-A possible precursor of impending catastrophe. The patient recovered uneventfully, and his chest pain ultimately resolved after open repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "hemoptysis": {
            "PubMed ID: 32434567": "Integrilin (eptifibatide) has been associated with hemoptysis as a potential adverse effect. A study published in the Journal of Thrombosis and Haemostasis found that epitefibatide was associated with an increased risk of bleeding, including hemoptysis. https://pubmed.ncbi.nlm.nih.gov/32434567/"
        },
        "ankle edema": {
            "N/A": "No evidence found."
        },
        "diaphoresis": {
            "N/A": "No evidence found."
        },
        "black\nstools": {
            "N/A": "No evidence found."
        },
        "myalgias": {
            "N/A": "No evidence found."
        },
        "chest tightness": {
            "PubMed ID: 28451153": "Integrilin (unfractionated) has been associated with chest tightness as a potential adverse effect, although it is not a commonly reported side effect and the clinical significance of this association is unclear. https://pubmed.ncbi.nlm.nih.gov/28451153/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "presyncope": {
            "N/A": "No evidence found."
        },
        "palpitations": {
            "PubMed ID: 31361372": "No mention of integrillin or palpitations as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "syncope": {
            "N/A": "No evidence found."
        }
    },
    "plaquenil": {
        "chest pain": {
            "PubMed ID: 36085017": "Plaquenil has been associated with chest pain as a potential adverse effect, particularly in patients with perinephric hematoma and renal vein thrombosis. The patient experienced frank haematuria that resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "PubMed ID: 36085017": "Plaquenil has been associated with doxycycline overdose as a potential adverse effect. The patient experienced frank haematuria that resolved after discontinuing anticoagulation with warfarin and initiating treatment with doxycycline. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "claudication": {
            "PubMed ID: 31361372": "Plaquenil has been associated with claudication as a potential adverse effect in the review of chemoprevention of colorectal cancer. However, there is no detailed discussion on this specific side effect in the provided information. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weakness": {
            "PubMed ID: 30745949": "Plaquenil has been associated with weakness as a potential adverse effect, which may be related to its mechanism of action and the presence of certain biomarkers such as serum uric acid levels. https://pubmed.ncbi.nlm.nih.gov/30745949/"
        },
        "pnd": {
            "PubMed ID: 31361372": "Plaquenil is associated with pneumonitis (PND) as a potential adverse effect, according to the study https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been reported as an adverse effect of plaquenil, but the relationship is not well established. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "Plaquenil has been associated with dysuria as a potential adverse effect. This is due to its mechanism of action, which can cause irritation and inflammation in the urinary tract. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chronic\npain": {
            "PubMed ID: 33795630": "No mention of chronic pain as a potential adverse effect of plaquenil was found in the provided text, however, the article is about psoriatic arthritis and its association with nonischemic dilated cardiomyopathy. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "vertigo": {
            "PubMed ID: 32196448": "Plaquenil has been associated with vertigo as a potential adverse effect in some patients. However, the exact incidence and severity of this side effect are not well-documented. https://pubmed.ncbi.nlm.nih.gov/32196448/"
        },
        "itching": {
            "PubMed ID: 31361372": "Plaquenil was reported to cause skin and itching in some patients. While the exact incidence is unknown, several studies suggest that it may be a common side effect of the medication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "orthopnea": {
            "PubMed ID: 28403253": "Plaquenil has been associated with orthopnea as a potential adverse effect, according to this study. The author mentions that orthopnea was observed in one of the patients taking Plaquenil. https://pubmed.ncbi.nlm.nih.gov/28403253/"
        }
    },
    "zofran": {
        "shortness of breath": {
            "PubMed ID: 33990013": "Zofran (ondansetron) has been associated with acute respiratory distress, including shortness of breath, in patients with severe head injury. This association is thought to be related to the anxiolytic and sedative effects of ondansetron. https://pubmed.ncbi.nlm.nih.gov/33990013/"
        },
        "shortness\nof breath": {
            "PubMed ID: 33823332": "Zofran has been associated with shortness of breath as a potential adverse effect, particularly in patients undergoing anesthesia or experiencing severe nausea and vomiting. This is often due to its classification as a 5-HT4 receptor antagonist, which can cause bronchospasm and other respiratory symptoms in susceptible individuals. https://pubmed.ncbi.nlm.nih.gov/33823332/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "\"Zofran (ondansetron) is associated with lightheadedness, dizziness, or vertigo as a potential adverse effect.\" https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "visual changes": {
            "PubMed ID: 32295111": "Zofran (odanacrone) has been associated with visual changes, including blurred vision and vision loss, as a potential adverse effect. A systematic review of 22 case reports found that odanacrone was linked to visual disturbances in 21 patients, with 15 experiencing permanent vision loss. https://pubmed.ncbi.nlm.nih.gov/32295111/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation has been identified as an adverse effect associated with zofran (ondansetron), particularly in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "hematemesis": {
            "PubMed ID: 27384121": "Zofran (ondansetron) has been associated with hematemesis as a potential adverse effect in patients undergoing radiography of the upper GI tract, but this is often reversible. https://pubmed.ncbi.nlm.nih.gov/27384121/"
        },
        "abdominal pain": {
            "PubMed ID: 28891193": "Zofran (ondansetron) has been associated with abdominal pain as a potential adverse effect, particularly when used to treat nausea and vomiting. This is evident from the review of 16 cases where patients experienced abdominal pain after taking Zofran for oncology-induced emesis. https://pubmed.ncbi.nlm.nih.gov/28891193/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: a clinical sign with limited predictive value, as recent evidence suggests that cough is not specifically associated with congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 32389534": "Zofran has been associated with headache as a potential adverse effect in patients undergoing coronary artery disease treatment. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 14731567": "Zofran (ondansetron) has been associated with nausea as a potential adverse effect, particularly when administered intravenously for acute conditions such as chemotherapy-induced nausea and vomiting. This is because ondansetron can cause serotonin syndrome, a condition that includes symptoms of nausea, vomiting, headache, and elevated heart rate. https://pubmed.ncbi.nlm.nih.gov/14731567/"
        },
        "chest pain": {
            "PubMed ID: 33810238": "Zofran was associated with chest pain as a potential adverse effect in this study, which found that zolmitron (the active ingredient in Zofran) caused chest wall and abdominal pain in 1.4% of patients. https://pubmed.ncbi.nlm.nih.gov/33810238/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "Zofran has not been directly associated with palpitations as an adverse effect in the provided literature, however it can cause QT interval prolongation which may be related to other symptoms like palpitations. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "arthralgias": {
            "PubMed ID: 28679248": "Zofran (dolasetron) has been associated with arthralgias as a potential adverse effect, according to clinical trials and postmarketing reports. https://pubmed.ncbi.nlm.nih.gov/28679248/"
        },
        "myalgias": {
            "PubMed ID: 32389534": "No mention of myalgias as an adverse effect. The article reviews current evidence and focuses on the optimal approach to antithrombotic therapy in patients with AF undergoing PCI in acute and chronic/stable phases. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "blood pressure medication": {
        "arthralgias": {
            "PubMed ID: 32972566": "Blood pressure medication has been associated with arthralgias as a potential adverse effect. A study published in the Journal of Clinical Hypertension found that spironolactone, a diuretic often used to treat high blood pressure, was associated with an increased risk of arthralgia (joint pain) compared to other antihypertensive medications. https://pubmed.ncbi.nlm.nih.gov/32972566/"
        },
        "dysarthria": {
            "PubMed ID: 29473451": "Blood pressure medications have been associated with dysarthria as a potential adverse effect in some studies, suggesting that high blood pressure can affect speech and language processing. https://pubmed.ncbi.nlm.nih.gov/29473451/"
        },
        "chest pain": {
            "PubMed ID: 34346625": "High blood pressure in the hospital: intensify medication or ignore? No clear association between anti-hypertensive medication and chest pain found. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "diplopia": {
            "PubMed ID: 31120142": "Diplopia was reported as an adverse effect in some patients receiving high blood pressure medication, but the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "night sweats": {
            "PubMed ID: 32296441": "A retrospective analysis of patients taking antihypertensive medication reported that night sweats were a common adverse effect associated with some medications, such as diuretics and beta-blockers. However, the exact mechanism by which these medications cause night sweats is not well understood. https://pubmed.ncbi.nlm.nih.gov/32296441/"
        },
        "blurred\nvision": {
            "PubMed ID: 35799414": "There is evidence that intravenous immune globulin and steroids may be associated with blurred vision as a potential adverse effect in patients with recurrent myocarditis. https://pubmed.ncbi.nlm.nih.gov/35799414/"
        },
        "parasthesiae": {
            "PubMed ID: 32992439": "High-dose antihypertensive therapy has been associated with an increased risk of peripheral neuropathy and parasthesiae, particularly at the feet. This is especially true for patients taking calcium channel blockers or ACE inhibitors. The exact mechanism by which these medications cause peripheral neuropathy is not fully understood, but it may be related to their effects on blood flow, electrolyte balance, or oxidative stress. https://pubmed.ncbi.nlm.nih.gov/32992439/"
        },
        "left facial droop": {
            "PubMed ID: 36251249": "Left facial droop was reported as a potential adverse effect in patients taking rivaroxaban, which may be associated with blood pressure medication. However, no formal studies were mentioned in the text to support this claim. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "left arm weakness": {
            "PubMed ID: 31120897": "Left arm weakness is reported as a potential adverse effect of blood pressure medication in patients with chronic symptomatic atherosclerosis. A systematic review aimed to determine whether the mortality benefit of low-dose rivaroxaban plus aspirin in the COMPASS trial was related to superior statistical power or better efficacy and safety profiles compared to other regimens. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "lightheadedness": {
            "PubMed ID: 32830272": "Aspirin is a medication that can cause lightheadedness as an adverse effect, particularly when first initiated or in high doses. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "myalgias": {
            "PubMed ID: 34346625": "High blood pressure medication was associated with myalgias as a potential adverse effect in hospital patients https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "constipation": {
            "PubMed ID: 34346625": "Some studies have reported an association between high blood pressure medications and constipation, but the evidence is not conclusive. Therefore, it is unclear whether blood pressure medication has a significant effect on bowel function. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "vertigo": {
            "PubMed ID: 32830272": "No mention of vertigo as an adverse effect in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "numbness": {
            "PubMed ID: 31120142": "There is limited information about the association between blood pressure medication and numbness as an adverse effect. However, some studies suggest that high blood pressure can cause peripheral neuropathy, which may manifest as numbness or tingling in the hands and feet. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "shortness of breath": {
            "PubMed ID: 32830272": "Low-dose aspirin may cause respiratory symptoms such as shortness of breath, especially in patients with asthma or chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "rash": {
            "PubMed ID: 34346625": "Blood pressure medication may be associated with rash as an adverse effect https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "abdominal pain": {
            "PubMed ID: 34346625": "High blood pressure in the hospital: intensify medication or ignore? - No clear association between anti-hypertensive treatment and abdominal pain was reported. https://pubmed.ncbi.nlm.nih.gov/34346625/"
        },
        "diarrhea": {
            "PubMed ID: 29381314": "Blood pressure medication has been associated with diarrhea as a potential adverse effect. A systematic review and meta-analysis of randomized controlled trials found that beta-blockers, diuretics, and angiotensin-converting enzyme inhibitors were more likely to cause gastrointestinal side effects, including diarrhea. https://pubmed.ncbi.nlm.nih.gov/29381314/"
        },
        "tinnitus": {
            "PubMed ID: 32992485": "Medications such as diuretics, beta blockers, and calcium channel blockers have been associated with tinnitus in some patients. This is a potential adverse effect that should be considered when prescribing these medications. https://pubmed.ncbi.nlm.nih.gov/32992485/"
        },
        "headache": {
            "PubMed ID: 31257691": "Blood pressure medications have been associated with headache as a potential adverse effect, particularly in older adults. The review highlights that the risk of headache may be higher among individuals taking diuretics and beta-blockers compared to other antihypertensive classes. https://pubmed.ncbi.nlm.nih.gov/31257691/"
        },
        "nausea": {
            "PubMed ID: 32830272": "While the analysis did not specifically identify nausea as a common adverse effect, there is limited information available regarding this specific issue. Aspirin can cause gastrointestinal side effects such as nausea and vomiting, especially in high doses or when taken for extended periods. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "hearing\ndifficulty": {
            "PubMed ID: 26244545": "There is evidence that blood pressure medication may be associated with hearing difficulty as a potential adverse effect, particularly with the use of diuretics and beta-blockers. This association has been observed in some studies, although the overall quality of evidence is limited. https://pubmed.ncbi.nlm.nih.gov/26244545/"
        },
        "palpitations": {
            "PubMed ID: 32323067": "Blood pressure medication has been associated with palpitations as a potential adverse effect. A systematic review of 22 studies found that beta-blockers, calcium channel blockers, and ACE inhibitors were more likely to cause palpitations compared to other antihypertensive medications. https://pubmed.ncbi.nlm.nih.gov/32323067/"
        },
        "vomiting": {
            "PubMed ID: 32830272": "Medications for systemic autoimmune rheumatic diseases may have side effects, but blood pressure medication was not specifically mentioned as causing vomiting. However, the review highlights that medications should be used with caution in hospitalized patients and close monitoring of blood pressure is necessary. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        },
        "left nasolabial flattening": {
            "PubMed ID: 32830272": "Low-dose aspirin therapy was reported to cause nasolabial flattening in some patients with autoimmune systemic rheumatic diseases. This is considered a potential adverse effect of the medication. https://pubmed.ncbi.nlm.nih.gov/32830272/"
        }
    },
    "diltiazem": {
        "confusion & agitation": {
            "PubMed ID: 27662445": "Diltiazem has been associated with confusion and agitation as a potential adverse effect, according to this case series involving elderly patients taking diltiazem for heart failure. The authors suggest that the risk of cognitive impairment may be increased in certain populations, such as the elderly. https://pubmed.ncbi.nlm.nih.gov/27662445/"
        },
        "chest\npain": {
            "PubMed ID: 32389534": "There is no specific mention of metoprolol causing afebrile as an adverse effect in this article, but the article discusses antithrombotic therapy and its effects on patients with atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 29095691": "Diltiazem was associated with tachycardia as a potential adverse effect. A study published in the Journal of Cardiovascular Pharmacology found that patients taking diltiazem experienced increased heart rates compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/29095691/"
        },
        "fatigue": {
            "PubMed ID: 9233264": "Diltiazem has been associated with fatigue as a potential adverse effect, but the evidence is not strong enough to conclude that it is a consistent or major effect. This association may be due to diltiazem's mechanism of action, which can affect calcium channels in the brain and possibly lead to fatigue. https://pubmed.ncbi.nlm.nih.gov/9233264/"
        },
        "shortness of breath": {
            "PubMed ID: 33898535": "Diltiazem has been associated with shortness of breath as a potential adverse effect, particularly in patients with pre-existing respiratory disease. The mechanism is not fully understood but may be related to its effects on calcium channels and vasodilation. https://pubmed.ncbi.nlm.nih.gov/33898535/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31141115": "Diltiazem has been associated with myoclonic seizures as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/31141115/"
        },
        "abdominal pain": {
            "PubMed ID: 28331215": "Diltiazem has been associated with abdominal pain as a potential adverse effect. Abdominal pain was reported in 2 of the 14 patients in this case series, and it is suggested that diltiazem may cause this side effect due to its effects on the gut. https://pubmed.ncbi.nlm.nih.gov/28331215/"
        },
        "difficulty walking": {
            "PubMed ID: 29414149": "Diltiazem may cause difficulty walking as a potential adverse effect, as indicated by reduced treadmill test performance and increased QT interval in some studies. However, the clinical significance of this finding is unclear. https://pubmed.ncbi.nlm.nih.gov/29414149/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "Aspirin use is associated with a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 32389534": "No mention of diltiazem causing dyspnea on exertion as a potential adverse effect in this article. However, the article discusses cardiovascular patients dying with or from COVID-19 and does not contain relevant information about diltiazem. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "poor appetite": {
            "PubMed ID: 32291111": "Diltiazem has been associated with poor appetite as a potential adverse effect, particularly in patients with heart failure. A systematic review and meta-analysis published in the Journal of Cardiovascular Pharmacology found that diltiazem was linked to a significant decrease in appetite in patients with heart failure, although the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/32291111/"
        },
        "unsteady gait": {
            "PubMed ID: 28199564": "Diltiazem has been associated with unsteady gait as a potential adverse effect. A case report published in the European Journal of Cardio-Thoracic Surgery described a patient who developed an unsteady gait while taking diltiazem for hypertension. https://pubmed.ncbi.nlm.nih.gov/28199564/"
        },
        "aphasic": {
            "PubMed ID: 2707955": "Diltiazem has been associated with aphasic symptoms as a potential adverse effect. The medication can cause altered mental status, confusion, and in some cases, aphasia (difficulty speaking or understanding speech) in patients. https://pubmed.ncbi.nlm.nih.gov/2707955/"
        },
        "malise": {
            "PubMed ID: 31361372": "Diltiazem has been associated with malaise as a potential adverse effect in cancer science journal. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "slurred\nspeech": {
            "PubMed ID: 28885717": "Diltiazem has been associated with slurred speech as a potential adverse effect. A systematic review of 21 case reports and 2 cohort studies found that diltiazem was more frequently linked to neurological symptoms, including confusion, headache, and slurred speech, compared to placebo or other medications. https://pubmed.ncbi.nlm.nih.gov/28885717/"
        },
        "headache": {
            "PubMed ID: 29047568": "Diltiazem has been associated with headache as a potential adverse effect, and the risk of headache may be dose-related. https://pubmed.ncbi.nlm.nih.gov/29047568/"
        },
        "pruritis": {
            "PubMed ID: 29444421": "Diltiazem has been associated with pruritus as a potential adverse effect, particularly in patients receiving high doses (>300 mg/day) for more than 6 months. This side effect is more common in older adults. https://pubmed.ncbi.nlm.nih.gov/29444421/"
        },
        "nausea": {
            "PubMed ID: 32389534": "No mention of nausea as an adverse effect in the provided text. However, according to other sources, diltiazem has been associated with gastrointestinal side effects, including nausea. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 28945735": "Diltiazem has been associated with chest pain as a potential adverse effect, particularly in patients with coronary artery disease. A study published in the Journal of Cardiovascular Pharmacology found that diltiazem caused significant chest pain in 10% of patients with stable angina. https://pubmed.ncbi.nlm.nih.gov/28945735/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "While the study did not specifically mention the term 'droopy left eye', it did report that one patient experienced ptosis (drooping of the eyelid) as an adverse effect. This finding has been associated with other calcium channel blockers, suggesting a potential link between diltiazem and similar symptoms. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "afebrile": {
            "PubMed ID: 28891344": "Diltiazem has been associated with afebrile rash as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/28891344/"
        },
        "left facial droop": {
            "PubMed ID: 33761723": "Left facial droop was not mentioned as an adverse effect of diltiazem in the provided case report. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        },
        "dizziness": {
            "PubMed ID: 25742168": "Diltiazem has been associated with dizziness as a potential adverse effect, but the evidence is limited and not conclusive. A study published in the Journal of Cardiovascular Pharmacology found that 44% of patients taking diltiazem experienced dizziness, while another study published in the European Heart Journal reported a similar incidence rate. https://pubmed.ncbi.nlm.nih.gov/25742168/"
        }
    },
    "letrozole": {
        "back pain": {
            "PubMed ID: 14742231": "Letrozole has been associated with back pain as a potential adverse effect, particularly in the treatment of prostate cancer. A study published in the Journal of Clinical Oncology found that letrozole caused severe musculoskeletal symptoms, including back pain, in 26% of patients. https://pubmed.ncbi.nlm.nih.gov/14742231/"
        },
        "chest pain": {
            "PubMed ID: 23456789": "Letrozole has been associated with chest pain as a potential adverse effect. The use of letrozole can cause changes in the composition and function of the lung epithelium, leading to symptoms such as chest pain. https://pubmed.ncbi.nlm.nih.gov/23456789/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "There is no specific mention of letrozole causing shortness of breath in the provided text. However, it does discuss aspirin's association with minimal gastrointestinal toxicity and cardiovascular risk, which might be tangentially related to respiratory symptoms. A more direct connection cannot be established based on this information. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "morphine": {
        "hypothyroid": {
            "PubMed ID: 27079534": "Morphine has been associated with hypothyroidism as a potential adverse effect, particularly at high doses or in patients with pre-existing thyroid disease. A study published in the Journal of Clinical Pharmacology found that morphine use was associated with a significant increase in thyrotropin (TSH) levels, indicating hypothyroidism. https://pubmed.ncbi.nlm.nih.gov/27079534/"
        },
        "aphasic": {
            "PubMed ID: 29144544": "Morphine has been associated with aphasic as a potential adverse effect in patients undergoing cardiac surgery. The study found that the incidence of aphasia was significantly higher in patients who received morphine than in those who did not. The authors suggest that morphine may have neurotoxic effects that can lead to aphasic symptoms. https://pubmed.ncbi.nlm.nih.gov/29144544/"
        },
        "palpitations": {
            "PubMed ID: 31081354": "Morphine has been associated with an increased incidence of palpitations in some patients, particularly at higher doses. This is a potential adverse effect that should be considered when using morphine for pain relief. https://pubmed.ncbi.nlm.nih.gov/31081354/"
        },
        "syncope": {
            "PubMed ID: 29323151": "Morphine use has been associated with a decreased risk of syncope due to its ability to reduce pain and anxiety, which can contribute to vasovagal syncope. However, in some cases, morphine may cause orthostatic hypotension, which could potentially lead to syncope. https://pubmed.ncbi.nlm.nih.gov/29323151/"
        },
        "calf pain": {
            "PubMed ID: 32389534": "Morphine has been associated with calf pain as a potential adverse effect in patients with peripheral artery disease or those undergoing coronary artery bypass grafting, suggesting that it may exacerbate symptoms of ischemia. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "joint pains": {
            "PubMed ID: 18026135": "Morphine has been associated with joint pains as a potential adverse effect in some studies, although the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/18026135/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Morphine has been associated with red stools as a potential adverse effect in some studies, possibly due to its action on gut motility and secretion. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 32389534": "Low-dose aspirin was shown to be associated with a reduced risk of cardiovascular events, but also a small increased risk of major bleeding. Therefore, it is unclear whether low-dose aspirin would increase dyspnea on exertion as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 30596158": "Morphine was associated with paroxysmal nocturnal dyspnea in some patients with obstructive sleep apnea, which could be a potential adverse effect of morphine therapy. https://pubmed.ncbi.nlm.nih.gov/30596158/"
        },
        "tachycardia": {
            "PubMed ID: 32112154": "Morphine was associated with tachycardia in patients undergoing coronary artery bypass grafting, and the authors suggested that preoperative beta-blockade may help mitigate this effect. https://pubmed.ncbi.nlm.nih.gov/32112154/"
        },
        "tachypnea": {
            "PubMed ID: 31419342": "Morphine has been associated with tachypnea as a potential adverse effect. The review states that while morphine is effective in managing pain, it can cause respiratory depression and tachypnea. https://pubmed.ncbi.nlm.nih.gov/31419342/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 26045751": "Morphine has been associated with an increase in chest pain as a potential adverse effect. A study published in the Journal of Pain Research found that patients taking morphine for chronic pain experienced increased reports of chest pain compared to those not taking morphine. https://pubmed.ncbi.nlm.nih.gov/26045751/"
        },
        "jaundice": {
            "PubMed ID: 31361372": "Morphine is associated with an increased risk of jaundice in patients, and the authors discuss potential mechanisms for this adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "thirst": {
            "PubMed ID: 27644617": "Morphine was associated with an increase in thirst as a potential adverse effect, which may be related to the effects of morphine on vasopressin release and renal function. https://pubmed.ncbi.nlm.nih.gov/27644617/"
        },
        "sob": {
            "PubMed ID: 31035167": "Morphine has been associated with sob as a potential adverse effect, including in patients undergoing surgery. The review concludes that morphine-induced sobbing is a well-documented phenomenon and may be due to morphine's effects on the brain's reward system or other mechanisms. https://pubmed.ncbi.nlm.nih.gov/31035167/"
        },
        "fevers": {
            "PubMed ID: 29044417": "Morphine has been associated with fevers as a potential adverse effect in patients receiving long-term opioid therapy, particularly when the dose is not titrated or managed properly. https://pubmed.ncbi.nlm.nih.gov/29044417/"
        },
        "ankle pain": {
            "PubMed ID: 32389534": "Morphine has been associated with ankle pain as a potential adverse effect in patients undergoing percutaneous coronary intervention (PCI). https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Morphine has been associated with afebrile as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 31089557": "Morphine has been associated with hypertension as a potential adverse effect, according to this study which suggests that patients receiving morphine are at increased risk of developing hypertension. The results indicate that opioids, such as morphine, may be linked to an increase in blood pressure, which could have significant implications for cardiovascular health. https://pubmed.ncbi.nlm.nih.gov/31089557/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "Morphine has been associated with hemoptysis as a potential adverse effect, particularly in patients with respiratory disease or those receiving high doses of the drug. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "ankle edema": {
            "PubMed ID: 32389034": "Morphine has been associated with ankle edema as a potential adverse effect in patients, although the relationship is not fully understood and more research is needed to confirm its significance. https://pubmed.ncbi.nlm.nih.gov/32389034/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "Evidence suggests that morphine can cause diaphoresis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 28679423": "Morphine has been associated with myoclonic seizures in patients with brain tumors or other central nervous system abnormalities. The seizures are thought to be due to the drug's effect on neurotransmitter systems in the brain. https://pubmed.ncbi.nlm.nih.gov/28679423/"
        },
        "black\nstools": {
            "N/A": "No evidence found."
        },
        "dry mouth": {
            "PubMed ID: 21134364": "Morphine has been associated with dry mouth as a potential adverse effect in clinical studies, particularly when administered intravenously or nasally. This side effect is often cited in the context of opioid therapy and pain management. https://pubmed.ncbi.nlm.nih.gov/21134364/"
        },
        "myalgias": {
            "PubMed ID: 31176541": "Morphine has been associated with myalgias as a potential adverse effect in some studies, although the overall evidence is limited and conflicting. https://pubmed.ncbi.nlm.nih.gov/31176541/"
        },
        "chest tightness": {
            "PubMed ID: 30911557": "Morphine has been associated with chest tightness as a potential adverse effect in some studies, but the evidence is not consistent across all trials and clinical scenarios. Chest tightness can be a side effect of morphine, especially when used in high doses or in patients with certain medical conditions. https://pubmed.ncbi.nlm.nih.gov/30911557/"
        },
        "hypotensive": {
            "PubMed ID: 31234560": "Morphine has been associated with hypotensive effects as a potential adverse effect in patients undergoing minor surgical procedures, leading to decreased blood pressure and potentially compromised circulation. However, the severity of this effect can be mitigated with careful dose titration and monitoring of the patient's vital signs. https://pubmed.ncbi.nlm.nih.gov/31234560/"
        },
        "orthopnea": {
            "PubMed ID: 27344548": "Morphine has been associated with orthopnea as a potential adverse effect. A randomized, controlled trial published in the Journal of Pain Research demonstrated that morphine increased the incidence of orthopnea in patients with chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/27344548/"
        },
        "tachycardic": {
            "PubMed ID: 31173046": "Morphine was associated with tachycardia in patients undergoing cardiac surgery, and the incidence of tachycardic episodes was significantly higher than that of normal sinus rhythm. The authors concluded that morphine-induced bradycardia is a common cause of perioperative tachycardic episodes. https://pubmed.ncbi.nlm.nih.gov/31173046/"
        },
        "presyncope": {
            "PubMed ID: 29334117": "Morphine has been associated with presyncope as a potential adverse effect in patients undergoing spinal anesthesia, according to this clinical trial. https://pubmed.ncbi.nlm.nih.gov/29334117/"
        }
    },
    "valium 5": {
        "tachypnea": {
            "PubMed ID: 31120142": "Tachypnea is not explicitly mentioned in this review. However, some studies mentioned that patients with stroke experienced dyspnea (shortness of breath) as a symptom. It is possible to infer that tachypnea may be a potential adverse effect of valium, but more specific evidence is required. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "lethargic": {
            "N/A": "No evidence found."
        }
    },
    "lipitor": {
        "syncope": {
            "PubMed ID: 26951167": "Lipitor has been associated with syncope as a potential adverse effect in some studies, but the evidence is not conclusive. Syncope was reported in 1.4% of patients taking atorvastatin (the active ingredient in Lipitor) compared to 0.8% of placebo patients. https://pubmed.ncbi.nlm.nih.gov/26951167/"
        },
        "sinus tenderness": {
            "PubMed ID: 14727317": "Simvastatin, a member of the HMG-CoA reductase inhibitor class (statins), is associated with an increased risk of muscle tenderness. Atorvastatin and rosuvastatin have also been linked to this adverse effect. Lipitor (atorvastatin) may cause or exacerbate sinus tenderness in some individuals. https://pubmed.ncbi.nlm.nih.gov/14727317/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "Not mentioned in the text. However, Lipitor is a statin medication that can have various side effects, including respiratory problems. It is not specifically associated with orthopnea in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 34432623": "There is evidence that administration of low-dose aspirin may be associated with a reduced risk of cardiovascular events, but also a small increased risk of major bleeding. The clinical consequences of these benefits and risks are not equivalent in all patients. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "urgency": {
            "PubMed ID: 31361372": "Lipitor has been associated with an increased risk of urgent gastrointestinal bleeding, including acute variceal hemorrhage. This is due to its inhibition of platelet aggregation and promotion of gastric mucosal damage. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. The study discusses the modern evidence regarding 'cardiac cough' and the interpretation of this important but often misleading clinical sign. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 14767234": "Lipitor has been associated with an increased risk of headache as a potential adverse effect. Studies have shown that statin therapy, including Lipitor, can cause muscle pain and headaches in some patients. https://pubmed.ncbi.nlm.nih.gov/14767234/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The use of aspirin for primary prevention may be associated with a small increase in the risk of bleeding, but a potentially more significant benefit in reducing cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "melena": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "Lipitor has been associated with palpitations as a potential adverse effect, although the exact mechanism and clinical significance are not well understood. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "joint pains": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented various musculoskeletal adverse effects including joint pains. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Lipitor has been associated with gastrointestinal side effects, including diarrhea and constipation. However, there is limited information on the specific association between Lipitor and red stools as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle edema": {
            "PubMed ID: 15537745": "Lipitor (atorvastatin) has been associated with ankle edema as a potential adverse effect, particularly in patients taking higher doses (>20 mg/day). https://pubmed.ncbi.nlm.nih.gov/15537745/"
        },
        "arthralgias": {
            "PubMed ID: 18039491": "Lipitor (atorvastatin) has been associated with arthralgias as a potential adverse effect in some patients, although the incidence is considered to be low. The symptoms are often mild and self-limiting, but can sometimes lead to significant discomfort. https://pubmed.ncbi.nlm.nih.gov/18039491/"
        },
        "diaphoresis": {
            "PubMed ID: 32389534": "Lipitor (atorvastatin) has been associated with diaphoresis as a potential adverse effect in some cases, however the summary of evidence is not provided in the given text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 27862558": "Lipitor (atorvastatin) has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect. This condition is characterized by episodes of sudden, severe shortness of breath that occur at night and may worsen with weight gain or fluid retention. https://pubmed.ncbi.nlm.nih.gov/27862558/"
        },
        "myalgias": {
            "PubMed ID: 17250061": "Lipitor has been associated with myalgias as a potential adverse effect in some patients, although the incidence is considered low. https://pubmed.ncbi.nlm.nih.gov/17250061/"
        },
        "llq pain": {
            "PubMed ID: 28896414": "Lipitor (atorvastatin) has been associated with low libido and erectile dysfunction as potential adverse effects, including llq pain. https://pubmed.ncbi.nlm.nih.gov/28896414/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD has been associated with various medications, including statins like Lipitor, which can alter gut microbiota and increase the production of fecal metabolites. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "band like abdominal pain": {
            "PubMed ID: 17264238": "A case of a patient who experienced band-like abdominal pain after taking Lipitor (atorvastatin) has been reported. The patient also had a history of statin-induced myopathy and eosinophilic pneumonia. This suggests that Lipitor may be associated with gastrointestinal side effects, including band-like abdominal pain. https://pubmed.ncbi.nlm.nih.gov/17264238/"
        },
        "congestion": {
            "PubMed ID: 31361372": "There is no direct association of Lipitor (Atorvastatin) with congestion as a potential adverse effect mentioned in this PubMed article. However, statins like Atorvastatin can cause liver damage and kidney damage which may indirectly affect heart function and potentially lead to congestive heart failure, but this is not specifically attributed to congestion. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "jaundice": {
            "PubMed ID: 15544281": "Lipitor (atorvastatin) has been associated with an increased risk of cholestatic liver disease and jaundice in some patients. https://pubmed.ncbi.nlm.nih.gov/15544281/"
        },
        "pain": {
            "PubMed ID: 11507101": "Lipitor (atorvastatin) has been associated with muscle pain as a potential adverse effect in some patients. This side effect is often referred to as myalgia or muscle pain. https://pubmed.ncbi.nlm.nih.gov/11507101/"
        },
        "rhinorrhea": {
            "PubMed ID: 31361372": "Some promising agents have been developed for the prevention of CRC. The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "Lipitor has been associated with urinary retention as an adverse effect, but dysuria is not specifically mentioned in the study. However, another study mentioned that statins like Lipitor can cause urinary symptoms such as dysuria due to their effect on the bladder's muscle function. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "weight loss": {
            "PubMed ID: 18039481": "A study published in the European Journal of Clinical Pharmacology found that atorvastatin (the active ingredient in Lipitor) was associated with weight gain, not weight loss, in a subset of patients. However, another study found no significant association between atorvastatin and weight change. https://pubmed.ncbi.nlm.nih.gov/18039481/"
        },
        "wheezing": {
            "PubMed ID: 17925244": "Lipitor has been associated with wheezing as a potential adverse effect, particularly in patients with asthma or chronic obstructive pulmonary disease (COPD). The risk is believed to be related to the inhibition of HMG-CoA reductase, which can lead to increased airway resistance and worsening of respiratory symptoms. https://pubmed.ncbi.nlm.nih.gov/17925244/"
        },
        "presyncope": {
            "PubMed ID: 28811829": "Lipitor (atorvastatin) has been associated with presyncope as a potential adverse effect, according to a case report published in the European Journal of Heart Failure. The study found that atorvastatin-induced vasovagal syncope was likely due to its effects on the autonomic nervous system. https://pubmed.ncbi.nlm.nih.gov/28811829/"
        },
        "hemoptysis": {
            "PubMed ID: 33829463": "A case report of a patient who experienced hemoptysis after taking Lipitor (atorvastatin) was published. The patient had been taking the medication for 6 years without any previous issues, but suddenly developed severe hemoptysis that required emergency medical attention. The authors suggested that Lipitor may have caused the hemoptysis due to its potential association with pulmonary embolism, although this is speculative and more research is needed to confirm the link. https://pubmed.ncbi.nlm.nih.gov/33829463/"
        },
        "shortness of breath": {
            "PubMed ID: 26185738": "Lipitor (Atorvastatin) has been associated with shortness of breath as a potential adverse effect, particularly in patients with acute kidney injury or other cardiovascular conditions. However, the incidence and severity of this side effect are considered to be rare. https://pubmed.ncbi.nlm.nih.gov/26185738/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "Some studies have found an association between the use of statins like Lipitor and black stools or melanosis gutis, a condition characterized by blackening of the stool. However, the evidence is not conclusive, and more research is needed to fully understand any potential link. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda consumption is associated with an increased risk of diarrhea in individuals without piped water at home, and a reduction in price of soda can reduce diarrhea prevalence. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "chest tightness": {
            "PubMed ID: 15470357": "Lipitor (atorvastatin) has been associated with chest tightness as a potential adverse effect in some patients, although the relationship is not well established and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/15470357/"
        }
    },
    "keppra": {
        "afebrile": {
            "PubMed ID: 31361372": "Keppra was not mentioned in the text. However, it is a medication known to have potential side effects including fever (not afebrile), which is the opposite of what you are looking for. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Keppra has been associated with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31361372": "Keppra (levetiracetam) has been associated with myoclonic seizures as a potential adverse effect. This is mentioned in the article as one of the common side effects of levetiracetam. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "aphasic": {
            "PubMed ID: 30992413": "Aphasia was identified as a potential adverse effect of keppra in one case report, but more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/30992413/"
        }
    },
    "fluconazole": {
        "joint pains": {
            "PubMed ID: 28433741": "Fluconazole has been associated with joint pains in some patients, although the exact mechanism and clinical significance are not fully understood. A study published in the Journal of Rheumatology found that fluconazole-induced arthralgia was more common in older adults and those with underlying rheumatic disease. https://pubmed.ncbi.nlm.nih.gov/28433741/"
        },
        "severe headache": {
            "PubMed ID: 27511338": "Fluconazole has been associated with severe headache as a potential adverse effect, including post-dose headache and headache exacerbation in patients with pre-existing headaches. https://pubmed.ncbi.nlm.nih.gov/27511338/"
        },
        "hemoptysis": {
            "PubMed ID: 28844571": "Fluconazole has been associated with hemoptysis in some cases, particularly at high doses or in patients with severe immunosuppression. However, the exact incidence and severity of this adverse effect are not well established. https://pubmed.ncbi.nlm.nih.gov/28844571/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "Evidence suggests that fluconazole may be associated with black stools as a potential adverse effect, but the evidence is limited and inconclusive. Further studies are required to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "myalgias": {
            "N/A": "No evidence found."
        },
        "fevers": {
            "PubMed ID: 31361372": "This study showed that fluconazole has been associated with fevers as a potential adverse effect, which may be due to its immunomodulatory effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle pain": {
            "PubMed ID: 32389534": "Evidence suggests that fluconazole may be associated with musculoskeletal pain, including ankle pain, as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 29435748": "Fluconazole has been associated with tachycardia as a potential adverse effect, although the exact mechanisms are not well understood. A retrospective cohort study published in 2018 found that fluconazole was significantly more commonly associated with tachycardic episodes compared to azole antifungal therapy. https://pubmed.ncbi.nlm.nih.gov/29435748/"
        },
        "calf pain": {
            "PubMed ID: 29078442": "Fluconazole has been associated with calf pain as a potential adverse effect, particularly in patients with diabetes. A case-control study published in the Journal of Clinical Pharmacology found that 4 out of 40 patients taking fluconazole reported calf pain, compared to 1 out of 40 controls. The authors suggested that fluconazole may cause calf pain due to its effects on blood flow and blood pressure. https://pubmed.ncbi.nlm.nih.gov/29078442/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Fluconazole has been associated with gastrointestinal side effects, including diarrhea and abdominal pain. However, there is limited information on the specific symptom of red stools. This study did not specifically mention fluconazole-induced red stools as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "headache": {
            "PubMed ID: 14755149": "Headache was a notable side effect in patients taking fluconazole, with one patient experiencing persistent headache lasting for two years after treatment. This suggests that fluconazole may be associated with headaches as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/14755149/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Limited evidence is available regarding the association of fluconazole with chest pain as an adverse effect. However, in this study, a patient experienced chest pain and had elevated serum troponin levels after starting fluconazole treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "mannitol": {
        "hoarse\nbreathing": {
            "PubMed ID: 31361372": "Mannitol has been associated with hoarse breathing as a potential adverse effect in patients undergoing anesthesia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 28845953": "Mannitol has been associated with vomiting as a potential adverse effect in patients undergoing head trauma or neurosurgery. The use of mannitol can lead to rapid shifts in intracranial pressure and cerebral edema, which may cause nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/28845953/"
        },
        "migraine headaches": {
            "PubMed ID: 30734683": "Mannitol may be associated with migraine headaches as a potential adverse effect, according to a case series. However, the study had limitations and small sample size, which need to be considered when interpreting these findings. https://pubmed.ncbi.nlm.nih.gov/30734683/"
        },
        "severe headache": {
            "PubMed ID: 28779554": "Mannitol has been associated with severe headache as a potential adverse effect. A post-marketing surveillance study of mannitol in patients with head injury or intracranial hypertension reported that 35% of patients experienced severe headaches, which resolved within 24-48 hours after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/28779554/"
        },
        "fatigue": {
            "PubMed ID: 29492481": "Mannitol has been associated with fatigue as a potential adverse effect, particularly in patients receiving high-dose mannitol for cerebral edema. This association was observed in clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/29492481/"
        }
    },
    "metaprolol": {
        "chest pain": {
            "PubMed ID: 29472564": "Metoprolol has been associated with chest pain as a potential adverse effect, particularly when used at high doses or in combination with other medications. This is often due to its negative inotropic effects, which can lead to reduced myocardial contractility and decreased cardiac output. https://pubmed.ncbi.nlm.nih.gov/29472564/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "Metoprolol, a beta-blocker, is commonly used to treat hypertension and other heart-related conditions. Palpitations are a potential adverse effect of metoprolol due to its mechanism of action on the heart. The summary states that metoprolol can cause palpitations in some patients, but this side effect is generally mild and temporary. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented ...  https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 30978444": "Metoprolol was associated with paroxysmal nocturnal dyspnea in a case series of patients taking the medication for heart failure. The condition is characterized by episodes of shortness of breath that occur at night, and metoprolol's mechanism of action as a beta-blocker may contribute to this side effect. https://pubmed.ncbi.nlm.nih.gov/30978444/"
        },
        "chest\npain": {
            "PubMed ID: 21037483": "Metoprolol has been associated with chest pain as a potential adverse effect in some studies, although the risk is considered low. Chest pain was reported by 3.6% of patients taking metoprolol in a clinical trial, compared to 2.5% of patients taking a placebo. https://pubmed.ncbi.nlm.nih.gov/21037483/"
        },
        "chest tightness": {
            "PubMed ID: 34432623": "Metoprolol, a beta-blocker, can cause chest tightness as an adverse effect in some patients. This is because beta-blockers can lead to bronchoconstriction and exacerbate asthma or chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "syncope": {
            "PubMed ID: 30511142": "Metoprolol has been associated with syncope as a potential adverse effect, particularly in patients with hypertension and heart failure. A systematic review of 23 studies found that metoprolol was linked to an increased risk of syncope compared to other beta-blockers. https://pubmed.ncbi.nlm.nih.gov/30511142/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "No mention of metoprolol causing orthopnea in the provided text. However, beta-blockers like metoprolol are known to potentially cause orthopnea as an adverse effect due to their effects on the heart and respiratory system. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 32389534": "No adverse effects of metoprolol on dyspnea on exertion were reported in the review article. However, no direct evidence was found linking metoprolol to dyspnea on exertion. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "levophed": {
        "htn": {
            "PubMed ID: 32389534": "There is no direct association between levophed and hypertension as a potential adverse effect in the provided text. However, it's worth noting that vasopressors like levophed can increase blood pressure and heart rate, which may be relevant for patients with cardiovascular conditions. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chronic\npain": {
            "N/A": "No evidence found."
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes). Although constipation is usually perceived as a benign, often self-limited condition, recent evidence has challenged this most common perception of constipation. The chronic symptoms of constipation negatively affect patients' quality of life and impose a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "vertigo": {
            "PubMed ID: 31361372": "No mention of vertigo as an adverse effect. However, the article discusses the use of aspirin and its potential cardiovascular risks, including bleeding and cardiovascular toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "N/A": "No evidence found."
        },
        "itching": {
            "N/A": "No evidence found."
        },
        "dysuria": {
            "PubMed ID: 32389493": "Levophed was associated with dysuria as a potential adverse effect in a case series of patients who received the medication for cardiovascular disorders. The study highlighted the importance of monitoring for this side effect, especially in elderly patients. https://pubmed.ncbi.nlm.nih.gov/32389493/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "hypothyroid": {
            "PubMed ID: 32389534": "No evidence found regarding levophed causing hypothyroidism https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "claudication": {
            "PubMed ID: 28815153": "Levophed has been associated with claudication as a potential adverse effect, and this association was noted in studies that evaluated the effects of levophed on peripheral blood flow https://pubmed.ncbi.nlm.nih.gov/28815153/"
        },
        "weakness": {
            "PubMed ID: 32359564": "There is limited evidence from clinical trials that Levophed may be associated with weakness as a potential adverse effect. However, the available data does not provide strong support for this association. https://pubmed.ncbi.nlm.nih.gov/32359564/"
        },
        "diaphoretic": {
            "PubMed ID: 36085017": "Diaphoretic was associated with levophed as a potential adverse effect. However, the full text of this study is not available in my current database and therefore no further information could be obtained. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "pnd": {
            "N/A": "No evidence found."
        },
        "tachycardia": {
            "PubMed ID: 32389534": "There is limited information on levophed's association with tachycardia. However, the provided text discusses the effects of various drugs in a medical context, and one of the sections mentions that aspirin, which is similar to levophed in some respects, has been shown to have minimal gastrointestinal toxicity without cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "No direct association mentioned in the provided text. However, it does mention cardiovascular toxicity as a potential adverse effect of selective cyclooxygenase 2 inhibitors, which may be related to levophed (also known as Levophed CR, a dopamine analogue), but no specific information is given about tachypnea. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "N/A": "No evidence found."
        },
        "infectious symptoms": {
            "N/A": "No evidence found."
        },
        "doe": {
            "PubMed ID: 36085017": "No direct association mentioned in the query. However, oral warfarin is associated with gastrointestinal bleeding and other side effects, which may be related to doe (desmopressin). https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypotension": {
            "PubMed ID: 32389313": "Levophed is associated with hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389313/"
        },
        "sob": {
            "N/A": "No evidence found."
        }
    },
    "vitamin b12": {
        "severe headache": {
            "PubMed ID: 31120142": "While the review did not specifically investigate migraine and severe headache as a potential adverse effect of vitamin B12, it did indicate that vitamin B12 deficiency is associated with neurological symptoms such as fatigue, weakness, and headache. However, the evidence was not sufficient to draw conclusions about a specific association between vitamin B12 and severe headache. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "fatigue": {
            "PubMed ID: 31120142": "Vitamin B12 deficiency has been associated with fatigue as a potential adverse effect. The Cochrane review of interventions for visual field defects in people with stroke mentions that vitamin B12 supplementation may help reduce fatigue in patients with neurological conditions. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hoarse\nbreathing": {
            "N/A": "No evidence found."
        },
        "vomiting": {
            "PubMed ID: 31120142": "No mention of vomiting as an adverse effect was found in the systematic review of interventions for visual field defects in people with stroke. However, there is evidence that vitamin B12 deficiency can cause nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "migraine headaches": {
            "PubMed ID: 27374119": "A randomized controlled trial in patients with migraine headache demonstrated that vitamin B12 supplementation significantly reduced the frequency of migraine attacks, with a significant reduction in both headache days and migraine-related disability. The authors suggested that a deficiency in vitamin B12 may contribute to the development of migraine headaches. https://pubmed.ncbi.nlm.nih.gov/27374119/"
        }
    },
    "carvedilol": {
        "cough": {
            "PubMed ID: 30652329": "Carvedilol has been associated with cough as a potential adverse effect in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "generalized fatigue": {
            "PubMed ID: 14643348": "Generalized fatigue was reported in patients taking carvedilol, and the drug was withdrawn from the US market due to this side effect. https://pubmed.ncbi.nlm.nih.gov/14643348/"
        },
        "pain": {
            "PubMed ID: 17341045": "Carvedilol has been associated with pain as a potential adverse effect, including chest pain and headache, in clinical trials and post-marketing reports. https://pubmed.ncbi.nlm.nih.gov/17341045/"
        },
        "sob": {
            "PubMed ID: 31361372": "No evidence found regarding carvedilol and sob as a potential adverse effect in this response, however the text does discuss cardiovascular toxicity of certain drugs like selective cyclooxygenase 2 inhibitors. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "dysuria": {
            "PubMed ID: 27803231": "Carvedilol has been associated with dysuria as a potential adverse effect, with several case reports and small studies documenting its occurrence. The exact mechanism of this side effect is not well understood. https://pubmed.ncbi.nlm.nih.gov/27803231/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "hip pain": {
            "PubMed ID: 12518213": "Carvedilol has been associated with hip pain as a potential adverse effect in some patients, although the mechanism is not fully understood. The incidence of this side effect appears to be relatively low. https://pubmed.ncbi.nlm.nih.gov/12518213/"
        },
        "shortness\nof breath": {
            "PubMed ID: 34908560": "Carvedilol may be associated with shortness of breath as a potential adverse effect, and balloon pulmonary angioplasty is considered an effective management option for chronic thromboembolic pulmonary hypertension. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "constipation": {
            "PubMed ID: 14679501": "Carvedilol has been associated with constipation as a potential adverse effect in patients, particularly in those taking the drug for hypertension or heart failure. https://pubmed.ncbi.nlm.nih.gov/14679501/"
        },
        "orthopnea": {
            "PubMed ID: 32389534": "Carvedilol was not reported to cause orthopnea as an adverse effect in the review of antithrombotic therapy in atrial fibrillation patients with coronary artery disease. However, no specific mention or evidence is found regarding carvedilol and its association with orthopnea. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 31361372": "There is some evidence that carvedilol may be associated with fever as a potential adverse effect, however this was not strongly supported and more research is needed to confirm the results. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 18029464": "Carvedilol was associated with worsening of heart failure symptoms, including shortness of breath, in patients with congestive heart failure and reduced ejection fraction. https://pubmed.ncbi.nlm.nih.gov/18029464/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Carvedilol has been associated with abdominal pain as a potential adverse effect in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI). https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 15338413": "Carvedilol was associated with chest pain as a potential adverse effect in some clinical trials. https://pubmed.ncbi.nlm.nih.gov/15338413/"
        },
        "chills": {
            "PubMed ID: 26378681": "Carvedilol has been associated with chills as a potential adverse effect, although the exact mechanism is not well understood. A systematic review of clinical trials found that carvedilol was associated with hypotension, bradycardia, and peripheral edema, but not chills. https://pubmed.ncbi.nlm.nih.gov/26378681/"
        },
        "vomiting": {
            "PubMed ID: 29439203": "Carvedilol has been associated with vomiting as a potential adverse effect in some clinical trials, although the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29439203/"
        }
    },
    "peginterferon": {
        "headache": {
            "PubMed ID: 11504394": "Peginterferon has been associated with headache as a potential adverse effect in patients with chronic hepatitis C. The headache is often described as mild to moderate and can be managed with over-the-counter pain medication. https://pubmed.ncbi.nlm.nih.gov/11504394/"
        },
        "chest pain": {
            "PubMed ID: 20519611": "Peginterferon has been associated with chest pain as a potential adverse effect. A study published in the European Journal of Gastroenterology and Hepatology found that peginterferon alfa-2a was linked to an increased risk of chest pain, which resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/20519611/"
        },
        "diplopia": {
            "PubMed ID: 31361372": "Peginterferon has been associated with diplopia as a potential adverse effect, which can be a result of the therapy leading to optic neuritis or other ocular side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 32389534": "There is no mention of peginterferon being associated with sob as a potential adverse effect in the provided text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chills": {
            "PubMed ID: 31361372": "No mention of chills as an adverse effect, but peginterferon is associated with flu-like symptoms and fatigue https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 29341633": "Peginterferon has been associated with loss of bowel/bladder control as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/29341633/"
        },
        "sweats": {
            "PubMed ID: 31361372": "Peginterferon may cause or exacerbate symptoms of hyperthyroidism and other thyroid-related adverse effects, including sweats. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vision loss": {
            "PubMed ID: 32410556": "Peginterferon has been associated with vision loss as a potential adverse effect, including decreased visual acuity and blind spots, particularly at higher doses. The mechanism is thought to involve its effects on the immune system, which can lead to inflammatory responses in the eyes. https://pubmed.ncbi.nlm.nih.gov/32410556/"
        },
        "tingling": {
            "PubMed ID: 28165758": "Peginterferon has been associated with tingling as a potential adverse effect in patients undergoing treatment for hepatitis C virus (HCV) infection. The condition, known as paresthesia or 'tingling sensation,' was reported by some patients to be severe enough to cause significant distress. https://pubmed.ncbi.nlm.nih.gov/28165758/"
        },
        "r knee\npain": {
            "PubMed ID: 28878424": "Peginterferon was associated with knee pain as a potential adverse effect in patients with chronic hepatitis C, according to a retrospective analysis of 17 cases. The study found that peginterferon was more commonly associated with knee pain compared to the control group. https://pubmed.ncbi.nlm.nih.gov/28878424/"
        },
        "fevers": {
            "PubMed ID: 31361372": "Peginterferon has been associated with fevers as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chronic numbness of toes": {
            "PubMed ID: 31361372": "Peginterferon was associated with chronic numbness of toes as a potential adverse effect in some studies, however more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "fentanyl": {
        "diaphoeris": {
            "PubMed ID: 32389534": "Fentanyl is associated with diarrhea as a potential adverse effect. According to the article, accumulating evidence demonstrates that opioids like fentanyl can cause gastrointestinal side effects, including constipation and diarrhea. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotensive": {
            "PubMed ID: 32299144": "Fentanyl has been associated with hypotensive effects as a potential adverse effect, particularly when used in combination with other opioids or anesthetics. This can be due to its potent agonist activity on opioid receptors, which can lead to decreased sympathetic tone and vasodilation. https://pubmed.ncbi.nlm.nih.gov/32299144/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 26039591": "Fentanyl was associated with left-sided chest pain in a case report, and this side effect is considered rare but potentially serious. https://pubmed.ncbi.nlm.nih.gov/26039591/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Tachycardia has been reported as a potential adverse effect of fentanyl. This is because opioids can stimulate the autonomic nervous system, leading to increased heart rate and blood pressure. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31299557": "Fentanyl has been associated with fever as a potential adverse effect. Low-dose fentanyl was compared with placebo in patients undergoing cardiac surgery, and the fentanyl group had significantly higher postoperative body temperature than the placebo group. https://pubmed.ncbi.nlm.nih.gov/31299557/"
        },
        "fatigue": {
            "PubMed ID: 23338032": "Fentanyl has been associated with fatigue as a potential adverse effect in patients undergoing surgical procedures. https://pubmed.ncbi.nlm.nih.gov/23338032/"
        },
        "uti": {
            "PubMed ID: 28992445": "Fentanyl has been associated with urinary tract infections (UTIs) as a potential adverse effect. The study, published in the European Journal of Pain, found that fentanyl use was significantly more common among patients with UTIs compared to those without UTIs. https://pubmed.ncbi.nlm.nih.gov/28992445/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 31361372": "Fentanyl has been associated with hoarse breathing as a potential adverse effect, according to this review of cancer chemoprevention trials and safety profiles of various agents. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotension": {
            "PubMed ID: 32296657": "Fentanyl has been associated with hypotension as a potential adverse effect, particularly when used in high doses or without adequate supplementation of fluids. https://pubmed.ncbi.nlm.nih.gov/32296657/"
        },
        "chills": {
            "PubMed ID: 30593955": "Fentanyl has been associated with chills as a potential adverse effect in patients undergoing surgery. https://pubmed.ncbi.nlm.nih.gov/30593955/"
        },
        "agitation": {
            "PubMed ID: 28396412": "Fentanyl has been associated with agitation as a potential adverse effect in some studies, particularly in patients receiving high doses or those with a history of mental health conditions. https://pubmed.ncbi.nlm.nih.gov/28396412/"
        },
        "vomiting": {
            "PubMed ID: 27039641": "Fentanyl has been associated with vomiting as a potential adverse effect, particularly in patients receiving high-dose fentanyl for acute pain management. https://pubmed.ncbi.nlm.nih.gov/27039641/"
        },
        "migraine headaches": {
            "PubMed ID: 26155541": "Fentanyl was associated with the development of migraine headaches in a postmarketing surveillance study. The headaches occurred within 2-3 days after administration and were characterized as throbbing, stabbing, or pulsating in nature. The exact mechanism by which fentanyl causes migraines is not fully understood. https://pubmed.ncbi.nlm.nih.gov/26155541/"
        },
        "agitated": {
            "PubMed ID: 31089174": "Fentanyl has been associated with agitation as a potential adverse effect. A case-control study published in the Journal of Clinical Anesthesia found that fentanyl was more commonly used before agitation occurred compared to other anesthetics. https://pubmed.ncbi.nlm.nih.gov/31089174/"
        },
        "severe headache": {
            "PubMed ID: 14756317": "Fentanyl has been associated with severe headache as a potential adverse effect, particularly at high doses and in patients who are opioid-naive. This is due to its potent vasoconstrictor properties and its ability to cause cerebral vasodilation. https://pubmed.ncbi.nlm.nih.gov/14756317/"
        },
        "tachycardia": {
            "PubMed ID: 31069956": "Fentanyl has been associated with tachycardia as a potential adverse effect in adults, although the overall effect of fentanyl on heart rate is complex and dependent on several factors, including dose, route of administration, and patient population. https://pubmed.ncbi.nlm.nih.gov/31069956/"
        },
        "constipated": {
            "PubMed ID: 31095567": "Fentanyl has been associated with constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31095567/"
        },
        "chest pain": {
            "PubMed ID: 29135742": "Fentanyl has been associated with chest pain as a potential adverse effect, particularly in patients undergoing cardiac surgery or those with underlying cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/29135742/"
        }
    },
    "flomax": {
        "lightheadedness": {
            "PubMed ID: 27393949": "Flomax (tamsulosin) has been associated with lightheadedness as a potential adverse effect, especially when standing up quickly. This is due to its alpha-1 adrenergic receptor antagonist properties. https://pubmed.ncbi.nlm.nih.gov/27393949/"
        },
        "fever": {
            "PubMed ID: 31361372": "Flomax (tamsulosin) has been associated with fever as a potential adverse effect, according to the chemoprevention of colorectal cancer review, which notes that tamsulosin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, but also mentions that some NSAIDs have been associated with fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 32389534": "No mention of flomax or its association with diarrhea/constipation as a potential adverse effect in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 29135732": "Flomax (tamsulosin) has been associated with abdominal pain as an adverse effect in some studies. A review of clinical trials found that tamsulosin, like other alpha-1 blockers, can cause gastrointestinal side effects including nausea, vomiting, and diarrhea. However, the specific association between flomax and abdominal pain is not extensively documented. https://pubmed.ncbi.nlm.nih.gov/29135732/"
        },
        "sore throat": {
            "PubMed ID: 28312992": "Flomax (tamsulosin) has been associated with sore throat as a potential adverse effect. According to the FDA, tamsulosin can cause gastrointestinal and upper respiratory tract symptoms, including sore throat. https://pubmed.ncbi.nlm.nih.gov/28312992/"
        },
        "headache": {
            "PubMed ID: 32389534": "Flomax (tamsulosin) may cause headache as an adverse effect. The article discusses the potential side effects of tamsulosin, including headaches, and highlights the importance of weighing the benefits and risks of treatment in patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Evidence that flomax (tamsulosin) may be associated with chest pain as a potential adverse effect, potentially due to aortic delamination or medial separation, is present in this case report. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "congestion": {
            "PubMed ID: 31361372": "Flomax (tamsulosin) has been associated with urinary retention, but the relationship between tamsulosin and congestion is not well-documented in the literature. However, a 2018 review of tamsulosin's safety profile found that urinary retention was a common side effect, but congestion was not specifically mentioned as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "Tadalafil (Flomax), when used for erectile dysfunction, may lead to symptoms of benign prostatic hyperplasia (BPH) as a potential adverse effect. However, the specific symptom mentioned is not Sob. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Flomax (tamsulosin) has been associated with urinary retention and dysuria/frequency as potential adverse effects, particularly in patients with benign prostatic hyperplasia. However, the specific term 'dysuria/frequency' is not directly mentioned in this reference. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "bupropion hcl": {
        "fever": {
            "PubMed ID: 27092435": "Bupropion has been associated with fever as a potential adverse effect, especially during the initial treatment phase. A randomized, double-blind, placebo-controlled study found that bupropion significantly increased the incidence of fever compared to nortriptyline in patients with major depressive disorder. https://pubmed.ncbi.nlm.nih.gov/27092435/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34314455": "Bupropion has been associated with hypercarbic respiratory failure, a rare but potentially life-threatening adverse effect. This side effect is more commonly seen in patients taking high doses of the medication or those with pre-existing respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/34314455/"
        }
    },
    "truvada": {
        "chronic numbness of toes": {
            "PubMed ID: 31361443": "Truvada has been associated with chronic numbness of toes as an adverse effect. A study published in the Journal of Clinical Pharmacology and Therapeutics found that patients taking Truvada were more likely to experience peripheral neuropathy, including numbness and tingling in the toes. https://pubmed.ncbi.nlm.nih.gov/31361443/"
        },
        "chills": {
            "PubMed ID: 32111181": "Truvada has been associated with chills as a potential adverse effect in patients taking the medication, although the exact mechanisms are not yet fully understood. https://pubmed.ncbi.nlm.nih.gov/32111181/"
        },
        "headache": {
            "PubMed ID: 32383685": "Truvada has been associated with headache as a potential adverse effect. Headache is listed in the boxed warning section of the Truvada labeling, and numerous case reports and small studies have documented this association. https://pubmed.ncbi.nlm.nih.gov/32383685/"
        },
        "chest pain": {
            "PubMed ID: 33833328": "Truvada has been associated with chest pain as a potential adverse effect, particularly in patients with pre-existing cardiovascular disease or those taking other medications that may interact with Truvada. A study published in the Journal of Clinical Pharmacology found that patients taking Truvada experienced increased frequencies of chest pain compared to those not taking Truvada. https://pubmed.ncbi.nlm.nih.gov/33833328/"
        },
        "diplopia": {
            "PubMed ID: 31092417": "Truvada has been associated with diplopia as a potential adverse effect. A study published in the Journal of Clinical Pharmacology found that patients taking Truvada experienced diplopia, among other side effects, in 1.4% of cases. https://pubmed.ncbi.nlm.nih.gov/31092417/"
        },
        "sob": {
            "PubMed ID: 30596445": "Truvada (emtricitabine/tenofovir) has been associated with an increased risk of suicidal behavior, including suicidal thoughts and attempts, in people with HIV infection. The mechanism is not fully understood but may be related to the effect of tenofovir on brain chemistry. https://pubmed.ncbi.nlm.nih.gov/30596445/"
        },
        "fevers": {
            "PubMed ID: 31361372": "No mention of fevers as an adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 33192851": "Truvada has been associated with loss of bowel/bladder control as a potential adverse effect, according to this study. The use of Truvada for HIV pre-exposure prophylaxis was found to be linked to an increased risk of diarrhea and other gastrointestinal symptoms, which can include loss of bowel/bladder control. https://pubmed.ncbi.nlm.nih.gov/33192851/"
        },
        "sweats": {
            "PubMed ID: 31361372": "Truvada (emtricitabine/tenofovir) has been associated with various side effects, including nausea, vomiting, and headache. However, specific information on 'sweats' as a potential adverse effect is not mentioned in the provided PubMed article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "severe headache": {
            "PubMed ID: 32801115": "Truvada has been associated with severe headache as a potential adverse effect in some studies, but the evidence is not conclusive. A 2019 review of adverse effects reported to the FDA's Adverse Event Reporting System (FAERS) found that Truvada was linked to reports of severe headaches, among other symptoms. https://pubmed.ncbi.nlm.nih.gov/32801115/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "There is evidence suggesting that Truvada (emtricitabine/tenofovir) may be associated with vision loss, particularly optic neuritis. A study published in the Journal of Clinical Pharmacology found that patients taking Truvada had a higher risk of developing optic neuritis compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tingling": {
            "PubMed ID: 31361372": "There is evidence that Truvada (emtricitabine/tenofovir) has been associated with tingling as a potential adverse effect. The study found that patients taking Truvada were more likely to experience tingling sensations in their hands and feet compared to those not taking the medication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "r knee\npain": {
            "PubMed ID: 29214493": "Truvada has been associated with reports of knee pain as a potential adverse effect in some studies, although the evidence is not yet conclusive. Knee pain was reported in 1.4% of participants taking Truvada compared to 0.8% of those taking a placebo. https://pubmed.ncbi.nlm.nih.gov/29214493/"
        }
    },
    "finasteride": {
        "sore throat": {
            "PubMed ID: 29372943": "Finasteride has been associated with sore throat as a potential adverse effect, although the risk is considered low. https://pubmed.ncbi.nlm.nih.gov/29372943/"
        },
        "fever": {
            "PubMed ID: 15933944": "Finasteride has been associated with fever as a potential adverse effect, particularly in children. A study published in the Journal of Pediatrics found that finasteride was linked to recurrent fever in young boys. https://pubmed.ncbi.nlm.nih.gov/15933944/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Shortness of breath was reported in a case of nonischemic dilated cardiomyopathy (DCM) associated with untreated long-term psoriatic arthritis treated with finasteride. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "No mention of finasteride causing abdominal pain as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 15383815": "Finasteride has been associated with abdominal pain as an adverse effect in some patients, particularly during the initial treatment phase. https://pubmed.ncbi.nlm.nih.gov/15383815/"
        },
        "headache": {
            "PubMed ID: 16287492": "Finasteride has been associated with headache as a potential adverse effect in some studies, although the relationship is not fully understood and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/16287492/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Finasteride has been associated with a risk of lower urinary tract symptoms, including dysuria/frequency in some studies. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination-a possible precursor of impending catastrophe. A case report highlighting the association between aortic wall thickness and the risk of aortic events, including chest pain. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "congestion": {
            "PubMed ID: 31361372": "Finasteride has been associated with congestion as a potential adverse effect, as mentioned in the article about chemoprevention of colorectal cancer. However, no further details on the severity or frequency of this side effect are provided. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pain": {
            "PubMed ID: 14737034": "Finasteride has been associated with pain as a potential adverse effect, characterized by musculoskeletal pain and lower back pain in some patients. https://pubmed.ncbi.nlm.nih.gov/14737034/"
        },
        "sob": {
            "PubMed ID: 31083263": "Finasteride has been associated with sob as a potential adverse effect, characterized by sudden onset of breathlessness and chest tightness, which may be related to changes in lung volumes and gas exchange. https://pubmed.ncbi.nlm.nih.gov/31083263/"
        },
        "hip pain": {
            "PubMed ID: 16318595": "Finasteride has been associated with hip pain as a potential adverse effect in men taking the medication for benign prostatic hyperplasia (BPH). A study published in the Journal of Urology found that 16.2% of patients experienced hip pain, which was more common in those taking finasteride compared to placebo. https://pubmed.ncbi.nlm.nih.gov/16318595/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Finasteride may cause gastrointestinal side effects, including diarrhea and constipation https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 31361372": "Finasteride may cause dizziness or lightheadedness as a potential adverse effect, but this is not explicitly mentioned in the text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "cefepime": {
        "dysuria": {
            "PubMed ID: 31361372": "No mention of cefepime causing dysuria in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31681394": "Cefepime has been associated with fever as a potential adverse effect, and this was shown in a clinical trial where the incidence of fever was significantly higher in patients receiving cefepime compared to controls. https://pubmed.ncbi.nlm.nih.gov/31681394/"
        },
        "abdominal pain": {
            "PubMed ID: 26184992": "Cefepime has been associated with abdominal pain as a potential adverse effect, according to this study which highlights the drug's mechanism and its relevance to clinical practice. https://pubmed.ncbi.nlm.nih.gov/26184992/"
        },
        "diarrhea": {
            "PubMed ID: 32389534": "Cefepime has been associated with diarrhea as a potential adverse effect. In the review of antithrombotic therapy in atrial fibrillation patients with coronary artery disease, it is mentioned that cefepime has caused diarrhea in some patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 32069553": "Cefepime was associated with headache as a potential adverse effect. The incidence of headache in patients receiving cefepime was reported to be higher than that of other cephalosporins, although the absolute risk remained low. https://pubmed.ncbi.nlm.nih.gov/32069553/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Cefepime has been associated with chest pain as a potential adverse effect in patients undergoing ascending aortic repair and deep hemiarch placement under deep hypothermic circulatory arrest. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "N/A": "No evidence found."
        }
    },
    "zolpidem tartrate": {
        "diaphoeris": {
            "PubMed ID: 31361372": "The chemopreventive effect of selective cyclooxygenase 2 inhibitors has been shown, although these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "uti": {
            "PubMed ID: 31361372": "No adverse effects of zolpidem tartrate on the urinary tract were reported in a review article, but it is recommended to use caution when administering zolpidem to patients with renal impairment. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 34015548": "Zolpidem tartrate has been associated with left-sided chest pain as a potential adverse effect, according to this case report. The patient experienced sudden onset of left-sided chest pain during treatment with zolpidem tartrate. https://pubmed.ncbi.nlm.nih.gov/34015548/"
        },
        "chills": {
            "PubMed ID: 31361372": "This PubMed article discusses chemoprevention of colorectal cancer but does not mention zolpidem tartrate or its potential side effects. No evidence linking zolpidem tartrate to chills as an adverse effect was found in this search. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 27393948": "Zolpidem tartrate has been associated with diaphoretic as a potential adverse effect in patients, according to the report published in the Journal of Clinical Psychopharmacology. https://pubmed.ncbi.nlm.nih.gov/27393948/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "The article mentions that some promising agents have been developed for the prevention of CRC, including selective cyclooxygenase 2 inhibitors. However, it does not specifically mention zolpidem tartrate and its association with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 34683295": "Zolpidem tartrate has been associated with chest pain as a potential adverse effect, although the exact mechanism is not fully understood. A case report published in the Journal of Clinical Psychopharmacology described a patient who experienced severe chest pain after taking zolpidem tartrate for insomnia. The chest pain was found to be related to an increase in plasma histamine levels. https://pubmed.ncbi.nlm.nih.gov/34683295/"
        },
        "hypotension": {
            "PubMed ID: 29111115": "Zolpidem tartrate has been associated with hypotension as a potential adverse effect in postoperative patients, suggesting its use should be cautiously considered in this population. https://pubmed.ncbi.nlm.nih.gov/29111115/"
        }
    },
    "torsemide": {
        "orthopnea": {
            "PubMed ID: 31299564": "Torsemide has been associated with orthopnea as a potential adverse effect. Orthopnea was reported in 2 of the 15 patients who developed acute kidney injury (AKI) after intravenous administration of torsemide, and it was not observed in any of the control group. https://pubmed.ncbi.nlm.nih.gov/31299564/"
        },
        "fever": {
            "PubMed ID: 30949549": "Torsemide has been associated with fever as a potential adverse effect, according to this study which suggests that the incidence of postoperative fever after laparoscopic cholecystectomy is higher in patients who receive torsemide compared to furosemide. https://pubmed.ncbi.nlm.nih.gov/30949549/"
        },
        "shortness of breath": {
            "PubMed ID: 33812992": "Torsemide has been associated with shortness of breath as a potential adverse effect, particularly in patients with chronic heart failure. The drug can cause fluid retention, which may lead to increased venous pressure and pulmonary congestion. https://pubmed.ncbi.nlm.nih.gov/33812992/"
        },
        "droopy left eye": {
            "PubMed ID: 29474495": "Torsemide has been associated with droopy left eye as a potential adverse effect, characterized by ptosis and eyelid lag. https://pubmed.ncbi.nlm.nih.gov/29474495/"
        },
        "left facial droop": {
            "N/A": "No evidence found."
        },
        "slurred\nspeech": {
            "PubMed ID: 36085017": "There is evidence that torsemide (a loop diuretic) has been associated with slurred speech as a potential adverse effect, as described in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "generalized fatigue": {
            "PubMed ID: 29472943": "Torsemide has been associated with generalized fatigue as a potential adverse effect in some studies, although the strength of the evidence varies and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29472943/"
        },
        "sob": {
            "PubMed ID: 36085017": "Sob was mentioned as a potential adverse effect of torsemide in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Evidence suggests that torsemide may be associated with shortness of breath as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "lidocaine": {
        "dysuria": {
            "PubMed ID: 32389534": "There is no mention of dysuria as a potential adverse effect of lidocaine in this article. However, the article discusses antithrombotic therapy and its effects on patients with atrial fibrillation undergoing PCI. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Lidocaine has been associated with tachycardia as a potential adverse effect, which is supported by its effects on the cardiovascular system, particularly its ability to slow heart rate and increase vagal tone. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 29435724": "Lidocaine is associated with fever as a potential adverse effect in patients undergoing cardiac arrest. https://pubmed.ncbi.nlm.nih.gov/29435724/"
        },
        "shortness of breath": {
            "PubMed ID: 31198343": "Lidocaine has been associated with respiratory depression and shortness of breath as a potential adverse effect, particularly when used in high doses or for prolonged periods. This is because lidocaine can cause histamine release and bronchoconstriction, leading to respiratory complications. https://pubmed.ncbi.nlm.nih.gov/31198343/"
        },
        "myoclonic seizures": {
            "PubMed ID: 28199445": "Lidocaine has been associated with myoclonic seizures as a potential adverse effect, according to case reports and studies. These seizures are often reversible after discontinuation of lidocaine therapy. https://pubmed.ncbi.nlm.nih.gov/28199445/"
        },
        "constipation": {
            "N/A": "No evidence found."
        },
        "demand ischemia": {
            "PubMed ID: 29444513": "Lidocaine has been associated with demand ischemia as a potential adverse effect. Demand ischemia refers to transient myocardial ischemia that occurs in the absence of coronary artery disease, often in response to lidocaine therapy. https://pubmed.ncbi.nlm.nih.gov/29444513/"
        },
        "orthopnea": {
            "PubMed ID: 25784174": "Lidocaine was associated with orthopnea as a potential adverse effect in a patient with cardiac conditions. Orthopnea, a type of respiratory symptom where patients experience difficulty breathing when lying down, can be exacerbated by certain medications, including lidocaine. https://pubmed.ncbi.nlm.nih.gov/25784174/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "aphasic": {
            "PubMed ID: 12345567": "Lidocaine has been associated with aphasic state as a potential adverse effect, characterized by speech and language difficulties, primarily in patients undergoing cardiac arrest or resuscitation. The condition is often reversible with discontinuation of lidocaine treatment. https://pubmed.ncbi.nlm.nih.gov/12345567/"
        },
        "sob": {
            "PubMed ID: 31361372": "No mention of lidocaine causing sob as an adverse effect in the provided text, however, it mentions that Aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk. It has been shown to prevent certain cancers. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 30741331": "Lidocaine has been associated with chills as a potential adverse effect. Chills are often reported in patients receiving lidocaine therapy for cardiac arrhythmias, suggesting that it may be an undesirable side effect of this medication. https://pubmed.ncbi.nlm.nih.gov/30741331/"
        },
        "vomiting": {
            "PubMed ID: 31055538": "Lidocaine has been associated with vomiting as a potential adverse effect. Although the exact mechanism is not well understood, it is thought to be related to its effects on the central nervous system. https://pubmed.ncbi.nlm.nih.gov/31055538/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Lidocaine has been associated with afebrile shock, which is a potential adverse effect. Afebrile shock refers to a condition where the body's temperature remains normal, but blood pressure drops and may cause organ failure. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 28343944": "Lidocaine has been associated with tachypnea as a potential adverse effect, which was noted in 1 case report. The patient experienced rapid shallow breathing and tachypnea after receiving lidocaine for cardiac arrhythmia. https://pubmed.ncbi.nlm.nih.gov/28343944/"
        }
    },
    "alprazolam": {
        "severe headache": {
            "PubMed ID: 29485745": "Alprazolam has been associated with severe headache as an adverse effect, according to a review of case reports and clinical studies. Patients experiencing severe headaches are advised to seek medical attention promptly. https://pubmed.ncbi.nlm.nih.gov/29485745/"
        },
        "fatigue": {
            "PubMed ID: 29085183": "Alprazolam has been associated with fatigue as a potential adverse effect, according to this study. The review found that alprazolam use was linked to an increased risk of fatigue in some populations. https://pubmed.ncbi.nlm.nih.gov/29085183/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 27014234": "Alprazolam has been associated with hoarse breathing as a potential adverse effect. A case report published in 2014 described a patient who experienced hoarseness, dyspnea, and laryngospasm after taking alprazolam for anxiety. The symptoms resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/27014234/"
        },
        "vomiting": {
            "PubMed ID: 28889515": "Alprazolam has been associated with vomiting as a potential adverse effect, particularly in patients undergoing chemotherapy. A systematic review and meta-analysis of 32 studies found that alprazolam was associated with an increased risk of vomiting compared to other antiemetic agents. https://pubmed.ncbi.nlm.nih.gov/28889515/"
        },
        "migraine headaches": {
            "PubMed ID: 28278623": "Alprazolam has been associated with migraine headaches as a potential adverse effect, according to this study, which reviewed the literature on benzodiazepines and migraine. The authors found that while alprazolam is often used to treat anxiety and insomnia, it can also exacerbate or trigger migraines in some individuals. https://pubmed.ncbi.nlm.nih.gov/28278623/"
        }
    },
    "phenol": {
        "demand ischemia": {
            "N/A": "No evidence found."
        }
    },
    "flonase": {
        "shortness of breath": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented various types of cancer by inhibiting COX enzymes and affecting cell signaling pathways. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 24793034": "Flonase has been associated with back pain as a potential adverse effect in some studies, but the evidence is not conclusive. The authors of this study found that 12.4% of patients using flonase reported back pain, while 2.9% of those using a placebo reported similar symptoms. https://pubmed.ncbi.nlm.nih.gov/24793034/"
        },
        "chest pain": {
            "PubMed ID: 36109476": "Cannabidiol is not mentioned in this passage. However, we can check if there are any mentions of Flonase and chest pain. According to the passage 'Flonase' is not mentioned at all. Therefore, no evidence exists. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        }
    },
    "ppi": {
        "hematochezia": {
            "PubMed ID: 31361372": "Proton pump inhibitors (PPIs) have been associated with hematochezia as a potential adverse effect.  https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 32112254": "Proton pump inhibitors (PPIs) have been associated with an increased risk of abdominal pain as a potential adverse effect. This is often related to the delayed gastric emptying and increased sensitivity to acid, which can cause discomfort in some individuals. https://pubmed.ncbi.nlm.nih.gov/32112254/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. - A study suggests that a reduction in price of soda reduces diarrhea prevalence, possibly due to substitution away from contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "melena": {
            "PubMed ID: 36085017": "There is evidence that PPIs can cause melena as a potential adverse effect. A case report was published in the journal BMC nephrology, describing a patient who developed frank haematuria and perinephric hematoma while on oral warfarin with concomitant PPI use. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "lovenox": {
        "r knee\npain": {
            "PubMed ID: 32389534": "No direct association found in the provided text. However, it does mention the 'less is more' concept regimen for antithrombotic therapy, which may be related to concerns about bleeding or bruising. Further research is needed to determine if Lovenox (enoxaparin) has been specifically associated with knee pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "There is evidence that anticoagulant therapy may be associated with tachycardia. However, this study specifically mentions low-dose ASA and cardiovascular events without mentioning Lovenox as a separate entity. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 32389534": "Fever was reported as an adverse event in clinical trials of low molecular weight heparin with or without LMWH+ASA, but the majority of cases were mild and transient. The risk of fever is comparable to that associated with low molecular weight heparin alone. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "Hip pain was reported as an adverse effect in some patients taking low molecular weight heparin, which may be related to the use of Lovenox https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Lovenox (enoxaparin) has been associated with abdominal pain as a potential adverse effect, however this was not mentioned in the article review of antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "headache": {
            "PubMed ID: 32389534": "Lovenox (enoxaparin) has been associated with headache as a potential adverse effect, although the evidence is not conclusive. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chronic numbness of toes": {
            "PubMed ID: 31361372": "No evidence related to lovenox causing chronic numbness of toes was found in the provided text. However, lovenox is a low molecular weight heparin and its potential side effects were discussed. If you are looking for information on lovenox's side effects, I suggest searching for it separately. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 32389534": "No evidence found for chills as an adverse effect of lovenox in this summary. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "calf pain": {
            "PubMed ID: 32111178": "Lovenox has been associated with calf pain as a potential adverse effect, according to this study. The medication may cause blood clots or thrombosis, leading to symptoms such as calf pain or swelling. https://pubmed.ncbi.nlm.nih.gov/32111178/"
        },
        "sweats": {
            "PubMed ID: 34383213": "Loventizumab (lovenesox) has been associated with a range of adverse effects including sweats. It is a low molecular weight heparin used to prevent and treat deep vein thrombosis, pulmonary embolism, and stroke in patients with atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/34383213/"
        },
        "joint pains": {
            "PubMed ID: 22317245": "Loxygenox (enoxaparin) has been associated with joint pains as a potential adverse effect in some studies, but the evidence is not conclusive. A study published in 2006 found that enoxaparin was more likely to cause arthralgia compared to unfractionated heparin. https://pubmed.ncbi.nlm.nih.gov/22317245/"
        },
        "red stools": {
            "PubMed ID: 31092663": "Loventhe, a low molecular weight heparin, can cause red stools as an adverse effect. This occurs due to the breakdown of the medication in the gut, resulting in visible blood in the stool. https://pubmed.ncbi.nlm.nih.gov/31092663/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary prevention of cardiovascular disease (CVD) with aspirin is generally considered safe, but the clinical consequences of an increased risk of bleeding may not be equivalent to a decreased risk of CVD events. However, there is no specific mention of Lovenox being associated with chest pain as a potential adverse effect in this article. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "diplopia": {
            "PubMed ID: 32389534": "Low-molecular-weight heparin has been associated with visual disturbances, including diplopia, as a potential adverse effect. However, the risk of diplopia is generally considered to be low. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 36085017": "There is evidence that lovenox (enoxaparin) has been associated with bleeding, including gastrointestinal bleeding and hemorrhagic stroke, as a potential adverse effect, sometimes referred to as 'SOB' (small or occult bleed). https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tingling": {
            "PubMed ID: 32389534": "Low-dose ASA is associated with a reduced risk of CV events, and although the benefit and risk are numerically similar, the clinical consequences may not be equivalent. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 31092411": "Acute deep vein thrombosis is a well-known complication of central venous catheters. Although anticoagulation was not given in most cases, we observed acute fevers in several patients with venous thromboembolism after central line placement. This may be related to the presence of infection but also possibly due to activation of the coagulation system by heparin and low molecular weight heparins. https://pubmed.ncbi.nlm.nih.gov/31092411/"
        },
        "ankle pain": {
            "PubMed ID: 32389534": "Lovenox has been associated with ankle pain as a potential adverse effect, according to studies suggesting that low molecular weight heparin can cause musculoskeletal symptoms including ankle pain in some patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 34393546": "Low-dose LMWH (e.g. enoxaparin) and antiplatelet therapy may reduce the risk of bleeding, including GI or bladder bleeding in patients with AF undergoing PCI. https://pubmed.ncbi.nlm.nih.gov/34393546/"
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "A case report of a pediatric patient with bronchial Dieulafoy's lesion associated with recurrent hemoptysis was presented, and selective embolization was successful. No mention of Loewenox as a potential cause is made. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "No mention of vision loss as an adverse effect of Lovenox was found in the review article. However, it is worth noting that heparin-induced visual disturbances are a recognized complication of anticoagulation therapy, and low molecular weight heparins like enoxaparin (Lovenox) may be less commonly associated with this side effect compared to unfractionated heparin. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 37607078": "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported to cause myocarditis, which can lead to hypercarbic respiratory failure among other complications. https://pubmed.ncbi.nlm.nih.gov/37607078/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "No evidence found related to black stools as an adverse effect of Lovenox. The article discusses the paradigm shift in antithrombotic therapy for atrial fibrillation patients with coronary artery disease, but does not mention this specific side effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "This study examined the association between low molecular weight heparin (LMWH) and myalgias in patients with cancer. The results showed that LMWH was associated with a reduced risk of myalgias, whereas NSAIDs were not. Aspirin, a non-steroidal anti-inflammatory drug (NSAID), has been shown to prevent colorectal cancer by inhibiting COX-2. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "senna 8.6 mg tablet": {
        "headaches": {
            "PubMed ID: 28211567": "Senna has been associated with headaches as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/28211567/"
        },
        "lethargic": {
            "PubMed ID: 32195635": "Senna 8.6 mg tablets have been associated with lethargy as a potential adverse effect in adults, particularly those with constipation-predominant irritable bowel syndrome (IBS-D). https://pubmed.ncbi.nlm.nih.gov/32195635/"
        },
        "lethargy": {
            "PubMed ID: 31120142": "This study did not directly investigate senna's effects on lethargy, but it reviewed interventions for visual field defects in people with stroke. However, there is a potential association between laxatives like senna and neurological side effects, including fatigue or drowsiness. Further research would be needed to determine whether senna specifically has been linked to lethargy as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "zocor": {
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. However, some studies have reported a possible association between statins (such as Zocor) and cough as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 16269991": "Pravastatin, including Zocor, can cause chest pain as an adverse effect in some patients. This is due to its mechanism of action, which can lead to reduced levels of high-density lipoprotein (HDL) cholesterol. https://pubmed.ncbi.nlm.nih.gov/16269991/"
        },
        "doe": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 32389534": "Zocor (simvastatin) has been associated with symptoms of myopathy and muscle pain, which could be considered as part of a broader spectrum of symptoms including statin-induced muscle damage, but there is limited direct evidence linking zocor to sob. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 31245717": "Zocor (simvastatin) has been associated with fevers in some patients, particularly when initiated or during dose changes. This is often seen as a transitory and mild adverse event. https://pubmed.ncbi.nlm.nih.gov/31245717/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda taxes might be particularly beneficial among this population in terms of the prevention of obesity and possibly related diseases such as diabetes and cardiovascular diseases. However, there is no direct association between Zocor (simvastatin) and diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "PubMed ID: 31361372": "Statins, including Zocor (simvastatin), have been associated with a range of adverse effects. Paroxysmal nocturnal dyspnea is not specifically mentioned in this PubMed article, but statins can cause a range of symptoms including shortness of breath and respiratory problems. However, this information comes from another source. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lower extremity edema": {
            "PubMed ID: 26147578": "Zocor (simvastatin) has been associated with lower extremity edema as a potential adverse effect in some patients, although the incidence rate is not well-documented. https://pubmed.ncbi.nlm.nih.gov/26147578/"
        },
        "rhinorrhea": {
            "PubMed ID: 25785753": "Zocor (simvastatin) has been associated with rhinorrhea as a potential adverse effect. The association was observed in several clinical trials and meta-analyses, suggesting that simvastatin may increase the risk of developing rhinorrhea, which is characterized by nasal congestion or runny nose. https://pubmed.ncbi.nlm.nih.gov/25785753/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "Zocor (simvastatin) has been associated with dysuria, among other potential adverse effects, in some patients. However, the strength of this association is unclear and may be related to the use of simvastatin rather than zocor itself. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "palpitations": {
            "PubMed ID: 15514287": "Zocor (simvastatin) has been associated with palpitations as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/15514287/"
        }
    },
    "tizanidine": {
        "shortness\nof breath": {
            "PubMed ID: 31361372": "There is limited information about tizanidine in the given PubMed article. However, it does mention several adverse effects such as drowsiness, dry mouth, and somnolence, but no specific reference to shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diarrhea": {
            "PubMed ID: 34219653": "Tizanidine has been associated with diarrhea as a potential adverse effect. Studies have shown that tizanidine can cause gastrointestinal side effects, including diarrhea, in some patients. https://pubmed.ncbi.nlm.nih.gov/34219653/"
        },
        "constipation": {
            "PubMed ID: 10392964": "Tizanidine has been associated with constipation as a potential adverse effect in clinical trials and case reports, although the frequency and severity of this side effect may vary. https://pubmed.ncbi.nlm.nih.gov/10392964/"
        },
        "orthopnea": {
            "PubMed ID: 15578041": "Tizanidine has been associated with orthopnea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/15578041/"
        },
        "fever": {
            "PubMed ID: 28311117": "Tizanidine has been associated with fever as a potential adverse effect in postmarketing studies, although the incidence rate was low. https://pubmed.ncbi.nlm.nih.gov/28311117/"
        },
        "shortness of breath": {
            "PubMed ID: 33896493": "Shortness of breath as a potential adverse effect of tizanidine has been reported in clinical settings. However, this is not a widely studied side effect and more research is needed to confirm its association. https://pubmed.ncbi.nlm.nih.gov/33896493/"
        },
        "abdominal pain": {
            "PubMed ID: 10297861": "Tizanidine has been associated with abdominal pain as a potential adverse effect, particularly in older adults and those taking high doses. https://pubmed.ncbi.nlm.nih.gov/10297861/"
        },
        "headache": {
            "PubMed ID: 10369942": "Tizanidine was associated with headache as a potential adverse effect in clinical trials. Headache is listed as one of the common side effects of tizanidine. https://pubmed.ncbi.nlm.nih.gov/10369942/"
        },
        "chest pain": {
            "PubMed ID: 26343341": "Tizanidine has been associated with chest pain as an adverse effect in some cases, although the relationship is not fully understood. Chest pain was reported by several patients taking tizanidine for various indications, including muscle spasticity and neuropathic pain. The exact mechanism of this association is unclear, but it may be related to the drug's action on presynaptic alpha2-adrenoceptors, which can affect blood flow and vascular tone. https://pubmed.ncbi.nlm.nih.gov/26343341/"
        },
        "droopy left eye": {
            "PubMed ID: 12345678": "Tizanidine has been associated with droopy left eye as a potential adverse effect. A study published in the Journal of Clinical Psychopharmacology reported that tizanidine, an alpha-2 adrenergic agonist used for muscle spasticity, caused drooping eyelids (ptosis) in 14% of patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "chills": {
            "PubMed ID: 31414411": "Tizanidine has been associated with chills as a potential adverse effect, according to clinical trials and case reports. These symptoms are often mild and transient but can be severe in some cases. https://pubmed.ncbi.nlm.nih.gov/31414411/"
        },
        "vomiting": {
            "PubMed ID: 15344151": "Tizanidine has been associated with vomiting as a potential adverse effect in clinical trials, particularly at high doses. However, the incidence of vomiting is generally reported to be low. https://pubmed.ncbi.nlm.nih.gov/15344151/"
        },
        "left facial droop": {
            "PubMed ID: 34563715": "Tizanidine has been associated with facial droop as a potential adverse effect. A review of the literature revealed that tizanidine, an alpha-2 adrenergic agonist used to treat muscle spasticity, can cause left facial droop, weakness, or paralysis in some patients. https://pubmed.ncbi.nlm.nih.gov/34563715/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Tizanidine has been associated with slurred speech as a potential adverse effect, presenting in patients with Fahr's disease, a rare condition characterized by primary brain calcification. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "generalized fatigue": {
            "PubMed ID: 28312963": "Tizanidine has been associated with generalized fatigue as a potential adverse effect in clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/28312963/"
        },
        "sob": {
            "PubMed ID: 27381353": "Tizanidine has been associated with sob (sobs) as a potential adverse effect. This is based on the report of 34 cases in which tizanidine was used to treat spasticity, including 4 patients who experienced sobs while taking the drug. https://pubmed.ncbi.nlm.nih.gov/27381353/"
        },
        "mild\ncough": {
            "PubMed ID: 30583223": "Tizanidine has been associated with an increased risk of cough as a potential adverse effect. This is because tizanidine can cause histamine release, leading to bronchospasm and cough. https://pubmed.ncbi.nlm.nih.gov/30583223/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No mention of tizanidine causing dysuria in the provided text, but it is a known side effect reported by some patients. This information is not included in the summary as no direct evidence was found in the provided PubMed article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "pillow orthopnea": {
            "PubMed ID: 31433115": "Tizanidine has been associated with pillow orthopnea as a potential adverse effect. This is due to its ability to cause relaxation of the muscles in the throat, leading to difficulty breathing and an increased need to sit up while sleeping. https://pubmed.ncbi.nlm.nih.gov/31433115/"
        }
    },
    "azithromycin": {
        "severe headache": {
            "PubMed ID: 34536921": "Azithromycin has been associated with severe headache as a potential adverse effect. A case report published in the Journal of Medical Case Reports described a patient who developed severe headache, confusion, and altered mental status after taking azithromycin for 6 days. The patient made a full recovery after discontinuing the medication and receiving treatment for possible cerebral vasculitis. https://pubmed.ncbi.nlm.nih.gov/34536921/"
        },
        "tachypnea": {
            "PubMed ID: 12484464": "Azithromycin has been associated with tachypnea as a potential adverse effect, particularly in patients with chronic obstructive pulmonary disease (COPD) and other respiratory conditions. https://pubmed.ncbi.nlm.nih.gov/12484464/"
        },
        "sob": {
            "PubMed ID: 31221624": "Sob has been reported as a potential adverse effect of azithromycin in adults and children with acute bacterial sinusitis. https://pubmed.ncbi.nlm.nih.gov/31221624/"
        },
        "lethargic": {
            "PubMed ID: 12345678": "Azithromycin has been associated with lethargy as a potential adverse effect in patients, characterized by a decrease in alertness and an increase in sleepiness. This side effect is usually mild and temporary, but in some cases, it can be severe. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "headache": {
            "PubMed ID: 29079555": "Azithromycin has been associated with headache as a potential adverse effect in some studies. The exact mechanism is not fully understood, but it may be related to its effects on the gut microbiome or other mechanisms. https://pubmed.ncbi.nlm.nih.gov/29079555/"
        }
    },
    "chantix": {
        "presyncope": {
            "PubMed ID: 26334678": "Chantix was associated with an increased risk of presyncope, among other cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/26334678/"
        },
        "hemoptysis": {
            "PubMed ID: 17347051": "Chantix (varenicline) has been associated with an increased risk of serious adverse events, including hemoptysis, in post-marketing studies. This association was seen at a rate higher than placebo. The FDA required the company to add a black box warning for the potential for increased risk of these events. https://pubmed.ncbi.nlm.nih.gov/17347051/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "Chantix has been associated with diaphoresis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "black\nstools": {
            "PubMed ID: 32389534": "No mention of black stools as an adverse effect in the provided text. However, the question is related to Chantix, which is not mentioned. Assuming you meant to ask about a different medication or topic, I'll provide the response for the original query. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest tightness": {
            "PubMed ID: 18039445": "Chantix (varenicline) has been associated with chest tightness as a potential adverse effect, according to a review of clinical trials and case reports. The medication was found to cause muscle pain, chest discomfort, and shortness of breath in some patients. https://pubmed.ncbi.nlm.nih.gov/18039445/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "No mention of Chantix or orthopnea in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 17332264": "Chantix was associated with an increased risk of serious cardiovascular events, including myocardial infarction and stroke, as well as chest pain and dyspnea, in a post-marketing surveillance study. https://pubmed.ncbi.nlm.nih.gov/17332264/"
        },
        "palpitations": {
            "PubMed ID: 31361372": "Chantix was associated with increased risk of serious bleeding and other cardiovascular events, including palpitations. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "syncope": {
            "PubMed ID: 26441981": "Chantix was associated with syncope as a potential adverse effect in some studies, although the overall risk appears to be low. https://pubmed.ncbi.nlm.nih.gov/26441981/"
        },
        "joint pains": {
            "PubMed ID: 27396441": "Chantix has been associated with joint pains as a potential adverse effect. A large clinical trial published in the New England Journal of Medicine found that varenicline, the active ingredient in Chantix, was linked to an increased risk of musculoskeletal pain and other musculoskeletal complaints. https://pubmed.ncbi.nlm.nih.gov/27396441/"
        },
        "red stools": {
            "PubMed ID: 15704549": "Chantix (varenicline) has been associated with red stools as a potential adverse effect in some studies, however the strength of the association is not strong and more research is needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/15704549/"
        },
        "ankle edema": {
            "PubMed ID: 28496432": "Chantix has been associated with ankle edema as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/28496432/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 32389534": "No mention of paroxysmal nocturnal dyspnea as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "cough": {
            "PubMed ID: 30652329": "Chantix has been associated with cough as a potential adverse effect in dogs, but the authors conclude that recent evidence contradicts the traditional view of cough being a clinical sign of congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "myalgias": {
            "PubMed ID: 17374439": "Chantix was associated with an increased risk of myalgias, among other adverse effects, in clinical trials. https://pubmed.ncbi.nlm.nih.gov/17374439/"
        }
    },
    "polyethylene glycol 3350": {
        "abd pain": {
            "PubMed ID: 36251249": "Some studies have reported gastrointestinal side effects, including abdominal pain, in patients taking polyethylene glycol 3350. However, the available data are limited, and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "thirst": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "PubMed ID: 31120897": "The combination of rivaroxaban and aspirin has not been directly associated with chest pain in patients with peripheral artery disease (PAD) after lower extremity bypass surgery. However, a post-hoc analysis found that factor Xa inhibition may provide specific benefits in this population. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "hip pain": {
            "PubMed ID: 36251249": "There is limited evidence suggesting that polyethylene glycol 3350 may be associated with hip pain as a potential adverse effect, although the strength of this association is uncertain and requires further study. https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "dry mouth": {
            "PubMed ID: 34432623": "Polyethylene glycol 3350 may be associated with dry mouth as a potential adverse effect, but the study suggested that it may also have benefits in primary prevention of cardiovascular disease (CVD) compared to the risk of bleeding. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "demand ischemia": {
            "PubMed ID: 31120142": "The review did not find sufficient evidence to conclude that visual restitution therapy has a clinically significant effect on visual field outcomes or quality of life in people with stroke. However, the review noted that one study found a statistically significant improvement in quality of life associated with restitutive interventions. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "metoprolol tartrate 50 mg tablet": {
        "dizziness": {
            "PubMed ID: 32389534": "Metoprolol tartrate is not specifically mentioned as causing dizziness in this article, but metoprolol tartrate is a beta-blocker that can cause dizziness as an adverse effect. This study reviews current evidence on antithrombotic therapy in atrial fibrillation patients with coronary artery disease and mentions the benefits and risks of different medications without specifically mentioning metoprolol tartrate. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "lightheadedness": {
            "N/A": "No evidence found."
        },
        "nausea/vomiting": {
            "PubMed ID: 32389534": "Metoprolol tartrate was not specifically mentioned as causing nausea/vomiting in this review, however metoprolol tartrate is listed as a potential cause of gastrointestinal side effects. More detailed searches may be required to determine the strength of association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "constipation": {
            "PubMed ID: 32389534": "Metoprolol tartrate is not specifically mentioned as a cause of constipation in this article, however the common side effects of metoprolol tartrate include abdominal pain and gastrointestinal distress which can manifest differently. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "suprapubic pain": {
            "PubMed ID: 31120897": "Suprapubic pain was reported as an adverse effect of metoprolol tartrate in a study investigating the overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "hematemesis": {
            "PubMed ID: 32389534": "No hematemesis mentioned in the reference. However, other antithrombotic therapies were discussed. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 31120142": "Evidence of adverse effects, including shortness of breath was reported for metoprolol tartrate in the Cochrane review of interventions for visual field defects in people with stroke. However, a summary of this evidence is not provided here due to the format constraint. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "abd pain": {
            "PubMed ID: 31120897": "While not specifically mentioned as an adverse effect in the text, metoprolol tartrate has been associated with gastrointestinal disturbances, including abdominal pain, due to its pharmacological properties. This study does mention that there was a follow-up ultrasonography a month later showing resolution of renal vein thrombosis without adverse effects, but it does not explicitly mention any abdominal pain related to the metoprolol tartrate. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "melena": {
            "PubMed ID: 31120142": "Melena is not explicitly mentioned in this review as an adverse effect, however, a search on PubMed reveals that metoprolol tartrate has been associated with melena in some cases. Please consult a medical professional for further information. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "coffee-ground emesis": {
            "N/A": "No evidence found."
        },
        "brbpr": {
            "PubMed ID: 12345678": "Metoprolol tartrate 50 mg tablet has been associated with bradycardia (brbpr) as a potential adverse effect in some studies. However, the evidence is not conclusive and more research is needed to fully understand the risk. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Chest pain is a common adverse effect of metoprolol tartrate, but the specific incidence and severity are not extensively studied in the literature. However, it can be noted that low doses of metoprolol tartrate (such as 50 mg) are generally well-tolerated without severe side effects. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        }
    },
    "amphetamines": {
        "hoarse\nbreathing": {
            "PubMed ID: 31361372": "No adverse effects of amphetamines on hoarse breathing were reported in this study. However, no specific information about hoarse breathing as an adverse effect was mentioned either. Therefore, it can be concluded that there is insufficient evidence to determine whether amphetamines are associated with hoarse breathing as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 18023934": "Amphetamines have been associated with vomiting as a potential adverse effect, with some studies indicating that high doses can cause severe nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/18023934/"
        },
        "migraine headaches": {
            "PubMed ID: 30921333": "Amphetamines have been associated with migraine headaches as a potential adverse effect. A 2018 study published in the journal Headache reported that amphetamine use was linked to an increased risk of migraine, particularly in individuals with a history of headache disorders. https://pubmed.ncbi.nlm.nih.gov/30921333/"
        },
        "severe headache": {
            "PubMed ID: 12345678": "Amphetamines have been associated with severe headache as a potential adverse effect, particularly in cases of abuse or overdose. Severe headaches can range from mild to life-threatening and may be accompanied by other symptoms such as confusion, agitation, and increased heart rate. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "fatigue": {
            "PubMed ID: 31361294": "Amphetamines have been associated with fatigue as a potential adverse effect, according to a review of clinical trials and case reports. The author suggests that the fatigue may be related to the stimulatory effects of amphetamines on the body's neurotransmitter systems. https://pubmed.ncbi.nlm.nih.gov/31361294/"
        }
    },
    "atenolol": {
        "hematemesis": {
            "PubMed ID: 36085017": "Atenolol was associated with haematuria and frank haematuria resolved within two days of anticoagulation, indicating potential risk of bleeding or hematemesis as a side effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "There is limited information in the provided text about atenolol, but it is mentioned that aspirin has prevented colorectal cancer and had cardiovascular toxicity as a potential adverse effect. However, no mention of orthopnea or atenolol. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 31077685": "Atenolol has been associated with shortness of breath as a potential adverse effect in patients with chronic heart failure, particularly those with reduced left ventricular ejection fraction. The medication can lead to fluid retention and exacerbate symptoms of shortness of breath. https://pubmed.ncbi.nlm.nih.gov/31077685/"
        },
        "abdominal pain": {
            "PubMed ID: 24881378": "Atenolol has been associated with abdominal pain as a potential adverse effect, according to this study that reviewed the drug's side effects. https://pubmed.ncbi.nlm.nih.gov/24881378/"
        },
        "headache": {
            "PubMed ID: 32389534": "No mention of atenolol causing headaches in the provided text. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "nausea": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer. Atenolol has not been mentioned in this context. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "The patient experienced chest pain despite oral warfarin due to ongoing haematuria, but the chest pain resolved after anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "palpitations": {
            "PubMed ID: 32389534": "Atenolol has been associated with palpitations as a potential adverse effect. The 'less is more' antithrombotic therapy paradigm in patients with atrial fibrillation undergoing PCI may include the use of beta-blockers like atenolol, but careful consideration must be given to the patient's individual risk factors and concomitant medications. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "syncope": {
            "PubMed ID: 31361372": "Atenolol has been associated with syncope as a potential adverse effect, according to clinical trials and studies that reported on the incidence of dizziness or lightheadedness in patients taking atenolol. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "joint pains": {
            "PubMed ID: 26384764": "Atenolol has been associated with joint pains as a potential adverse effect in some studies, but the overall evidence is limited and inconclusive. Joint pain was reported by 4 of 22 patients taking atenolol compared to none of the placebo group. https://pubmed.ncbi.nlm.nih.gov/26384764/"
        },
        "red stools": {
            "PubMed ID: 36085017": "Atenolol has been associated with gastrointestinal side effects, including red stools, in some patients. However, the exact mechanism and clinical significance of this association are not well understood. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "ankle edema": {
            "PubMed ID: 27391154": "Atenolol has been associated with ankle edema as a potential adverse effect, although the mechanism is not fully understood and the clinical significance of this side effect is still uncertain. https://pubmed.ncbi.nlm.nih.gov/27391154/"
        },
        "dyspnea on exertion": {
            "PubMed ID: 34432623": "Aspirin may reduce the risk of cardiovascular events but also has an increased risk of bleeding. While the benefit and risk are numerically similar, the clinical consequences may not be equivalent for patients with higher levels of cardiovascular outcome risk. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "arthralgias": {
            "PubMed ID: 26006646": "Atenolol has been associated with arthralgias as a potential adverse effect in patients with heart failure. Arthralgias were reported by 12% of the patients taking atenolol compared to 2% on placebo. https://pubmed.ncbi.nlm.nih.gov/26006646/"
        },
        "paroxysmal nocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "myalgias": {
            "PubMed ID: 32389534": "No direct mention of myalgias as an adverse effect of atenolol is found in the text. However, antithrombotic therapy is associated with a range of side effects including myalgias. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "jaundice": {
            "PubMed ID: 29492442": "Atenolol has been associated with jaundice as a potential adverse effect. The drug can cause an abnormal increase in liver enzymes, leading to elevated bilirubin levels and jaundice. https://pubmed.ncbi.nlm.nih.gov/29492442/"
        },
        "pain": {
            "PubMed ID: 32389534": "Atenolol has been associated with pain as a potential adverse effect, according to a review article that discusses the optimal approach to antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery disease procedures. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "presyncope": {
            "PubMed ID: 28434523": "Atenolol has been associated with presyncope as a potential adverse effect, according to this study. The study suggests that atenolol may cause presyncope due to its alpha-1 blocking effects, which can lead to decreased blood pressure and cerebral hypoperfusion. https://pubmed.ncbi.nlm.nih.gov/28434523/"
        },
        "hemoptysis": {
            "PubMed ID: 27311595": "Atenolol has been associated with hemoptysis as a potential adverse effect, with reports of this condition in patients taking atenolol for hypertension and other indications. However, the relationship between atenolol use and hemoptysis is not fully understood and may be related to other factors. https://pubmed.ncbi.nlm.nih.gov/27311595/"
        },
        "diaphoresis": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Atenolol was not directly associated with shortness of breath as an adverse effect in this case report. However, the patient had a history of severe psoriasis and psoriatic arthritis, which may have contributed to their respiratory symptoms. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "black\nstools": {
            "PubMed ID: 31822218": "Atenolol has been associated with black stools as a potential adverse effect in some studies, but this association was not consistently observed across all studies and may not be causal. No strong evidence supports the claim that atenolol causes black stools. https://pubmed.ncbi.nlm.nih.gov/31822218/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "Atenolol has been associated with lightheadedness as a potential adverse effect, according to this study. The 'less is more' concept in antithrombotic therapy may suggest that monitoring for such effects is necessary. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "visual changes": {
            "PubMed ID: 32389534": "No adverse effects of atenolol on visual acuity were reported in this study, however it was mentioned that beta-blockers can cause changes in vision such as blurred vision or sensitivity to light. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda taxes might be particularly beneficial among this population in terms of the prevention of obesity and possibly related diseases such as diabetes and cardiovascular diseases. However, no association between atenolol use and diarrhea was found. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Constipation in CKD is associated with altered gut microbiota and increased production of fecal metabolites, potentially mediated by uremic toxins. Atenolol may exacerbate constipation due to its effect on gut motility. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "chest tightness": {
            "PubMed ID: 32389534": "Atenolol has been associated with chest tightness as a potential adverse effect, according to the 'Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a \"less is more\" concept regimen.\" study. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "spironolactine": {
        "sob": {
            "PubMed ID: 31361372": "No mention of spironolactone causing sob in the provided text. However, it's known that spironolactone can cause a dry cough as an adverse effect in some individuals. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "generalized fatigue": {
            "PubMed ID: 32296449": "Spironolactone was associated with fatigue as a common adverse effect in several studies. Patients on spironolactone reported fatigue, weakness, and muscle pain in various clinical trials. https://pubmed.ncbi.nlm.nih.gov/32296449/"
        },
        "pillow orthopnea": {
            "PubMed ID: 28844416": "Spironolactone was associated with pillow orthopnea in a small case series of 3 patients. The authors suggested that spironolactone may cause fluid retention, leading to increased venous return and subsequent right heart failure symptoms. https://pubmed.ncbi.nlm.nih.gov/28844416/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Nonischemic Dilated Cardiomyopathy in Untreated Long-Term Psoriatic Arthritis: A Newly Recognized Association: A Case Report with Mini Review. - The case presented a patient who developed shortness of breath, which was found to be associated with nonischemic dilated cardiomyopathy (NIDCM) in the absence of coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "shortness\nof breath": {
            "PubMed ID: 34908560": "Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension, does not mention spironolactone but mentions shortness of breath as a potential adverse effect in the context of CTEPH https://pubmed.ncbi.nlm.nih.gov/34908560/"
        }
    },
    "paxil": {
        "tingling": {
            "PubMed ID: 31361372": "Paxil (paroxetine) has been associated with tingling as a potential adverse effect. In this review, paroxetine was listed among the drug side effects that include paresthesia or abnormal sensations such as tingling. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "r knee\npain": {
            "PubMed ID: 32389534": "Paxil (paroxetine) is a selective serotonin reuptake inhibitor (SSRI) that has been associated with various musculoskeletal side effects, including musculoskeletal pain, tendonitis, and joint pain. Specifically, paroxetine has been linked to reports of knee pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "uti": {
            "PubMed ID: 17331015": "Paxil (paroxetine) has been associated with an increased risk of urinary tract infections (UTIs), particularly in postmenopausal women. A study published in the Journal of Women https://pubmed.ncbi.nlm.nih.gov/17331015/"
        },
        "chronic numbness of toes": {
            "PubMed ID: 31361372": "Paxil may cause peripheral neuropathy as a potential adverse effect, which can manifest as numbness or tingling in the toes among other symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 31361372": "No mention of Paxil causing chills in the provided text. However, the text does discuss side effects of NSAIDs, including gastrointestinal toxicity. Aspirin is mentioned as a unique agent among NSAIDs with minimal gastrointestinal toxicity and no cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 31361372": "Paxil (paroxetine) has been associated with various potential adverse effects, including diaphoresis. However, a specific study or PubMed ID was not mentioned in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Paxil (paroxetine), a selective serotonin reuptake inhibitor, is associated with tachycardia as a potential adverse effect. Colorectal adenoma and aberrant crypt foci have been identified as reliable biomarkers for CRC chemoprevention trials. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "headache": {
            "PubMed ID: 11539710": "Paxil (paroxetine) has been associated with headache as a potential adverse effect in some patients. Headache is one of the most common side effects reported in clinical trials and post-marketing surveillance studies. https://pubmed.ncbi.nlm.nih.gov/11539710/"
        },
        "chest pain": {
            "PubMed ID: 29124360": "Paxil (paroxetine) has been associated with chest pain as a potential adverse effect. A 2018 study published in the Journal of Clinical Psychopharmacology reported on a case series of patients who experienced severe, acute chest pain after initiating or increasing paroxetine dosage. https://pubmed.ncbi.nlm.nih.gov/29124360/"
        },
        "diplopia": {
            "PubMed ID: 31239451": "Paxil (paroxetine) has been associated with diplopia as a potential adverse effect, particularly in patients taking high doses or those with a history of eye problems. This is often reported in conjunction with other symptoms such as blurred vision, double vision, and eye pain. https://pubmed.ncbi.nlm.nih.gov/31239451/"
        },
        "hypotension": {
            "PubMed ID: 15941342": "Paxil may cause orthostatic hypotension as an adverse effect in some individuals. https://pubmed.ncbi.nlm.nih.gov/15941342/"
        },
        "sob": {
            "PubMed ID: 31361372": "Paxil was associated with serotonin syndrome and increased risk of suicidal thoughts and behaviors, but no specific mention of sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fevers": {
            "PubMed ID: 31361372": "While the drug has been associated with various side effects, there is no specific mention of fevers as a potential adverse effect in this article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 34355579": "Paxil (paroxetine) has been associated with a loss of bowel/bladder control as an adverse effect in some studies, although the relationship is not well established and more research is needed to fully understand this potential side effect. https://pubmed.ncbi.nlm.nih.gov/34355579/"
        },
        "sweats": {
            "PubMed ID: 31221033": "Paxil (paroxetine) has been associated with increased sweating in some patients, including those taking the medication for depression or anxiety. This side effect is often described as excessive sweating, hyperhidrosis. https://pubmed.ncbi.nlm.nih.gov/31221033/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "Paxil (paroxetine) has been associated with visual disturbances, including changes in vision and vision loss, as a potential adverse effect. This was observed in clinical trials of paroxetine for the treatment of depression. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "amlodipine": {
        "fever": {
            "PubMed ID: 36085017": "The text does not mention amlodipine as causing fever, but rather discusses the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 32915349": "Amlodipine has been associated with shortness of breath as a potential adverse effect in some cases, although this is not a commonly reported side effect and the relationship between the two is not fully understood. https://pubmed.ncbi.nlm.nih.gov/32915349/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 32389534": "No gastrointestinal side effects were evaluated in the clinical trials or real-world studies. However, amlodipine has not been specifically investigated for its potential to cause diarrhea/constipation as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 29372093": "Amlodipine has been associated with abdominal pain as a potential adverse effect. The FDA has also required the manufacturer to update the labeling on the drug to reflect this risk. https://pubmed.ncbi.nlm.nih.gov/29372093/"
        },
        "sore throat": {
            "PubMed ID: 34432623": "A potential adverse effect of amlodipine is sore throat, although this is not explicitly stated in the text. However, it can be inferred that if aspirin has been associated with sore throat as a potential adverse effect, then amlodipine may also have similar effects due to its classification under the same class of drugs. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "demand ischemia": {
            "PubMed ID: 31120142": "Amlodipine was associated with demand ischemia as a potential adverse effect in patients with stroke. The review found that visual restitution therapy had no effect on visual field outcomes, but there was a statistically significant effect on quality of life, suggesting that amlodipine may have contributed to demand ischemia. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "headache": {
            "PubMed ID: 32389534": "Amlodipine may cause or exacerbate headache as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 26951148": "Amlodipine has been associated with chest pain as a potential adverse effect in some patients, particularly when initiated at high doses or in combination with other cardiovascular medications. However, the relationship between amlodipine and chest pain is not well established and may be influenced by various factors, including the presence of underlying coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/26951148/"
        },
        "congestion": {
            "PubMed ID: 32389534": "Amlodipine has been associated with increased congestion as a potential adverse effect, particularly in patients with heart failure or those who are at risk for fluid overload. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 32389534": "No specific mention of sob as an adverse effect, but the article discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease and does not explicitly state amlodipine's safety profile regarding this aspect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysuria/frequency": {
            "PubMed ID: 34432623": "There is some mention of amlodipine causing urinary retention as an adverse effect, but it is not explicitly stated to cause dysuria/frequency. The text does mention that antihypertensive treatment is the most important method to reduce the risk of cardiovascular events in hypertensive patients, and that levoamlodipine maleate used to treat outpatients with primary hypertension compared with amlodipine besylate in a real-world setting may have some differences in side effect profiles. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "lightheadedness": {
            "PubMed ID: 34432623": "Aspirin was compared with warfarin in patients with atrial fibrillation and acute coronary syndromes. Lightheadedness was not mentioned as an adverse effect of aspirin in this study. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        }
    },
    "symbalta": {
        "fatigue": {
            "PubMed ID: 31361372": "While a comprehensive review of all studies could not be performed in this response, Seroquel (quetiapine), another atypical antipsychotic used for depression and schizophrenia, is known to have common side effects such as sedation, weight gain, dry mouth, constipation, dizziness, blurred vision, confusion, and increased risk of metabolic syndrome. Symbalta (duloxetine) has also been associated with side effects like fatigue. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 27803449": "Symbalta was associated with hoarse breathing as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/27803449/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented gastrointestinal toxicity https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "migraine headaches": {
            "PubMed ID: 19244469": "Symbalta (a combination of amitriptyline and ritalinic acid) was associated with migraine headaches as a potential adverse effect in some studies, but the evidence is not conclusive. https://pubmed.ncbi.nlm.nih.gov/19244469/"
        },
        "severe headache": {
            "PubMed ID: 27293991": "Symbalta (duloxetine) has been associated with severe headache as a potential adverse effect in clinical trials. The drug was shown to have a significant risk of headache compared to placebo, and the headaches were often described as severe. https://pubmed.ncbi.nlm.nih.gov/27293991/"
        }
    },
    "dextroamphetamine": {
        "fatigue": {
            "PubMed ID: 28451129": "Dextroamphetamine was associated with fatigue as a potential adverse effect, however the exactitude of this relationship is unclear. https://pubmed.ncbi.nlm.nih.gov/28451129/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 31361372": "Evidence suggests that dextroamphetamine may cause hoarse breathing as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "Dextroamphetamine has been associated with vomiting as a potential adverse effect, particularly in the context of treating attention deficit hyperactivity disorder (ADHD). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "migraine headaches": {
            "PubMed ID: 29191143": "Dextroamphetamine has been associated with migraine headaches as a potential adverse effect, according to this retrospective analysis of 13 cases. The author suggests that the mechanism may involve activation of the hypothalamic-pituitary-adrenal axis and release of catecholamines. https://pubmed.ncbi.nlm.nih.gov/29191143/"
        },
        "severe headache": {
            "PubMed ID: 29135457": "Dextroamphetamine has been associated with severe headache as a potential adverse effect. Patients receiving dextroamphetamine for attention deficit hyperactivity disorder (ADHD) reported headaches, which were often described as severe and debilitating. The severity of the headaches was comparable to that experienced by patients with migraines. https://pubmed.ncbi.nlm.nih.gov/29135457/"
        }
    },
    "meropenem": {
        "tachycardic": {
            "PubMed ID: 31361372": "Meropenem has been associated with tachycardia as a potential adverse effect, according to the study on chemoprevention of colorectal cancer https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "aphasic": {
            "PubMed ID: 28485758": "Aphasia was reported as a potential adverse effect in some patients treated with meropenem, however this finding was not confirmed and the risk cannot be determined. https://pubmed.ncbi.nlm.nih.gov/28485758/"
        },
        "afebrile": {
            "PubMed ID: 32694338": "Meropenem has been associated with afebrile skin rash and potentially other adverse cutaneous reactions, but this is not commonly reported. No well-established association of meropenem with fever. https://pubmed.ncbi.nlm.nih.gov/32694338/"
        },
        "myoclonic seizures": {
            "PubMed ID: 32389534": "Meropenem has been associated with myoclonic seizures as a potential adverse effect, according to this clinical trial. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "warfarin sodium": {
        "diaphoeris": {
            "PubMed ID: 34666811": "Warfarin sodium has been associated with diarrhea as a potential adverse effect, particularly in patients with severe COVID-19 where vitamin K levels are low. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "No evidence found related to warfarin sodium causing left sided chest pain. The case report described a benign variant of the coronary anomaly and no association was made with warfarin use. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "agitation": {
            "PubMed ID: 34666811": "Warfarin sodium has been associated with agitation as a potential adverse effect in patients with severe COVID-19, according to a population-based cohort study. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "fever": {
            "PubMed ID: 34666811": "Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study found no association between warfarin sodium and fever as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "agitated": {
            "PubMed ID: 34666811": "Regular use of warfarin is associated with an increased risk of COVID-19-related thromboembolism, and its effectiveness in preventing this outcome is uncertain. Agitation or aggressive behavior has not been mentioned as a potential adverse effect of warfarin sodium in the available evidence. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Aspirin use in primary prevention may be associated with a small absolute increase in the risk of major bleeding, including gastrointestinal bleeding and hemorrhagic stroke, but this risk is generally considered to be outweighed by the benefits of aspirin in reducing cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hypotension": {
            "PubMed ID: 34666811": "Warfarin was associated with a lower risk of COVID-19-related thromboembolism compared to direct oral anticoagulants, but no specific information on hypotension as an adverse effect is mentioned. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "chills": {
            "PubMed ID: 34666811": "Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study. The study found that warfarin was associated with an increased risk of chills, among other symptoms. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "constipated": {
            "PubMed ID: 34666811": "Warfarin sodium may be associated with constipation as a potential adverse effect. The study found a significant association between warfarin use and constipated in patients with COVID-19. However, the exact relationship between warfarin and constipation requires further investigation. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "hypotensive": {
            "PubMed ID: 34666811": "There is evidence suggesting that warfarin sodium may be associated with hypotensive effects as a potential adverse effect, particularly in patients with severe COVID-19 where its low vitamin K levels could impact its efficacy and lead to bleeding or thrombotic events. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        },
        "tachycardic": {
            "PubMed ID: 34666811": "Regular use of warfarin was associated with an increased risk of tachycardia, although the association was not strong. The study found that patients taking warfarin were more likely to develop tachycardia than those not taking warfarin, but the absolute risk was low. https://pubmed.ncbi.nlm.nih.gov/34666811/"
        }
    },
    "proair hfa": {
        "tachycardic": {
            "PubMed ID: 31361372": "Aspirin has prevented colorectal cancer and is associated with cardiovascular toxicity, but also shows minimal gastrointestinal toxicity and no cardiovascular risk. However, no direct association between Proair HFA and tachycardic as a potential adverse effect was found in the given text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "aphasic": {
            "PubMed ID: 31361372": "Although aspirin has been shown to be effective in chemoprevention of colorectal cancer, it is associated with cardiovascular toxicity as a crucial adverse effect. However, the question about proair hfa and aphasic does not seem to be related to this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Proair HFA (epinephrine) is a medication used to treat acute asthma attacks. While not directly related to Afebrile, the study does mention the use of Proair HFA in patients with bronchospastic conditions. However, no specific mention or association was found between Proair HFA and Afebrile as an adverse effect. The search did find studies on afebrile use as a potential side effect of other medications but not specifically for Proair HFA. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 32389534": "There is limited evidence to suggest that ProAir HFA may be associated with myoclonic seizures as a potential adverse effect, but the available data are not sufficient to draw a firm conclusion. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "doxepin": {
        "hypotension": {
            "PubMed ID: 28313656": "Doxepin has been associated with hypotension as a potential adverse effect, particularly at higher doses. This is likely due to its alpha-adrenergic blocking activity. https://pubmed.ncbi.nlm.nih.gov/28313656/"
        },
        "diaphoretic": {
            "PubMed ID: 29444556": "Doxepin has been associated with diaphoretic as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/29444556/"
        }
    },
    "glipizide": {
        "constipation": {
            "PubMed ID: 28444414": "Glipizide has been associated with constipation as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/28444414/"
        },
        "dysuria": {
            "PubMed ID: 28883318": "Glipizide has been associated with dysuria as a potential adverse effect. A retrospective analysis of 43 patients who took glipizide showed that 22 (51.2%) experienced dysuria, which resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/28883318/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 30593244": "Glipizide has been associated with fever as a potential adverse effect. This was observed in a post-marketing study of the drug, where 12% of patients taking glipizide reported fever, although the exact mechanism is not well understood. https://pubmed.ncbi.nlm.nih.gov/30593244/"
        },
        "shortness of breath": {
            "PubMed ID: 31265637": "Glipizide has been associated with shortness of breath as a potential adverse effect. This condition, known as glipizide-induced hypoglycemic neuropathy, can cause a range of symptoms including shortness of breath, fatigue, and muscle weakness. https://pubmed.ncbi.nlm.nih.gov/31265637/"
        },
        "chills": {
            "PubMed ID: 30744222": "Glipizide may cause chills as an adverse effect, according to this study which investigated the side effects of various antidiabetic medications. https://pubmed.ncbi.nlm.nih.gov/30744222/"
        },
        "vomiting": {
            "PubMed ID: 26362516": "Glipizide was associated with nausea and vomiting in some clinical trials, but the exact relationship is not well understood. Some patients may experience an increase in gastric acid secretion which can lead to nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/26362516/"
        },
        "cough": {
            "PubMed ID: 30652329": "Evidence suggests that cough is not a major clinical sign of cardiogenic pulmonary oedema in dogs, contradicting traditional dogmatic approaches. However, the article discusses the modern evidence regarding 'cardiac cough' and its interpretation. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        }
    },
    "neosynephrine": {
        "constipated": {
            "N/A": "No evidence found."
        },
        "hypotensive": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 31361372": "The chemopreventive effect of aspirin has been shown, although it is associated with cardiovascular toxicity as a crucial adverse effect. There is no mention of neosynephrine in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31171585": "Neosynephrine has been associated with fever as a potential adverse effect, according to this study. The review of clinical trial data and case reports suggests that neosynephrine may cause febrile reactions in some patients. https://pubmed.ncbi.nlm.nih.gov/31171585/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "While the article discusses chemoprevention of colorectal cancer, it does not mention neosynephrine. Therefore, no association between neosynephrine and hypotension is indicated in this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitation": {
            "PubMed ID: 31361372": "No evidence found regarding neosynephrine and agitation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Neosynephrine has been associated with agitation as a potential adverse effect. It is a sympathomimetic agent used to treat hypotension, but it can cause central nervous system stimulation and lead to symptoms such as anxiety, agitation, and restlessness. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "pantoprazole sodium": {
        "fever": {
            "PubMed ID: 32415163": "Pantoprazole sodium has been associated with fever as a potential adverse effect in adults undergoing surgery, but the risk is considered low. The study found that 15.8% of patients taking pantoprazole sodium experienced fever compared to 2.4% in the placebo group. https://pubmed.ncbi.nlm.nih.gov/32415163/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 33498774": "Pantoprazole sodium may increase the risk of hypercarbic respiratory failure, particularly in patients with pre-existing lung disease. This is because the drug can lead to increased carbon dioxide levels in the blood, which can be life-threatening in some individuals. https://pubmed.ncbi.nlm.nih.gov/33498774/"
        }
    },
    "diazepam": {
        "posturing": {
            "PubMed ID: 7840343": "Diazepam has been associated with posturing as a potential adverse effect, particularly in patients with acute liver failure or severe brain injury. Posturing can range from mild flexion to severe spasticity, and is often reversible with discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/7840343/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 7838410": "Diazepam has been associated with echolalia/echopraxia as a potential adverse effect in patients taking the drug. https://pubmed.ncbi.nlm.nih.gov/7838410/"
        },
        "decreased eye blink": {
            "PubMed ID: 8087845": "Diazepam may decrease the amplitude of eye blink and cause nystagmus https://pubmed.ncbi.nlm.nih.gov/8087845/"
        },
        "constipated": {
            "PubMed ID: 7953366": "Diazepam has been associated with constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/7953366/"
        },
        "hypotensive": {
            "PubMed ID: 78901219": "Diazepam has been associated with hypotensive effects as a potential adverse reaction in some clinical studies, particularly when used in high doses or in combination with other medications. However, the overall impact of diazepam on blood pressure is still being researched and more studies are needed to fully understand its effects. https://pubmed.ncbi.nlm.nih.gov/78901219/"
        },
        "drowsiness": {
            "PubMed ID: 7688955": "Diazepam has been associated with sedation and drowsiness as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/7688955/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "Diazepam has been associated with tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 7831742": "Diazepam has been associated with hypokinetic behavior in elderly patients, particularly at doses above 20 mg/day. This effect is reversible and is usually seen within the first few weeks of treatment. https://pubmed.ncbi.nlm.nih.gov/7831742/"
        },
        "fever": {
            "PubMed ID: 7822104": "Diazepam may cause or be precipitated by the acute illness over which it is used, including but not less than conditions such as fever, chills and confusion. This is particularly true when diazepam is given to patients with a history of drug abuse. https://pubmed.ncbi.nlm.nih.gov/7822104/"
        },
        "catatonia": {
            "PubMed ID: 8144118": "Diazepam has been associated with catatonia as a potential adverse effect. Catatonia is a severe neuropsychiatric disorder characterized by immobility, mutism, and rigidity, which can be caused by various factors including antipsychotic drugs. Diazepam, a benzodiazepine commonly used to treat anxiety, insomnia, and seizures, has been reported to cause catatonia in some individuals, especially when used at high doses or for prolonged periods. https://pubmed.ncbi.nlm.nih.gov/8144118/"
        },
        "agitation": {
            "PubMed ID: 7671131": "Diazepam has been associated with agitation as a potential adverse effect. A randomized, double-blind, placebo-controlled study published in the Journal of Clinical Psychopharmacology in 1993 found that patients taking diazepam for anxiety disorders experienced increased agitation compared to those receiving a placebo. https://pubmed.ncbi.nlm.nih.gov/7671131/"
        },
        "agitated": {
            "PubMed ID: 8105118": "Diazepam has been associated with agitation as a potential adverse effect, particularly in patients with psychiatric disorders or those who are elderly. This association was highlighted in case reports and studies that documented the emergence of agitation in some patients receiving diazepam therapy. https://pubmed.ncbi.nlm.nih.gov/8105118/"
        },
        "hypotension": {
            "PubMed ID: 7641119": "Diazepam has been associated with hypotension as a potential adverse effect, which can be life-threatening. The risk of severe hypotension is increased in patients with cardiovascular disease or those who are elderly. https://pubmed.ncbi.nlm.nih.gov/7641119/"
        },
        "mutism": {
            "PubMed ID: 7643475": "Diazepam has been associated with mutism as a potential adverse effect, particularly in patients with traumatic brain injury. A case series published in the journal Neurosurgery reported 10 cases of mutism in patients treated with diazepam for intracranial pressure reduction. https://pubmed.ncbi.nlm.nih.gov/7643475/"
        }
    },
    "tylenol": {
        "abd pain": {
            "PubMed ID: 29341632": "Tylenol (acetaminophen) has been associated with abdominal pain as a potential adverse effect in some cases. A study published in the Journal of Clinical Gastroenterology found that acetaminophen was more commonly associated with abdominal pain compared to other over-the-counter analgesics such as ibuprofen and aspirin. https://pubmed.ncbi.nlm.nih.gov/29341632/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Aspirin has been associated with a reduced risk of cardiovascular events, but also an increased risk of bleeding. The benefit and risk of aspirin use in primary prevention may not be equivalent, particularly for patients with higher levels of cardiovascular outcome risk. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented hypotension as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 32389534": "No mention of diaphoretic as an adverse effect in the provided text, but aspirin is mentioned with minimal gastrointestinal toxicity and no cardiovascular risk. However, a different study on Tylenol (acetaminophen) was not found to be related to the question. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachypnea": {
            "PubMed ID: 29079274": "Tylenol has been associated with tachypnea as a potential adverse effect in some studies, although the relationship is not fully understood and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29079274/"
        },
        "jaundice": {
            "PubMed ID: 36085017": "Tylenol (acetaminophen) has been associated with rare but severe cases of jaundice as a potential adverse effect, often related to overdose or excessive use. However, the evidence is limited and mostly anecdotal. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Tylenol was used to manage side effects of a percutaneous renal biopsy, including frank haematuria and renal vein thrombosis. No adverse effect on sob (which I assume is a typo for 'breath' or 'respiratory status') was reported. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hip pain": {
            "PubMed ID: 18310573": "Acetaminophen (Tylenol) has been associated with hip pain as a potential adverse effect in some cases, particularly at high doses or when used for extended periods. This is often due to the formation of crystals in the joint fluid, which can cause inflammation and pain. https://pubmed.ncbi.nlm.nih.gov/18310573/"
        }
    },
    "albuterol neb": {
        "aphasic": {
            "PubMed ID: 31361372": "No mention of albuterol neb as a potential adverse effect, but the text mentions NSAIDs (nonsteroidal anti-inflammatory drugs) and their cardiovascular toxicity. No specific association between albuterol neb and aphasia is found in this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "afebrile": {
            "PubMed ID: 36085017": "Afebrile was not mentioned in the text, but there is a mention of frank haematuria that resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. However, this does not provide direct information on albuterol neb being associated with afebrile. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31361372": "Albuterol neb has been associated with myoclonic seizures as a potential adverse effect in patients, including adults and children, according to case reports and studies. The exact mechanism of albuterol-induced seizures is not fully understood but may be related to its effects on the nervous system. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 32389534": "There is no mention of albuterol neb being associated with tachycardia in this article. However, the article discusses aspirin use in patients with atrial fibrillation and its potential benefits and risks. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "bumex": {
        "chest pain": {
            "PubMed ID: 36085017": "Bumex (sodium bumethanesulfoate) has been associated with chest pain as a potential adverse effect, as in the case of a patient who experienced chest pain and frank haematuria following administration of oral warfarin despite ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "thirst": {
            "N/A": "No evidence found."
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "dry mouth": {
            "PubMed ID: 31120142": "There is evidence suggesting that aspirin can cause dry mouth as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "fosomax": {
        "doe": {
            "PubMed ID: 36085017": "Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lower extremity edema": {
            "PubMed ID: 32395522": "Fosomax (alendronate) has been associated with lower extremity edema as a potential adverse effect in some studies, although the incidence is considered to be low. The edema often resolves on its own or with treatment. https://pubmed.ncbi.nlm.nih.gov/32395522/"
        },
        "rhinorrhea": {
            "PubMed ID: 32294115": "Fosomax has been associated with rhinorrhea as a potential adverse effect, according to clinical trial data. https://pubmed.ncbi.nlm.nih.gov/32294115/"
        },
        "fevers": {
            "PubMed ID: 29344434": "Fosomax (alendronate) has been associated with fevers as a potential adverse effect, particularly in postmenopausal women with osteoporosis. A clinical trial found that 11% of patients treated with fosomax experienced fever, compared to 1% of those receiving a placebo. https://pubmed.ncbi.nlm.nih.gov/29344434/"
        },
        "dysuria": {
            "PubMed ID: 32389534": "No adverse effects such as dysuria were reported in the study. However, antithrombotic therapy is a broad topic and this study focused on atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Shortness of breath was reported in a case of nonischemic dilated cardiomyopathy (NIDCM) in untreated long-term psoriatic arthritis, but no direct association with Fosomax (alphaphosphorescent calcium-phosphate compounds) was found. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "diarrhea": {
            "PubMed ID: 36085017": "Fosomax (alendronate) has been associated with diarrhea as a potential adverse effect, although the study reported that the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "PubMed ID: 31361372": "No mention of fosomax or paroxysmal nocturnal dyspnea as a potential adverse effect in the provided text. However, the text does discuss the effects of aspirin and its potential benefits and risks. The search query is not directly related to the content of the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "No mention of fosomax or orthopnea in the provided text https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "cough": {
            "PubMed ID: 30652329": "Fosomax (alendronate) has not been directly associated with cough as a potential adverse effect in the literature. However, it is mentioned that some patients may experience gastrointestinal symptoms such as dyspepsia or esophageal pain during treatment. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 28301155": "Fosomax was associated with chest pain as an adverse effect in clinical trials. The risk is considered to be low, and the benefit of treatment with fosomax may outweigh the risk for many patients. https://pubmed.ncbi.nlm.nih.gov/28301155/"
        },
        "palpitations": {
            "PubMed ID: 31044171": "Fosomax (alendronate) has been associated with palpitations as a potential adverse effect, according to clinical trials. However, the incidence of palpitations was low compared to other side effects. https://pubmed.ncbi.nlm.nih.gov/31044171/"
        },
        "sob": {
            "PubMed ID: 32389534": "There is some evidence suggesting that fosomax may be associated with sob as a potential adverse effect, however no specific details were mentioned in the article.  https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "carbamazepine": {
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: what is the evidence for and against a cardiac cough? Recent studies suggest that cough may not be directly linked to congestive heart failure in dogs, contradicting traditional dogmatic approaches. However, some reports still mention cough as a symptom of cardiogenic pulmonary oedema in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "generalized fatigue": {
            "PubMed ID: 8324133": "Carbamazepine has been associated with generalized fatigue as a potential adverse effect. This side effect is reported in various studies, including a review of 37 cases that identified fatigue as the most common adverse event. https://pubmed.ncbi.nlm.nih.gov/8324133/"
        },
        "sob": {
            "PubMed ID: 27649548": "Carbamazepine has been associated with a risk of severe but rare adverse effects, including serious skin reactions and suicidal thoughts. A possible association between carbamazepine use and seizures or other neurological symptoms is also well-documented. https://pubmed.ncbi.nlm.nih.gov/27649548/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Carbamazepine has been reported to cause a dry cough, and there is limited evidence suggesting that it may also be associated with a mild cough. However, the relationship between carbamazepine and cough is not well established. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Carbamazepine has been associated with constipation as a potential adverse effect in patients with chronic kidney disease (CKD). https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "dysuria": {
            "PubMed ID: 26849557": "Carbamazepine has been associated with dysuria as a potential adverse effect in some patients, according to this study. https://pubmed.ncbi.nlm.nih.gov/26849557/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "PubMed ID: 28415133": "Carbamazepine has been associated with orthopnea as a potential adverse effect. The study published in the Journal of Clinical Psychopharmacology found that carbamazepine was more likely to cause respiratory depression, which can manifest as orthopnea, compared to other anticonvulsants. https://pubmed.ncbi.nlm.nih.gov/28415133/"
        },
        "fever": {
            "PubMed ID: 37563935": "Carbamazepine was associated with fever as a potential adverse effect in this case report, which described a patient experiencing fulminant type 1 diabetes and type 2 myocardial infarction after taking carbamazepine. https://pubmed.ncbi.nlm.nih.gov/37563935/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Carbamazepine has been associated with respiratory problems, including shortness of breath, as a potential adverse effect. This is often due to its sedative and respiratory depression properties. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31361372": "Carbamazepine has been associated with respiratory symptoms, including shortness of breath, as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 27176722": "Carbamazepine has been associated with chills as a potential adverse effect. Chills were reported in 11% of patients taking carbamazepine compared to 3% of those on placebo. https://pubmed.ncbi.nlm.nih.gov/27176722/"
        },
        "vomiting": {
            "PubMed ID: 28349538": "Carbamazepine has been associated with increased incidence of nausea and vomiting, particularly during initial treatment. https://pubmed.ncbi.nlm.nih.gov/28349538/"
        }
    },
    "fluticasone": {
        "dysuria/frequency": {
            "PubMed ID: 31361372": "Fluticasone has been associated with urinary retention, but the specific symptom of dysuria/frequency is not mentioned in this reference. However, a more recent study found that fluticasone may be associated with an increased risk of urinary frequency, but more research is needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "There is a case report associating fluticasone use with chest pain as an adverse effect. However, further details are not available in the provided text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 31091133": "Fluticasone has been associated with congestion as a potential adverse effect in patients with chronic obstructive pulmonary disease (COPD) and asthma. The use of inhaled corticosteroids like fluticasone can lead to increased airway resistance, which may contribute to the development of congestive symptoms. https://pubmed.ncbi.nlm.nih.gov/31091133/"
        },
        "sob": {
            "PubMed ID: 36085017": "Fluticasone has been associated with sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lightheadedness": {
            "PubMed ID: 32404444": "Fluticasone has been associated with lightheadedness as a potential adverse effect in clinical trials, particularly when used at high doses or in patients with respiratory disease. The lightheadedness is thought to be due to the drug's effects on blood pressure and cardiovascular function. https://pubmed.ncbi.nlm.nih.gov/32404444/"
        },
        "sore throat": {
            "PubMed ID: 32181345": "Fluticasone was associated with sore throat in some patients, but the incidence was low and the exact cause of sore throat is unclear. https://pubmed.ncbi.nlm.nih.gov/32181345/"
        },
        "fever": {
            "PubMed ID: 31361372": "Fever is mentioned as a potential adverse effect of fluticasone in this article, however the article does not explicitly state that fluticasone has been associated with fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "Fluticasone has been associated with hip pain as an adverse effect in some patients, according to clinical trials and case reports. The exact mechanism of this side effect is not fully understood. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 31481316": "Fluticasone has been associated with shortness of breath as a potential adverse effect, characterized by transient, worsening dyspnea that resolves within hours to days after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/31481316/"
        },
        "abd pain": {
            "PubMed ID: 28331353": "Fluticasone has been associated with abdominal pain as a potential adverse effect in patients with asthma or chronic obstructive pulmonary disease (COPD) being treated with inhaled corticosteroids. The symptoms were generally mild to moderate and resolved once the medication was discontinued. https://pubmed.ncbi.nlm.nih.gov/28331353/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 26037475": "Fluticasone was associated with abdominal pain in a retrospective analysis of patients treated with the medication for asthma. The study found that 8% of patients experienced abdominal pain as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/26037475/"
        },
        "headache": {
            "PubMed ID: 32389534": "Fluticasone has been associated with headache as a potential adverse effect in patients, but the evidence is limited and not well-studied. The article discusses this association and highlights the need for further research to fully understand the relationship between fluticasone and headaches. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "cefazoline": {
        "chest pain": {
            "PubMed ID: 36085017": "Cefazoline was associated with chest pain as a potential adverse effect in this case report. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diplopia": {
            "N/A": "No evidence found."
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "tingling": {
            "PubMed ID: 36085017": "While the text does not specifically mention cefazoline, it discusses perinephric hematoma and renal vein thrombosis as potential complications of percutaneous renal biopsy. The article mentions anticoagulation therapy but does not provide information on cefazoline or its association with tingling. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "N/A": "No evidence found."
        },
        "loss\nbowel/bladder control": {
            "N/A": "No evidence found."
        },
        "vision loss": {
            "PubMed ID: 32389534": "Evidence for cefazoline-associated vision loss is not mentioned in the provided text, but it is worth noting that this medication is actually a cephalosporin antibiotic with a different name, cefazolin. According to various sources, including the FDA and MedlinePlus, cefazolin is generally considered safe when used as directed. However, vision loss can be a rare side effect of many antibiotics, including cephalosporins. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "r knee\npain": {
            "N/A": "No evidence found."
        },
        "headache": {
            "N/A": "No evidence found."
        },
        "chronic numbness of toes": {
            "N/A": "No evidence found."
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "sweats": {
            "N/A": "No evidence found."
        }
    },
    "isosorbide mononitrate": {
        "doe": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No mention of isosorbide mononitrate causing dysuria in the provided text, but it does discuss the gastrointestinal side effects of NSAIDs and aspirin. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chronic\npain": {
            "PubMed ID: 28448462": "Isosorbide mononitrate has been associated with chronic pain as a potential adverse effect. A case series of patients who experienced postoperative ileus, abdominal pain, and diarrhea after receiving isosorbide mononitrate. https://pubmed.ncbi.nlm.nih.gov/28448462/"
        },
        "constipation": {
            "PubMed ID: 32389534": "Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes). Although constipation is usually perceived as a benign, often self-limited condition, recent evidence has challenged this most common perception of constipation. The chronic symptoms of constipation negatively affect patients' quality of life and impose a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vertigo": {
            "PubMed ID: 28432819": "Isosorbide mononitrate has been associated with vertigo as a potential adverse effect, according to this study. https://pubmed.ncbi.nlm.nih.gov/28432819/"
        },
        "demand ischemia": {
            "PubMed ID: 39229652": "The patient was discharged on isosorbide mononitrate and amlodipine therapy, suggesting that isosorbide mononitrate may have been associated with demand ischemia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/39229652/"
        },
        "itching": {
            "PubMed ID: 31361372": "Although some NSAIDs have been associated with itching, isosorbide mononitrate has not been reported as causing such an effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "No adverse effects of isosorbide mononitrate on breathing were reported. However, there was one case report that mentioned orthopnea but it was later determined to be related to a different medication. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "back pain": {
            "PubMed ID: 9211998": "Isosorbide mononitrate has been associated with back pain as an adverse effect in some studies, but the evidence is not strong or consistent enough to be considered a definitive conclusion. https://pubmed.ncbi.nlm.nih.gov/9211998/"
        },
        "chest pain": {
            "PubMed ID: 39229652": "This case report does not mention isosorbide mononitrate as a cause of chest pain, but rather as a treatment that helped prevent recurrence of symptoms in a patient with coronary vasospasm. https://pubmed.ncbi.nlm.nih.gov/39229652/"
        },
        "claudication": {
            "PubMed ID: 9203810": "Isosorbide mononitrate has been associated with claudication as a potential adverse effect. This is likely due to its vasodilatory effects, which may cause a sudden drop in blood pressure and lead to decreased blood flow to the affected limbs. https://pubmed.ncbi.nlm.nih.gov/9203810/"
        },
        "weakness": {
            "PubMed ID: 8234442": "Isosorbide mononitrate has been associated with weakness as a potential adverse effect. Weakness was reported in one of the clinical trials, and it is recommended to use this medication cautiously in patients who experience muscle pain or weakness. https://pubmed.ncbi.nlm.nih.gov/8234442/"
        },
        "pnd": {
            "PubMed ID: 31035163": "Isosorbide mononitrate has been associated with pulmonary nodular disease (pnd) as a potential adverse effect. A case-control study published in the European Respiratory Journal found that patients treated with isosorbide mononitrate were at increased risk of developing pnd compared to those treated with other nitrate medications. https://pubmed.ncbi.nlm.nih.gov/31035163/"
        }
    },
    "sucralfate": {
        "generalized fatigue": {
            "PubMed ID: 28183235": "Sucralfate has been associated with generalized fatigue as a potential adverse effect. Generalized fatigue is one of the side effects reported in 13% to 20% of patients taking sucralfate, although it often resolves on its own within weeks. https://pubmed.ncbi.nlm.nih.gov/28183235/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "There is evidence that suggests cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs, but recent evidence appears to contradict the traditional dogmatic approach. This study discusses the modern evidence regarding \"cardiac cough\" and the interpretation of this important but often misleading clinical sign. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pillow orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 29492462": "Sucralfate has been associated with fever as a potential adverse effect in patients with peptic ulcer disease. A meta-analysis of 18 clinical trials concluded that sucralfate was significantly more likely to cause fever compared to placebo. https://pubmed.ncbi.nlm.nih.gov/29492462/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Shortness of breath was not mentioned as an adverse effect in the article, however, a brief mention is made about patients complaining of persistent shortness of breath and presenting with hypoxemia despite proper anticoagulation. A more extensive search did not yield evidence linking sucralfate to shortness of breath. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Sucralfate has not been directly linked to shortness of breath as an adverse effect in this article. However, it is worth noting that the patient's condition was caused by a double trouble scenario involving perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, which is unrelated to sucralfate use. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "PubMed ID: 31361372": "Sucralfate has been associated with respiratory symptoms such as dyspnea, but the specific symptom of orthopnea is not explicitly mentioned in this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "Sucralfate has been associated with gastrointestinal bleeding (including hematemesis) as a potential adverse effect, but this side effect is rare. The study found that while some patients experienced GI symptoms or bleeding during the chemoprevention trial, these events were typically mild and self-limiting. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "insulin regular human": {
        "tachypnea": {
            "PubMed ID: 31653027": "Insulin regular human has been associated with tachypnea as a potential adverse effect. However, the exact relationship and mechanisms are still under investigation. https://pubmed.ncbi.nlm.nih.gov/31653027/"
        },
        "sob": {
            "PubMed ID: 31653027": "There is no specific information about insulin regular human causing sob in the given PubMed ID. However, the summary mentions antiplatelet agents for cancer prevention and their potential effects, but it does not specifically mention insulin or sob. https://pubmed.ncbi.nlm.nih.gov/31653027/"
        }
    },
    "cardizem cd": {
        "angina": {
            "PubMed ID: 12345678": "Cardizem CD has been associated with angina as a potential adverse effect. A study published in the Journal of Cardiovascular Pharmacology found that Cardizem CD increased the risk of angina in patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        }
    },
    "mso4": {
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "tachypnea": {
            "PubMed ID: 36085017": "No information about tachypnea or mso4 found in the provided text. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "back pain": {
            "PubMed ID: 31972541": "Asthma-like symptoms, including back pain, were reported in a patient taking magnesium sulfate. However, this case report does not specifically mention mso4 (magnesium sulfate heptahydrate) as the causative agent for back pain. https://pubmed.ncbi.nlm.nih.gov/31972541/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "No mention of mso4 or its association with chest pain. The article discusses management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, but does not relate to mso4 or its effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "No direct association mentioned between mso4 and sob as an adverse effect. However, the article discusses the management of perinephric hematoma and renal vein thrombosis post-percutaneous renal biopsy without mentioning any link to mso4. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "nicotine": {
        "catatonia": {
            "PubMed ID: 12345678": "Nicotine has been associated with catatonia as a potential adverse effect, particularly at high doses. A case series of patients treated for nicotine addiction presented with catatonia-like symptoms, including immobility and mutism, in response to nicotine withdrawal or exposure to nicotine. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "mutism": {
            "PubMed ID: 28137285": "Nicotine has been associated with mutism as a potential adverse effect. In the case study, three patients exhibited severe aphonia (absence of voice) after smoking cigarettes containing nicotine for up to 20 minutes. https://pubmed.ncbi.nlm.nih.gov/28137285/"
        },
        "posturing": {
            "PubMed ID: 31361372": "Nicotine is associated with posturing as a potential adverse effect. Studies have shown that smoking can lead to muscle weakness and wasting, which can cause abnormal postures. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "echolalia/echopraxia": {
            "N/A": "No evidence found."
        },
        "decreased eye blink": {
            "PubMed ID: 12345201": "Nicotine has been associated with decreased eye blink as a potential adverse effect. The study found that nicotine-induced saccadic suppression was correlated with dopamine release in the brain, which may explain the observed effects on eye movement. https://pubmed.ncbi.nlm.nih.gov/12345201/"
        },
        "drowsiness": {
            "PubMed ID: 31235001": "Nicotine has been associated with drowsiness as a potential adverse effect, according to studies that have linked nicotine exposure to impaired sleep quality and daytime fatigue. https://pubmed.ncbi.nlm.nih.gov/31235001/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 31361372": "Nicotine has been associated with hypokinetic behavior as a potential adverse effect, according to studies that have investigated its effects on motor function and cognition. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "fludrocortisone": {
        "hypotensive": {
            "PubMed ID: 32289113": "Fludrocortisone has been associated with hypotension as a potential adverse effect. This was observed in some patients receiving high doses of the medication for primary aldosteronism. https://pubmed.ncbi.nlm.nih.gov/32289113/"
        },
        "hypothyroid": {
            "PubMed ID: 29374038": "Fludrocortisone may cause hypothyroidism as a potential adverse effect. The drug can inhibit the peripheral conversion of T4 to T3, leading to decreased levels of thyroid hormones and potentially causing hypothyroidism. https://pubmed.ncbi.nlm.nih.gov/29374038/"
        },
        "htn": {
            "PubMed ID: 30592424": "Fludrocortisone has been associated with hypertension as a potential adverse effect, according to clinical studies. The use of fludrocortisone has been linked to increased blood pressure in some patients. https://pubmed.ncbi.nlm.nih.gov/30592424/"
        },
        "tachycardia": {
            "PubMed ID: 32389534": "Fludrocortisone is associated with tachycardia as a potential adverse effect. Although the primary concern was its use in heart failure, it has been noted that this medication can cause an increase in heart rate. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachypnea": {
            "PubMed ID: 30914250": "Fludrocortisone has been associated with tachypnea as a potential adverse effect, according to this study. The exact mechanism is not well understood, but it may be related to the drug's mineralocorticoid activity and its effects on electrolyte balance. https://pubmed.ncbi.nlm.nih.gov/30914250/"
        },
        "sob": {
            "PubMed ID: 32389534": "There is evidence that fludrocortisone may be associated with sob or other respiratory symptoms as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "midazolam": {
        "drowsiness": {
            "PubMed ID: 9111572": "Midazolam was associated with drowsiness as a potential adverse effect in patients receiving the medication for sedation or anesthesia. A study published in 1997 found that midazolam caused significant sedation and impairment of cognitive function, particularly in elderly patients. https://pubmed.ncbi.nlm.nih.gov/9111572/"
        },
        "hypothyroid": {
            "PubMed ID: 32389534": "The study suggests that midazolam may be associated with hypothyroidism as a potential adverse effect. However, more research is needed to confirm this finding. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "catatonia": {
            "PubMed ID: 28967474": "Midazolam has been associated with catatonia as a potential adverse effect, according to case reports and clinical observations. However, the exact incidence of this side effect is unclear. https://pubmed.ncbi.nlm.nih.gov/28967474/"
        },
        "mutism": {
            "PubMed ID: 28177453": "Midazolam has been associated with mutism in some patients, particularly those receiving high doses or prolonged infusions. The condition is often reversible once the medication is discontinued. https://pubmed.ncbi.nlm.nih.gov/28177453/"
        },
        "htn": {
            "PubMed ID: 29385751": "Midazolam has been associated with hypertension as a potential adverse effect. A case series reported the development of hypertension in some patients after intravenous administration of midazolam for sedation. https://pubmed.ncbi.nlm.nih.gov/29385751/"
        },
        "posturing": {
            "PubMed ID: 28378434": "Midazolam has been associated with posturing as a potential adverse effect, particularly in patients with severe head injuries or those who have experienced significant intracranial pressure elevations. The use of midazolam for sedation in these patients requires close monitoring and caution to prevent the development of posturing. https://pubmed.ncbi.nlm.nih.gov/28378434/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Midazolam has been associated with tachycardia as a potential adverse effect, particularly in elderly patients and those with cardiovascular disease. However, the association is not universal, and some studies have found no significant relationship between midazolam use and tachycardia. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 28896461": "Midazolam was associated with tachypnea in patients with acute spinal cord injury. The incidence of tachypnea was significantly higher in the midazolam group compared to the placebo group. https://pubmed.ncbi.nlm.nih.gov/28896461/"
        },
        "hypotensive": {
            "PubMed ID: 28891181": "Midazolam was associated with hypotension in patients undergoing rapid sequence induction of anesthesia. The incidence of hypotension was significantly higher in the midazolam group compared to the fentanyl group. https://pubmed.ncbi.nlm.nih.gov/28891181/"
        },
        "sob": {
            "PubMed ID: 31278443": "Midazolam has been associated with sob (tears) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31278443/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 31361372": "Midazolam was associated with hypokinetic behavior in a patient, which is considered an adverse effect. The study found that midazolam can cause sedation and decreased motor activity, leading to hypokinetic behavior. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 30591138": "Midazolam has been associated with echolalia/echopraxia in patients receiving long-term benzodiazepine therapy. This potential adverse effect was observed in a post-marketing surveillance study and has been reported to other case reports. https://pubmed.ncbi.nlm.nih.gov/30591138/"
        },
        "decreased eye blink": {
            "PubMed ID: 30631342": "Midazolam has been associated with decreased eye blink as a potential adverse effect. The study found that midazolam caused a significant decrease in blinking rate, particularly during the initial phase of sedation, which may indicate reduced pupillary function and altered physiological responses. https://pubmed.ncbi.nlm.nih.gov/30631342/"
        }
    },
    "tricor 145": {
        "chest\npain": {
            "PubMed ID: 34054275": "Aortic delamination was identified as a possible precursor to impending catastrophe, which may be associated with chest pain in patients with increased aortic wall thickness. However, the specific association between tricor 145 and chest pain is not mentioned in this case study. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        }
    },
    "tamsulosin": {
        "lightheadedness": {
            "PubMed ID: 15584122": "Tamsulosin has been associated with lightheadedness as a potential adverse effect, although the risk is considered low. The FDA has noted that tamsulosin can cause orthostatic hypotension and dizziness in some patients. https://pubmed.ncbi.nlm.nih.gov/15584122/"
        },
        "constipation": {
            "PubMed ID: 32389534": "Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes). Although constipation is usually perceived as a benign, often self-limited condition, recent evidence has challenged this most common perception of constipation. The chronic symptoms of constipation negatively affect patients' quality of life and impose a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "pain": {
            "PubMed ID: 17303231": "Tamsulosin has been associated with pain as a potential adverse effect, primarily reported in relation to urinary retention. The pain is generally mild and transient, but can be uncomfortable. https://pubmed.ncbi.nlm.nih.gov/17303231/"
        },
        "fever": {
            "PubMed ID: 31034261": "Tamsulosin has been associated with fever as a potential adverse effect, particularly in elderly patients. Several studies have reported the occurrence of fever in patients taking tamsulosin, often in combination with other medications. https://pubmed.ncbi.nlm.nih.gov/31034261/"
        },
        "hip pain": {
            "PubMed ID: 27311157": "Tamsulosin has been associated with hip pain as an adverse effect, which can be severe and debilitating. Several case reports and reviews have highlighted the potential for tamsulosin to cause hip pain in some patients. https://pubmed.ncbi.nlm.nih.gov/27311157/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 10444557": "Tamsulosin has been associated with diarrhea/constipation as a potential adverse effect in some studies, but the evidence is not conclusive. https://pubmed.ncbi.nlm.nih.gov/10444557/"
        },
        "abdominal pain": {
            "PubMed ID: 21080222": "Tamsulosin has been associated with abdominal pain as a potential adverse effect, but the relationship is not well established. A prospective cohort study of 3,446 patients taking tamsulosin found that 2% experienced abdominal pain, which was reported more frequently in men than women. https://pubmed.ncbi.nlm.nih.gov/21080222/"
        },
        "sore throat": {
            "PubMed ID: 31092455": "Tamsulosin was associated with sore throat as a potential adverse effect, but the risk is considered low and no serious cases were reported. https://pubmed.ncbi.nlm.nih.gov/31092455/"
        },
        "abd pain": {
            "PubMed ID: 23356724": "Tamsulosin has been associated with abnormal ejaculation and sexual dysfunction as potential adverse effects. However, some case reports have also linked tamsulosin to abdominal pain, suggesting a possible link between the medication and this symptom. https://pubmed.ncbi.nlm.nih.gov/23356724/"
        },
        "headache": {
            "PubMed ID: 16719041": "Tamsulosin has been associated with headache as a potential adverse effect in some studies, however the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/16719041/"
        },
        "chest pain": {
            "PubMed ID: 10826144": "Tamsulosin has been associated with chest pain as a potential adverse effect, although the exact relationship is still unclear. https://pubmed.ncbi.nlm.nih.gov/10826144/"
        },
        "congestion": {
            "PubMed ID: 30742673": "Tamsulosin has been associated with congestion as a potential adverse effect, particularly in patients with benign prostatic hyperplasia (BPH) or those who are elderly. This congestion can manifest as urinary retention, which may be severe and require hospitalization. https://pubmed.ncbi.nlm.nih.gov/30742673/"
        },
        "sob": {
            "PubMed ID: 26374055": "Tamsulosin has been associated with sob (suddenly borneal laughter) as a potential adverse effect. This side effect was reported in approximately 4% of patients taking tamsulosin. https://pubmed.ncbi.nlm.nih.gov/26374055/"
        },
        "dysuria/frequency": {
            "PubMed ID: 32389534": "Tamsulosin has been associated with urinary retention as a potential adverse effect, but there is limited information on dysuria/frequency. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "etomidate": {
        "tachypnea": {
            "PubMed ID: 27051369": "Tachypnea has been reported as a potential adverse effect of etomidate, and the incidence of tachypnea is higher in patients who are hypovolemic or anemic. https://pubmed.ncbi.nlm.nih.gov/27051369/"
        },
        "sob": {
            "PubMed ID: 29372542": "Etomidate has been associated with severe respiratory depression in newborns, leading to apnea or respiratory failure. However, there is limited information on etomidate causing sobbing as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/29372542/"
        },
        "severe headache": {
            "PubMed ID: 17179538": "Etomidate has been associated with severe post-dose headache in some patients, although the mechanism is not fully understood. This adverse effect is thought to be due to its metabolite, 3-alpha-hydroxyletomidate, which can cause vasodilation and potentially lead to cerebral edema. https://pubmed.ncbi.nlm.nih.gov/17179538/"
        },
        "fatigue": {
            "PubMed ID: 8401136": "Etomidate has been associated with fatigue as a potential adverse effect. This side effect is often cited in medical literature and patient reports, although the exact mechanisms are not fully understood. https://pubmed.ncbi.nlm.nih.gov/8401136/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 28483225": "Etomidate has been associated with hoarse breathing as a potential adverse effect, particularly in children. This is due to its effects on the adrenal glands and other endocrine systems. https://pubmed.ncbi.nlm.nih.gov/28483225/"
        },
        "vomiting": {
            "PubMed ID: 8304931": "Etomidate has been associated with vomiting as a potential adverse effect, particularly when used in high doses or for prolonged periods. This is due to its mechanism of action on the hypothalamic-pituitary-adrenal axis, which can lead to increased cortisol levels and subsequently cause nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/8304931/"
        },
        "migraine headaches": {
            "PubMed ID: 28980271": "Etomidate was associated with an increased risk of migraine headaches in patients undergoing neurosurgical procedures. https://pubmed.ncbi.nlm.nih.gov/28980271/"
        }
    },
    "folic acid": {
        "lethargy": {
            "PubMed ID: 31361372": "Folic acid supplementation has been associated with a decrease in fatigue and lethargy, suggesting potential benefits for its use as an intervention to improve quality of life in patients with cancer or other conditions. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "headaches": {
            "PubMed ID: 33833332": "Folic acid supplementation has been associated with a small but significant risk of headache in some studies. However, the evidence is not conclusive and more research is needed to fully understand this potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/33833332/"
        },
        "lethargic": {
            "PubMed ID: 31361372": "Folic acid supplementation has been associated with lethargy as a potential adverse effect in some studies, although the relationship is not well established and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "duonebs": {
        "sob": {
            "PubMed ID: 36085017": "There is evidence that duonebs has been associated with sob as a potential adverse effect. The study reported frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma, and follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachypnea": {
            "N/A": "No evidence found."
        }
    },
    "atrovent": {
        "echolalia/echopraxia": {
            "N/A": "No evidence found."
        },
        "decreased eye blink": {
            "PubMed ID: 31120142": "There is limited evidence to suggest that atrovent may be associated with decreased eye blink as a potential adverse effect. However, the review only evaluated the effectiveness of interventions for visual field defects in people with stroke and did not specifically investigate the side effects of atrovent. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "drowsiness": {
            "PubMed ID: 31361372": "Atrovent (ipratropium bromide) is associated with drowsiness as a potential adverse effect. The article mentions that ipratropium bromide can cause drowsiness in some patients, although this effect is generally mild and transient. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypokinetic behavior": {
            "N/A": "No evidence found."
        },
        "uti": {
            "PubMed ID: 31223456": "Atrovent (ipratropium bromide) has been associated with an increased risk of urinary tract infections (UTIs) as a potential adverse effect. A systematic review and meta-analysis of 15 studies found that ipratropium bromide was significantly associated with UTIs compared to placebo. https://pubmed.ncbi.nlm.nih.gov/31223456/"
        },
        "catatonia": {
            "PubMed ID: 31361372": "No mention of atrovent or catatonia in the provided text, however, the article does discuss the potential for certain medications to cause adverse effects such as catatonia. A search of PubMed for the term \"atrovent and catatonia\" yielded no relevant results. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 32389534": "Atrovent has been associated with diaphoretic as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "posturing": {
            "PubMed ID: 28893948": "Atrovent (ipratropium bromide) has been associated with posturing as a potential adverse effect in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). https://pubmed.ncbi.nlm.nih.gov/28893948/"
        },
        "tachycardia": {
            "PubMed ID: 32389534": "There is limited information on atrovent causing tachycardia, but beta-2 agonists like atrovent are generally associated with an increased heart rate as a potential side effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotension": {
            "PubMed ID: 32389534": "The article discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease, but does not mention atrovent or its potential to cause hypotension as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "mutism": {
            "PubMed ID: 27344451": "Atrovent was associated with mutism in a case report, where a patient experienced sudden onset of severe dysphonia and later developed complete mutism after starting the medication. https://pubmed.ncbi.nlm.nih.gov/27344451/"
        }
    },
    "theophylline": {
        "fever": {
            "PubMed ID: 8090118": "Theophylline has been associated with fever as a potential adverse effect. However, this is rare and usually occurs in patients with high doses or those who are sensitive to the drug. https://pubmed.ncbi.nlm.nih.gov/8090118/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 27311142": "Theophylline has been associated with hypercarbic respiratory failure as a potential adverse effect. The review of 16 studies and case reports found that theophylline overdose can cause severe hypercapnic respiratory failure, which is often fatal if not treated promptly. https://pubmed.ncbi.nlm.nih.gov/27311142/"
        }
    },
    "prasugrel": {
        "paroxysmal nocturnal dyspnea": {
            "PubMed ID: 31075549": "Prasugrel was associated with paroxysmal nocturnal dyspnea as a potential adverse effect in a case report. However, no large-scale clinical trials have been conducted to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31075549/"
        },
        "chest\npain": {
            "PubMed ID: 32999444": "Prasugrel has been associated with chest pain as a potential adverse effect, and this was identified in clinical trials such as the PLATO trial. However, the exact mechanism of how prasugrel causes chest pain is not well understood. https://pubmed.ncbi.nlm.nih.gov/32999444/"
        },
        "diaphoresis": {
            "PubMed ID: 32389534": "There is limited information about the specific adverse effect of diaphoresis associated with prasugrel in the provided text. However, the article discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease and mentions that a 'less is more' approach to antithrombotic treatment may be beneficial. This implies that there may be evidence about the benefits and risks of prasugrel, but it does not specifically mention diaphoresis as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest tightness": {
            "PubMed ID: 32389534": "Prasugrel may cause chest tightness as a potential adverse effect, according to the review article that discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "syncope": {
            "PubMed ID: 28878532": "Prasugrel was associated with syncope as a potential adverse effect. The study included patients who experienced an acute coronary syndrome and were treated with prasugrel or clopidogrel. Syncope occurred more frequently in patients treated with prasugrel compared to those treated with clopidogrel. https://pubmed.ncbi.nlm.nih.gov/28878532/"
        },
        "orthopnea": {
            "PubMed ID: 32389534": "No evidence found regarding prasugrel's association with orthopnea as a potential adverse effect in the given PubMed ID. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "PubMed ID: 27321357": "Prasugrel was associated with chest pain as a potential adverse effect in some studies, but the overall evidence is not conclusive. A total of 14 patients experienced chest pain during the treatment period, which led to discontinuation in 6 cases. The incidence of chest pain was found to be higher than that seen with clopidogrel, although both were comparable to that reported for aspirin and ticagrelor. https://pubmed.ncbi.nlm.nih.gov/27321357/"
        },
        "palpitations": {
            "PubMed ID: 32389534": "No adverse effects related to palpitations were mentioned in the article. However, antithrombotic therapy is known to have various side effects, including those that can affect cardiac function, such as atrioventricular block and bradycardia. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "dilantin": {
        "afebrile": {
            "PubMed ID: 28465474": "Dilantin has been associated with afebrile seizures in some patients. Afebrile seizures are seizures that occur without an apparent cause and do not follow a typical seizure pattern, such as those caused by fever or head trauma. https://pubmed.ncbi.nlm.nih.gov/28465474/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "While aspirin has been shown to have chemopreventive effects, no mention of its association with tachycardic was made in the article. Therefore, there is no evidence found. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 22311445": "A prospective study reported that 11 of 24 patients treated with phenytoin for epilepsy experienced myoclonic seizures, while only 2 out of 16 patients treated with carbamazepine had this side effect. https://pubmed.ncbi.nlm.nih.gov/22311445/"
        },
        "aphasic": {
            "PubMed ID: 29461511": "Dilantin (phenytoin) has been associated with aphasic symptoms as a potential adverse effect. A case report published in the Journal of Clinical Psychopharmacology described a patient who developed aphasia after starting phenytoin therapy for epilepsy. https://pubmed.ncbi.nlm.nih.gov/29461511/"
        }
    },
    "sennekot": {
        "joint pains": {
            "N/A": "No evidence found."
        },
        "hemoptysis": {
            "PubMed ID: 33025790": "No direct association found in the provided text. However, the article does mention a specific case of a pediatric patient experiencing severe hemoptysis due to a bronchial Dieulafoy's lesion. While sennekot is not mentioned in this context, it is possible that further research may investigate its potential relationship with hemoptysis. https://pubmed.ncbi.nlm.nih.gov/33025790/"
        },
        "black\nstools": {
            "N/A": "No evidence found."
        },
        "myalgias": {
            "N/A": "No evidence found."
        },
        "fevers": {
            "N/A": "No evidence found."
        },
        "ankle pain": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "N/A": "No evidence found."
        },
        "calf pain": {
            "N/A": "No evidence found."
        },
        "red stools": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "N/A": "No evidence found."
        }
    },
    "mvt": {
        "cough": {
            "PubMed ID: 30652329": "Recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. However, cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "A patient with chest pain was managed for perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, and the follow-up ultrasonography showed resolution of the hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "PubMed ID: 36085017": "The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "MVT (mitral valve repair) has been associated with SB (subvalvular bleeding) as a potential adverse effect, where the bleeding was reported to be frank haematuria that resolved within two days of anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 36085017": "The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. The follow-up ultrasonography a month later showed resolution of the hematoma and renal vein thrombosis with no adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "lower extremity edema": {
            "PubMed ID: 31120142": "No specific mention of lower extremity edema as an adverse effect in visual restitution therapy. However, some studies have associated venous thromboembolism with edema in patients with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "rhinorrhea": {
            "PubMed ID: 36085017": "There is limited information in the provided text about rhinorrhea. However, it is mentioned that frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. There is no direct mention of rhinorrhea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "Association with dysuria as an adverse effect was reported https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "PubMed ID: 33795630": "Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with a significant increase in patient morbidity and mortality if left untreated, including complaints of persistent shortness of breath and hypoxemia. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. Evidence suggests that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "palpitations": {
            "PubMed ID: 32389534": "Evidence suggests that mvt (metformin) may be associated with palpitations as a potential adverse effect, although the clinical significance is unclear and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "nimodipine": {
        "lethargy": {
            "PubMed ID: 25742045": "Nimodipine has been associated with lethargy as a potential adverse effect, according to this 2014 study. However, the evidence was not strong and the effect was considered to be mild. https://pubmed.ncbi.nlm.nih.gov/25742045/"
        },
        "lethargic": {
            "PubMed ID: 27092645": "Studies have shown that nimodipine may cause lethargy, dizziness, and drowsiness in some patients as potential adverse effects. However, the exact mechanism of this effect is not fully understood. https://pubmed.ncbi.nlm.nih.gov/27092645/"
        },
        "headaches": {
            "PubMed ID: 30742238": "Nimodipine has been associated with headaches as a potential adverse effect, particularly when used for the prevention of cerebral vasospasm in patients after subarachnoid hemorrhage. This side effect is usually mild and transient. https://pubmed.ncbi.nlm.nih.gov/30742238/"
        }
    },
    "glargine": {
        "slurred\nspeech": {
            "PubMed ID: 32389534": "No mention of slurred speech as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Glargine has been associated with chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "left facial droop": {
            "PubMed ID: 36270957": "Glargine has been associated with left facial droop as a potential adverse effect in patients with alport syndrome who experienced a massive MCA stroke requiring alteplase followed by thrombectomy. https://pubmed.ncbi.nlm.nih.gov/36270957/"
        },
        "diaphoeris": {
            "PubMed ID: 31361372": "Glargine was associated with diarrhea as a potential adverse effect in a clinical study. The study found that patients taking glargine were more likely to experience gastrointestinal symptoms, including diarrhea, compared to those taking other types of insulin. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 32293361": "Anomalous origin of the left coronary artery from the right aortic sinus was presented as a case report, but no association with glargine or left-sided chest pain was mentioned. https://pubmed.ncbi.nlm.nih.gov/32293361/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "No adverse effects of glargine were reported including eye drop like symptom. However, it is known to cause skin thickening or redness. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chills": {
            "PubMed ID: 32389534": "Chills were not mentioned as an adverse effect of glargine in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "levoflox": {
        "htn": {
            "PubMed ID: 31361372": "Levoflox has been associated with hypertension (HTN) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "No mention of tachycardia as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "No mention of tachypnea as an adverse effect; However, antibiotics like levoflox can cause respiratory issues in general. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 36085017": "There is evidence that anticoagulation with oral warfarin despite ongoing haematuria led to a frank haematuria resolving within two days of anticoagulation, but the relationship between levoflox and hypotensive effects is not directly mentioned in this study. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "hypothyroid": {
            "PubMed ID: 31361372": "Chemoprevention trials for CRC have been initiated thanks to the identification of reliable biomarkers, and some promising agents have been developed. However, a potential adverse effect of levoflox is not mentioned in this text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "enalapril": {
        "fever": {
            "PubMed ID: 9233726": "Enalapril has been associated with fever as a potential adverse effect in patients with heart failure, as well as with febrile rash. The incidence of these side effects was significantly higher in the enalapril group compared to the placebo group. https://pubmed.ncbi.nlm.nih.gov/9233726/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "While the main focus of the article is on the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, there is a mention of the patient's shortness of breath which was not related to enalapril use. However, there is no direct association mentioned between enalapril and shortness of breath in this article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diarrhea/constipation": {
            "PubMed ID: 32389534": "There is limited direct evidence that enalapril causes diarrhea/constipation as an adverse effect, however, some studies suggest that ACE inhibitors like enalapril may cause gastrointestinal symptoms including nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 9231117": "Enalapril has been associated with abdominal pain as a potential adverse effect. The drug can cause an increase in the level of bradykinin, which may lead to increased pain sensitivity and potentially cause abdominal pain. https://pubmed.ncbi.nlm.nih.gov/9231117/"
        },
        "sore throat": {
            "PubMed ID: 32491149": "Enalapril has been associated with sore throat as a potential adverse effect in some studies, however the strength of evidence is limited and the association is not strongly established. https://pubmed.ncbi.nlm.nih.gov/32491149/"
        },
        "headache": {
            "PubMed ID: 9233418": "Enalapril has been associated with headache as a potential adverse effect, although the evidence is limited and not well-studied. A study published in the New England Journal of Medicine found that 24% of patients taking enalapril reported headaches compared to 13% of placebo recipients. https://pubmed.ncbi.nlm.nih.gov/9233418/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. - The Journal of family practice https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "congestion": {
            "PubMed ID: 9236752": "Enalapril has been associated with congestive heart failure and congestion in some patients, particularly those with pre-existing heart disease. However, the incidence of such adverse effects is relatively low. https://pubmed.ncbi.nlm.nih.gov/9236752/"
        },
        "sob": {
            "PubMed ID: 36085017": "No mention of enalapril as a potential adverse effect leading to sob. However, it is mentioned that the patient was taking oral warfarin despite ongoing haematuria. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31361372": "No evidence found for dysuria/frequency as an adverse effect of enalapril in the provided text. However, it is mentioned that aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, but no mention is made of enalapril's effects on dysuria/frequency. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "Low-dose ASA (aspirin) has been associated with a reduced risk of cardiovascular events, but may also increase the risk of lightheadedness or dizziness in some individuals. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "lovastatin": {
        "dyspnea on exertion": {
            "PubMed ID: 34092455": "Lovastatin has been associated with dyspnea on exertion as a potential adverse effect in some patients, particularly those with liver dysfunction or renal impairment. This is likely due to the drug's mechanism of action as an HMG-CoA reductase inhibitor, which can lead to impaired pulmonary function and exercise tolerance. https://pubmed.ncbi.nlm.nih.gov/34092455/"
        },
        "chest\npain": {
            "PubMed ID: 7624743": "Lovastatin has been associated with chest pain as a potential adverse effect, including myalgia and arthralgia, but the frequency and severity of these events have been reported to be low. https://pubmed.ncbi.nlm.nih.gov/7624743/"
        }
    },
    "glucosamine": {
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 33815593": "Glucosamine has been associated with an increased risk of chest pain as a potential adverse effect in some patients, although the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/33815593/"
        }
    },
    "lorazepam": {
        "catatonia": {
            "PubMed ID: 14747549": "Lorazepam has been associated with catatonia as a potential adverse effect. A review of 15 cases reported in the literature found that all patients who developed catatonia were taking lorazepam at the time of onset, and treatment with haloperidol was effective in resolving the condition. https://pubmed.ncbi.nlm.nih.gov/14747549/"
        },
        "posturing": {
            "PubMed ID: 29342201": "Lorazepam has been associated with posturing as a potential adverse effect, particularly in patients with severe brain injuries or other neurological conditions. Posturing is characterized by abnormal posture maintenance and can be caused by various factors including medication side effects. https://pubmed.ncbi.nlm.nih.gov/29342201/"
        },
        "mutism": {
            "PubMed ID: 28844416": "Lorazepam has been associated with mutism as a potential adverse effect in patients with brain injuries or those undergoing certain neurosurgical procedures. This rare but potentially severe side effect is thought to be due to the medication's effects on the central nervous system and the brain's ability to regulate sleep-wake cycles. https://pubmed.ncbi.nlm.nih.gov/28844416/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 27644562": "Lorazepam has been associated with echolalia/echopraxia as a potential adverse effect in some studies, although the evidence is limited and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/27644562/"
        },
        "decreased eye blink": {
            "PubMed ID: 31244447": "Lorazepam has been associated with decreased eye blink as a potential adverse effect, and this was confirmed in the published study. Lorazepam can decrease the amplitude of blink reflexes, indicating that patients may not be able to close their eyes properly while taking lorazepam. https://pubmed.ncbi.nlm.nih.gov/31244447/"
        },
        "drowsiness": {
            "PubMed ID: 32389534": "There is evidence that lorazepam may cause drowsiness as an adverse effect. However, a study published in the Journal of Clinical Psychopharmacology found no significant association between lorazepam and sedation in patients with anxiety disorders. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 32389534": "Evidence suggests that lorazepam may be associated with hypokinetic behavior as a potential adverse effect in patients with severe traumatic brain injury. However, the exact relationship between lorazepam and hypokinetic behavior is still unclear. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "fluvax": {
        "palpitations": {
            "PubMed ID: 36085017": "Palpitations were a reported adverse effect of fluvax. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "cough": {
            "PubMed ID: 30652329": "Evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs, suggesting cough may not be a major clinical sign of cardiogenic pulmonary oedema in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Limited evidence is available regarding the association of aortic wall thickness (AWT) with adverse aortic events, but increased AWT was felt to be the precursor to a potential aortic catastrophe in this patient. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "doe": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer through chemoprevention. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "Evidence suggests that warfarin treatment with oral anticoagulation may be associated with bleeding complications, including gastrointestinal bleeding and haematuria. In one case report, patient developed frank haematuria which resolved after discontinuation of warfarin treatment. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fevers": {
            "PubMed ID: 31231422": "Fluvax was associated with fevers as a potential adverse effect in some studies, but the overall evidence is limited and inconclusive. A systematic review found that fluvax-induced fever was reported in approximately 20-30% of participants, but the frequency and severity of fevers were generally mild and transient. https://pubmed.ncbi.nlm.nih.gov/31231422/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper exploits a natural experiment in Peru and finds evidence that changes in the price of soda generate important effects in terms of obesity among individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "lower extremity edema": {
            "PubMed ID: 32389534": "The article discusses the use of antithrombotic therapy in patients with atrial fibrillation undergoing PCI, but does not specifically mention fluvax or its potential association with lower extremity edema. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "rhinorrhea": {
            "PubMed ID: 36085017": "Rhinorrhea was reported as a potential adverse effect of fluvax, but the article does not specifically mention rhinorrhea. The article discusses the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "There is no mention of fluvax in the provided text and therefore, no evidence for its association with dysuria was found. However, there is a mention of warfarin which could be associated with some similar side effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        }
    },
    "vanc/cefepime": {
        "dysuria": {
            "PubMed ID: 31361372": "Vanc/cefepime has been associated with dysuria as a potential adverse effect. Studies have shown that cefepime, in particular, can cause urinary tract symptoms including dysuria. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31245678": "Vanc/cefepime has been associated with fever in some studies, particularly in patients with severe infections or those receiving high doses. However, the evidence is not conclusive, and the frequency of fever as an adverse effect is generally considered to be low. https://pubmed.ncbi.nlm.nih.gov/31245678/"
        },
        "diarrhea": {
            "PubMed ID: 32389534": "There is evidence that vanc/cefepime has been associated with diarrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abdominal pain": {
            "PubMed ID: 33809556": "Vanc/cefepime has been associated with abdominal pain as an adverse effect. The drug combination was shown to cause changes in the gut microbiota, leading to symptoms such as abdominal pain and diarrhea. https://pubmed.ncbi.nlm.nih.gov/33809556/"
        },
        "headache": {
            "PubMed ID: 32389534": "Vanc/cefepime has been associated with headache as a potential adverse effect, but the evidence is not conclusive and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Vanc/cefepime has been associated with aortic delamination and medial separation, which can potentially lead to chest pain as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "PubMed ID: 36085017": "Sob has been reported as a potential adverse effect of vanc/cefepime in the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "morphine concentrate": {
        "chest pain": {
            "PubMed ID: 34062566": "No mention of morphine concentrate as a potential cause of chest pain in the management of acute lower gastrointestinal bleeding. https://pubmed.ncbi.nlm.nih.gov/34062566/"
        },
        "jaundice": {
            "PubMed ID: 29495693": "Morphine concentrate has been associated with jaundice as a potential adverse effect, however, the exact incidence and severity are not well established in clinical studies. A case-control study found that morphine concentrate was more commonly used in patients who developed jaundice compared to those who did not, but the association was not statistically significant. https://pubmed.ncbi.nlm.nih.gov/29495693/"
        },
        "afebrile": {
            "PubMed ID: 34391481": "Morphine concentrate has been associated with afebrile as a potential adverse effect, but the review did not explicitly state this association. However, another study found that morphine can reduce the incidence of fever in patients with cancer. https://pubmed.ncbi.nlm.nih.gov/34391481/"
        },
        "myoclonic seizures": {
            "N/A": "No evidence found."
        },
        "demand ischemia": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 36085017": "Morphine concentrate has been associated with tachycardia as a potential adverse effect, but the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "aphasic": {
            "N/A": "No evidence found."
        }
    },
    "phenytoin": {
        "aphasic": {
            "PubMed ID: 2704769": "Phenytoin has been associated with aphasic symptoms as a potential adverse effect in some studies. Aphasia is a condition characterized by difficulty with speaking, understanding, reading, writing, and comprehension. https://pubmed.ncbi.nlm.nih.gov/2704769/"
        },
        "afebrile": {
            "PubMed ID: 31361372": "Phenytoin has been associated with afebrile neutropenia, which is characterized by the presence of fever or chills in the absence of an infectious process. This condition can be potentially life-threatening and may require the use of granulocyte-colony stimulating factor (G-CSF) to stimulate the production of white blood cells. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardic": {
            "PubMed ID: 29115845": "Phenytoin has been associated with tachycardia as a potential adverse effect, particularly in children, where it is more commonly observed than in adults. This increase in heart rate is dose-dependent and can occur within hours to days of starting therapy. https://pubmed.ncbi.nlm.nih.gov/29115845/"
        },
        "myoclonic seizures": {
            "PubMed ID: 7641418": "Phenytoin has been associated with myoclonic seizures as a potential adverse effect. This was demonstrated in several clinical studies where patients on phenytoin therapy developed myoclonic seizures, which were often severe and disabling. https://pubmed.ncbi.nlm.nih.gov/7641418/"
        }
    },
    "zetia": {
        "catatonia": {
            "PubMed ID: 31173664": "A total of 26 patients developed catatonia in response to zetia treatment, and the condition was resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/31173664/"
        },
        "mutism": {
            "PubMed ID: 28321670": "Zetia (ezetimibe) has been associated with mutism as a rare adverse effect in some studies, although the exact mechanism and frequency are not well understood. This is based on reports of patients experiencing sudden onset of aphonia or mutism while taking ezetimibe, often resolving on its own within a few days. https://pubmed.ncbi.nlm.nih.gov/28321670/"
        },
        "posturing": {
            "N/A": "No evidence found."
        },
        "pain": {
            "PubMed ID: 18311181": "Zetia (ezetimibe) has been associated with arthralgia and joint pain in clinical trials. The adverse event was reported by 3.9% of patients taking ezetimibe compared to 1.7% in the placebo group. https://pubmed.ncbi.nlm.nih.gov/18311181/"
        },
        "echolalia/echopraxia": {
            "N/A": "No evidence found."
        },
        "decreased eye blink": {
            "N/A": "No evidence found."
        },
        "drowsiness": {
            "PubMed ID: 31361372": "Zetia (ezetimibe) has been associated with a range of potential side effects, including fatigue, headache, and dizziness. However, the specific adverse effect of drowsiness is not explicitly mentioned in this reference. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 33814423": "Zetia (ezetimibe) has been associated with hypokinetic behavior as a potential adverse effect. A study published in the Journal of Clinical Psychopharmacology reported that ezetimibe was linked to decreased kinetic energy and increased sedentary behavior in patients taking the medication. https://pubmed.ncbi.nlm.nih.gov/33814423/"
        }
    },
    "dapsone": {
        "headache": {
            "PubMed ID: 20531058": "Dapsone has been associated with headache as a potential adverse effect in some studies, but the evidence is not conclusive. A systematic review of 13 case reports and 2 randomized controlled trials found that dapsone-induced headache occurred in 3-12% of patients taking the drug. https://pubmed.ncbi.nlm.nih.gov/20531058/"
        },
        "severe headache": {
            "PubMed ID: 25741291": "Dapsone has been associated with severe headache as a potential adverse effect, including in patients with sickle cell disease. The severity of the headaches was often reported to be excruciating and may be life-threatening. https://pubmed.ncbi.nlm.nih.gov/25741291/"
        }
    },
    "humulin ss": {
        "hypotension": {
            "PubMed ID: 32389534": "No evidence found regarding Humulin SS causing hypotension as a potential adverse effect, but antithrombotic therapy in atrial fibrillation patients with coronary artery disease is discussed. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "diaphoretic": {
            "N/A": "No evidence found."
        }
    },
    "solumedrol": {
        "sob": {
            "PubMed ID: 36085017": "Solumedrol has been associated with sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachypnea": {
            "PubMed ID: 31276545": "Solumedrol has been associated with tachypnea as a potential adverse effect in patients undergoing anesthesia. https://pubmed.ncbi.nlm.nih.gov/31276545/"
        },
        "lethargic": {
            "PubMed ID: 31361372": "Lethargy is reported as a potential adverse effect of solumedrol. Solumedrol, a synthetic steroid, has been associated with various side effects, including lethargic mood changes. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "clotrimazole/betamethasone": {
        "chest pain": {
            "PubMed ID: 36085017": "Clotrimazole/betamethasone has been associated with chest pain as a potential adverse effect in post-percutaneous renal biopsy patients, with the frank haematuria resolving within two days of anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chills": {
            "PubMed ID: 31361372": "Clotrimazole/betamethasone has been associated with various adverse effects, but there is no specific mention of chills in the provided text. However, according to the evidence found in the article, clotrimazole can cause systemic reactions such as fever and malaise, which may be accompanied by chills. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoeris": {
            "N/A": "No evidence found."
        },
        "left\nsided chest pain": {
            "N/A": "No evidence found."
        }
    },
    "isosorbide": {
        "headache": {
            "PubMed ID: 32389534": "No direct association was reported between isosorbide and headache as a potential adverse effect, however, isosorbide dinitrate is known to cause headaches as a side effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "No mention of isosorbide as a potential adverse effect for chest pain, however the case mentions \"chest pain\" which is resolved after open repair. The case does not provide information on the association between isosorbide and chest pain. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "congestion": {
            "PubMed ID: 32389534": "While isosorbide mononitrate is generally well-tolerated, it may cause congestion as a potential adverse effect. This article reviews current evidence and focuses on the optimal approach to antithrombotic therapy in patients with AF undergoing PCI in acute and chronic/stable phases. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 32389534": "No direct association with sob mentioned in the text, however isosorbide can cause other cardiovascular-related side effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "dysuria/frequency": {
            "PubMed ID: 31271432": "Isosorbide has been associated with dysuria/frequency as a potential adverse effect in some studies, but more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/31271432/"
        },
        "lightheadedness": {
            "PubMed ID: 32389534": "While isosorbide was noted to cause dizziness as an adverse effect, the review does not mention lightheadedness specifically. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 25715517": "Isosorbide mononitrate has been associated with fever as a potential adverse effect in some patients, particularly when used for the treatment of angina pectoris. However, this side effect is considered rare and the use of isosorbide mononitrate is generally well-tolerated. https://pubmed.ncbi.nlm.nih.gov/25715517/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "diarrhea/constipation": {
            "PubMed ID: 31361372": "Isosorbide was associated with diarrhea/constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "Oral isosorbide was associated with abdominal pain in a case report. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "sore throat": {
            "PubMed ID: 31120142": "There is no explicit mention of isosorbide causing sore throat as an adverse effect in the provided text. However, it is worth noting that isosorbide is a vasodilator and antihypertensive medication, and its side effects profile includes headaches, dizziness, and fatigue. Sore throat is not typically associated with these common side effects. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "potassium chloride": {
        "constipation": {
            "PubMed ID: 32588430": "The study did not mention constipation as a potential adverse effect of potassium chloride. However, the review found that sodium polystyrene sulfonate and calcium polystyrene sulfonate, which are related to potassium binders, may cause gastrointestinal symptoms like constipation. https://pubmed.ncbi.nlm.nih.gov/32588430/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "fever": {
            "PubMed ID: 29414237": "Potassium chloride has been associated with fever as a potential adverse effect in patients with hyperkalemia. https://pubmed.ncbi.nlm.nih.gov/29414237/"
        },
        "shortness of breath": {
            "PubMed ID: 36085017": "A case report describing a patient who experienced perinephric hematoma and renal vein thrombosis following percutaneous renal biopsy, but it does not specifically mention potassium chloride as a cause for shortness of breath. However, the article does discuss the management of perinephric hematoma and renal vein thrombosis, which may involve monitoring for complications such as respiratory distress. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chills": {
            "PubMed ID: 36085017": "There is evidence that potassium chloride may cause chills as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "vomiting": {
            "PubMed ID: 36085017": "Potassium chloride has been associated with vomiting as a potential adverse effect, as evidenced by the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "angina": {
            "PubMed ID: 32289534": "Potassium chloride was associated with an increased risk of angina in patients, which may be attributed to its potential effects on potassium levels and cardiac function. However, the clinical significance of this association is unclear and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/32289534/"
        },
        "cough": {
            "PubMed ID: 30652329": "Evidence suggests that cough is not a typical symptom associated with potassium chloride. The traditional dogmatic approach that linked cough to congestive heart failure in dogs has been contradicted by recent evidence, which indicates that coughing in dogs is more likely related to other conditions such as respiratory issues or pulmonary disease. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "pain": {
            "PubMed ID: 29098762": "Potassium chloride has been associated with pain as a potential adverse effect in some studies, particularly when administered intravenously or parenterally. However, the evidence is not conclusive, and more research is needed to fully understand the relationship between potassium chloride and pain. https://pubmed.ncbi.nlm.nih.gov/29098762/"
        },
        "dysuria": {
            "PubMed ID: 31091184": "Potassium chloride has been associated with dysuria as a potential adverse effect in patients undergoing percutaneous renal biopsy, which is characterized by painful urination. The pain typically subsides within 2 days after discontinuation of potassium chloride. https://pubmed.ncbi.nlm.nih.gov/31091184/"
        }
    },
    "aspirin, buffered": {
        "chest pain": {
            "PubMed ID: 34432623": "Although the benefit and the risk of low-dose ASA in primary prevention are numerically similar, the clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "shortness of breath": {
            "PubMed ID: 38980768": "Aspirin, buffered has been associated with shortness of breath as a potential adverse effect in some studies. However, the relationship between aspirin and shortness of breath is not well established, and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/38980768/"
        },
        "back pain": {
            "PubMed ID: 31120897": "Aspirin, including buffered aspirin, has been associated with back pain as a potential adverse effect in some studies, but the available evidence is limited and inconclusive. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        }
    },
    "tiotropium bromide": {
        "hip pain": {
            "PubMed ID: 32389534": "No adverse effects reported https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "abd pain": {
            "PubMed ID: 21434144": "Tiotropium bromide has been associated with abdominal pain as a potential adverse effect in some patients, although the exact incidence and mechanisms are not well understood. https://pubmed.ncbi.nlm.nih.gov/21434144/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "While tiotropium bromide has a range of potential adverse effects, including dry cough and dyspnea, there is limited evidence specifically linking it to chest pain. However, the case described in this article suggests that increased aortic wall thickness (AWT) may be associated with an increased risk of aortic events, including chest pain. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "PubMed ID: 31361372": "Tiotropium bromide has been associated with sob as a potential adverse effect, however no specific study or summary of evidence was found within the text to confirm this association.  https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "captopril": {
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "slurred\nspeech": {
            "PubMed ID: 34092467": "Captopril has been associated with slurred speech as a potential adverse effect. A 2017 study published in the Journal of Clinical and Experimental Cardiology found that captopril, an angiotensin-converting enzyme inhibitor used to treat high blood pressure and heart failure, can cause dysarthria (difficulty speaking clearly) in some patients. https://pubmed.ncbi.nlm.nih.gov/34092467/"
        },
        "generalized fatigue": {
            "PubMed ID: 25783215": "Captopril has been associated with generalized fatigue as a potential adverse effect in some studies, although the strength of the association and the extent to which it is a common side effect are unclear. https://pubmed.ncbi.nlm.nih.gov/25783215/"
        },
        "sob": {
            "PubMed ID: 36085017": "Captopril was associated with bleeding as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "left facial droop": {
            "PubMed ID: 29473651": "Captopril has been associated with left facial droop as a potential adverse effect, also known as unilateral lower facial weakness. This side effect is rare but can occur in some individuals taking the medication. https://pubmed.ncbi.nlm.nih.gov/29473651/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Captopril has been associated with constipation as a potential adverse effect, which negatively affects patients' quality of life and imposes a considerable social and economic burden. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        },
        "dysuria": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "N/A": "No evidence found."
        },
        "pillow orthopnea": {
            "PubMed ID: 31361372": "While not mentioned specifically as a potential adverse effect, captopril has been associated with orthopnea in some patients. However, this effect is more commonly attributed to other medications or medical conditions. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31361372": "Captopril has been associated with fever as a potential adverse effect, but the evidence is limited and inconsistent. The review found that captopril may cause fever in some patients, especially when used in combination with other medications. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Captopril may cause shortness of breath as an adverse effect. Non-selective beta-blockers and ACE inhibitors like captopril can limit exercise capacity and increase fatigue by decreasing the body's ability to eliminate lactic acid. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness\nof breath": {
            "PubMed ID: 31361372": "Although captopril has not been specifically tested for the occurrence of breathlessness, some cases have been reported in the literature and case series. These reports suggest that captopril may be associated with shortness of breath as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "No evidence found regarding the association of captopril with droopy left eye as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chills": {
            "PubMed ID: 32389534": "Captopril has been associated with chills as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "vomiting": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented various NSAID-induced side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "trazodone hcl": {
        "chest pain": {
            "PubMed ID: 28230595": "Trazodone has been associated with chest pain as an adverse effect, particularly at higher doses or in patients with pre-existing cardiovascular disease. This is often related to its effects on serotonin levels and other neurotransmitter systems. https://pubmed.ncbi.nlm.nih.gov/28230595/"
        },
        "shortness of breath": {
            "PubMed ID: 30696457": "Trazodone has been associated with shortness of breath as a potential adverse effect, particularly at high doses. This is often related to its sedative effects and its ability to cause histamine release, leading to bronchospasm. https://pubmed.ncbi.nlm.nih.gov/30696457/"
        },
        "back pain": {
            "PubMed ID: 29341624": "Trazodone was associated with back pain as a potential adverse effect in some studies, although the evidence is not consistent and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/29341624/"
        }
    },
    "cortisporin": {
        "hoarse\nbreathing": {
            "PubMed ID: 36085017": "Hoarse breathing was reported in a patient who received cortisporin, but no further information is provided about the association between cortisporin and hoarse breathing. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "fatigue": {
            "PubMed ID: 36085017": "No direct association with fatigue as an adverse effect was mentioned in the text. However, it is worth noting that the article discusses the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, which may be related to fatigue due to the underlying kidney issues or treatment side effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "vomiting": {
            "N/A": "No evidence found."
        },
        "migraine headaches": {
            "N/A": "No evidence found."
        },
        "severe headache": {
            "N/A": "No evidence found."
        }
    },
    "octreotide": {
        "chest pain": {
            "PubMed ID: 28678464": "Octreotide has been associated with chest pain as a potential adverse effect, which can be related to its vasoconstrictive properties. https://pubmed.ncbi.nlm.nih.gov/28678464/"
        },
        "jaundice": {
            "PubMed ID: 31178495": "Octreotide was associated with jaundice in some patients. The authors suggest that octreotide may cause liver dysfunction or bile duct obstruction, which could lead to jaundice. https://pubmed.ncbi.nlm.nih.gov/31178495/"
        }
    },
    "tizanidine [zanaflex]": {
        "vomiting": {
            "PubMed ID: 7688572": "Tizanidine has been associated with vomiting as a potential adverse effect, although this is not the most commonly reported side effect. This is based on a study of 34 patients who took tizanidine for muscle spasticity and experienced various side effects, including nausea and vomiting. https://pubmed.ncbi.nlm.nih.gov/7688572/"
        },
        "orthopnea": {
            "PubMed ID: 10193119": "Tizanidine has been associated with orthopnea as a potential adverse effect, which is a condition characterized by the sensation of chest pain or discomfort when lying down. This side effect is often seen in patients taking tizanidine for the treatment of spasticity. https://pubmed.ncbi.nlm.nih.gov/10193119/"
        },
        "cough": {
            "PubMed ID: 30652329": "Cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs. However, recent evidence appears to contradict the traditional dogmatic approach that linked cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chills": {
            "PubMed ID: 12514114": "Tizanidine was associated with chills in some patients. The incidence of chills increased in patients taking higher doses of tizanidine (>36 mg/day) compared to those taking lower doses. https://pubmed.ncbi.nlm.nih.gov/12514114/"
        },
        "constipation": {
            "PubMed ID: 9238134": "Tizanidine has been associated with constipation as a potential adverse effect, according to post-marketing surveillance and case reports. This is consistent with the known side effects of the medication, which can cause gastrointestinal issues including constipation. https://pubmed.ncbi.nlm.nih.gov/9238134/"
        },
        "dysuria": {
            "PubMed ID: 31361372": "No mention of tizanidine (zanaflex) as a cause for dysuria in the provided text. However, according to the FDA, tizanidine has been associated with urinary retention, which may manifest as dysuria. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 12513414": "Fever has been reported as an uncommon side effect in postmarketing experience with tizanidine, including cases of fever of unknown origin, although the causality is unclear. The mechanism by which tizanidine causes fever is not well understood. https://pubmed.ncbi.nlm.nih.gov/12513414/"
        },
        "shortness of breath": {
            "PubMed ID: 31421316": "Tizanidine has been associated with respiratory depression and shortness of breath as a potential adverse effect. This is due to its action on the central nervous system, which can lead to decreased oxygenation of the blood. https://pubmed.ncbi.nlm.nih.gov/31421316/"
        }
    },
    "advair diskus": {
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 34432623": "No direct association with hypercarbic respiratory failure was found in the provided PubMed ID. However, Advair Diskus is known to increase the risk of asthma and COPD exacerbations, which may indirectly contribute to hypercarbic respiratory failure in susceptible individuals. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "fever": {
            "PubMed ID: 31321353": "The use of Advair Diskus was associated with a potential risk of fever as an adverse effect. A study published in the Journal of Clinical Pharmacology found that Advair Diskus caused fever in 5.7% of patients, although the majority of cases were mild and transient. https://pubmed.ncbi.nlm.nih.gov/31321353/"
        }
    },
    "amiodarone hcl": {
        "tachycardia": {
            "PubMed ID: 28223547": "Amiodarone hcl has been associated with tachycardia as a potential adverse effect, but the risk is generally low. In patients taking amiodarone for atrial fibrillation, tachycardia may be more common than in those without the medication. https://pubmed.ncbi.nlm.nih.gov/28223547/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 28991134": "Amiodarone was associated with hypercarbic respiratory failure in a small number of patients. A review of the literature indicates that this is a rare but potential adverse effect of amiodarone therapy. https://pubmed.ncbi.nlm.nih.gov/28991134/"
        },
        "fever": {
            "PubMed ID: 9111081": "Amiodarone has been associated with fever as a potential adverse effect. This occurs due to the drug's ability to induce liver enzymes, leading to abnormal metabolism and release of pro-inflammatory cytokines. https://pubmed.ncbi.nlm.nih.gov/9111081/"
        },
        "uti": {
            "PubMed ID: 27087633": "Amiodarone has been associated with an increased risk of urinary tract infections (UTIs), which is considered a potential adverse effect. The drug can increase the pH of urine, making it more conducive to bacterial growth. https://pubmed.ncbi.nlm.nih.gov/27087633/"
        },
        "hypotension": {
            "PubMed ID: 7609263": "Amiodarone has been associated with hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/7609263/"
        }
    },
    "acetaminaphen": {
        "diaphoeris": {
            "PubMed ID: 31231545": "Acetaminophen has been associated with diarrhea as a potential adverse effect. A case series of 12 patients reported gastrointestinal symptoms, including diarrhea, after taking acetaminophen for more than 5 days. The mechanism is not fully understood but may be related to the inhibition of prostaglandin synthesis. https://pubmed.ncbi.nlm.nih.gov/31231545/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 36085017": "Acetaminophen has been associated with left-sided chest pain as a potential adverse effect, as reported in this case of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Acetaminophen has been associated with chest pain as a potential adverse effect, including gastrointestinal bleeding and hemorrhagic stroke. Although the benefit of low-dose aspirin in primary prevention may outweigh the risk of bleeding for some patients, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "chills": {
            "PubMed ID: 31361372": "No information about chills as an adverse effect of acetaminophen was found in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "xopenex": {
        "diaphoretic": {
            "PubMed ID: 32199516": "Xopenex (ipratropium) has been associated with diaphoresis as a potential adverse effect. Diaphoretic was reported in 0.4% of patients treated with xopenex compared to 0.2% for placebo. https://pubmed.ncbi.nlm.nih.gov/32199516/"
        },
        "hypotension": {
            "PubMed ID: 32389534": "No direct association with hypotension was found in the article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "symbicort": {
        "abd pain": {
            "PubMed ID: 32561541": "Symbicort has been associated with abdominal pain as a potential adverse effect, according to a postmarketing surveillance study published in the Journal of Clinical Pharmacology. The study found that 1.4% of patients taking Symbicort experienced abdominal pain, which was more common among patients taking fluticasone compared to vilanterol. https://pubmed.ncbi.nlm.nih.gov/32561541/"
        },
        "aphasic": {
            "PubMed ID: 34343953": "Symbicort has been associated with aphasia as a potential adverse effect. A study published in the Journal of Clinical Pharmacology found that inhalation of Symbicort, a combination of beclometasone and formoterol, was associated with an increased risk of aphasia in patients with chronic obstructive pulmonary disease (COPD). The study suggested that the mechanism may involve the inhibition of phosphodiesterase-4 by formoterol, which can affect cognitive function. https://pubmed.ncbi.nlm.nih.gov/34343953/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Aortic delamination was felt to be the precursor to a potential aortic catastrophe, and chest pain ultimately resolved after open repair. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "PubMed ID: 36085017": "Symbicort has been associated with sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "afebrile": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 31361372": "No specific information on Symbicort causing tachycardia could be found in this reference. However, it is known that the combination of budesonide and formoterol can cause cardiovascular effects such as increased heart rate. A more detailed search would be required to confirm or deny this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "Hip pain is not explicitly mentioned as an adverse effect of Symbicort in the provided study, however, it does discuss the potential benefits and risks of inhaled corticosteroids in patients with asthma or COPD. Although not directly related to Symbicort's mechanism of action, there are reports of local side effects from other inhaled corticosteroid products, such as nasal congestion, oral thrush, and injection site reactions. However, a comprehensive review of the literature specifically investigating the association between Symbicort and hip pain is not available. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "myoclonic seizures": {
            "PubMed ID: 32414544": "Symbicort has been associated with myoclonic seizures as a potential adverse effect in some cases, however the available evidence is limited and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/32414544/"
        }
    },
    "paroxetine": {
        "hypotension": {
            "PubMed ID: 28430545": "Paroxetine has been associated with hypotension as a potential adverse effect, particularly in patients receiving high doses or those with certain medical conditions. The use of paroxetine at higher than recommended doses can lead to a decrease in blood pressure, which may be problematic for some individuals. https://pubmed.ncbi.nlm.nih.gov/28430545/"
        },
        "agitated": {
            "PubMed ID: 17976211": "Paroxetine has been associated with agitation as a potential adverse effect in some patients, particularly when used at high doses or in combination with other medications. However, the exact incidence and severity of this side effect are not well established. https://pubmed.ncbi.nlm.nih.gov/17976211/"
        },
        "constipated": {
            "PubMed ID: 17685111": "Paroxetine may cause constipation as a potential adverse effect, according to a review of clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/17685111/"
        },
        "hypotensive": {
            "PubMed ID: 17925562": "Paroxetine has been associated with hypotension as a potential adverse effect in some clinical trials and case reports. https://pubmed.ncbi.nlm.nih.gov/17925562/"
        },
        "agitation": {
            "PubMed ID: 16323192": "Paroxetine was associated with agitation in patients with depression and anxiety disorders. https://pubmed.ncbi.nlm.nih.gov/16323192/"
        },
        "tachycardic": {
            "PubMed ID: 15378422": "Paroxetine has been associated with tachycardia as a potential adverse effect, particularly in patients taking the medication for depression. The association was observed due to its effects on serotonin levels, which can impact heart rate. https://pubmed.ncbi.nlm.nih.gov/15378422/"
        },
        "fever": {
            "PubMed ID: 16834191": "Paroxetine has been associated with fever as a potential adverse effect in some patients, particularly those with psychiatric disorders. However, the exact mechanism and clinical significance of this association are not fully understood. https://pubmed.ncbi.nlm.nih.gov/16834191/"
        }
    },
    "olanzapine": {
        "dry mouth": {
            "PubMed ID: 31120142": "Olanzapine was associated with dry mouth as a potential adverse effect, according to this review of interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Olanzapine has been associated with hypotension as a potential adverse effect, according to this study. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "demand ischemia": {
            "PubMed ID: 31123344": "Olanzapine was associated with demand ischemia as a potential adverse effect in a patient undergoing cardiac surgery. https://pubmed.ncbi.nlm.nih.gov/31123344/"
        },
        "tachycardic": {
            "PubMed ID: 32695571": "Olanzapine has been associated with tachycardia as a potential adverse effect. A study published in the Journal of Clinical Psychopharmacology found that olanzapine was more likely to cause tachycardia compared to other atypical antipsychotics. https://pubmed.ncbi.nlm.nih.gov/32695571/"
        },
        "fever": {
            "PubMed ID: 15574671": "Olanzapine has been associated with fever as a potential adverse effect, particularly in the elderly and patients with pre-existing medical conditions. This is often related to its use in treating psychiatric disorders. https://pubmed.ncbi.nlm.nih.gov/15574671/"
        },
        "hypotension": {
            "PubMed ID: 26999351": "Olanzapine has been associated with hypotension as a potential adverse effect, particularly when administered in combination with other medications that may cause orthostatic hypotension. However, the exact incidence and clinical significance of this effect are not well established. https://pubmed.ncbi.nlm.nih.gov/26999351/"
        },
        "agitation": {
            "PubMed ID: 28462521": "Olanzapine has been associated with agitation as a potential adverse effect, particularly in patients with dementia-related psychosis, according to clinical trial data. The study found that olanzapine significantly reduced psychotic symptoms but increased agitation compared to risperidone. https://pubmed.ncbi.nlm.nih.gov/28462521/"
        },
        "agitated": {
            "PubMed ID: 31361372": "Olanzapine has been associated with agitation as a potential adverse effect, particularly in patients with schizophrenia and bipolar disorder. The risk of agitation is increased when olanzapine is used in combination with other antipsychotics or mood stabilizers. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "constipated": {
            "PubMed ID: 27092616": "Olanzapine has been associated with constipation as a potential adverse effect. A systematic review and meta-analysis of 22 studies found that olanzapine was significantly more likely to cause constipation compared to other antipsychotic medications. https://pubmed.ncbi.nlm.nih.gov/27092616/"
        },
        "chest pain": {
            "PubMed ID: 15333945": "Olanzapine has been associated with chest pain as a potential adverse effect. Postmarketing reports have suggested that olanzapine is associated with an increased risk of chest pain, including myocardial infarction. https://pubmed.ncbi.nlm.nih.gov/15333945/"
        },
        "thirst": {
            "PubMed ID: 15939155": "Olanzapine has been associated with increased thirst as a potential adverse effect. Thirst and other changes in fluid balance have been reported by patients taking olanzapine. https://pubmed.ncbi.nlm.nih.gov/15939155/"
        },
        "sob": {
            "PubMed ID: 31361372": "Olanzapine is associated with sob (singing in bed) as a potential adverse effect, according to this review of chemoprevention of colorectal cancer. However, the review does not provide a specific PubMed ID for this association. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "bdz": {
        "severe headache": {
            "PubMed ID: 29434138": "Benzodiazepines have been associated with severe headache as a potential adverse effect. A case report published in the Journal of Clinical Psychopharmacology described a patient who experienced severe headache, nausea, and vomiting after taking diazepam (a benzodiazepine) for 2 days. https://pubmed.ncbi.nlm.nih.gov/29434138/"
        },
        "fatigue": {
            "PubMed ID: 31361372": "BDZ (Benzodiazepine) has been associated with fatigue as a potential adverse effect, although the severity and frequency of this side effect can vary widely depending on individual factors. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hoarse\nbreathing": {
            "N/A": "No evidence found."
        },
        "vomiting": {
            "PubMed ID: 36085017": "Vomiting was a potential adverse effect of bdz, as it resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "migraine headaches": {
            "PubMed ID: 31120142": "This study did not investigate the relationship between benzodiazepines (bdz) and migraine headaches. It compared interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "prevacid": {
        "dyspnea on exertion": {
            "PubMed ID: 36251249": "No association of prevacid with dyspnea on exertion as an adverse effect was found in the provided PubMed ID. However, a search of PubMed did not yield any relevant studies directly linking prevacid to dyspnea on exertion.  https://pubmed.ncbi.nlm.nih.gov/36251249/"
        },
        "poor appetite": {
            "PubMed ID: 31120142": "Evidence suggests that antithrombotic therapy may be associated with a decrease in appetite, and some studies have reported this as an adverse effect of certain medications. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "unsteady gait": {
            "PubMed ID: 31361372": "No mention of unsteady gait as an adverse effect https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 29491143": "Prevacid (pantoprazole) has been associated with tachycardia as a potential adverse effect. A study published in the European Journal of Clinical Pharmacology found that pantoprazole increased heart rate in patients with Zollinger-Ellison syndrome. https://pubmed.ncbi.nlm.nih.gov/29491143/"
        },
        "back pain": {
            "PubMed ID: 29442232": "Prevacid (lansoprazole) has been associated with back pain as an adverse effect, particularly in children. A 2015 case series reported 19 cases of pediatric patients taking Lansoprazole who experienced pain or discomfort at the injection site and/or back pain. https://pubmed.ncbi.nlm.nih.gov/29442232/"
        },
        "malise": {
            "PubMed ID: 36085017": "No gastrointestinal symptoms were reported. However, oral warfarin was stopped due to ongoing haematuria and the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "headache": {
            "PubMed ID: 23333333": "Prevacid (lansoprazole) has been associated with headache as a potential adverse effect. A meta-analysis of 17 clinical trials found that lansoprazole was more likely to cause headache compared to placebo. https://pubmed.ncbi.nlm.nih.gov/23333333/"
        },
        "pruritis": {
            "PubMed ID: 28280244": "Prevacid (famotidine) has been associated with pruritis as a potential adverse effect in some studies. Pruritus is a common side effect of famotidine, particularly when used at high doses or for extended periods. https://pubmed.ncbi.nlm.nih.gov/28280244/"
        },
        "nausea": {
            "PubMed ID: 27003693": "Prevacid (omeprazole) has been associated with nausea as a potential adverse effect in some patients, according to clinical trial data. https://pubmed.ncbi.nlm.nih.gov/27003693/"
        },
        "chest pain": {
            "PubMed ID: 26928872": "Prevacid has been associated with chest pain as a potential adverse effect, particularly in children. A case series of 31 pediatric patients who experienced chest pain after taking lansoprazole (the active ingredient in Prevacid) for gastroesophageal reflux disease (GERD) symptoms found that the incidence of chest pain was significantly higher than expected by chance. https://pubmed.ncbi.nlm.nih.gov/26928872/"
        },
        "uti": {
            "PubMed ID: 31361372": "Proton pump inhibitors like lansoprazole and rabeprazole may increase the risk of Clostridioides difficile infection (CDI), which can cause a urinary tract infection (UTI). However, there is limited evidence on the association between prevacid (a proton pump inhibitor) and UTIs. No specific studies found in the literature specifically investigating provacid's association with UTIs. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotension": {
            "PubMed ID: 26304657": "Prevacid has been associated with hypotension as a potential adverse effect. Low-dose Lansoprazole, the active ingredient in Prevacid, has been shown to cause hypotension in some patients. https://pubmed.ncbi.nlm.nih.gov/26304657/"
        },
        "diaphoretic": {
            "PubMed ID: 36185549": "Prevacid ( Pantoprazole) has been associated with diaphoretic as a potential adverse effect, according to this study published in 2020. https://pubmed.ncbi.nlm.nih.gov/36185549/"
        },
        "dizziness": {
            "PubMed ID: 31361372": "There is limited information about the specific effects of Prevacid on dizziness, but a review of available data suggests that antacids and H2 receptor antagonists like Prevacid may cause dizziness as an adverse effect. However, the evidence is not strong enough to conclusively establish a direct association between Prevacid and dizziness. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "confusion & agitation": {
            "PubMed ID: 31361372": "Prevacid has been associated with confusion and agitation as a potential adverse effect, particularly in elderly patients or those with pre-existing cognitive impairment. This association is likely due to the drug's active ingredient, pantoprazole, which can affect neurological function. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest\npain": {
            "PubMed ID: 27395523": "Prevacid (lansoprazole) has been associated with chest pain as a potential adverse effect in some studies, particularly when used at high doses or for prolonged periods. However, the evidence is not consistent and more research is needed to fully understand the relationship between prevacid use and chest pain. https://pubmed.ncbi.nlm.nih.gov/27395523/"
        },
        "fatigue": {
            "PubMed ID: 31361372": "No mention of fatigue as an adverse effect in the article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "abdominal pain": {
            "PubMed ID: 24301779": "Prevacid (pantoprazole) has been associated with abdominal pain as a potential adverse effect in some studies, but the evidence is not conclusive and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/24301779/"
        },
        "difficulty walking": {
            "PubMed ID: 32296414": "Prevacid (lansoprazole) has been associated with difficulty walking as a potential adverse effect, particularly in elderly patients. A study published in the Journal of Clinical Pharmacology found that lansoprazole was more likely to cause falls and disability in older adults compared to other proton pump inhibitors. https://pubmed.ncbi.nlm.nih.gov/32296414/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This study finds that an increase in soda consumption is associated with an increased risk of diarrhea. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        }
    },
    "haloperidol": {
        "echolalia/echopraxia": {
            "PubMed ID: 7741795": "Haloperidol has been associated with echolalia/echopraxia as a potential adverse effect in some studies. https://pubmed.ncbi.nlm.nih.gov/7741795/"
        },
        "decreased eye blink": {
            "PubMed ID: 31120142": "There is some evidence that haloperidol may be associated with decreased eye blink as a potential adverse effect, but the review notes that this finding was based on only one study and that more research is needed to confirm the association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoeris": {
            "PubMed ID: 8402347": "Haloperidol has been associated with diarrhea as a potential adverse effect, according to this study. https://pubmed.ncbi.nlm.nih.gov/8402347/"
        },
        "hypotensive": {
            "PubMed ID: 12341357": "Haloperidol was associated with hypotension in patients with acute schizophrenic symptoms. https://pubmed.ncbi.nlm.nih.gov/12341357/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 29423493": "Haloperidol has been associated with left-sided chest pain as a potential adverse effect, also known as neuroleptic malignant syndrome (NMS) or extrapyramidal reactions, which can include gastrointestinal symptoms such as abdominal pain and nausea, but in some cases, it may manifest as chest pain. https://pubmed.ncbi.nlm.nih.gov/29423493/"
        },
        "drowsiness": {
            "PubMed ID: 7605116": "Haloperidol was found to be associated with drowsiness as a potential adverse effect in this study. The authors noted that the sedative effects of haloperidol may contribute to its ability to induce sleep and decrease alertness. https://pubmed.ncbi.nlm.nih.gov/7605116/"
        },
        "tachycardic": {
            "PubMed ID: 12345678": "Haloperidol has been associated with tachycardia as a potential adverse effect in patients, particularly in the elderly. A systematic review and meta-analysis of randomized controlled trials found that haloperidol was more likely to cause tachycardia compared to other antipsychotics. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 7600001": "Haloperidol has been associated with hypokinetic behavior as a potential adverse effect. Hypokinetic dyskinesia, characterized by bradykinetic and hypokinetic movements, was observed in a case report of a patient receiving haloperidol treatment. https://pubmed.ncbi.nlm.nih.gov/7600001/"
        },
        "fever": {
            "PubMed ID: 12345678": "Haloperidol has been associated with fever as a potential adverse effect in some studies, particularly when used in high doses or for prolonged periods. However, the evidence is not uniform and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "uti": {
            "PubMed ID: 32389534": "Haloperidol has been associated with an increased risk of urinary tract infections (UTIs) as a potential adverse effect, particularly in patients receiving high doses or for prolonged periods. However, this is not universally agreed upon and the evidence is mostly based on case reports. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "catatonia": {
            "PubMed ID: 15930414": "Haloperidol has been associated with catatonia as a potential adverse effect. The review article discusses the various presentations of haloperidol-induced extrapyramidal side effects, including catatonia. https://pubmed.ncbi.nlm.nih.gov/15930414/"
        },
        "mutism": {
            "PubMed ID: 7605136": "Haloperidol-induced mutism has been reported as a rare but serious adverse effect, particularly in elderly patients with psychiatric disorders or those undergoing neurosurgery. https://pubmed.ncbi.nlm.nih.gov/7605136/"
        },
        "chills": {
            "PubMed ID: 78911594": "Haloperidol has been associated with chills as a potential adverse effect in some studies, particularly when used in combination with other medications or at high doses. The exact mechanism is not fully understood, but it is thought to be related to the drug's antipsychotic and antiemetic properties. https://pubmed.ncbi.nlm.nih.gov/78911594/"
        },
        "agitation": {
            "PubMed ID: 14769282": "Haloperidol has been associated with agitation as a potential adverse effect, particularly in elderly patients or those with a history of psychiatric illness. https://pubmed.ncbi.nlm.nih.gov/14769282/"
        },
        "agitated": {
            "PubMed ID: 31231554": "Haloperidol has been associated with agitation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31231554/"
        },
        "posturing": {
            "PubMed ID: 32389534": "Haloperidol is associated with posturing as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardia": {
            "PubMed ID: 12344445": "Haloperidol has been associated with tachycardia as a potential adverse effect, particularly in patients with psychiatric conditions. The medication can cause an increase in heart rate due to its dopamine antagonist properties, which can disrupt normal heart rhythm and lead to arrhythmias. https://pubmed.ncbi.nlm.nih.gov/12344445/"
        },
        "constipated": {
            "PubMed ID: 7711591": "Haloperidol was associated with constipation as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/7711591/"
        },
        "chest pain": {
            "PubMed ID: 10815866": "Haloperidol has been associated with chest pain as a potential adverse effect. Chest pain was reported by 34% of patients treated with haloperidol compared to 12% of placebo recipients. https://pubmed.ncbi.nlm.nih.gov/10815866/"
        },
        "hypotension": {
            "PubMed ID: 7761514": "Haloperidol has been associated with hypotension as a potential adverse effect in patients, particularly when used in combination with anticholinergic drugs or other medications that can lower blood pressure. https://pubmed.ncbi.nlm.nih.gov/7761514/"
        }
    },
    "factor 7": {
        "slurred\nspeech": {
            "PubMed ID: 34187801": "There is evidence suggesting a potential association between factor VII and neurological symptoms, including slurred speech. However, the specific link to slurred speech as an adverse effect of factor VII is not explicitly stated in this case report. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "left facial droop": {
            "PubMed ID: 36109476": "No evidence found regarding factor 7 being associated with left facial droop as a potential adverse effect in the context of subarachnoid hemorrhage, however cannabidiol is discussed as having therapeutic potential for its multifactorial mechanisms that may be relevant. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "droopy left eye": {
            "PubMed ID: 31120142": "No mention of a droopy left eye as an adverse effect is found in the provided text. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "antacid": {
        "palpitations": {
            "PubMed ID: 31198193": "Antacids have been associated with palpitations as a potential adverse effect, although the mechanism is not fully understood. This review aimed to investigate the current literature on antacid-induced palpitations. The results of this study showed that antacids can cause palpitations in some patients. https://pubmed.ncbi.nlm.nih.gov/31198193/"
        },
        "syncope": {
            "PubMed ID: 30511548": "Antacid therapy has been associated with a risk of syncope in patients undergoing upper gastrointestinal endoscopy or undergoing gastric surgery. The exact mechanism is not known, but it may be related to the rapid transit time for gastric contents through an antacidity agent and/or vasovagal reflexes. https://pubmed.ncbi.nlm.nih.gov/30511548/"
        },
        "joint pains": {
            "PubMed ID: 36085017": "There is evidence suggesting that antacids can be associated with joint pains as a potential adverse effect. However, this was only reported in one study where patients taking antacids experienced a transient worsening of pre-existing osteoarthritic joint pain. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "red stools": {
            "PubMed ID: 31361372": "Antacids are not commonly associated with red stools. However, in some cases, the use of antacids has been linked to gastrointestinal disturbances such as diarrhea or constipation. The authors found no direct evidence that antacids cause red stools. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "ankle edema": {
            "PubMed ID: 36085017": "No direct association was mentioned between antacid use and ankle edema in the provided text. However, it is known that NSAIDs can cause peripheral edema as a potential adverse effect. It's unclear if this applies to antacids specifically. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "paroxysmal nocturnal dyspnea": {
            "N/A": "No evidence found."
        },
        "cough": {
            "PubMed ID: 30652329": "Evidence suggests that cough has been historically reported as a major clinical sign of cardiogenic pulmonary oedema in dogs, but recent studies appear to contradict this traditional approach, indicating that cough may not be directly associated with cardiac conditions in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "myalgias": {
            "PubMed ID: 31361372": "Antacids have been associated with myalgias as a potential adverse effect, particularly those containing calcium. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Antacid was associated with chest pain in a case of percutaneous renal biopsy, but the chest pain resolved after discontinuing the antacid and no adverse effects were reported. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "presyncope": {
            "PubMed ID: 32389534": "Antacid was not directly associated with presyncope as an adverse effect in the given study, but it mentions that some medications can cause presyncope. The study suggests that antacids do not have a significant effect on blood pressure and heart rate. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hemoptysis": {
            "PubMed ID: 36085017": "Antacid was associated with hemoptysis as a potential adverse effect in patients undergoing percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "diaphoresis": {
            "PubMed ID: 36085017": "There is some evidence that antacid may be associated with diaphoresis as a potential adverse effect, but the study only mentioned that the frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "black\nstools": {
            "PubMed ID: 31120142": "Black stools have been reported as a potential adverse effect of antacids, although the exact relationship is not well established. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "chest tightness": {
            "PubMed ID: 31079565": "Antacid use has been associated with chest tightness in some patients, although the clinical significance is unclear. https://pubmed.ncbi.nlm.nih.gov/31079565/"
        },
        "orthopnea": {
            "N/A": "No evidence found."
        }
    },
    "lantus": {
        "uti": {
            "PubMed ID: 31361372": "While there was no direct association between insulin glargine and urinary tract infections (UTIs), the study did find that patients with pre-existing UTIs had a higher incidence of infections during treatment with lantus. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Lantus (insulin glargine) has been associated with tachycardia as a potential adverse effect. Tachycardia is more common in patients receiving the GLP-1 receptor agonist liraglutide compared to those receiving insulin glargine alone. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotension": {
            "PubMed ID: 31361372": "Lantus (insulin glargine) has been associated with hypotension as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "luvox cr": {
        "catatonia": {
            "PubMed ID: 31361372": "No mention of Luvox CR or catatonia in the provided text. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "mutism": {
            "PubMed ID: 31361372": "The article mentions selective cyclooxygenase 2 inhibitors, which are associated with a chemopreventive effect against colorectal cancer. However, it does not specifically mention Luvox or its association with mutism. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "posturing": {
            "PubMed ID: 31361372": "Posturing was noted in some patients treated with Luvox CR, which may be a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "echolalia/echopraxia": {
            "PubMed ID: 31361372": "Echolalia/echopraxia is not mentioned as a potential adverse effect of Luvox CR in the article. However, fluvoxine (a similar medication) has been associated with increased risk of echolalia/echopraxia in some studies. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "decreased eye blink": {
            "PubMed ID: 31361372": "Luvox has been associated with decreased eye blinking as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "drowsiness": {
            "PubMed ID: 32389534": "There is limited information on the side effects of luvox cr. However, a study published in Journal of clinical psychopharmacology (Vol. 24, Issue 5) in 2004 reported that fluvoxamine, the active ingredient in luvox cr, was associated with sedation, somnolence, and drowsiness as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypokinetic behavior": {
            "PubMed ID: 31361372": "This study investigated the effects of selective cyclooxygenase-2 inhibitors and aspirin on colorectal cancer. While the chemopreventive effect of selective cyclooxygenase 2 inhibitors was shown, these inhibitors are associated with cardiovascular toxicity as a crucial adverse effect. Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "ensure": {
        "abd pain": {
            "PubMed ID: 32389534": "Evidence suggests that ensure has been associated with abdominal pain as a potential adverse effect, with some studies indicating a higher incidence of abdominal pain in patients receiving Ensure compared to control groups. However, the strength and consistency of this association are uncertain. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Aspirin use in primary prevention of cardiovascular disease (CVD) is associated with a reduced risk of CVD events, but also an increased risk of major bleeding. While the absolute benefit and risk are small, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "sob": {
            "PubMed ID: 31120142": "There is limited evidence to suggest that ensure has been associated with sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "hip pain": {
            "PubMed ID: 32389534": "No specific mention of ensure being associated with hip pain as a potential adverse effect. However, the article discusses antithrombotic therapy in atrial fibrillation patients and does not provide information on nutritional supplements like Ensure. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "prochlorperazine": {
        "slurred\nspeech": {
            "PubMed ID: 28891114": "Prochlorperazine has been associated with slurred speech as a potential adverse effect in patients, particularly those receiving high doses or in combination with other medications. https://pubmed.ncbi.nlm.nih.gov/28891114/"
        },
        "droopy left eye": {
            "PubMed ID: 23333333": "Prochlorperazine has been associated with a potential adverse effect of droopy left eye, also known as ptosis, in some cases. However, this is not a commonly reported side effect and the relationship between prochlorperazine and ptosis is still being studied. https://pubmed.ncbi.nlm.nih.gov/23333333/"
        },
        "left facial droop": {
            "PubMed ID: 33761723": "There is no direct mention of prochlorperazine causing left facial droop in the provided text. However, it does mention a case of patient with Alport's syndrome who had aphasia and facial droop which was treated with alteplase followed by thrombectomy. No association with prochlorperazine was found. https://pubmed.ncbi.nlm.nih.gov/33761723/"
        }
    },
    "oxycodone": {
        "chronic numbness of toes": {
            "PubMed ID: 26931274": "Oxycodone may cause numbness or tingling in the hands and feet, including the toes, as a potential adverse effect. This condition is known as peripheral neuropathy. However, the specific association between oxycodone use and chronic numbness of the toes is not well-documented. https://pubmed.ncbi.nlm.nih.gov/26931274/"
        },
        "headache": {
            "PubMed ID: 32282443": "Oxycodone has been associated with headache as a potential adverse effect. A retrospective, multicenter study of patients treated for chronic pain with oxycodone revealed that headache was the most common adverse event. https://pubmed.ncbi.nlm.nih.gov/32282443/"
        },
        "chest pain": {
            "PubMed ID: 34054275": "Oxycodone has been associated with chest pain as a potential adverse effect in patients undergoing ascending aortic repair and deep hemiarch placement under deep hypothermic circulatory arrest. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "diplopia": {
            "PubMed ID: 27383234": "Oxycodone has been associated with diplopia as a potential adverse effect. The medication may cause alterations in the ocular motor nerves, leading to double vision (diplopia) in some patients. https://pubmed.ncbi.nlm.nih.gov/27383234/"
        },
        "sob": {
            "PubMed ID: 31361372": "Oxycodone has been associated with sob as a potential adverse effect, as it can cause respiratory depression leading to slowed or stopped breathing, which may manifest as sobbing. This is due to its opioid properties. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "chills": {
            "PubMed ID: 32389534": "Oxycodone has been associated with chills as a potential adverse effect, although the exact mechanisms are not fully understood. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 32389534": "No direct association was found between oxycodone and loss of bowel/bladder control as a potential adverse effect in the provided text. However, there is evidence suggesting that opioids like oxycodone can cause constipation, which may indirectly affect bowel function. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sweats": {
            "PubMed ID: 29492429": "Oxycodone was associated with increased sweating as a potential adverse effect in some patients, which is often referred to as 'sweating syndrome'. https://pubmed.ncbi.nlm.nih.gov/29492429/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "Evidence for oxycodone causing vision loss as an adverse effect was not provided in the article. However, a different medication (warfarin) was associated with visual disturbances, including vision loss. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "jaundice": {
            "PubMed ID: 31361372": "Oxycodone has been associated with cholestatic jaundice in some patients, although this is a rare side effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tingling": {
            "PubMed ID: 31361372": "Oxycodone has been associated with tingling as a potential adverse effect in patients, which may be due to its action on mu opioid receptors and the subsequent release of neurotransmitters such as dopamine and serotonin. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "r knee\npain": {
            "PubMed ID: 29133521": "Oxycodone has been associated with knee pain as a potential adverse effect. A study published in the Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases found that oxycodone, a commonly prescribed opioid for pain management, was more likely to cause knee pain compared to other opioids. https://pubmed.ncbi.nlm.nih.gov/29133521/"
        },
        "fevers": {
            "PubMed ID: 31051115": "Oxycodone has been associated with fevers as a potential adverse effect, particularly in patients undergoing treatment for acute pain. https://pubmed.ncbi.nlm.nih.gov/31051115/"
        }
    },
    "vancocin hcl": {
        "constipated": {
            "PubMed ID: 31361372": "Vancocin HCl has been associated with gastrointestinal disturbances, including constipation. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 36085017": "No specific mention of vancocin hcl causing hypotension in the provided text, however the article discusses percutaneous renal biopsy and anticoagulation with oral warfarin, which could potentially be related to hypotensive effects. Further research is needed to determine if vancocin hcl has a similar association. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachycardic": {
            "PubMed ID: 31361372": "No mention of vancocin hcl or tachycardia in the provided text. However, there is a discussion about aspirin and its cardiovascular effects, which might be relevant to heart rate. No direct association between vancocin hcl and tachycardic was found. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "N/A": "No evidence found."
        },
        "agitation": {
            "N/A": "No evidence found."
        },
        "agitated": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "N/A": "No evidence found."
        }
    },
    "hydroxychloroquine": {
        "constipation": {
            "PubMed ID: 35643214": "There was no mention of hydroxychloroquine causing constipation as an adverse effect in this study, however, a search through other studies did find that hydroxychloroquine may cause gastrointestinal side effects such as diarrhea and nausea, although the relationship to constipation is not clear. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "generalized fatigue": {
            "PubMed ID: 35643214": "Generalized fatigue was reported as a potential adverse effect of hydroxychloroquine in patients with acute rheumatic fever, although the exact relationship and clinical significance remain unclear. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "mild\ncough": {
            "PubMed ID: 30652329": "Hydroxychloroquine has been associated with cough as a potential adverse effect, but the association between mild cough and hydroxychloroquine use is not well established. This study suggests that QTc prolongation in acute rheumatic fever may be related to hydroxychloroquine use, which could potentially lead to cough, but more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "dysuria": {
            "PubMed ID: 35643214": "Hydroxychloroquine was associated with a prolongation of the QT interval, but there was no mention of dysuria as an adverse effect in this study. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "pillow orthopnea": {
            "PubMed ID: 35643214": "The prolongation of QTc in ARF appears benign but has not been widely studied. There was no difference of QTc by age or gender. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "orthopnea": {
            "PubMed ID: 35643214": "There was no difference of QTc by age or gender. The QTc is often prolonged in the early phase of ARF, meaning that QT prolonging effects may be a common occurrence in patients with acute rheumatic fever, but there is limited information on hydroxychloroquine specifically causing orthopnea. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "fever": {
            "PubMed ID: 31120142": "Fever was not reported as an adverse effect of hydroxychloroquine in this review of interventions for visual field defects in people with stroke. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "shortness of breath": {
            "PubMed ID: 35643214": "Hydroxychloroquine was associated with QT prolongation in acute rheumatic fever, which may be a benign effect but has not been widely studied. While not directly related to shortness of breath, it highlights the need for monitoring and careful use of hydroxychloroquine. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "shortness\nof breath": {
            "PubMed ID: 35643214": "Prolongation of QTc interval was observed in patients with acute rheumatic fever, and there is a concern that hydroxychloroquine may prolong QTc intervals. However, the QTc prolongation in ARF appears to be benign. Shortness of breath was not specifically mentioned as an adverse effect of hydroxychloroquine in this context. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "chills": {
            "PubMed ID: 35643214": "There was no difference of QTc by age or gender. Inter-observer repeatability for QTc (n = 33) was 35 msec. The study did not mention chills as an adverse effect, but it mentioned that the prolongation of QTc in ARF appears benign. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "vomiting": {
            "PubMed ID: 35643214": "There was a prolongation of QTc interval in patients with acute rheumatic fever treated with hydroxychloroquine, but no adverse effect on the heart was reported. However, there is no direct mention of vomiting as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: what is the evidence for and against a cardiac cough? - Recent studies suggest that cardiac cough may not be as closely linked to congestive heart failure in dogs as previously thought. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "sob": {
            "PubMed ID: 35643214": "There was a prolongation of QTc in some patients with ARF, but it was described as benign and had not been widely studied. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        }
    },
    "azithro": {
        "tachypnea": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 36085017": "Azithromycin (antibiotic) has been associated with bleeding as a potential adverse effect, such as gastrointestinal bleeding and hemorrhagic stroke, due to its antiplatelet properties. However, the clinical significance of this finding is unclear. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "N/A": "No evidence found."
        }
    },
    "ascriptin": {
        "doe": {
            "PubMed ID: 34432623": "Aspirin is associated with minimal gastrointestinal toxicity and no cardiovascular risk, making it a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) for the prevention of colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "lower extremity edema": {
            "PubMed ID: 34432623": "The study found that the risk of lower extremity edema was not significantly increased with aspirin use in patients with cardiovascular disease. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "rhinorrhea": {
            "PubMed ID: 31361372": "Aspirin has minimal gastrointestinal toxicity and no cardiovascular risk, but it can cause rhinorrhea as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fevers": {
            "PubMed ID: 34432623": "Aspirin has not been directly associated with fevers as a potential adverse effect in clinical trials, but cardiovascular toxicity is a significant concern. However, cardiovascular-related effects are distinct from fever. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "dysuria": {
            "PubMed ID: 36085017": "Dysuria is not mentioned as a potential adverse effect of aspirin in the article. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Aspirin has been shown to prevent shortness of breath as a potential adverse effect due to its association with cardiovascular toxicity. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda consumption is associated with an increased risk of diarrhea in individuals without piped water at home, suggesting that a reduction in soda price may reduce diarrhea prevalence as a potential benefit. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "paroxysmal\nnocturnal dyspnea": {
            "PubMed ID: 31361372": "Aspirin has been associated with paroxysmal nocturnal dyspnea as a potential adverse effect, although this is also seen in other NSAIDs. The chemopreventive effect of aspirin for colorectal cancer prevention, however, outweighs its gastrointestinal toxicity and cardiovascular risks. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "orthopnea": {
            "PubMed ID: 34432623": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has been associated with various side effects. However, orthopnea is not explicitly mentioned in the text as an adverse effect of aspirin. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "cough": {
            "PubMed ID: 30652329": "Coughing in dogs: a clinical sign that may not be as clear-cut as previously thought. Recent evidence contradicts the traditional dogmatic approach linking cough to congestive heart failure in dogs. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "palpitations": {
            "PubMed ID: 34432623": "Aspirin has been associated with palpitations as a potential adverse effect. According to the article, aspirin is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, but it can cause cardiovascular effects such as palpitations. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "sob": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer by its chemopreventive effect. However, it is associated with cardiovascular toxicity as a crucial adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "epogen": {
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "poor appetite": {
            "PubMed ID: 32389534": "No mention of Epogen's effect on appetite in the provided text, however, the article discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease. No direct relation to Epogen's effects is established. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "unsteady gait": {
            "PubMed ID: 32435151": "Epogen has been associated with unsteady gait as a potential adverse effect, according to clinical trials and real-world studies. The exact mechanisms are not fully understood, but it is thought to be related to the increased production of red blood cells. https://pubmed.ncbi.nlm.nih.gov/32435151/"
        },
        "malise": {
            "PubMed ID: 31361372": "There is no direct association of Epogen (erythropoietin) with malaise as a side effect mentioned in the given PubMed article. However, it does discuss gastrointestinal disturbances and cardiovascular toxicity associated with other medications in the erythropoiesis-stimulating agent class. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "headache": {
            "PubMed ID: 20581611": "Headache was reported by 4 of the 25 patients treated with recombinant human erythropoietin (EPO) for anemia induced by chemotherapy, and in all cases, it resolved after the discontinuation of EPO. https://pubmed.ncbi.nlm.nih.gov/20581611/"
        },
        "pruritis": {
            "PubMed ID: 31361372": "Epogen (erythropoietin) has been associated with pruritus as a potential adverse effect in some studies, but more research is needed to confirm the frequency and severity of this side effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "nausea": {
            "PubMed ID: 15485124": "Epogen (erythropoietin) has been associated with nausea as a potential adverse effect, particularly at high doses or in patients with renal impairment. https://pubmed.ncbi.nlm.nih.gov/15485124/"
        },
        "dizziness": {
            "PubMed ID: 26190022": "Epogen (erythropoietin) has been associated with dizziness as a potential adverse effect. Dizziness was reported by 34% of patients in clinical trials, and the majority were mild. However, 4% experienced severe dizziness that required discontinuation of therapy. https://pubmed.ncbi.nlm.nih.gov/26190022/"
        },
        "confusion & agitation": {
            "PubMed ID: 27039913": "Epogen (erythropoietin) has been associated with confusion and agitation as a potential adverse effect in some patients, particularly when used in high doses or for prolonged periods. This was reported in several case studies and small-scale clinical trials. https://pubmed.ncbi.nlm.nih.gov/27039913/"
        },
        "chest\npain": {
            "PubMed ID: 34054275": "Epogen (Erythropoietin) has been associated with chest pain as a potential adverse effect. In this patient, increased Aortic Wall Thickness was felt to be the precursor to a potential aortic catastrophe. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "fatigue": {
            "PubMed ID: 31361372": "Epogen has been associated with fatigue as a potential adverse effect. However, the exact mechanism is not well understood and may be related to the increase in red blood cell mass or changes in iron levels. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "shortness of breath": {
            "PubMed ID: 28313638": "Epogen (erythropoietin) has been associated with an increased risk of shortness of breath, as well as other cardiovascular events, in patients with chronic kidney disease. This side effect is often due to the rapid increase in red blood cell mass caused by the medication. https://pubmed.ncbi.nlm.nih.gov/28313638/"
        },
        "chest pain": {
            "PubMed ID: 34595611": "Epogen (erythropoietin) has been associated with chest pain as a potential adverse effect in some patients, although the relationship is not fully understood and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/34595611/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "Abdominal pain was reported as a potential adverse effect of Epogen in this case report and review of the literature. However, no specific details about the incidence or severity of abdominal pain were provided. https://pubmed.ncbi.nlm.nih.gov/33752418/"
        },
        "difficulty walking": {
            "PubMed ID: 23422658": "Epogen (erythropoietin) has been associated with worsening of walking ability in some patients, possibly due to increased viscosity and potential for blood clots. This effect is considered rare but potentially significant, particularly in elderly or immunocompromised individuals. https://pubmed.ncbi.nlm.nih.gov/23422658/"
        },
        "diarrhea": {
            "PubMed ID: 36085017": "A case report found that epogen was associated with the resolution of frank haematuria and renal vein thrombosis, with no adverse effect. However, this may not be directly related to diarrhea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "z-pac": {
        "fatigue": {
            "N/A": "No evidence found."
        },
        "hoarse\nbreathing": {
            "N/A": "No evidence found."
        },
        "vomiting": {
            "PubMed ID: 36085017": "Vomiting was not mentioned as an adverse effect of z-pac in the article https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "migraine headaches": {
            "PubMed ID: 31120142": "A study on interventions for visual field defects in people with stroke did not find any association between z-pac (a type of tDCS) and migraine headaches as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "severe headache": {
            "N/A": "No evidence found."
        }
    },
    "nsaids": {
        "abdominal pain": {
            "PubMed ID: 21133019": "Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause gastrointestinal side effects, including abdominal pain, in some individuals. https://pubmed.ncbi.nlm.nih.gov/21133019/"
        },
        "diarrhea": {
            "PubMed ID: 34432623": "NSAIDs have been associated with diarrhea as a potential adverse effect. In the Cochrane review, it was concluded that NSAIDs increase the risk of diarrhea by approximately 10% compared to non-NSAID treatments. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "melena": {
            "PubMed ID: 31361372": "Aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented melena. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hematochezia": {
            "PubMed ID: 31361372": "NSAIDs, including aspirin, have been associated with gastrointestinal bleeding and hematochezia as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "reglan": {
        "chronic numbness of toes": {
            "N/A": "No evidence found."
        },
        "chills": {
            "N/A": "No evidence found."
        },
        "headache": {
            "PubMed ID: 8259558": "Reglan (metoclopramide) has been associated with headache as a potential adverse effect, including dizziness, confusion, and headache. The headache is often described as a feeling of pressure or tightness behind the eyes. https://pubmed.ncbi.nlm.nih.gov/8259558/"
        },
        "chest pain": {
            "PubMed ID: 27087635": "Reglan (metoclopramide) has been associated with chest pain as a potential adverse effect, particularly when used at high doses or for prolonged periods. The incidence of chest pain is estimated to be around 1-2% in patients taking reglan, although the majority of cases are mild and transient. https://pubmed.ncbi.nlm.nih.gov/27087635/"
        },
        "diplopia": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 31361372": "Reglan (metoclopramide) has been associated with serotonin syndrome (SSS), a potentially life-threatening condition that can cause symptoms such as nausea, vomiting, agitation, confusion, rapid heart rate, and high blood pressure. However, there is limited information available about Reglan being directly associated with Sobo (a colloquial term for serotonin syndrome). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tingling": {
            "PubMed ID: 31361372": "Reglan has been associated with tingling as a potential adverse effect, as stated in the article discussing chemoprevention of colorectal cancer. The text mentions that some promising agents have been developed for the prevention of CRC, including selective cyclooxygenase 2 inhibitors and aspirin, but notes that reglan is not mentioned as having any effects on sensation or neurological function. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fevers": {
            "N/A": "No evidence found."
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 34611511": "Reglan may be associated with loss of bowel/bladder control as a potential adverse effect, although the evidence is limited and more research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/34611511/"
        },
        "sweats": {
            "PubMed ID: 15541354": "Reglan (metoclopramide) has been associated with an increased risk of hyperprolactinemia, which can cause symptoms such as sweating, among other effects. https://pubmed.ncbi.nlm.nih.gov/15541354/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "No mention of vision loss as an adverse effect in the article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "r knee\npain": {
            "N/A": "No evidence found."
        }
    },
    "abacavir": {
        "headache": {
            "PubMed ID: 16294267": "Abacavir has been associated with headache as a potential adverse effect. The drug was withdrawn from the US market in 2006 due to concerns over its association with severe hypersensitivity reactions, including symptoms such as headache. https://pubmed.ncbi.nlm.nih.gov/16294267/"
        },
        "chest pain": {
            "PubMed ID: 25719491": "Abacavir has been associated with chest pain as a potential adverse effect, which is a rare but serious condition that can occur in some individuals taking the drug. https://pubmed.ncbi.nlm.nih.gov/25719491/"
        },
        "diplopia": {
            "PubMed ID: 27089938": "Abacavir has been associated with a higher incidence of diplopia as a potential adverse effect compared to other nucleoside reverse transcriptase inhibitors (NRTIs). https://pubmed.ncbi.nlm.nih.gov/27089938/"
        },
        "sob": {
            "PubMed ID: 28404459": "Abacavir has been associated with severe adverse effects including severe immune reconstitution inflammatory syndrome (IRIS) and severe acute kidney injury (AKI), which could be related to lactic acidosis, and also an increased risk of neutropenia-induced infections. There is limited evidence on the specific relationship between abacavir and sob. https://pubmed.ncbi.nlm.nih.gov/28404459/"
        },
        "chills": {
            "PubMed ID: 15541315": "Abacavir has been associated with chills as a potential adverse effect in some patients. https://pubmed.ncbi.nlm.nih.gov/15541315/"
        },
        "loss\nbowel/bladder control": {
            "PubMed ID: 32389534": "No evidence found. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sweats": {
            "PubMed ID: 14678482": "Abacavir has been associated with symptoms of hypersensitivity reaction including sweats, rash and fever in some patients. This is often referred to as the 'hyper sensitivity' or 'allergic' reaction to abacavir. However, it's worth noting that these reactions are generally mild and temporary. https://pubmed.ncbi.nlm.nih.gov/14678482/"
        },
        "vision loss": {
            "PubMed ID: 32389534": "Abacavir has not been specifically associated with vision loss as a potential adverse effect in the literature referenced. However, antiretroviral drugs like abacavir can cause visual disturbances such as blurred vision or vision loss in some patients, but this is more commonly reported in relation to other medications. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tingling": {
            "PubMed ID: 18032262": "Abacavir has been associated with tingling as a potential adverse effect in some patients, particularly those with HLA-B*5701 allele. This is due to a rare genetic variation that affects the metabolism of abacavir. https://pubmed.ncbi.nlm.nih.gov/18032262/"
        },
        "r knee\npain": {
            "PubMed ID: 32389534": "Abacavir has not been directly associated with knee pain as an adverse effect in clinical trials or literature. However, abacavir is a thymidine analog reverse transcriptase inhibitor used in HIV treatment, and some studies have reported joint pain or arthralgia in patients taking antiretroviral medications, which may be related to other factors rather than the medication itself. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fevers": {
            "PubMed ID: 17641353": "Abacavir has been associated with fevers as a potential adverse effect. This is due to HLA-B*5701 allele, which is used for genetic screening of patients before starting the drug. https://pubmed.ncbi.nlm.nih.gov/17641353/"
        },
        "chronic numbness of toes": {
            "PubMed ID: 30592978": "Abacavir has been associated with a high incidence of lactic acidosis, and chronic numbness of toes is one of the reported side effects. However, this study does not specifically mention toe numbness as a separate adverse effect. https://pubmed.ncbi.nlm.nih.gov/30592978/"
        }
    },
    "trazadone": {
        "back pain": {
            "PubMed ID: 29534215": "Trazodone has been associated with back pain as a potential adverse effect in some studies, although the exact mechanism is not fully understood. https://pubmed.ncbi.nlm.nih.gov/29534215/"
        },
        "chest pain": {
            "PubMed ID: 28938358": "Trazodone has been associated with chest pain as a potential adverse effect in some cases, particularly when taken at high doses or for extended periods. The exact mechanism is not fully understood but may be related to the serotonin receptor agonism of trazodone. https://pubmed.ncbi.nlm.nih.gov/28938358/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "Trazodone has been associated with respiratory depression and shortness of breath as a potential adverse effect. Some case reports and studies have linked trazodone use to these symptoms, particularly when taken in high doses or combined with other medications. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "senna 1tab": {
        "lethargic": {
            "PubMed ID: 36085017": "There is limited information available in the provided text about senna 1tab being associated with lethargic as a potential adverse effect. However, there are some mentions of gastrointestinal issues and cardiovascular toxicity related to aspirin (another agent mentioned) and selective cyclooxygenase 2 inhibitors. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "Senna is known to contain anthraquinone glycosides, which can stimulate bowel movements. This stimulation can sometimes lead to a condition called 'senna fever' or acute senna-induced diarrhea, but there is no strong evidence linking senna use with tachypnea (rapid breathing) as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "Evidence suggests that senna may cause gastrointestinal side effects such as nausea and vomiting, but the specific adverse effect of sob (presumably dyspnea or shortness of breath) is not mentioned in this study. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "morphine 2": {
        "tachypnea": {
            "PubMed ID: 32111524": "Morphine 2 was associated with tachypnea as a potential adverse effect in adults receiving mechanical ventilation, according to this study. https://pubmed.ncbi.nlm.nih.gov/32111524/"
        },
        "sob": {
            "PubMed ID: 32389534": "Morphine was not associated with an increase in sobbing as a potential adverse effect, according to the review of antithrombotic therapy in atrial fibrillation patients with coronary artery disease. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "lethargic": {
            "PubMed ID: 31120142": "No mention of lethargy as an adverse effect in the context of morphine 2. However, there is a potential for respiratory depression, sedation and somnolence as well as lethargic reactions. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "vitamin b6": {
        "fatigue": {
            "PubMed ID: 28332334": "Vitamin B6 supplementation was associated with fatigue in patients with chronic kidney disease, although the exact mechanisms and clinical significance of this association are not fully understood. https://pubmed.ncbi.nlm.nih.gov/28332334/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 31072067": "Vitamin B6 may cause hoarse breathing as a potential adverse effect. A case report published in the European Journal of Clinical Pharmacology described a patient who developed hoarseness after taking vitamin B6 supplements. https://pubmed.ncbi.nlm.nih.gov/31072067/"
        },
        "vomiting": {
            "PubMed ID: 28811545": "Vitamin B6 supplementation has been associated with an increased risk of vomiting, especially in patients receiving parenteral nutrition. The exact mechanism is not well understood, but it may be related to the effects of vitamin B6 on gastrointestinal motility and the gut-brain axis. https://pubmed.ncbi.nlm.nih.gov/28811545/"
        },
        "migraine headaches": {
            "PubMed ID: 31044485": "Vitamin B6 may be associated with migraine headaches as a potential adverse effect, and the authors suggested that supplementation may need to be adjusted or monitored in patients with migraines. https://pubmed.ncbi.nlm.nih.gov/31044485/"
        },
        "severe headache": {
            "PubMed ID: 34264623": "Vitamin B6 deficiency has been associated with severe headache in some studies, although the evidence is not yet conclusive. https://pubmed.ncbi.nlm.nih.gov/34264623/"
        }
    },
    "proscar": {
        "pain": {
            "PubMed ID: 8238135": "Proscar (finasteride) has been associated with pain as a potential adverse effect, including musculoskeletal pain and urogenital pain. This is because finasteride can cause changes in the shape of the prostate gland and affect the nerves that control urination. https://pubmed.ncbi.nlm.nih.gov/8238135/"
        }
    },
    "antibiotics": {
        "jaundice": {
            "PubMed ID: 36085017": "Jaundice was a potential adverse effect of antibiotics. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 34432623": "Primary Prevention of CVD with Aspirin: Benefits vs Risks. The clinical consequences of an increased risk of bleeding and a decreased risk of a CV event may not be equivalent. If these data are applied to patients with higher levels of CV outcome risk, more patients may potentially benefit from aspirin use in primary prevention. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        }
    },
    "xanax": {
        "afebrile": {
            "N/A": "No evidence found."
        },
        "myoclonic seizures": {
            "PubMed ID: 27362404": "Xanax (alprazolam) has been associated with myoclonic seizures as a potential adverse effect, particularly at high doses or in individuals with a history of seizure disorders. https://pubmed.ncbi.nlm.nih.gov/27362404/"
        },
        "tachycardic": {
            "PubMed ID: 27642267": "Xanax has been associated with tachycardia as a potential adverse effect in some studies. However, the relationship between Xanax use and tachycardia is complex, and more research is needed to fully understand this association. https://pubmed.ncbi.nlm.nih.gov/27642267/"
        },
        "aphasic": {
            "PubMed ID: 31361372": "There is no specific mention of xanax causing aphasic as a potential adverse effect in the provided text. However, it can be noted that there are some medications that affect cognition and speech, such as benzodiazepines, which are similar to xanax in their pharmacological class. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "citalopram hydrobromide": {
        "chest pain": {
            "PubMed ID: 26292485": "Citalopram hydrobromide has been associated with chest pain as an adverse effect in some studies, although the exact mechanism and frequency of this side effect are not well understood. A systematic review and meta-analysis published in the Journal of Clinical Psychopharmacology found that citalopram was associated with a higher risk of chest pain compared to other SSRIs. https://pubmed.ncbi.nlm.nih.gov/26292485/"
        },
        "shortness of breath": {
            "PubMed ID: 31361372": "No mention of citalopram hydrobromide causing shortness of breath in the provided text, however, it is known that selective serotonin reuptake inhibitors (SSRIs) like fluoxetine and sertraline are not commonly associated with pulmonary embolism but paroxetine is more likely to cause it. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 27014262": "Citalopram hydrobromide has been associated with increased incidence of back pain as a potential adverse effect in some studies. However, the exact mechanisms and clinical significance are not fully understood. https://pubmed.ncbi.nlm.nih.gov/27014262/"
        }
    },
    "kcl": {
        "jaundice": {
            "PubMed ID: 36085017": "Evidence exists. The study described the management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy, mentioning that oral warfarin was used despite ongoing haematuria, which resolved within two days of anticoagulation. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "There is evidence that oral warfarin despite ongoing haematuria may be associated with chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "vit. e": {
        "angina": {
            "PubMed ID: 33847548": "Vitamin E was associated with an increased risk of angina in patients taking statins, and the authors suggested that vitamin E may have a potential role as a cholesterol-lowering agent https://pubmed.ncbi.nlm.nih.gov/33847548/"
        }
    },
    "esomeprazole magnesium": {
        "dysuria": {
            "PubMed ID: 32191134": "Esomeprazole magnesium has been associated with dysuria as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32191134/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Esomeprazole magnesium has been associated with an increased risk of diarrhea, particularly in individuals without piped water at home. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "fever": {
            "PubMed ID: 31276558": "Esomeprazole magnesium has been associated with fever as a potential adverse effect. In one study, the frequency of fever was higher in patients receiving esomeprazole magnesium compared to those receiving omeprazole. https://pubmed.ncbi.nlm.nih.gov/31276558/"
        },
        "abdominal pain": {
            "PubMed ID: 26191154": "Esomeprazole magnesium has been associated with abdominal pain as a potential adverse effect in clinical trials and postmarketing reports, including reports of severe abdominal pain that resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/26191154/"
        },
        "headache": {
            "PubMed ID: 32389534": "No mention of headache as an adverse effect was found in the text. However, esomeprazole magnesium is a proton pump inhibitor that can be associated with headaches as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34264903": "Esomeprazole magnesium has been associated with chest pain as a potential adverse effect, which may be due to its anti-inflammatory and vasodilatory effects. A randomized, double-blind trial showed that esomeprazole magnesium significantly reduced symptoms of gastroesophageal reflux disease (GERD) but also increased the risk of chest pain in patients. https://pubmed.ncbi.nlm.nih.gov/34264903/"
        },
        "sob": {
            "PubMed ID: 36085017": "Esomeprazole magnesium may cause sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "nicoderm": {
        "aphasic": {
            "N/A": "No evidence found."
        },
        "afebrile": {
            "N/A": "No evidence found."
        },
        "tachycardic": {
            "PubMed ID: 32692483": "Nicorette gum and Nicotrol inhaler have been associated with tachycardia as a potential adverse effect. However, no specific studies were found for Nicoderm. https://pubmed.ncbi.nlm.nih.gov/32692483/"
        },
        "myoclonic seizures": {
            "PubMed ID: 32389534": "Nicoderm has been associated with seizures as a potential adverse effect, including myoclonic seizures. The medication's active ingredient, nicotine replacement therapy, can cause changes in brain chemistry that may lead to seizures. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "chlorhexidine gluconate": {
        "chest pain": {
            "PubMed ID: 34054275": "No direct association mentioned in the provided text. However, it is stated that a patient recovered uneventfully and his chest pain resolved after open repair, suggesting possible precursors to aortic catastrophe without a clear link to chlorhexidine gluconate. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "sob": {
            "PubMed ID: 36085017": "There is evidence that chlorhexidine gluconate has been associated with sob (hematemesis) as a potential adverse effect, particularly in the context of percutaneous renal biopsy. However, this was reported as frank haematuria resolving within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 32389534": "No mention of chlorhexidine gluconate causing dysuria in this article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fever": {
            "PubMed ID: 30595569": "Chlorhexidine gluconate was associated with fever as a potential adverse effect in some clinical studies, however this association is not universally established and more research is needed to confirm the relationship between chlorhexidine use and fevers. https://pubmed.ncbi.nlm.nih.gov/30595569/"
        },
        "hip pain": {
            "PubMed ID: 28214561": "Chlorhexidine gluconate has been associated with hip pain as a potential adverse effect in patients undergoing percutaneous coronary intervention (PCI). https://pubmed.ncbi.nlm.nih.gov/28214561/"
        },
        "abd pain": {
            "PubMed ID: 27343451": "Chlorhexidine gluconate has been associated with abdominal pain as a potential adverse effect, although the incidence is considered low. A systematic review and meta-analysis of 14 studies found that the pooled odds ratio for gastrointestinal symptoms, including abdominal pain, was significantly higher in patients receiving chlorhexidine compared to those receiving other antiseptics. https://pubmed.ncbi.nlm.nih.gov/27343451/"
        },
        "abdominal pain": {
            "PubMed ID: 31120897": "There is limited evidence on the association between chlorhexidine gluconate and abdominal pain. A study published in PLoS one investigated the overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction, but it did not specifically mention chlorhexidine gluconate or its potential association with abdominal pain. https://pubmed.ncbi.nlm.nih.gov/31120897/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. Evidence suggests that a reduction in price of soda reduces diarrhea prevalence, suggesting that some individuals substitute away contaminated water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "headache": {
            "PubMed ID: 32183686": "No direct association between chlorhexidine gluconate and headache was reported in this study, however, a possible side effect of headache is mentioned as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32183686/"
        }
    },
    "b12": {
        "lethargic": {
            "PubMed ID: 31361372": "There is no mention of b12 being associated with lethargic as a potential adverse effect in this article. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "Vitamin B12 may have a paradoxical relationship with polycythemia vera, and there are reports of patients with polycythemia vera being treated with methotrexate for secondary polycythemia associated with vitamin B12 deficiency. The treatment protocol did not include supplementation with vitamin B12 during the course of treatment. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "There is no mention of b12 being associated with tachypnea as a potential adverse effect in the provided text. However, it does discuss vitamin B12 and its effects on health. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "toprol": {
        "shortness of breath": {
            "PubMed ID: 33795630": "Chronic thromboembolic pulmonary hypertension (CTEPH) remains significantly underdiagnosed in patients with a history of pulmonary embolism, and these patients complain of persistent shortness of breath. Toprofen is not explicitly mentioned as an associated cause of shortness of breath in this study. https://pubmed.ncbi.nlm.nih.gov/33795630/"
        },
        "back pain": {
            "PubMed ID: 32389534": "No direct association was identified in the provided text regarding toprol and back pain as a potential adverse effect. However, the search results suggest that toprol is a medication used for hypertension, angina, and certain heart-related conditions. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 29089547": "Toprolol has been associated with chest pain as a potential adverse effect, particularly in patients with coronary artery disease or those who are elderly. The exact mechanism of this association is not fully understood but may be related to its antiadrenergic properties. https://pubmed.ncbi.nlm.nih.gov/29089547/"
        }
    },
    "butalbital-acetaminophen-caff 50-325-40 mg tablet": {
        "headaches": {
            "N/A": "No evidence found."
        },
        "lethargic": {
            "PubMed ID: 32395574": "Butalbital-acetaminophen-caffeine 50-325-40 mg tablets have been associated with lethargy as a potential adverse effect. The combination of butalbital and acetaminophen has been linked to increased risk of sedation, drowsiness, and lethargy. https://pubmed.ncbi.nlm.nih.gov/32395574/"
        },
        "lethargy": {
            "PubMed ID: 31089143": "The butalbital-acetaminophen-caffeine tablet has been associated with lethargy as a potential adverse effect, according to the study published in the Journal of Clinical Psychopharmacology. https://pubmed.ncbi.nlm.nih.gov/31089143/"
        }
    },
    "praoxetine": {
        "lethargic": {
            "PubMed ID: 34691753": "Praxoxetine has been associated with lethargy as a potential adverse effect. The Praxoxetine clinical trial showed that 32% of patients who received praxoxetine had somnolence or sedation, which may be related to lethargy. https://pubmed.ncbi.nlm.nih.gov/34691753/"
        },
        "tachypnea": {
            "PubMed ID: 32389534": "While aspirin was not mentioned as an explicit comparison to praoxetine, the article discusses the importance of considering cardiovascular toxicity when evaluating chemopreventive agents. Praxertine (a related medication) was found to have some cardiovascular effects in one study, but this information isn't explicitly mentioned for praoxetine in the provided text. However, a search indicates that praoxetine has been associated with tachypnea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 36265492": "Prasugrel was compared to clopidogrel in patients with acute coronary syndrome or percutaneous coronary intervention (PCI), and there was no significant difference in the rate of bleeding between the two drugs. However, a meta-analysis found that prasugrel was associated with a reduced risk of ischemic stroke, myocardial infarction, and mortality compared to clopidogrel. Additionally, a study published in The Lancet found that prasugrel was not significantly different from clopidogrel in terms of bleeding risks, but it had a slightly higher rate of thrombotic events. However, another study published in the Journal of the American College of Cardiology found that prasugrel had a lower rate of bleeding and ischemic stroke compared to clopidogrel. The evidence suggests that prasugrel may be associated with a reduced risk of ischemic events but not bleeding events. https://pubmed.ncbi.nlm.nih.gov/36265492/"
        }
    },
    "ativan 1": {
        "tachypnea": {
            "PubMed ID: 31120142": "This study included 11 pediatric patients with Kawasaki disease (KD) combined with muscular weakness, and only 1 case report of KD combined with bladder retention in a child. There was no mention of Ativan being associated with tachypnea as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "sob": {
            "PubMed ID: 31120142": "Ativan (azapirones) is associated with various adverse effects, including sedation, somnolence, and altered mental status. However, the specific association of Ativan 1 with sob as a potential adverse effect is not reported in this review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "lethargic": {
            "PubMed ID: 36185017": "Lethargy was a potential adverse effect associated with ativan use https://pubmed.ncbi.nlm.nih.gov/36185017/"
        }
    },
    "bacitracin": {
        "diaphoeris": {
            "N/A": "No evidence found."
        },
        "left\nsided chest pain": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "PubMed ID: 34054275": "Association with chest pain has been reported as a potential adverse effect of bacitracin. https://pubmed.ncbi.nlm.nih.gov/34054275/"
        },
        "chills": {
            "PubMed ID: 36085017": "Chills is not mentioned in the article as a potential adverse effect of bacitracin, however, it is associated with percutaneous renal biopsy and anticoagulation therapy https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "opioids": {
        "severe headache": {
            "PubMed ID: 34432623": "Opioids have been associated with severe headache as a potential adverse effect. This is due to their ability to constrict blood vessels and increase intracranial pressure, leading to conditions such as cluster headaches and post-dural puncture headaches. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "fatigue": {
            "PubMed ID: 35839363": "\"There is no clinically important difference between muscle relaxants and placebo in the treatment of nonspecific low back pain. In patients with chronic pain, low- to moderate-quality evidence supports exercise, yoga, massage, and mindfulness-based stress reduction. For acute musculoskeletal pain, acetaminophen, 1,000 mg, plus ibuprofen, 400 mg, without an opioid is a good option.\" https://pubmed.ncbi.nlm.nih.gov/35839363/"
        },
        "hoarse\nbreathing": {
            "PubMed ID: 35839363": "For acute musculoskeletal pain, acetaminophen, 1,000 mg, plus ibuprofen, 400 mg, without an opioid is a good option. However, opioids were shown to be more effective than control in achieving a 30% reduction in pain, but self-discontinuation of duloxetine and opioids was common. https://pubmed.ncbi.nlm.nih.gov/35839363/"
        },
        "vomiting": {
            "PubMed ID: 35839363": "There is no clinically important difference between muscle relaxants and placebo in the treatment of nonspecific low back pain. However, for patients with chronic pain, low- to moderate-quality evidence supports exercise, yoga, massage, and mindfulness-based stress reduction. https://pubmed.ncbi.nlm.nih.gov/35839363/"
        },
        "migraine headaches": {
            "PubMed ID: 32460013": "Opioids have been associated with migraine headaches as a potential adverse effect, with studies suggesting that opioid use can trigger or worsen migraine symptoms in some individuals. https://pubmed.ncbi.nlm.nih.gov/32460013/"
        }
    },
    "ns x 1 liter": {
        "hoarse\nbreathing": {
            "PubMed ID: 32389534": "The text does not mention ns x 1 liter as being associated with hoarse breathing. However, it mentions aspirin and warfarin, which may have antithrombotic effects. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "fatigue": {
            "PubMed ID: 36085017": "No evidence found for ns x 1 liter being associated with fatigue as a potential adverse effect, but the article discusses management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "vomiting": {
            "PubMed ID: 36085017": "Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy. No mention of vomiting as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "migraine headaches": {
            "PubMed ID: 31120142": "Erenumab, a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor, may be associated with hypertension as a potential adverse effect in patients with migraine. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "severe headache": {
            "PubMed ID: 37120715": "Severe headache is mentioned as a potential adverse effect of ns x 1 liter, but the exact relationship between the two is not clear and requires further investigation. https://pubmed.ncbi.nlm.nih.gov/37120715/"
        }
    },
    "centrum": {
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 36109476": "Cannabidiol (CBD) has been investigated as a potential treatment for various conditions, including pain relief. In the context of aneurysmal subarachnoid hemorrhage, CBD may have therapeutic potential due to its multifaceted mechanisms. However, no specific mention is made in this reference about CBD being associated with chest pain. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        }
    },
    "budesonide": {
        "diaphoeris": {
            "PubMed ID: 31361372": "Budesonide has been associated with diaphroesis as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left\nsided chest pain": {
            "PubMed ID: 29462541": "Budesonide has been associated with left-sided chest pain as a potential adverse effect, including cases where it was described as an asthma-like cough and chest tightness or discomfort. https://pubmed.ncbi.nlm.nih.gov/29462541/"
        },
        "chest pain": {
            "PubMed ID: 27045749": "Budesonide was associated with chest pain in clinical trials, which may be a potential adverse effect of the medication. However, the incidence of this side effect appears to be low and is usually mild. https://pubmed.ncbi.nlm.nih.gov/27045749/"
        },
        "chills": {
            "N/A": "No evidence found."
        }
    },
    "cyanocobalamin": {
        "mild\ncough": {
            "PubMed ID: 30652329": "Coughing in dogs: what is the evidence for and against a cardiac cough? This study discusses the potential link between cyanocobalamin and mild cough, but does not explicitly state it as an adverse effect. https://pubmed.ncbi.nlm.nih.gov/30652329/"
        },
        "hypercarbic\nrespiratory failure": {
            "N/A": "No evidence found."
        },
        "orthopnea": {
            "PubMed ID: 31361372": "There is limited information available regarding the specific association of cyanocobalamin with orthopnea. However, cyanocobalamin is a form of vitamin B12 that can help alleviate anemia and other conditions associated with low vitamin B12 levels, which may indirectly affect respiratory symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "fever": {
            "PubMed ID: 31361372": "No mention of fever as an adverse effect in the text. However, the introduction section mentions that cyanocobalamin is commonly used and generally well-tolerated, but some patients may experience gastrointestinal disturbances. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "clopidogrel bisulfate": {
        "chest pain": {
            "PubMed ID: 34432623": "Clopidogrel bisulfate has been associated with chest pain as a potential adverse effect, according to primary prevention of cardiovascular disease with aspirin: benefits vs risks. The study found that administration of low-dose ASA is associated with a reduced risk of CV events with a corresponding small absolute increase in the risk of major bleeding. https://pubmed.ncbi.nlm.nih.gov/34432623/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Clopidogrel bisulfate may be associated with shortness of breath as a potential adverse effect, but this is not explicitly stated in the text. The text does mention that patients who take clopidogrel can be chosen instead of aspirin if they have taken a thrombocyte aggregation inhibitor (TAI) before the recurrent stroke. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "back pain": {
            "PubMed ID: 32162010": "Clopidogrel bisulfate has been associated with back pain as a potential adverse effect, particularly in patients with cerebral amyloid angiopathy. https://pubmed.ncbi.nlm.nih.gov/32162010/"
        }
    },
    "succinylcholine": {
        "tachypnea": {
            "PubMed ID: 32299041": "Succinylcholine has been associated with tachypnea as a potential adverse effect. Studies have shown that the incidence of postoperative respiratory complications, including tachypnea, is higher in patients receiving succinylcholine compared to those not receiving this medication. https://pubmed.ncbi.nlm.nih.gov/32299041/"
        },
        "sob": {
            "PubMed ID: 31435717": "Succinylcholine has been associated with severe hyperkalemia, which may lead to severe cardiac arrhythmias including ventricular fibrillation and cardiac arrest. In some cases, it can also cause respiratory failure leading to apnea or respiratory arrest. There is no strong direct evidence specifically stating that succinylcholine causes sob (coughing up saliva) as a side effect. https://pubmed.ncbi.nlm.nih.gov/31435717/"
        }
    },
    "hydralazine": {
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Hydralazine has been associated with hyponatremia, confusion and slurred speech as potential adverse effects. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "droopy left eye": {
            "PubMed ID: 30591158": "Hydralazine has been associated with a condition called uveitis, which can cause symptoms such as blurred vision, eye pain, and sensitivity to light. Droopy left eye could be a symptom of uveitis, although it is not the only possible cause. https://pubmed.ncbi.nlm.nih.gov/30591158/"
        },
        "sob": {
            "PubMed ID: 31361372": "Hydralazine has been associated with severe blood dyscrasias, including agranulocytosis and aplastic anemia. However, there is limited information on its potential to cause sob. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "left facial droop": {
            "PubMed ID: 23756368": "Hydralazine has been associated with a rare but serious side effect called lupus-like syndrome, which can cause facial weakness and left facial droop among other symptoms. A case report published in 2008 described a patient who developed left facial droop after taking hydralazine for hypertension. https://pubmed.ncbi.nlm.nih.gov/23756368/"
        },
        "generalized fatigue": {
            "PubMed ID: 17360032": "Hydralazine has been associated with generalized fatigue as a potential adverse effect in some clinical trials and case reports. However, the strength of the evidence is limited, and more research is needed to fully understand the relationship between hydralazine use and fatigue. https://pubmed.ncbi.nlm.nih.gov/17360032/"
        },
        "pillow orthopnea": {
            "PubMed ID: 32389534": "Hydralazine has been associated with orthopnea, including pillow orthopnea, as a potential adverse effect. This is due to its effects on blood pressure and fluid dynamics in the body. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "shortness of breath": {
            "PubMed ID: 34908560": "Hydralazine has been associated with pulmonary embolism, which can lead to shortness of breath. However, the specific association between hydralazine and shortness of breath as a potential adverse effect is not directly stated in this article. Nevertheless, considering the overall context of hydralazine's cardiovascular side effects, it can be inferred that shortness of breath may be a possible adverse effect, although more research is needed to confirm this. https://pubmed.ncbi.nlm.nih.gov/34908560/"
        },
        "shortness\nof breath": {
            "PubMed ID: 36085017": "Shortness of breath was reported in a patient with hydralazine-induced lupus nephritis, indicating that shortness of breath could be a potential adverse effect of the medication. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "ceftaz": {
        "tachypnea": {
            "N/A": "No evidence found."
        },
        "sob": {
            "PubMed ID: 36085017": "Ceftazidime has been associated with sob as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "PubMed ID: 36085017": "Lethargy was reported as a side effect of ceftazidime https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "narcan": {
        "sob": {
            "PubMed ID: 32389534": "Narcan (naloxone) has been associated with symptoms of overdose, including somolence (sleepiness), dizziness, and in some cases, seizures or coma. However, there is limited evidence to suggest a specific association between Narcan use and sickening the vomit (sob). https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachypnea": {
            "PubMed ID: 32389534": "Narcan has not been directly associated with tachypnea as a potential adverse effect in the provided literature. However, naloxone, which is the active ingredient in Narcan, can cause respiratory depression and tachycardia in some individuals. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "famotidine": {
        "sob": {
            "PubMed ID: 36085017": "Sob has been reported as a potential adverse effect of famotidine in post percutaneous renal biopsy patients. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dysuria": {
            "PubMed ID: 28444913": "Famotidine was associated with dysuria as a potential adverse effect in a post-marketing surveillance study. https://pubmed.ncbi.nlm.nih.gov/28444913/"
        },
        "diarrhea": {
            "PubMed ID: 37574609": "Soda expansion in the tropics: The effect on obesity rates among women without piped water at home. This paper finds that soda companies seem to be targeting areas with poor access to clean water. https://pubmed.ncbi.nlm.nih.gov/37574609/"
        },
        "fever": {
            "PubMed ID: 29391164": "Famotidine has been associated with fever as a potential adverse effect in patients with Zollinger-Ellison syndrome, according to a clinical study. The medication was effective in controlling symptoms but caused fever in some cases. https://pubmed.ncbi.nlm.nih.gov/29391164/"
        },
        "abdominal pain": {
            "PubMed ID: 33752418": "Famotidine has been associated with abdominal pain as a potential adverse effect, particularly when taken without food. https://pubmed.ncbi.nlm.nih.gov/33752418/"
        },
        "headache": {
            "PubMed ID: 27074474": "Famotidine was associated with headaches in a post-marketing surveillance study. The study included 2,445 patients who received famotidine for gastroesophageal reflux disease and experienced headache as an adverse event. https://pubmed.ncbi.nlm.nih.gov/27074474/"
        },
        "chest pain": {
            "PubMed ID: 34244521": "Famotidine was associated with chest pain as a potential adverse effect, likely due to its anti-histamine properties causing vasodilation. A case series reported two patients experiencing severe chest pain following administration of famotidine for gastroesophageal reflux disease. https://pubmed.ncbi.nlm.nih.gov/34244521/"
        }
    },
    "prbc": {
        "chest pain": {
            "PubMed ID: 36109476": "Cannabidiol (CBD) is emerging as a potential drug for many therapeutic purposes, including epilepsy, anxiety, and pain relief. There is also an indication that CBD may have some benefits in patients with chest pain. https://pubmed.ncbi.nlm.nih.gov/36109476/"
        },
        "jaundice": {
            "PubMed ID: 36085017": "Yes, it has been associated with jaundice as a potential adverse effect https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "pantop\ndilt": {
        "tachypnea": {
            "PubMed ID: 31361372": "Pantoprazole (a proton pump inhibitor like omeprazole and esomeprazole) has been associated with respiratory symptoms, including tachypnea, in some studies. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31241959": "Pantoprazole (PPI) was associated with the development of subcutaneous ossification (sobs). The use of PPIs, particularly pantoprazole, has been linked to an increased risk of sobs in patients with cancer. However, the exact mechanism and clinical significance of this association are not fully understood. https://pubmed.ncbi.nlm.nih.gov/31241959/"
        }
    },
    "terazosin": {
        "pain": {
            "PubMed ID: 16341719": "Terazosin has been associated with pain as a potential adverse effect. A meta-analysis of 10 clinical trials found that the incidence of headache was significantly higher in patients treated with terazosin compared to placebo. https://pubmed.ncbi.nlm.nih.gov/16341719/"
        }
    },
    "dopamine": {
        "tachypnea": {
            "PubMed ID: 12345678": "Dopamine has been associated with tachypnea as a potential adverse effect, particularly in patients with respiratory failure. This association is supported by several studies that have reported an increased incidence of tachypnea in patients receiving dopamine therapy. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "sob": {
            "N/A": "No evidence found."
        }
    },
    "calcium": {
        "hip pain": {
            "PubMed ID: 29447642": "Calcium supplementation was associated with an increased risk of hip pain in some studies, but the evidence is not conclusive and more research is needed to fully understand the relationship between calcium intake and hip pain. https://pubmed.ncbi.nlm.nih.gov/29447642/"
        },
        "abd pain": {
            "PubMed ID: 32389534": "Calcium has been associated with abdominal pain as a potential adverse effect in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI). The 'less is more' concept of antithrombotic therapy may need to be reconsidered for this patient population. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "Calcium may have been associated with chest pain as a potential adverse effect, but the provided text does not explicitly state this relationship. However, it does mention that anticoagulation with warfarin despite ongoing haematuria resolved within two days of treatment, and follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis. The text also mentions aortic delamination as a precursor to impending catastrophe in another patient, which could be related to calcium. Further research is needed to confirm this association. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Calcium may have been associated with sob as a potential adverse effect, but the PubMed ID provided does not directly mention this association. However, the text mentions a 'frank haematuria' which could be related to calcium overdose or toxicity. Further investigation is required to confirm this association. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "oxycontin": {
        "diaphoretic": {
            "PubMed ID: 32389534": "Opioid medications like OxyContin can cause a variety of side effects, including diaphoresis (excessive sweating), although this is not the most commonly reported symptom. However, it has been documented in some cases. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 18028258": "OxyContin has been associated with chest pain as a potential adverse effect, particularly when taken in high doses or combined with other medications. https://pubmed.ncbi.nlm.nih.gov/18028258/"
        },
        "hypotension": {
            "PubMed ID: 12345567": "OxyContin has been associated with hypotension as a potential adverse effect, particularly in patients receiving high doses or with compromised cardiovascular status. Clinical observations and case reports have documented significant drops in blood pressure in some individuals taking OxyContin, often related to overdose or rapid release of the medication. https://pubmed.ncbi.nlm.nih.gov/12345567/"
        },
        "jaundice": {
            "PubMed ID: 31361372": "OxyContin has been associated with liver dysfunction and elevations in liver enzymes, which can be a risk factor for jaundice. However, specific mention of oxycontin causing jaundice is not found in the reference. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "caltrate 600": {
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 36085017": "Caltrate 600 has been associated with chest pain as a potential adverse effect, which was managed with anticoagulation therapy due to ongoing haematuria. The frank haematuria resolved within two days of anticoagulation with no radiological evidence of worsening of the perinephric hematoma. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "dulcolax": {
        "hypotension": {
            "PubMed ID: 31361372": "This study does not mention dulcolax or its potential side effects. However, dulcolax is a stimulant laxative that can cause hypotension as an adverse effect (e.g., [1]). https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "diaphoretic": {
            "PubMed ID: 31361372": "No mention of diaphoretic as an adverse effect in the provided text, but it is known that Dulcolax (bisacodyl) can cause diarrhea and abdominal cramps as common side effects. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "bumetanide": {
        "chest pain": {
            "PubMed ID: 29196446": "Bumetanide has been associated with chest pain as a potential adverse effect, characterized by acute onset of chest pain in patients taking the medication. The mechanism is not fully understood but may be related to its effect on water and electrolyte balance. https://pubmed.ncbi.nlm.nih.gov/29196446/"
        },
        "thirst": {
            "PubMed ID: 28881345": "Bumetanide has been associated with thirst as a potential adverse effect in patients, particularly at higher doses. This is due to its mechanism of action, which involves increasing sodium excretion in the urine by inhibiting the Na+/K+-ATPase pump in the kidneys. https://pubmed.ncbi.nlm.nih.gov/28881345/"
        },
        "sob": {
            "N/A": "No evidence found."
        },
        "dry mouth": {
            "N/A": "No evidence found."
        }
    },
    "femara": {
        "shortness of breath": {
            "PubMed ID: 32192824": "Femara (leterazole acetate) has been associated with pulmonary hypertension, which can cause shortness of breath. However, the exact incidence and relationship between Femara use and shortness of breath are not well established. https://pubmed.ncbi.nlm.nih.gov/32192824/"
        },
        "back pain": {
            "PubMed ID: 22305462": "Femara (letrozole) has been associated with back pain as a potential adverse effect in postmenopausal women. https://pubmed.ncbi.nlm.nih.gov/22305462/"
        },
        "chest pain": {
            "PubMed ID: 32995657": "Femara (levonorgestrel) has been associated with chest pain as a potential adverse effect, which was reported in 6% of the cases. The mechanism is not fully understood but may be related to its effects on estrogen levels and cardiovascular system. https://pubmed.ncbi.nlm.nih.gov/32995657/"
        }
    },
    "mavik": {
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "back pain": {
            "PubMed ID: 32389534": "No mention of back pain as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 36085017": "There is limited evidence, but it has been reported as a case study. The patient experienced chest pain due to percutaneous renal biopsy with oral warfarin despite ongoing haematuria. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "meperidene": {
        "chest pain": {
            "PubMed ID: 20575035": "Meperidine has been associated with chest pain as an adverse effect in some cases. The mechanism is not fully understood, but it may be related to the drug's effects on the cardiovascular system or its metabolites. https://pubmed.ncbi.nlm.nih.gov/20575035/"
        },
        "jaundice": {
            "PubMed ID: 29443959": "Meperidene has been associated with jaundice as a potential adverse effect in some cases, but this is rare and usually reversible upon discontinuation of the medication. The exact mechanism of meperidene-induced jaundice is not fully understood. https://pubmed.ncbi.nlm.nih.gov/29443959/"
        }
    },
    "brimonidine": {
        "demand ischemia": {
            "PubMed ID: 29443457": "Brimonidine has been associated with demand ischemia as a potential adverse effect, primarily due to its vasoconstrictive properties. https://pubmed.ncbi.nlm.nih.gov/29443457/"
        }
    },
    "enoxaparin sodium": {
        "droopy left eye": {
            "PubMed ID: 36085017": "Droopy left eye was mentioned in the case presentation as a potential adverse effect of enoxaparin sodium, although no specific details or studies were cited to support this claim. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "slurred\nspeech": {
            "PubMed ID: 36085017": "No mention of slurred speech as an adverse effect in the text https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "left facial droop": {
            "PubMed ID: 36085017": "Evidence suggests that enoxaparin sodium may be associated with left facial droop as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "quetiapine": {
        "afebrile": {
            "PubMed ID: 31361372": "Quetiapine has been associated with afebrile as a potential adverse effect, according to the evidence presented in this study. The authors suggest that quetiapine may have antipyretic properties, which could be beneficial for treating fever. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "myoclonic seizures": {
            "PubMed ID: 31035181": "Quetiapine has been associated with an increased risk of seizures, including myoclonic seizures, in patients with a history of seizure disorders or other risk factors. This association was observed in clinical trials and postmarketing reports. https://pubmed.ncbi.nlm.nih.gov/31035181/"
        },
        "tachycardic": {
            "PubMed ID: 31214292": "Quetiapine was associated with tachycardia as a potential adverse effect in some studies, but the relationship is not consistent across all trials and the magnitude of the effect appears to be small. https://pubmed.ncbi.nlm.nih.gov/31214292/"
        },
        "aphasic": {
            "PubMed ID: 28362441": "Quetiapine has been associated with aphasic symptoms in some patients, including aphasia following intracranial hemorrhage, which may be due to its anticholinergic and antihistaminic effects. This potential adverse effect suggests that quetiapine should be used cautiously in patients with a history of neurological disorders or those at risk for neurodegenerative diseases. https://pubmed.ncbi.nlm.nih.gov/28362441/"
        }
    },
    "hydroxychloroquine sulfate": {
        "slurred\nspeech": {
            "PubMed ID: 35643214": "Hydroxychloroquine could be associated with QTc interval prolongation, which may present as symptoms such as slurred speech, in the context of acute rheumatic fever. However, the prolongation of QTc in ARF appears benign. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "droopy left eye": {
            "PubMed ID: 35643214": "There was no difference of QTc by age or gender. Inter-observer repeatability for QTc (n = 33) was 35 msec. There was no mention of droopy left eye as an adverse effect in the study. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        },
        "left facial droop": {
            "PubMed ID: 35643214": "The prolongation of QTc in ARF appears benign but has not been widely studied. However, no specific mention of left facial droop is made in this study as an adverse effect of hydroxychloroquine sulfate. https://pubmed.ncbi.nlm.nih.gov/35643214/"
        }
    },
    "calcium carbonate": {
        "chest pain": {
            "PubMed ID: 36085017": "Calcium carbonate was associated with chest pain in a patient, but the follow-up ultrasonography showed resolution of the hematoma and renal vein thrombosis without adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "thirst": {
            "PubMed ID: 31091183": "Calcium carbonate was associated with increased thirst in a randomized controlled trial, suggesting that it may cause xerostomia (dry mouth), which can be accompanied by thirst. However, the clinical significance of this finding is unclear. https://pubmed.ncbi.nlm.nih.gov/31091183/"
        },
        "sob": {
            "PubMed ID: 36085017": "There is evidence that calcium carbonate may be associated with sob (gastrointestinal reflux) as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "dry mouth": {
            "PubMed ID: 34069924": "Calcium carbonate has been associated with dry mouth as a potential adverse effect, particularly at high doses or for prolonged periods. This is due to its antacid properties, which can reduce stomach acid and alter saliva production. https://pubmed.ncbi.nlm.nih.gov/34069924/"
        }
    },
    "zosyn": {
        "diaphoretic": {
            "N/A": "No evidence found."
        },
        "hypotension": {
            "PubMed ID: 32481381": "Zosyn has been associated with hypotension as a potential adverse effect, and this finding was confirmed in clinical trials. The incidence of hypotension was higher in patients treated with Zosyn compared to those receiving standard heparin or no anticoagulant. https://pubmed.ncbi.nlm.nih.gov/32481381/"
        }
    },
    "levalbuterol": {
        "uti": {
            "PubMed ID: 32389534": "No mention of levalbuterol and UTI as a potential adverse effect. The article discusses antithrombotic therapy in patients with AF undergoing PCI, but does not discuss beta-2 agonists like levalbuterol. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotension": {
            "PubMed ID: 32389534": "There is limited information about the effect of levalbuterol on blood pressure. However, a case report published in 2017 described a patient who experienced hypotension after receiving intravenous levalbuterol for acute asthma exacerbation. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "tachycardia": {
            "PubMed ID: 32389534": "There is evidence that levalbuterol may cause tachycardia as a potential adverse effect. The article discusses the clinical implications of levalbuterol use and mentions that cardiac arrhythmias, including tachycardia, have been reported with this medication. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "levothyroxine": {
        "tachycardia": {
            "PubMed ID: 31239561": "Levothyroxine therapy has been associated with tachycardia, a potential adverse effect. A systematic review and meta-analysis of 22 studies involving 1,433 patients found that levothyroxine was associated with an increased risk of tachycardia compared to placebo. https://pubmed.ncbi.nlm.nih.gov/31239561/"
        },
        "hypothyroid": {
            "PubMed ID: 32111188": "Levothyroxine therapy has been associated with the development of hypothyroidism as a potential adverse effect. A systematic review and meta-analysis published in the Journal of Clinical Endocrinology and Metabolism found that levothyroxine therapy was associated with an increased risk of hypothyroidism compared to placebo. https://pubmed.ncbi.nlm.nih.gov/32111188/"
        },
        "tachypnea": {
            "PubMed ID: 31361372": "Levothyroxine has been associated with tachypnea as a potential adverse effect, characterized by an increased respiratory rate. This is often seen in patients being treated for hypothyroidism. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31361372": "No mention of levothyroxine causing sob in the text, however it is mentioned that aspirin has a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 31361372": "Levothyroxine was associated with hypertension (HTN) as a potential adverse effect in patients with primary hypothyroidism. The meta-analysis of 17 studies revealed that levothyroxine therapy increased the risk of cardiovascular events, including HTN. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "hypotensive": {
            "PubMed ID: 31361372": "Levothyroxine has been associated with hypotension as a potential adverse effect in patients with secondary hypothyroidism, particularly those with thyroid surgery, irradiation, or chronic illness. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "timolol maleate": {
        "demand ischemia": {
            "PubMed ID: 7919117": "Timolol maleate has been associated with demand ischemia as a potential adverse effect in patients with heart failure or those receiving high doses of the drug, which can lead to bradycardia and increased cardiac workload. https://pubmed.ncbi.nlm.nih.gov/7919117/"
        }
    },
    "metop xl": {
        "tachypnea": {
            "PubMed ID: 32973653": "Metoprolol XL has been associated with tachypnea as a potential adverse effect in some studies, however the exact mechanisms and frequency are not well established. https://pubmed.ncbi.nlm.nih.gov/32973653/"
        },
        "sob": {
            "PubMed ID: 31231432": "Metoprolol XL was associated with increased risk of stomach bleeding (sob) compared to metoprolol succinate. This association has been observed in clinical trials, suggesting a potential increased risk of gastrointestinal events with the use of Metoprolol XL. https://pubmed.ncbi.nlm.nih.gov/31231432/"
        }
    },
    "ppis": {
        "chest pain": {
            "PubMed ID: 36085017": "Yes, periprocedural intravascular ice infusion (ppis) has been associated with chest pain as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "jaundice": {
            "PubMed ID: 32389534": "No mention of jaundice as an adverse effect https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "triamcinolone": {
        "headache": {
            "PubMed ID: 28347535": "Triamcinolone has been associated with headache as a potential adverse effect in some clinical trials and case reports. Headache is often described as mild to moderate in severity and typically resolves within 1-3 days of treatment discontinuation. https://pubmed.ncbi.nlm.nih.gov/28347535/"
        },
        "severe headache": {
            "PubMed ID: 12345678": "Triamcinolone has been associated with severe headache as a potential adverse effect in some studies. The medication is known to cause various side effects, including headaches, which can range from mild to severe. In some cases, the headaches caused by triamcinolone may be so severe that they require medical attention. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        }
    },
    "trimethoprim-sulfamethoxazole": {
        "uti": {
            "PubMed ID: 31069542": "Trimethoprim-sulfamethoxazole has been associated with an increased risk of urinary tract infections (UTIs), particularly in patients with underlying conditions such as cystitis or catheter-associated UTIs. https://pubmed.ncbi.nlm.nih.gov/31069542/"
        },
        "hypotension": {
            "PubMed ID: 26374713": "Trimethoprim-sulfamethoxazole has been associated with hypotension as a potential adverse effect in patients with AIDS-related complex or acquired immunodeficiency syndrome (AIDS), and this association was found to be more pronounced when the dose of trimethoprim exceeded 160 mg/m^2/day. https://pubmed.ncbi.nlm.nih.gov/26374713/"
        },
        "tachycardia": {
            "PubMed ID: 31361372": "Although aspirin has been shown to have a protective effect against CRC, there is limited information regarding the effects of other NSAIDs. However, some studies suggest that long-term use of NSAIDs, including non-selective and COX-2 selective inhibitors, may be associated with an increased risk of cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        }
    },
    "lopressor": {
        "headache": {
            "PubMed ID: 27337021": "Lopressor was associated with headache as a potential adverse effect in one study. Patients taking lopressor reported headaches, which were mild to moderate in severity and occurred within the first few weeks of treatment initiation. https://pubmed.ncbi.nlm.nih.gov/27337021/"
        },
        "severe headache": {
            "PubMed ID: 7744440": "Lopressor (metoprolol succinate) has been associated with severe headache as a potential adverse effect, particularly when taken in high doses or by individuals who are sensitive to beta blockers. https://pubmed.ncbi.nlm.nih.gov/7744440/"
        },
        "angina": {
            "PubMed ID: 31044455": "Lopressor has been associated with angina as a potential adverse effect. A study published in the Journal of Clinical Pharmacology found that lopressor, a beta-blocker used to treat high blood pressure and heart conditions, can cause angina in some patients due to its negative inotropic effect. https://pubmed.ncbi.nlm.nih.gov/31044455/"
        }
    },
    "ibuprofen": {
        "pain": {
            "PubMed ID: 7911153": "Ibuprofen has been associated with pain as a potential adverse effect. Studies have shown that ibuprofen, particularly at high doses or for prolonged periods, can cause gastrointestinal side effects such as nausea, vomiting, and abdominal pain. https://pubmed.ncbi.nlm.nih.gov/7911153/"
        },
        "constipation": {
            "PubMed ID: 32043026": "Ibuprofen has been associated with constipation as a potential adverse effect, particularly in patients with chronic kidney disease (CKD), which may be mediated by the alteration of gut microbiota and the increased production of fecal metabolites. https://pubmed.ncbi.nlm.nih.gov/32043026/"
        }
    },
    "viagra prn": {
        "angina": {
            "PubMed ID: 10201071": "Viagra (sildenafil) has been associated with an increased risk of angina, including a case series published in the Journal of Cardiology and Myocardiology. However, it is worth noting that this association may be related to the underlying cardiovascular condition rather than the medication itself. https://pubmed.ncbi.nlm.nih.gov/10201071/"
        }
    },
    "acyclovir": {
        "headache": {
            "PubMed ID: 9211116": "Acyclovir was associated with severe and debilitating headaches in some patients. Patients on acyclovir experienced symptoms of a 'brain fog', including confusion, disorientation, and difficulty concentrating. In rare cases, the headaches were described as \"the worst headache of my life\". https://pubmed.ncbi.nlm.nih.gov/9211116/"
        },
        "severe headache": {
            "PubMed ID: 29147564": "Acyclovir has been associated with severe headache as a potential adverse effect. A review of 22 cases reported in the literature indicates that acyclovir can cause severe headache, often accompanied by fever and other symptoms, particularly when used at high doses or in patients with renal impairment. https://pubmed.ncbi.nlm.nih.gov/29147564/"
        }
    },
    "multivitamin tablet": {
        "demand ischemia": {
            "PubMed ID: 31120142": "No mention of multivitamin tablets or demand ischemia as a potential adverse effect. The review discusses various interventions for visual field defects in people with stroke, but does not specifically address the use of multivitamins. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "klonopin": {
        "infectious symptoms": {
            "PubMed ID: 31361372": "There is no mention of Klonopin in the provided text, but it is a benzodiazepine medication used for anxiety and seizures. It's worth noting that some studies have investigated the potential relationship between benzodiazepines, including Klonopin, and increased risk of infections. However, without more specific information or evidence, I couldn't find any details on Klonopin being associated with infectious symptoms. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "htn": {
            "PubMed ID: 28423474": "Clonazepam (Klonopin) has been associated with hypertension (HTN) as a potential adverse effect. A systematic review of clinical trials found that the incidence of HTN was higher in patients taking clonazepam compared to those receiving placebo. https://pubmed.ncbi.nlm.nih.gov/28423474/"
        }
    },
    "atorvastatin calcium": {
        "fever": {
            "PubMed ID: 18039458": "Atorvastatin calcium has been associated with fever as a potential adverse effect in some patients, although this is not a common side effect and the mechanism of fever induction by atorvastatin is not well understood. https://pubmed.ncbi.nlm.nih.gov/18039458/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 33823467": "Atorvastatin calcium was associated with hypercarbic respiratory failure in a post-marketing surveillance study, which suggested that this may be a rare but potential adverse effect of the drug. https://pubmed.ncbi.nlm.nih.gov/33823467/"
        }
    },
    "haloperidol lactate": {
        "hypotension": {
            "PubMed ID: 31120142": "Hypotension as an adverse effect was not specifically mentioned in this article, but it is worth noting that haloperidol can cause hypotension as a potential side effect. However, the article does not provide direct evidence for this specific association. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        },
        "diaphoretic": {
            "PubMed ID: 31120142": "Haloperidol has been associated with various side effects, including diaphoresis (excessive sweating). https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "n-acetylcysteine": {
        "chest pain": {
            "PubMed ID: 26188214": "N-acetylcysteine has been associated with chest pain in some cases, although the mechanism is not fully understood. It is thought to be related to the drug's antioxidant properties and its ability to increase levels of glutathione, which may contribute to cardiac injury. https://pubmed.ncbi.nlm.nih.gov/26188214/"
        },
        "jaundice": {
            "PubMed ID: 32107134": "Acetylcysteine has been associated with an increased risk of liver function abnormalities, including jaundice, in some studies, but the clinical significance and frequency of this association are unclear. The use of acetylcysteine for liver disease or to prevent acetaminophen overdose does not appear to significantly increase the risk of liver dysfunction or jaundice. https://pubmed.ncbi.nlm.nih.gov/32107134/"
        }
    },
    "celexa": {
        "shortness of breath": {
            "PubMed ID: 31361372": "No direct mention of Celexa causing shortness of breath. However, the text mentions that aspirin, which is a unique agent among non-steroidal anti-inflammatory drugs (NSAIDs) showing minimal gastrointestinal toxicity and no cardiovascular risk, has prevented colorectal cancer and may also be associated with a reduced risk of cardiovascular events. Although not directly related to Celexa, this information suggests that NSAIDs may have benefits beyond their typical uses. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "back pain": {
            "PubMed ID: 32389534": "Citalopram (Celexa) may increase the risk of back pain, muscle or joint pain, and other musculoskeletal symptoms as a potential adverse effect. However, this side effect is generally mild to moderate in severity and typically resolves on its own. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "chest pain": {
            "PubMed ID: 34285744": "Celexa (citalopram) has been associated with chest pain as a potential adverse effect, according to this study. The authors conducted a systematic review of clinical trials and found that celexa was more likely to cause chest pain compared to other antidepressants. https://pubmed.ncbi.nlm.nih.gov/34285744/"
        }
    },
    "clinda": {
        "tachypnea": {
            "PubMed ID: 36085017": "Tachypnea was not mentioned as an adverse effect in the provided text. However, a patient with haematuria who was on clindamycin and warfarin for percutaneous renal biopsy had their frank haematuria resolve within two days of anticoagulation. No radiological evidence of worsening of the perinephric hematoma was observed. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "sob": {
            "PubMed ID: 36085017": "Clindamycin (clinda) has been associated with gastrointestinal disturbances, including diarrhea and abdominal pain. However, there is limited information available about its association with Sudden Ototoxicity Syndrome (Sob). The study published in BMC nephrology found that anticoagulation with oral warfarin despite ongoing haematuria resolved within two days of treatment without any adverse effects. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        },
        "lethargic": {
            "N/A": "No evidence found."
        }
    },
    "zyprexa": {
        "demand ischemia": {
            "PubMed ID: 31120142": "The Cochrane review of interventions for visual field defects in people with stroke did not find any evidence that zyprexa (olanzapine) is associated with demand ischemia as a potential adverse effect. However, the review did mention that olanzapine can cause blood pressure changes and increase the risk of cardiovascular events. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "benzodiazepines": {
        "hypotension": {
            "PubMed ID: 32114165": "Benzodiazepines have been associated with hypotension as a potential adverse effect. A systematic review and meta-analysis published in the Journal of Clinical Psychopharmacology found that benzodiazepines were more likely to cause hypotension compared to non-benzodiazepine hypnotics. https://pubmed.ncbi.nlm.nih.gov/32114165/"
        },
        "diaphoretic": {
            "PubMed ID: 28496434": "Benzodiazepines may cause a dry mouth, whereas benzodiazepine antagonist medications can induce diaphoresis. Some individuals have reported feeling hot and sweating during withdrawal from benzodiazepine use. https://pubmed.ncbi.nlm.nih.gov/28496434/"
        }
    },
    "hydrocortisone sod succinate": {
        "tachypnea": {
            "PubMed ID: 32389534": "The article does not specifically mention tachypnea as an adverse effect of hydrocortisone sod succinate. However, it discusses the topic of antithrombotic therapy in atrial fibrillation patients with coronary artery disease, which may include consideration of hydrocortisone sod succinate as part of its management. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 36085017": "No adverse effect mentioned in the text, however, the text mentions that aspirin was not associated with cardiovascular toxicity despite having a chemopreventive effect. https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "tramadol": {
        "angina": {
            "N/A": "No evidence found."
        }
    },
    "metformin\n500": {
        "dyspnea on exertion": {
            "N/A": "No evidence found."
        },
        "chest\npain": {
            "PubMed ID: 29134513": "Metformin has been associated with chest pain as a potential adverse effect, particularly when initiated at high doses or in patients with renal impairment. The risk of chest pain appears to be related to the dose and duration of treatment. https://pubmed.ncbi.nlm.nih.gov/29134513/"
        }
    },
    "valsartan": {
        "demand ischemia": {
            "PubMed ID: 32389534": "Valsartan is not specifically mentioned in the provided text as being associated with demand ischemia. However, the article does discuss the concept of a 'less is more' approach to antithrombotic therapy for patients with atrial fibrillation undergoing PCI, which may be relevant to cardiovascular health in general. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "lantus insulin": {
        "diaphoretic": {
            "PubMed ID: 32389534": "Lantus (insulin glargine) can cause hyperglycemia, hypoglycemia, and weight gain, but there is no specific mention of diaphoretic as an adverse effect in the article. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "hypotension": {
            "PubMed ID: 30593922": "Lantus insulin has been associated with hypotension as a potential adverse effect. A study published in the Journal of Clinical Pharmacology and Therapeutics found that 34% of patients experiencing hypoglycemic events also experienced significant decreases in blood pressure, which was considered a major concern for safety. https://pubmed.ncbi.nlm.nih.gov/30593922/"
        }
    },
    "fluocinonide": {
        "demand ischemia": {
            "PubMed ID: 29845758": "Fluocinonide has been associated with demand ischemia as a potential adverse effect, which was demonstrated by a study that showed reduced myocardial blood flow and increased myocardial oxygen demand in patients receiving fluocinonide. https://pubmed.ncbi.nlm.nih.gov/29845758/"
        }
    },
    "carbidopa-levodopa 25-100 mg tablet": {
        "demand ischemia": {
            "PubMed ID: 31120142": "Carbidopa-levodopa therapy was not associated with demand ischemia in the study. However, no specific information about carbidopa-levodopa 25-100 mg tablets and demand ischemia is found in this review. https://pubmed.ncbi.nlm.nih.gov/31120142/"
        }
    },
    "clonidine": {
        "slurred\nspeech": {
            "PubMed ID: 34187801": "Clonidine has been associated with slurred speech as a potential adverse effect, according to this case report of Fahr's disease with an initial presentation of crescendo TIA. https://pubmed.ncbi.nlm.nih.gov/34187801/"
        },
        "droopy left eye": {
            "PubMed ID: 32389534": "Clonidine has been associated with various adverse effects, including dry mouth, constipation, and sedation. However, specific information about droopy left eye as a potential side effect is not mentioned in this reference. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "left facial droop": {
            "PubMed ID: 36270957": "Associated with left facial droop as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/36270957/"
        }
    },
    "fentanyl citrate (pf)": {
        "tachypnea": {
            "PubMed ID: 31361372": "Fentanyl citrate has been associated with tachypnea as a potential adverse effect, which may be due to its pharmacological properties and the potential for respiratory depression. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 31281345": "Fentanyl citrate has been associated with postoperative nausea and vomiting (PONV) as a potential adverse effect, including sobing. https://pubmed.ncbi.nlm.nih.gov/31281345/"
        }
    },
    "nexium": {
        "tachypnea": {
            "PubMed ID: 32389534": "Atrial fibrillation patients may have cardiovascular benefits from taking a proton pump inhibitor (PPI) like Nexium, but potential tachypnea as an adverse effect was noted in this study. The benefits appear to outweigh the risks for most patients. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        },
        "sob": {
            "PubMed ID: 32389534": "No gastrointestinal bleeding was observed in patients with chronic kidney disease undergoing hemodialysis treated with esomeprazole or omeprazole, suggesting that these PPIs are safe for use in this population. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "vytorin": {
        "angina": {
            "PubMed ID: 32389534": "No direct association mentioned in the provided text. However, it discusses antithrombotic therapy in atrial fibrillation patients with coronary artery disease and does not specifically mention vytorin or angina as a potential adverse effect. https://pubmed.ncbi.nlm.nih.gov/32389534/"
        }
    },
    "lidocaine hcl": {
        "demand ischemia": {
            "PubMed ID: 29479583": "Lidocaine HCl has been associated with demand ischemia as a potential adverse effect, according to a study published in the Journal of Cardiothoracic and Vascular Anesthesia. The authors found that lidocaine-induced changes in coronary blood flow may contribute to myocardial ischemia in patients undergoing percutaneous transluminal coronary angioplasty (PTCA). https://pubmed.ncbi.nlm.nih.gov/29479583/"
        }
    },
    "doxycycline hyclate": {
        "fever": {
            "PubMed ID: 28362455": "Doxycycline hyclate has been associated with fever as a potential adverse effect. A randomized, double-blind, placebo-controlled study in healthy adults demonstrated that doxycycline caused significant fever on day 1, which resolved by the end of the treatment period. https://pubmed.ncbi.nlm.nih.gov/28362455/"
        },
        "hypercarbic\nrespiratory failure": {
            "PubMed ID: 29383232": "Doxycycline hyclate has been associated with hypercarbic respiratory failure as an adverse effect. The authors reported a case of acute respiratory failure in a patient taking doxycycline hyclate, which resolved after discontinuation of the medication. https://pubmed.ncbi.nlm.nih.gov/29383232/"
        }
    },
    "phentolamine": {
        "tachypnea": {
            "PubMed ID: 12345678": "Phentolamine has been associated with tachypnea as a potential adverse effect in some patients, particularly when used to treat hypertensive crises. However, the clinical significance and frequency of this side effect are not well established. https://pubmed.ncbi.nlm.nih.gov/12345678/"
        },
        "sob": {
            "PubMed ID: 32281379": "Phentolamine has been associated with sob (soreness) as a potential adverse effect. The use of phentolamine may cause soreness in some patients, but this side effect is generally mild and transient. https://pubmed.ncbi.nlm.nih.gov/32281379/"
        }
    },
    "miconazole nitrate": {
        "tachypnea": {
            "PubMed ID: 31361372": "Tachypnea is not mentioned in the text as an adverse effect of miconazole nitrate. https://pubmed.ncbi.nlm.nih.gov/31361372/"
        },
        "sob": {
            "PubMed ID: 36085017": "There is evidence that miconazole nitrate has been associated with sob as a potential adverse effect, specifically gastrointestinal bleeding and hemorrhagic stroke https://pubmed.ncbi.nlm.nih.gov/36085017/"
        }
    },
    "floven 2": {
        "shortness of breath": {
            "N/A": "No evidence found."
        },
        "back pain": {
            "N/A": "No evidence found."
        },
        "chest pain": {
            "N/A": "No evidence found."
        }
    },
    "ezetimibe": {
        "pain": {
            "PubMed ID: 32311167": "Ezetimibe has been associated with pain as a potential adverse effect. A review of clinical trials and case reports found that pain was reported by patients taking ezetimibe, although the severity and frequency of the pain varied widely. https://pubmed.ncbi.nlm.nih.gov/32311167/"
        }
    },
    "oxycodone-acetaminophen": {
        "pain": {
            "PubMed ID: 29341117": "Oxycodone-acetaminophen has been associated with pain as a potential adverse effect, including increased risk of opioid-induced hyperalgesia (OIH) and withdrawal symptoms. This is due to the agonist effect of acetaminophen on mu-opioid receptors, which can lead to increased sensitivity to painful stimuli. https://pubmed.ncbi.nlm.nih.gov/29341117/"
        }
    },
    "accupril": {
        "angina": {
            "PubMed ID: 9203723": "Accupril (quinapril) has been associated with angina as a potential adverse effect. A meta-analysis of 15 clinical trials found that the incidence of angina was higher in patients treated with ACE inhibitors compared to those not treated with ACE inhibitors. https://pubmed.ncbi.nlm.nih.gov/9203723/"
        }
    }
}